$RDFILE 1
$DATM 01/02/2025 15:47:00
$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(9-anthracenyl)-2-propen-1-one
C23H17NO
101467-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 7.7000 6.6685 0.0 0
M  V30 4 O 6.9300 8.0021 0.0 0
M  V30 5 N 13.8600 6.6685 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 5.3900 0.0000 0.0 0
M  V30 15 C 7.7000 1.3336 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 6.9300 0.0000 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 10.0100 5.3347 0.0 0
M  V30 22 C 10.0100 8.0021 0.0 0
M  V30 23 C 11.5500 5.3347 0.0 0
M  V30 24 C 11.5500 8.0021 0.0 0
M  V30 25 C 12.3200 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 20
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 2 11 13
M  V30 17 1 11 16
M  V30 18 2 12 17
M  V30 19 2 14 18
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(9-anthracenyl)-2-pyrimidinamine
C24H18N4
1266387-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 9.3358 0.0 0
M  V30 2 N 13.8600 6.6684 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 3.0800 1.3336 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 7.7000 1.3336 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 6.9300 0.0000 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 17 C 5.3900 5.3347 0.0 0
M  V30 18 C 6.9300 5.3347 0.0 0
M  V30 19 N 4.6200 6.6684 0.0 0
M  V30 20 C 7.7000 6.6684 0.0 0
M  V30 21 C 5.3900 8.0021 0.0 0
M  V30 22 N 6.9300 8.0021 0.0 0
M  V30 23 C 9.2400 6.6684 0.0 0
M  V30 24 C 10.0100 5.3347 0.0 0
M  V30 25 C 10.0100 8.0021 0.0 0
M  V30 26 C 11.5500 5.3347 0.0 0
M  V30 27 C 11.5500 8.0021 0.0 0
M  V30 28 C 12.3200 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 28
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 2 7 12
M  V30 13 2 8 10
M  V30 14 1 8 13
M  V30 15 2 9 14
M  V30 16 2 11 15
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101467-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-27-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20216229
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Dimethylamino)methylene]-5-(4-fluorophenyl)-1,3-cyclohexanedione
C15H16FNO2
1030419-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 5.3349 0.0 0
M  V30 2 O 3.8500 0.0000 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 N 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 F 13.0900 2.6674 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.1600 4.0011 0.0 0
M  V30 10 C 6.1600 1.3338 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 8.4700 2.6674 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 2 3 13
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 19
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-7-(4-fluorophenyl)-7,8-dihydro-5(6H)-quinazolinone
C14H12FN3O
351163-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 N 0.0000 4.6201 0.0 0
M  V30 3 F 12.0033 6.9302 0.0 0
M  V30 4 C 4.0012 3.8501 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 N 2.6673 4.6201 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 N 1.3337 2.3101 0.0 0
M  V30 14 C 8.0022 4.6201 0.0 0
M  V30 15 C 8.0022 6.1601 0.0 0
M  V30 16 C 9.3360 3.8501 0.0 0
M  V30 17 C 9.3360 6.9302 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 11
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1030419-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 351163-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13329142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Stage 2:
2-Amino-7-(4-chloro-phenyl)-7,8-dihydro-6H-quinazolin-5-one
5-(4-Chloro-phenyl)-2-dimethylaminomethylene-cyclohexane-1,3-dione (0.8
g, 2.89 mmol) from stage 1, guanidine hydrochloride (551 mg, 5.77 mmol)
and sodium carbonate (919 mg, 8.67 mmol) were stirred in ethanol (10 ml)
at reflux for 4h. The reaction mixture was cooled to ambient temperature
and water (10 ml) was added to the flask. The resulting precipitate was
recovered by filtration, washed with water (15 ml), heptane (15 ml) and
air dried. Yield: 744 mg (94%) Stage 2:
2-Amino-7-(4-fluoro-phenyl)-7,8-dihydro-6H-quinazolin-5-one The title
compound was prepared from
2-dimethylaminomethylene-5-(4-fluoro-phenyl)-cyclohexane-1,3-dione (600
mg, 2.29 mmol) prepared in stage 1, guanidine hydrochloride (438 mg, 4.59
mmol) and sodium carbonate (728 mg, 6.87 mmol), following the procedure
described for 2-amino-7-(4-chloro-phenyl)-7,8-dihydro-6H-quinazolin-5-one
(example 2/a stage 2). Yield: 588 mg (100%) Mass spectrum (ES-MS (+ve))
258 [MH]+, Retention time 1.64min, 100% UV. 1H NMR (400 MHz,
CHLOROFORM-d) δ ppm 8.92 (1 H, s), 7.21 - 7.26 (2 H, m), 7.02 - 7.11 (2
H, m), 5.56 (2 H, br. s), 3.42 - 3.51 (1 H, m), 3.05 -3.12 (2 H, m), 2.71
-2.94 (2 H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-amino-7,8-dihydro-6H-quinazolin-5-one oximes having
HSP90 inhibitory activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Courtney, Stephen Martin; Whittaker, Mark; Mather, Owen Clifford;
Yarnold, Christopher John; Barker, Oliver Robin; Montalbetti, Christian
Aldo Georges Napoleon; Hesterkamp, Thomas; Gardiner, Mihaly Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008142720 A2 2008-11-27

$RFMT $RIREG SCHEME3 STEP1
$RXN



  4  1
$MOL
Pimelic acid
C7H12O4
111-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 O 9.3360 0.0000 0.0 0
M  V30 11 O 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′-Aminoacetophenone
C8H9NO
99-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 N 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-carboxaldehyde
C8H6O3
120-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-[3-[2-Amino-6-(1,3-benzodioxol-5-yl)-4-pyrimidinyl]phenyl]heptanediamide
C24H25N5O4
349489-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7046 0.0000 0.0 0
M  V30 2 N 14.3731 3.8501 0.0 0
M  V30 3 C 15.7070 4.6201 0.0 0
M  V30 4 C 17.0406 3.8501 0.0 0
M  V30 5 O 15.7070 6.1601 0.0 0
M  V30 6 C 18.3743 4.6201 0.0 0
M  V30 7 C 19.7080 3.8501 0.0 0
M  V30 8 C 21.0418 4.6201 0.0 0
M  V30 9 C 22.3755 3.8501 0.0 0
M  V30 10 C 23.7091 4.6201 0.0 0
M  V30 11 N 25.0428 3.8501 0.0 0
M  V30 12 O 23.7091 6.1601 0.0 0
M  V30 13 C 5.0373 4.6201 0.0 0
M  V30 14 C 3.7035 3.8501 0.0 0
M  V30 15 C 5.0373 6.1601 0.0 0
M  V30 16 C 2.3698 4.6201 0.0 0
M  V30 17 C 3.7035 6.9302 0.0 0
M  V30 18 C 2.3698 6.1601 0.0 0
M  V30 19 O 0.9051 4.1442 0.0 0
M  V30 20 O 0.9052 6.6360 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 22 C 6.3710 3.8501 0.0 0
M  V30 23 C 7.7046 4.6201 0.0 0
M  V30 24 N 6.3710 2.3101 0.0 0
M  V30 25 C 9.0383 3.8501 0.0 0
M  V30 26 C 7.7046 1.5400 0.0 0
M  V30 27 N 9.0383 2.3101 0.0 0
M  V30 28 C 10.3721 4.6201 0.0 0
M  V30 29 C 11.7058 3.8501 0.0 0
M  V30 30 C 10.3721 6.1601 0.0 0
M  V30 31 C 13.0395 4.6201 0.0 0
M  V30 32 C 11.7058 6.9302 0.0 0
M  V30 33 C 13.0395 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 26
M  V30 2 1 2 3
M  V30 3 1 2 31
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 22
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 111-16-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-03-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 120-57-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 349489-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6406955
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, first stage attachment to
TentaGel Rink Amide resin
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Symmetric building blocks and combinatorial functional group
transformation as versatile strategies in combinatorial chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fruchtel, Jorg Steffen; Pflugseder, Karin; Gstach, Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biotechnology and Bioengineering (2001), 71(2), 94-103

$RFMT $RIREG SCHEME4 STEP1
$RXN



  4  1
$MOL
Pimelic acid
C7H12O4
111-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 O 9.3360 0.0000 0.0 0
M  V30 11 O 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′-Aminoacetophenone
C8H9NO
99-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 N 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dimethoxybenzaldehyde
C9H10O3
86-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 0.0000 3.0801 0.0 0
M  V30 5 O 6.6687 2.3101 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-[3-[2-Amino-6-(2,3-dimethoxyphenyl)-4-pyrimidinyl]phenyl]heptanediamide
C25H29N5O4
349489-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 O 1.3337 3.8501 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 N 8.0022 0.0000 0.0 0
M  V30 6 N 14.6707 3.8501 0.0 0
M  V30 7 C 16.0045 4.6201 0.0 0
M  V30 8 C 17.3382 3.8501 0.0 0
M  V30 9 O 16.0045 6.1601 0.0 0
M  V30 10 C 18.6718 4.6201 0.0 0
M  V30 11 C 20.0055 3.8501 0.0 0
M  V30 12 C 21.3393 4.6201 0.0 0
M  V30 13 C 22.6730 3.8501 0.0 0
M  V30 14 C 24.0067 4.6201 0.0 0
M  V30 15 N 25.3403 3.8501 0.0 0
M  V30 16 O 24.0067 6.1601 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 4.0010 3.8501 0.0 0
M  V30 19 C 5.3348 6.1601 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 6.9302 0.0 0
M  V30 22 C 2.6673 6.1601 0.0 0
M  V30 23 C 6.6685 3.8501 0.0 0
M  V30 24 C 8.0022 4.6201 0.0 0
M  V30 25 N 6.6685 2.3101 0.0 0
M  V30 26 C 9.3358 3.8501 0.0 0
M  V30 27 C 8.0022 1.5400 0.0 0
M  V30 28 N 9.3358 2.3101 0.0 0
M  V30 29 C 10.6697 4.6201 0.0 0
M  V30 30 C 12.0033 3.8501 0.0 0
M  V30 31 C 10.6697 6.1601 0.0 0
M  V30 32 C 13.3370 4.6201 0.0 0
M  V30 33 C 12.0033 6.9302 0.0 0
M  V30 34 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 27
M  V30 6 1 6 7
M  V30 7 1 6 32
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 2 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 111-16-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-03-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 86-51-1
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 349489-53-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15528085
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, first stage attachment to
TentaGel Rink Amide resin
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Symmetric building blocks and combinatorial functional group
transformation as versatile strategies in combinatorial chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fruchtel, Jorg Steffen; Pflugseder, Karin; Gstach, Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biotechnology and Bioengineering (2001), 71(2), 94-103

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(3-bromophenyl)-2-propen-1-one
C15H12BrNO
118004-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 Br 13.3370 1.5400 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 10.6697 1.5400 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 10.6697 4.6201 0.0 0
M  V30 12 C 12.0033 3.8501 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 4.0010 3.8501 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 13
M  V30 6 1 5 10
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(3-bromophenyl)-2-pyrimidinamine
C16H13BrN4
1266387-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 N 0.0000 6.9302 0.0 0
M  V30 3 Br 13.3370 3.8501 0.0 0
M  V30 4 C 5.3348 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 5.3348 2.3101 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 N 8.0022 2.3101 0.0 0
M  V30 10 C 4.0010 4.6201 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 4.0010 6.1601 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 2.6673 6.9302 0.0 0
M  V30 15 C 1.3337 6.1601 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 10.6697 6.9302 0.0 0
M  V30 21 C 12.0033 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 15
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118004-12-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20216224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME6 STEP1
$RXN



  3  1
$MOL
tert-Butoxybis(dimethylamino)methane
C9H22N2O
5815-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 O 2.6675 1.5400 0.0 0
M  V30 3 N 4.0012 3.8501 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 C 1.3338 2.3101 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 6.6687 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 0.5638 0.9764 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 2.1038 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Bromo-2′,3′,5′,6′-tetrahydrospiro[1H-indene-1,4′-[4H]pyran]-3-yl)ethanone
C15H15BrO2
1202768-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1752 1.0304 0.0 0
M  V30 2 C 5.6398 0.5546 0.0 0
M  V30 3 O 3.0307 0.0000 0.0 0
M  V30 4 Br 8.7354 5.0148 0.0 0
M  V30 5 C 2.6091 4.6947 0.0 0
M  V30 6 C 4.1155 5.0148 0.0 0
M  V30 7 C 2.4481 3.1631 0.0 0
M  V30 8 C 2.9292 6.2011 0.0 0
M  V30 9 C 1.1445 4.2188 0.0 0
M  V30 10 C 4.8855 3.6812 0.0 0
M  V30 11 C 4.8855 6.3486 0.0 0
M  V30 12 C 3.8549 2.5368 0.0 0
M  V30 13 C 1.7848 7.2315 0.0 0
M  V30 14 C 0.0000 5.2492 0.0 0
M  V30 15 C 6.4255 3.6812 0.0 0
M  V30 16 C 6.4255 6.3486 0.0 0
M  V30 17 O 0.3202 6.7556 0.0 0
M  V30 18 C 7.1954 5.0148 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(5-Bromo-2′,3′,5′,6′-tetrahydrospiro[1H-indene-1,4′-[4H]pyran]-3-yl)-2-pyri...
C17H16BrN3O
1202768-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 6.9245 0.0 0
M  V30 2 N 9.9050 8.1679 0.0 0
M  V30 3 C 4.7669 3.0631 0.0 0
M  V30 4 C 3.4333 3.8331 0.0 0
M  V30 5 C 5.9114 4.0936 0.0 0
M  V30 6 C 6.1739 2.4367 0.0 0
M  V30 7 C 3.5211 2.1580 0.0 0
M  V30 8 C 3.7534 5.3395 0.0 0
M  V30 9 C 1.9686 3.3572 0.0 0
M  V30 10 C 5.2850 5.5004 0.0 0
M  V30 11 C 6.3348 0.9052 0.0 0
M  V30 12 C 3.6820 0.6263 0.0 0
M  V30 13 C 2.6091 6.3699 0.0 0
M  V30 14 C 0.8242 4.3878 0.0 0
M  V30 15 O 5.0889 0.0000 0.0 0
M  V30 16 C 1.1444 5.8940 0.0 0
M  V30 17 C 6.0550 6.8341 0.0 0
M  V30 18 N 7.5950 6.8341 0.0 0
M  V30 19 C 5.2850 8.1679 0.0 0
M  V30 20 C 8.3650 8.1679 0.0 0
M  V30 21 C 6.0550 9.5015 0.0 0
M  V30 22 N 7.5950 9.5015 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 17
M  V30 16 1 11 15
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5815-08-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1202768-80-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202768-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6922349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-23-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(5-Bromo-2',3',5',6'-tetrahydrospiro[indene-1,4'-pyran-3-yl)-2-pyrimidinamine
A.309
1-(5-Bromo-2',3',5',6'-tetrahydrospiro[indene-1,4'-pyran]-3-yl)ethanone
A.308 (85 mg, 0.28 mmol) was treated neat with t-BuOCH(NMe2)2 (2.3 eq.,
0.11 g) at 105°C under N2 for 3 h. The mixture was cooled before n-PrOH
(8 mL), guanidine hydrochloride (5.0eq., 0.13 g), and MeONa (5.53 M in
methanol) (3.0 eq., 0.15 mL) were added sequentially. The resulting
mixture was stirred at 95°C for 3 h. Upon workup, the mixture was cooled
and poured into ice and saturated NaHCO3 aqueous solution and extracted
with ethyl acetate (1×). The organic layer was washed with brine (2×),
dried over anhydrous Na2SO4, and concentrated in vacuo to give
4-(5-bromo-2',3',5',6'-tetrahydrospiro[indene-1,4'-pyran]-3-yl)-2-pyrimidinamine
A.309 (0.1 g, quant. yield) as a light yellow solid. 1H NMR (500 MHz,
DMSO-d6) δ ppm 8.38 (1 H, d, J= 5.1 Hz), 8.27 (1 H, d, J= 2.0 Hz), 7.53
(1 H, s), 7.45 (1 H, dd, J= 7.8, 2.0 Hz), 7.23-7.33 (2 H, m), 6.99 (0 H,
d, J= 5.1 Hz), 5.17 (2 H, br. s.), 4.07-4.17 (2 H, m), 3.83 (2 H, td, J=
11.9, 1.8 Hz), 2.24 (2 H, ddd, J= 13.4, 12.4, 4.5 Hz), 1.39 (2 H, dd, J=
13.6, 1.3 Hz). LCMS-ESI (POS), M/Z, M+1: Found 358.0 and 360.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkynyl alcohols as kinase inhibitors and their preparation,
pharmaceutical compositions and use in the treatment of inflammation and
inflammatory disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Guoqing; Cushing, Timothy D.; Fisher, Benjamin; He, Xiao; Li,
Kexue; Li, Zhihong; McGee, Lawrence R.; Pattaropong, Vatee; Faulder,
Paul; Seganish, Jennifer L.; Shin, Youngsook
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009158011 A1 2009-12-30

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[(3-Methyl-1-oxo-2-buten-1-yl)amino]propyl]-N-[5-[[(4-methylphenyl)sulfo...
C32H54N2O5S
1258967-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 16.0041 0.0 0 VAL=6
M  V30 2 O 6.1049 14.6705 0.0 0
M  V30 3 O 4.5649 17.3379 0.0 0
M  V30 4 O 6.6685 16.7741 0.0 0
M  V30 5 C 7.6449 14.6705 0.0 0
M  V30 6 C 8.4149 13.3369 0.0 0
M  V30 7 C 9.9549 13.3369 0.0 0
M  V30 8 C 10.7249 12.0032 0.0 0
M  V30 9 C 12.2649 12.0032 0.0 0
M  V30 10 N 13.0349 10.6694 0.0 0
M  V30 11 C 14.5749 10.6694 0.0 0
M  V30 12 C 12.2649 9.3358 0.0 0
M  V30 13 C 15.3449 12.0032 0.0 0
M  V30 14 O 15.3449 9.3358 0.0 0
M  V30 15 C 13.0349 8.0021 0.0 0
M  V30 16 C 16.8849 12.0032 0.0 0
M  V30 17 C 12.2649 6.6684 0.0 0
M  V30 18 C 17.6549 13.3369 0.0 0
M  V30 19 N 13.0349 5.3347 0.0 0
M  V30 20 C 19.1947 13.3369 0.0 0
M  V30 21 C 12.2649 4.0011 0.0 0
M  V30 22 C 19.9647 14.6705 0.0 0
M  V30 23 C 13.0349 2.6674 0.0 0
M  V30 24 O 10.7249 4.0011 0.0 0
M  V30 25 C 21.5049 14.6705 0.0 0
M  V30 26 C 12.2649 1.3336 0.0 0
M  V30 27 C 22.2747 16.0041 0.0 0
M  V30 28 C 13.0349 0.0000 0.0 0
M  V30 29 C 10.7249 1.3336 0.0 0
M  V30 30 C 23.8147 16.0041 0.0 0
M  V30 31 C 24.5847 17.3379 0.0 0
M  V30 32 C 26.1247 17.3379 0.0 0
M  V30 33 C 26.8949 18.6716 0.0 0
M  V30 34 C 0.0000 12.9241 0.0 0
M  V30 35 C 4.0011 15.2341 0.0 0
M  V30 36 C 2.6674 16.0041 0.0 0
M  V30 37 C 4.0011 13.6941 0.0 0
M  V30 38 C 1.3338 15.2341 0.0 0
M  V30 39 C 2.6674 12.9241 0.0 0
M  V30 40 C 1.3338 13.6941 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 35
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 23 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 1 27 30
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 34 40
M  V30 35 2 35 36
M  V30 36 1 35 37
M  V30 37 1 36 38
M  V30 38 2 37 39
M  V30 39 2 38 40
M  V30 40 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(Aminoiminomethyl)amino]pentyl]-N-[3-[(3-methyl-1-oxo-2-buten-1-yl)amin...
C26H51N5O2
67534-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2401 10.6695 0.0 0
M  V30 2 C 10.0101 12.0034 0.0 0
M  V30 3 C 7.7001 10.6695 0.0 0
M  V30 4 C 10.0101 9.3359 0.0 0
M  V30 5 C 11.5501 12.0034 0.0 0
M  V30 6 O 9.2401 13.3370 0.0 0
M  V30 7 C 6.9301 12.0034 0.0 0
M  V30 8 C 9.2401 8.0022 0.0 0
M  V30 9 C 12.3201 13.3370 0.0 0
M  V30 10 C 5.3901 12.0034 0.0 0
M  V30 11 C 10.0101 6.6684 0.0 0
M  V30 12 C 13.8602 13.3370 0.0 0
M  V30 13 N 4.6201 13.3370 0.0 0
M  V30 14 C 9.2401 5.3348 0.0 0
M  V30 15 C 14.6302 14.6707 0.0 0
M  V30 16 C 3.0800 13.3370 0.0 0
M  V30 17 C 10.0101 4.0011 0.0 0
M  V30 18 C 16.1702 14.6707 0.0 0
M  V30 19 C 2.3100 14.6707 0.0 0
M  V30 20 O 2.3100 12.0034 0.0 0
M  V30 21 N 9.2401 2.6675 0.0 0
M  V30 22 C 16.9402 16.0043 0.0 0
M  V30 23 C 0.7700 14.6707 0.0 0
M  V30 24 C 10.0101 1.3337 0.0 0
M  V30 25 C 18.4802 16.0043 0.0 0
M  V30 26 C 0.0000 16.0043 0.0 0
M  V30 27 C 0.0000 13.3370 0.0 0
M  V30 28 N 11.5501 1.3337 0.0 0
M  V30 29 N 9.2401 0.0000 0.0 0
M  V30 30 C 19.2502 17.3381 0.0 0
M  V30 31 C 20.7902 17.3381 0.0 0
M  V30 32 C 21.5602 18.6718 0.0 0
M  V30 33 C 23.1003 18.6718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 2 19 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 23 26
M  V30 26 1 23 27
M  V30 27 2 24 28
M  V30 28 1 24 29
M  V30 29 1 25 30
M  V30 30 1 30 31
M  V30 31 1 31 32
M  V30 32 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1258967-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67534-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10020644
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):NOTES
$DATUM 25% overall yield in 6 steps starting from 5-aminopentanol
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-[5-(guanidinopentyl)-N-[3-[(3-methyl-1-oxo-2 butenyl)
amino] propyldodecanamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Walwil, Abdalla M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research Journal of Chemistry and Environment (2008), 12(4), 70-75

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-(cyclohexyloxy)-3-oxobutanoate
C12H20O4
126930-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 O 10.6697 2.3101 0.0 0
M  V30 8 O 9.3360 4.6201 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-[(cyclohexyloxy)methyl]-4(3H)-pyrimidinone
C11H17N3O2
1161825-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 O 4.0012 3.8501 0.0 0
M  V30 3 O 8.0023 0.0000 0.0 0
M  V30 4 N 10.6697 4.6201 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 N 8.0023 4.6201 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 N 9.3360 2.3101 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 2.6673 6.1601 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 1.3337 6.9302 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 2 3 8
M  V30 5 1 4 9
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126930-22-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1161825-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5956737
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: REFERENCE EXAMPLE 18.
2-Amino-6-(cyclohexyloxymethyl)pyrimid in-4-ol. Guanidine hydrochloride
(2.23 g, 23.4 mmol) and sodium methoxide (1.26 g, 23.4 mmol) were added
to a solution of the compound obtained in reference example 3 (2.78 g,
12.2 mmol) in absolute ethanol (195 mL) and the mixture was heated under
reflux overnight. The solvent was evaporated to dryness and the residue
was purified by chromatography over silica gel using mixtures of
hexane/EtOAc of increasing polarity as eluent, Providing the title
compound quantitative yield. LC-MS (Method 2): tR = 1.38 min; m/z 224
(MH+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-aminopyrimidine derivatives as histamine receptor H4
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carceller Gonzalez, Elena; Virgili Bernado, Marina; Marti Via, Josep;
Medina Fuentes, Eva Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009077608 A1 2009-06-25

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
C18H19NO4
179119-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 0.7700 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9302 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0
M  V30 9 C 9.3358 5.3901 0.0 0
M  V30 10 O 9.3358 6.9302 0.0 0
M  V30 11 N 14.6707 2.3101 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 4.0010 5.3901 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 12.0033 5.3901 0.0 0
M  V30 21 C 12.0033 2.3101 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 18
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(3,4,5-trimethoxyphenyl)-2-pyrimidinamine
C19H20N4O3
1266387-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 3.8501 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 4.0010 8.4702 0.0 0
M  V30 4 C 5.3348 9.2402 0.0 0
M  V30 5 N 8.0022 0.0000 0.0 0
M  V30 6 O 1.3337 6.9302 0.0 0
M  V30 7 C 0.0000 6.1601 0.0 0
M  V30 8 N 14.6707 6.9302 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 4.0010 6.9302 0.0 0
M  V30 14 C 2.6673 6.1601 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 N 6.6685 2.3101 0.0 0
M  V30 18 C 9.3358 3.8501 0.0 0
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 N 9.3358 2.3101 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 10.6697 6.1601 0.0 0
M  V30 23 C 12.0033 3.8501 0.0 0
M  V30 24 C 12.0033 6.9302 0.0 0
M  V30 25 C 13.3370 4.6201 0.0 0
M  V30 26 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 8 26
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 179119-35-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-23-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20216227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3aR,6aS)-hexahydro-5-hydroxy-1H-cyclopenta[c]furan-5-carboxylate
C9H14O4
1803553-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9699 2.5369 0.0 0
M  V30 2 O 7.3036 1.7669 0.0 0
M  V30 3 O 5.9699 4.0769 0.0 0
M  V30 4 C 8.6374 2.5369 0.0 0
M  V30 5 O 5.5415 0.5208 0.0 0
M  V30 6 C 4.6363 1.7669 0.0 0 CFG=1
M  V30 7 C 3.4917 0.7363 0.0 0
M  V30 8 C 4.0098 3.1737 0.0 0
M  V30 9 C 2.1580 1.5063 0.0 0 CFG=1
M  V30 10 C 2.4782 3.0128 0.0 0 CFG=2
M  V30 11 C 0.6265 1.3454 0.0 0
M  V30 12 C 1.1445 3.7828 0.0 0
M  V30 13 O 0.0000 2.7522 0.0 0
M  V30 14 H 1.8379 0.0000 0.0 0
M  V30 15 H 2.7984 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 6 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14 CFG=3
M  V30 13 1 10 12
M  V30 14 1 10 15 CFG=3
M  V30 15 1 11 13
M  V30 16 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2′-Amino-3a,4,6,6a-tetrahydrospiro[1H-cyclopenta[c]furan-5(3H),5′(4′H)-oxazol...
C9H12N2O3
1803553-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.4926 0.0000 0.0 0
M  V30 2 N 8.5213 3.6274 0.0 0
M  V30 3 C 4.6363 2.7406 0.0 0
M  V30 4 C 3.4917 1.7100 0.0 0
M  V30 5 C 4.0098 4.1475 0.0 0
M  V30 6 O 5.7807 3.7711 0.0 0
M  V30 7 C 5.2626 1.3337 0.0 0
M  V30 8 C 2.1580 2.4801 0.0 0
M  V30 9 C 2.4782 3.9865 0.0 0
M  V30 10 C 7.1143 3.0011 0.0 0
M  V30 11 N 6.7941 1.4948 0.0 0
M  V30 12 C 0.6265 2.3191 0.0 0
M  V30 13 C 1.1445 4.7565 0.0 0
M  V30 14 O 0.0000 3.7261 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 11
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1803553-43-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1803553-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2684039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-(spiro-piperidin-1-yl)oxazolones as modulators of
vasopressin V1a receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolente, Cosimo; Fasching, Bernhard; Runtz-Schmitt, Valerie; Schnider,
Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015124541 A1 2015-08-27

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1,1-Dimethylethyl)amino]-2-nitro-2-propenal
C7H12N2O3
181294-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 N 5.3348 2.3101 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 6.6687 3.0801 0.0 0
M  V30 10 C 7.4387 1.7464 0.0 0
M  V30 11 C 8.0023 3.8501 0.0 0
M  V30 12 C 5.8986 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-nitropyrimidine
C4H4N4O2
3073-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 N 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 181294-58-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3073-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30357299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3-Ethyl-2-imino-5-nitropyrimidine (12b). To a
solution of nitroenamine 4b (172 mg, 1.0 mmol) in ethanol (30 mL) were
added N-ethylguanidine hydrochloride 11b (247 mg, 2.0 mmol) and
triethylamine (0.28 mL, 2.0 mmol), and the mixture was heated at 80 °C
for 1 day. After removal of ethanol, the residue was extracted with
chloroform (3 x 30 mL). The organic layer was dried over magnesium
sulfate and concentrated to give almost pure pyrimidine 12b (336 mg, 2.0
mmol, quant.). Further purification was performed by recrystallization
from benzene giving 12b as colorless plates. Compound 12a, yield
quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Synthetic Equivalent of Nitromalonaldehyde Treatable in Organic Media
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishiwaki, Nagatoshi; Ogihara, Takuma; Takami, Toshiko; Tamura, Mina;
Ariga, Masahiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2004), 69(24), 8382-8386

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-[4-(dimethylamino)phenyl]-2-propen-1-one
C17H18N2O
25870-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 N 13.3370 4.6201 0.0 0
M  V30 7 C 13.3370 6.1601 0.0 0
M  V30 8 C 14.6707 3.8501 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 4.0010 3.8501 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 10.6697 1.5400 0.0 0
M  V30 17 C 9.3358 3.8501 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 15
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-[4-(dimethylamino)phenyl]-2-pyrimidinamine
C18H19N5
1266387-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 N 13.3370 6.9302 0.0 0
M  V30 3 C 14.6707 6.1601 0.0 0
M  V30 4 C 13.3370 8.4702 0.0 0
M  V30 5 N 0.0000 6.9302 0.0 0
M  V30 6 C 8.0022 3.8501 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 N 8.0022 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 C 9.3358 6.1601 0.0 0
M  V30 14 C 10.6697 3.8501 0.0 0
M  V30 15 C 10.6697 6.9302 0.0 0
M  V30 16 C 12.0033 4.6201 0.0 0
M  V30 17 C 12.0033 6.1601 0.0 0
M  V30 18 C 4.0010 4.6201 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 4.0010 6.1601 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 2.6673 6.9302 0.0 0
M  V30 23 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 17
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25870-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20216228
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(4-methoxyphenyl)-2-propen-1-one
C16H15NO2
25870-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 3.8501 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 9.3358 2.3101 0.0 0
M  V30 15 C 10.6697 1.5400 0.0 0
M  V30 16 C 9.3358 3.8501 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(4-methoxyphenyl)-2-pyrimidinamine
C17H16N4O
1266387-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 O 13.3370 6.9302 0.0 0
M  V30 3 C 14.6707 6.1601 0.0 0
M  V30 4 N 0.0000 6.9302 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 8.0022 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 9.3358 4.6201 0.0 0
M  V30 12 C 9.3358 6.1601 0.0 0
M  V30 13 C 10.6697 3.8501 0.0 0
M  V30 14 C 10.6697 6.9302 0.0 0
M  V30 15 C 12.0033 4.6201 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 4.0010 6.1601 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25870-73-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20216225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(4-methylphenyl)-2-propen-1-one
C16H15NO
25870-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 C 13.3370 4.6201 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 9.3360 2.3101 0.0 0
M  V30 14 C 10.6697 1.5400 0.0 0
M  V30 15 C 9.3360 3.8501 0.0 0
M  V30 16 C 12.0033 2.3101 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 13
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(4-methylphenyl)-2-pyrimidinamine
C17H16N4
911237-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 C 13.3370 6.9302 0.0 0
M  V30 3 N 0.0000 6.9302 0.0 0
M  V30 4 C 8.0022 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0022 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 N 5.3348 2.3101 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 3.8501 0.0 0
M  V30 12 C 9.3360 6.1601 0.0 0
M  V30 13 C 12.0033 4.6201 0.0 0
M  V30 14 C 10.6697 6.9302 0.0 0
M  V30 15 C 12.0033 6.1601 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 4.0010 6.1601 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 15
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25870-74-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 911237-90-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-30176943
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(4-chlorophenyl)-2-propen-1-one
C15H12ClNO
25870-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 Cl 13.3370 4.6201 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 9.3360 2.3101 0.0 0
M  V30 14 C 10.6697 1.5400 0.0 0
M  V30 15 C 9.3360 3.8501 0.0 0
M  V30 16 C 12.0033 2.3101 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 13
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(4-chlorophenyl)-2-pyrimidinamine
C16H13ClN4
1266387-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 Cl 13.3370 6.9302 0.0 0
M  V30 3 N 0.0000 6.9302 0.0 0
M  V30 4 C 8.0022 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0022 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 N 5.3348 2.3101 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 3.8501 0.0 0
M  V30 12 C 9.3360 6.1601 0.0 0
M  V30 13 C 12.0033 4.6201 0.0 0
M  V30 14 C 10.6697 6.9302 0.0 0
M  V30 15 C 12.0033 6.1601 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 4.0010 6.1601 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 15
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25870-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-17-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20216221
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Benzofuranyl)-3-[4-(dimethylamino)phenyl]-2-propen-1-one
C19H17NO2
30608-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 C 7.4148 2.3101 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 8.7485 1.5400 0.0 0
M  V30 5 N 14.0833 4.6201 0.0 0
M  V30 6 C 14.0833 6.1601 0.0 0
M  V30 7 C 15.4170 3.8501 0.0 0
M  V30 8 C 2.3101 2.8281 0.0 0
M  V30 9 C 3.0801 4.1618 0.0 0
M  V30 10 C 3.3405 1.6837 0.0 0
M  V30 11 C 0.7700 2.8281 0.0 0
M  V30 12 O 4.5864 3.8416 0.0 0
M  V30 13 C 2.3101 5.4956 0.0 0
M  V30 14 C 4.7473 2.3101 0.0 0
M  V30 15 C 0.0000 4.1618 0.0 0
M  V30 16 C 0.7700 5.4956 0.0 0
M  V30 17 C 10.0821 2.3101 0.0 0
M  V30 18 C 10.0821 3.8501 0.0 0
M  V30 19 C 11.4160 1.5400 0.0 0
M  V30 20 C 11.4160 4.6201 0.0 0
M  V30 21 C 12.7496 2.3101 0.0 0
M  V30 22 C 12.7496 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 22
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Benzofuranyl)-6-[4-(dimethylamino)phenyl]-2-pyrimidinamine
C20H18N4O
864668-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.4148 0.0000 0.0 0
M  V30 2 N 14.0833 6.9302 0.0 0
M  V30 3 C 14.0833 8.4702 0.0 0
M  V30 4 C 15.4170 6.1601 0.0 0
M  V30 5 C 4.7473 4.6201 0.0 0
M  V30 6 C 3.3405 3.9938 0.0 0
M  V30 7 O 4.5864 6.1517 0.0 0
M  V30 8 C 2.3101 5.1382 0.0 0
M  V30 9 C 3.0801 6.4718 0.0 0
M  V30 10 C 0.7700 5.1382 0.0 0
M  V30 11 C 2.3101 7.8057 0.0 0
M  V30 12 C 0.0000 6.4718 0.0 0
M  V30 13 C 0.7700 7.8057 0.0 0
M  V30 14 C 6.0811 3.8501 0.0 0
M  V30 15 C 7.4148 4.6201 0.0 0
M  V30 16 N 6.0811 2.3101 0.0 0
M  V30 17 C 8.7485 3.8501 0.0 0
M  V30 18 C 7.4148 1.5400 0.0 0
M  V30 19 N 8.7485 2.3101 0.0 0
M  V30 20 C 10.0821 4.6201 0.0 0
M  V30 21 C 10.0821 6.1601 0.0 0
M  V30 22 C 11.4160 3.8501 0.0 0
M  V30 23 C 11.4160 6.9302 0.0 0
M  V30 24 C 12.7496 4.6201 0.0 0
M  V30 25 C 12.7496 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 25
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30608-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864668-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9753693
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antitumor and antibacterial activities of certain substituted
pyrimidines bearing benzofuran
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babu, V. Harinadha; Kumar, P. Senthil; Srinivasan, K. K.; Bhat, G.
Varadaraja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Pharmaceutical Sciences (2004), 66(5), 647-652

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(2,4-dichlorophenyl)-2-propen-1-one
C15H11Cl2NO
360567-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 8.0022 0.0000 0.0 0
M  V30 5 Cl 2.6673 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 N 13.3370 4.6201 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 9.3360 3.8501 0.0 0
M  V30 16 C 10.6697 1.5400 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 14
M  V30 6 1 5 9
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(2,4-dichlorophenyl)-2-pyrimidinamine
C16H12Cl2N4
1266387-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6673 2.3101 0.0 0
M  V30 2 N 6.6685 0.0000 0.0 0
M  V30 3 Cl 0.0000 6.9302 0.0 0
M  V30 4 N 13.3370 6.9302 0.0 0
M  V30 5 C 4.0010 4.6201 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 4.0010 6.1601 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 2.6673 6.9302 0.0 0
M  V30 10 C 1.3337 6.1601 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 N 5.3348 2.3101 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 N 8.0022 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 10.6697 6.9302 0.0 0
M  V30 21 C 12.0033 4.6201 0.0 0
M  V30 22 C 12.0033 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 15
M  V30 3 1 3 10
M  V30 4 1 4 22
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 360567-41-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-18-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20216223
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl tetrahydro-3-oxo-2H-pyran-4-carboxylate
C8H12O4
388109-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6685 3.0800 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 8
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5,8-dihydro-3H-pyrano[3,4-d]pyrimidin-4(6H)-one
C7H9N3O2
1780804-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 O 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 388109-26-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1780804-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18513422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dihydropyranopyrimidines for the treatment of viral
infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jonckers, Tim Hugo Maria; Raboisson, Pierre Jean-Marie Bernard;
Guillemont, Jerome Emile Georges; Mc Gowan, David Craig; Embrechts,
Werner Constant Johan; Cooymans, Ludwig Paul; Calmus, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018002319 A1 2018-01-04

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(4-fluorophenyl)-2-propen-1-one
C15H12FNO
404902-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 F 13.3370 4.6201 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 9.3360 2.3101 0.0 0
M  V30 14 C 10.6697 1.5400 0.0 0
M  V30 15 C 9.3360 3.8501 0.0 0
M  V30 16 C 12.0033 2.3101 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 13
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(4-fluorophenyl)-2-pyrimidinamine
C16H13FN4
1266387-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 F 13.3370 6.9302 0.0 0
M  V30 3 N 0.0000 6.9302 0.0 0
M  V30 4 C 8.0022 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0022 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 N 5.3348 2.3101 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 3.8501 0.0 0
M  V30 12 C 9.3360 6.1601 0.0 0
M  V30 13 C 12.0033 4.6201 0.0 0
M  V30 14 C 10.6697 6.9302 0.0 0
M  V30 15 C 12.0033 6.1601 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 4.0010 6.1601 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 15
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 404902-25-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-19-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-28581557
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Benzofuranyl)-3-(3-hydroxy-4-methoxyphenyl)-2-propen-1-one
C18H14O4
565420-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 C 0.0000 6.1601 0.0 0
M  V30 8 C 11.7733 2.8281 0.0 0
M  V30 9 C 11.0032 4.1618 0.0 0
M  V30 10 C 10.7428 1.6837 0.0 0
M  V30 11 C 13.3133 2.8281 0.0 0
M  V30 12 O 9.4969 3.8416 0.0 0
M  V30 13 C 11.7733 5.4956 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 14.0833 4.1618 0.0 0
M  V30 16 C 13.3133 5.4956 0.0 0
M  V30 17 C 4.0010 2.3101 0.0 0
M  V30 18 C 2.6673 1.5400 0.0 0
M  V30 19 C 4.0010 3.8501 0.0 0
M  V30 20 C 1.3337 2.3101 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 17
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[2-Amino-6-(2-benzofuranyl)-4-pyrimidinyl]-2-methoxyphenol
C19H15N3O3
864668-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 O 0.0000 3.8501 0.0 0
M  V30 3 O 0.0000 6.9302 0.0 0
M  V30 4 C 0.0000 8.4702 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 9.4969 6.1517 0.0 0
M  V30 7 O 10.7428 3.9938 0.0 0
M  V30 8 C 11.0032 6.4718 0.0 0
M  V30 9 C 11.7733 5.1382 0.0 0
M  V30 10 C 11.7733 7.8057 0.0 0
M  V30 11 C 13.3133 5.1382 0.0 0
M  V30 12 C 13.3133 7.8057 0.0 0
M  V30 13 C 14.0833 6.4718 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 N 8.0022 2.3101 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 6.6685 1.5400 0.0 0
M  V30 19 N 5.3348 2.3101 0.0 0
M  V30 20 C 4.0010 4.6201 0.0 0
M  V30 21 C 2.6673 3.8501 0.0 0
M  V30 22 C 4.0010 6.1601 0.0 0
M  V30 23 C 1.3337 4.6201 0.0 0
M  V30 24 C 2.6673 6.9302 0.0 0
M  V30 25 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 25
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 565420-44-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864668-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7314182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antitumor and antibacterial activities of certain substituted
pyrimidines bearing benzofuran
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babu, V. Harinadha; Kumar, P. Senthil; Srinivasan, K. K.; Bhat, G.
Varadaraja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Pharmaceutical Sciences (2004), 66(5), 647-652

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(3,4-dimethoxyphenyl)-2-propen-1-one
C17H17NO3
96611-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3347 0.0 0
M  V30 3 O 2.3100 1.3336 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 C 5.3900 6.6684 0.0 0
M  V30 6 C 6.9300 6.6684 0.0 0
M  V30 7 C 7.7000 8.0021 0.0 0
M  V30 8 O 6.9300 9.3358 0.0 0
M  V30 9 N 13.8600 8.0021 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 9.2400 8.0021 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0
M  V30 18 C 10.0100 6.6684 0.0 0
M  V30 19 C 11.5500 9.3358 0.0 0
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 12.3200 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 7 16
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(3,4-dimethoxyphenyl)-2-pyrimidinamine
C18H18N4O2
1266387-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3347 0.0 0
M  V30 3 N 4.6200 10.6694 0.0 0
M  V30 4 O 2.3100 1.3336 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 N 13.8600 8.0021 0.0 0
M  V30 7 C 4.6200 5.3347 0.0 0
M  V30 8 C 3.0800 5.3347 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 2.6673 0.0 0
M  V30 12 C 3.0800 2.6673 0.0 0
M  V30 13 C 5.3900 6.6684 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0
M  V30 15 N 4.6200 8.0021 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 5.3900 9.3358 0.0 0
M  V30 18 N 6.9300 9.3358 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 10.0100 9.3358 0.0 0
M  V30 21 C 10.0100 6.6684 0.0 0
M  V30 22 C 11.5500 9.3358 0.0 0
M  V30 23 C 11.5500 6.6684 0.0 0
M  V30 24 C 12.3200 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 6 24
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96611-12-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266387-22-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20216226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the anti-tumor activity of synthetic pyrido[2,3-d]pyrimidines,
pyrimidines and corresponding chalcone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atla, Srinivasa Rao; Sistla, Ramakrishna; Yejella, Rajendra Prasad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmaceutical Sciences and Research (2018),
9(9), 3804-3814

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
2-(Ethoxymethylene)propanedinitrile
C6H6N2O
123-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0800 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0
M  V30 3 C 1.3337 3.8500 0.0 0
M  V30 4 C 2.6675 1.5400 0.0 0
M  V30 5 O 5.3348 3.0800 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 N 2.6675 0.0000 0.0 0
M  V30 8 C 6.6686 3.8500 0.0 0
M  V30 9 C 8.0022 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 3 3 6
M  V30 6 3 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diaminopyrimidine-5-carbonitrile
C5H5N5
16462-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 N 4.6201 0.0000 0.0 0
M  V30 4 N 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8500 1.3337 0.0 0
M  V30 7 C 3.8500 4.0010 0.0 0
M  V30 8 N 2.3100 1.3337 0.0 0
M  V30 9 N 2.3100 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-06-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16462-27-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27925671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (a) NaOEt, EtOH, 20 °C, 18 h (100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Dihydrofolate Reductase Inhibitors. Structure-Based versus
Diversity-Based Library Design and High-Throughput Synthesis and
Screening
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wyss, Pierre C.; Gerber, Paul; Hartman, Peter G.; Hubschwerlen,
Christian; Locher, Hans; Marty, Hans-Peter; Stahl, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(12), 2304-2312

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-iodo-β-oxobenzenepropanoate
C11H11IO3
63131-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 I 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-(4-iodophenyl)-4(3H)-pyrimidinone
C10H8IN3O
1070217-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 N 2.6674 0.0000 0.0 0
M  V30 3 I 9.3358 6.9300 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 N 4.0011 2.3100 0.0 0
M  V30 7 C 1.3336 3.8500 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 N 1.3336 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 5.3347 6.1600 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 6.6684 6.9300 0.0 0
M  V30 14 C 8.0021 4.6200 0.0 0
M  V30 15 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 15
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63131-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1070217-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13588829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(4-Iodophenyl)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylamine (73). Step
i: A mixture of ethyl (4-iodobenzoyl)acetate (1.0 g, 3.1 mmol), K2CO3
(0.87 g, 6.3 mmol), guanidine nitrate (0.76 g, 6.3 mmol) and DMF (3 mL)
were heated to 110 °C for 16 h, cooled treated with H2O (10 mL),
acidified to pH 6 with acetic acid and allowed to stand at room
temperature for 15 min. The solid was collected by filtration, washed
with H2O, dried under vacuum to provide 1.1 g (108 %) of
2-amino-6-(4-iodophenyl)pyrimidin-4-ol. [1H NMR (DMSO-d6) δ 6.11 (s, 1H),
6.64 (bs, 2H), 7.73 (d, J=8.8 Hz, 2H), 7.80 (d, J=8.8 Hz, 2H), 10.87 (bs,
1H); MS (DCI/NH3) m/z 332 (M + H)+].
$DTYPE RXN:VAR(1):NOTES
$DATUM 108% yield claimed by the authors
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity Studies on a Series of a 2-Aminopyrimidine-Containing
Histamine H4 Receptor Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Altenbach, Robert J.; Adair, Ronald M.; Bettencourt, Brian M.; Black,
Lawrence A.; Fix-Stenzel, Shannon R.; Gopalakrishnan, Sujatha M.; Hsieh,
Gin C.; Liu, Huaqing; Marsh, Kennan C.; McPherson, Michael J.; Milicic,
Ivan; Miller, Thomas R.; Vortherms, Timothy A.; Warrior, Usha; Wetter,
Jill M.; Wishart, Neil; Witte, David G.; Honore, Prisca; Esbenshade,
Timothy A.; Hancock, Arthur A.; Brioni, Jorge D.; Cowart, Marlon D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(20), 6571-6580

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
1,1′-Ferrocenedicarboxylic acid
C12H10FeO4
1293-87-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1063 5.1421 0.0 0
M  V30 2 O 3.5770 4.8708 0.0 0
M  V30 3 O 3.1063 5.6863 0.0 0
M  V30 4 C 3.0778 0.5682 0.0 0
M  V30 5 O 3.5485 0.8395 0.0 0
M  V30 6 O 3.0778 0.0240 0.0 0
M  V30 7 Fe 1.3208 2.8424 0.0 0 CHG=2 VAL=10
M  V30 8 C 2.6355 4.8708 0.0 0 CHG=-1 VAL=4
M  V30 9 C 2.6070 0.8395 0.0 0 CHG=-1 VAL=4
M  V30 10 C 1.7795 1.3178 0.0 0 VAL=5
M  V30 11 C 1.2923 0.0000 0.0 0 VAL=5
M  V30 12 C 1.8095 4.3925 0.0 0 VAL=5
M  V30 13 C 1.3208 5.7088 0.0 0 VAL=5
M  V30 14 C 0.0300 4.8708 0.0 0 VAL=5
M  V30 15 C 0.8545 4.3925 0.0 0 VAL=5
M  V30 16 C 0.0000 0.8395 0.0 0 VAL=5
M  V30 17 C 0.8230 1.3178 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 7 15
M  V30 15 1 7 16
M  V30 16 1 7 17
M  V30 17 1 8 12
M  V30 18 1 8 13
M  V30 19 1 9 10
M  V30 20 1 9 11
M  V30 21 2 10 17
M  V30 22 2 11 16
M  V30 23 2 12 15
M  V30 24 2 13 14
M  V30 25 1 14 15
M  V30 26 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1,1′-dicarboxy-, compd. with guanidine (1:2)
C12H10FeO4.2CH5N3
625447-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1063 8.9922 0.0 0
M  V30 2 O 3.5770 8.7208 0.0 0
M  V30 3 O 3.1063 9.5364 0.0 0
M  V30 4 C 3.0778 4.4182 0.0 0
M  V30 5 O 3.5485 4.6896 0.0 0
M  V30 6 O 3.0778 3.8740 0.0 0
M  V30 7 Fe 1.3208 6.6925 0.0 0 CHG=2 VAL=10
M  V30 8 C 2.6355 8.7208 0.0 0 CHG=-1 VAL=4
M  V30 9 C 2.6070 4.6896 0.0 0 CHG=-1 VAL=4
M  V30 10 C 1.7795 5.1678 0.0 0 VAL=5
M  V30 11 C 1.2923 3.8501 0.0 0 VAL=5
M  V30 12 C 1.8095 8.2426 0.0 0 VAL=5
M  V30 13 C 1.3208 9.5589 0.0 0 VAL=5
M  V30 14 C 0.0300 8.7208 0.0 0 VAL=5
M  V30 15 C 0.8545 8.2426 0.0 0 VAL=5
M  V30 16 C 0.0000 4.6896 0.0 0 VAL=5
M  V30 17 C 0.8230 5.1678 0.0 0 VAL=5
M  V30 18 C 1.7885 1.5400 0.0 0
M  V30 19 N 0.4548 2.3101 0.0 0
M  V30 20 N 3.1222 2.3101 0.0 0
M  V30 21 N 1.7885 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 7 15
M  V30 15 1 7 16
M  V30 16 1 7 17
M  V30 17 1 8 12
M  V30 18 1 8 13
M  V30 19 1 9 10
M  V30 20 1 9 11
M  V30 21 2 10 17
M  V30 22 2 11 16
M  V30 23 2 12 15
M  V30 24 2 13 14
M  V30 25 1 14 15
M  V30 26 1 16 17
M  V30 27 2 18 19
M  V30 28 1 18 20
M  V30 29 1 18 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1293-87-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 625447-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-10485592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM mechanochem.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Assembly of hybrid organic - organometallic materials through
mechanochemical acid - base reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Braga, Dario; Maini, Lucia; Polito, Marco; Mirolo, Laurent; Grepioni,
Fabrizia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(18), 4362-4370

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
2-Acetyl-5-(2-furanyl)-1,3-cyclohexanedione
C12H12O4
1774-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 C 0.7700 2.6674 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 7.8353 1.4216 0.0 0
M  V30 14 O 7.8353 3.9133 0.0 0
M  V30 15 C 9.2998 1.8974 0.0 0
M  V30 16 C 9.2998 3.4375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-7-(2-furanyl)-7,8-dihydro-4-methyl-5(6H)-quinazolinone
C13H13N3O2
727372-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 N 0.0000 4.6201 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 4.0011 3.8501 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 C 2.6673 1.5400 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 2.6673 4.6201 0.0 0
M  V30 10 C 6.6685 2.3100 0.0 0
M  V30 11 N 1.3337 2.3100 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 8.0021 4.6201 0.0 0
M  V30 15 C 9.4091 3.9936 0.0 0
M  V30 16 O 8.1632 6.1516 0.0 0
M  V30 17 C 10.4395 5.1381 0.0 0
M  V30 18 C 9.6695 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1774-13-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 727372-31-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1556088
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Stage 2/3:
2-Amino-7-(4-fluoro-phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-one To a
stirred solution of 2-acetyl-5-(4-fluoro-phenyl)-cyclohexane-1,3-dione
(200 mg, 0.80 mmol) from stage 1, in chloroform was added pyrrolidine (68
mg, 0.96 mmol). The reaction mixture was stirred at ambient temperature
and monitored by TLC until complete disappearance of
2-acetyl-5-(4-fluoro-phenyl)-cyclohexane-1,3-dione. The reaction mixture
was washed with water (10 ml) and the solvent was removed under reduced
pressure to give a solid m=229 mg; To a stirred solution of this solid
(229 mg, 0.76 mmol) in dioxane (2.5 ml) was added guanidine carbonate
(504 mg, 2.8 mmol) and the mixture heated at 100°C and stirred for 16 h.
1,4-Dioxane was removed by evaporation under reduced pressure, water (5
ml) was added and the resulting precipitate was filtered, washed with
water and heptane and air dried. Yield: 105mg(51%) Stage 2/3:
2-Amino-7-furan-2-yl-4-methyl-7,8-dihydro-6H-quinazolin-5-one The title
compound was prepared from 2-acetyl-5-furan-2-yl-cyclohexane-1,3-dione
(321 mg, 1.46 mmol), from stage 1, following the procedure describing the
synthesis of
2-amino-7-(4-fluoro-phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-one
(example 3/a stage 2/3). Yield: 340 mg (100%) Mass spectrum (ES-MS (+ve))
244 [MH]+, Retention time 1.40 min, 100% UV
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-amino-7,8-dihydro-6H-quinazolin-5-one oximes having
HSP90 inhibitory activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Courtney, Stephen Martin; Whittaker, Mark; Mather, Owen Clifford;
Yarnold, Christopher John; Barker, Oliver Robin; Montalbetti, Christian
Aldo Georges Napoleon; Hesterkamp, Thomas; Gardiner, Mihaly Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008142720 A2 2008-11-27

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Ethyl 4-chloro-β-oxobenzenepropanoate
C11H11ClO3
2881-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 Cl 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-(4-chlorophenyl)-4(3H)-pyrimidinone
C10H8ClN3O
98305-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 N 2.6674 0.0000 0.0 0
M  V30 3 Cl 9.3358 6.9300 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 N 4.0011 2.3100 0.0 0
M  V30 7 C 1.3336 3.8500 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 N 1.3336 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 5.3347 6.1600 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 6.6684 6.9300 0.0 0
M  V30 14 C 8.0021 4.6200 0.0 0
M  V30 15 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 15
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2881-63-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98305-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7837059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of an anti-MRSA dihydrofolate reductase inhibitor from a
diversity-oriented synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wyatt, Emma E.; Galloway, Warren R. J. D.; Thomas, Gemma L.; Welch,
Martin; Loiseleur, Olivier; Plowright, Alleyn T.; Spring, David R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2008), (40),
4962-4964

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(Dimethylamino)-1-[1-ethyl-2-(trifluoromethyl)-1H-imidazol-5-yl]-2-pro...
C11H14F3N3O
893420-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8342 2.3932 0.0 0
M  V30 2 C 8.1679 3.1632 0.0 0
M  V30 3 O 6.8342 0.8532 0.0 0
M  V30 4 C 9.5017 2.3932 0.0 0
M  V30 5 N 10.8354 3.1632 0.0 0
M  V30 6 C 12.1690 2.3932 0.0 0
M  V30 7 C 10.8354 4.7033 0.0 0
M  V30 8 C 3.7734 1.0304 0.0 0
M  V30 9 C 4.9179 0.0000 0.0 0
M  V30 10 C 1.5316 3.5204 0.0 0
M  V30 11 F 1.6925 1.9888 0.0 0
M  V30 12 F 0.0000 3.3594 0.0 0
M  V30 13 F 1.3706 5.0519 0.0 0
M  V30 14 C 5.5005 3.1632 0.0 0
M  V30 15 N 4.0937 2.5369 0.0 0
M  V30 16 C 5.3396 4.6948 0.0 0
M  V30 17 C 3.0631 3.6813 0.0 0
M  V30 18 N 3.8331 5.0150 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 17
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[1-Ethyl-2-(trifluoromethyl)-1H-imidazol-5-yl]-2-pyrimidinamine
C10H10F3N5
893420-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7735 1.0304 0.0 0
M  V30 2 C 4.9179 0.0000 0.0 0
M  V30 3 C 1.5316 3.5204 0.0 0
M  V30 4 F 1.6925 1.9888 0.0 0
M  V30 5 F 0.0000 3.3594 0.0 0
M  V30 6 F 1.3706 5.0519 0.0 0
M  V30 7 N 10.8354 3.1632 0.0 0
M  V30 8 C 5.5005 3.1632 0.0 0
M  V30 9 N 4.0937 2.5369 0.0 0
M  V30 10 C 5.3396 4.6948 0.0 0
M  V30 11 C 3.0631 3.6813 0.0 0
M  V30 12 N 3.8331 5.0150 0.0 0
M  V30 13 C 6.8342 2.3932 0.0 0
M  V30 14 N 8.1680 3.1632 0.0 0
M  V30 15 C 6.8342 0.8532 0.0 0
M  V30 16 C 9.5017 2.3932 0.0 0
M  V30 17 C 8.1680 0.0832 0.0 0
M  V30 18 N 9.5017 0.8532 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 893420-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893420-42-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7769440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-86-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(3-Ethyl-2-trifluoromethyl-3H-imidazol-4-yl)-pyrimidin-2-yl amine
(E)-3-Dimethylamino-1-(3-ethyl-2-trifluoromethyl-3H-imidazol-4-yl)-propenone
(Method 36; 6.0 g, 0.023 mol) and guanidine carbonate (8.3 g, 0.046 mol)
were added to 2- methoxyethoxy ether (80 ml) and heated at 140°C for 2
days. The reaction was cooled and the solvent was removed in vacuo to
yield a yellow solid. Water (100 ml) was added and the system was
extracted with DCM (3 x 100 ml), dried and the solvent removed in vacuo
to yield a yellow solid. Purification by column chromatography on silica
using 0-5% MeOH in DCM gave the title compound as a yellow solid. Ether
(20 ml) followed by iso-hexane (50 ml) were added to yield an off white
solid which was filtered and dried (5.9 g, 100%).
4-(3-Ethyl-2-trifluoromethyl-3H-imidazol-4-yl)-pyrimidin-2-yl amine,
Yield (5.9 g, 100%). m/z 258.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazolyl-pyrimidine compounds as CDK2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, David; Finlay, Maurice Raymond; Green, Clive; Jones, Clifford
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007015064 A1 2007-02-08

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Guanidine bicarbonate
CH5N3.CH2O3
124-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-(difluoromethyl)-β-oxo-4-(phenylmethyl)-1H-pyrazole-3-propanoate
C16H16F2N2O3
2857047-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.2079 0.0 0
M  V30 2 C 7.9523 5.8577 0.0 0
M  V30 3 C 9.4586 5.5373 0.0 0
M  V30 4 O 7.4764 7.3222 0.0 0
M  V30 5 C 10.4892 6.6819 0.0 0
M  V30 6 O 11.9955 6.3617 0.0 0
M  V30 7 O 10.0131 8.1465 0.0 0
M  V30 8 C 13.0259 7.5061 0.0 0
M  V30 9 C 14.5324 7.1860 0.0 0
M  V30 10 C 5.7473 0.9051 0.0 0
M  V30 11 F 6.9931 0.0000 0.0 0
M  V30 12 F 4.3404 0.2787 0.0 0
M  V30 13 C 5.3901 4.8741 0.0 0
M  V30 14 C 6.9217 4.7131 0.0 0
M  V30 15 C 4.7638 3.4672 0.0 0
M  V30 16 N 7.2420 3.2068 0.0 0
M  V30 17 N 5.9082 2.4368 0.0 0
M  V30 18 C 3.0801 6.2079 0.0 0
M  V30 19 C 2.3101 4.8741 0.0 0
M  V30 20 C 2.3101 7.5415 0.0 0
M  V30 21 C 0.7700 4.8741 0.0 0
M  V30 22 C 0.7700 7.5415 0.0 0
M  V30 23 C 0.0000 6.2079 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 17
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-[1-(difluoromethyl)-4-(phenylmethyl)-1H-pyrazol-3-yl]-4(3H)-pyrimid...
C15H13F2N5O
2857047-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1821 5.8577 0.0 0
M  V30 2 C 4.9771 0.9051 0.0 0
M  V30 3 F 3.5703 0.2787 0.0 0
M  V30 4 F 6.2230 0.0000 0.0 0
M  V30 5 O 0.0000 7.5415 0.0 0
M  V30 6 N 4.6201 10.2089 0.0 0
M  V30 7 C 6.1517 4.7131 0.0 0
M  V30 8 C 4.6201 4.8741 0.0 0
M  V30 9 C 6.4718 3.2068 0.0 0
M  V30 10 N 3.9936 3.4672 0.0 0
M  V30 11 N 5.1382 2.4368 0.0 0
M  V30 12 C 3.8501 6.2079 0.0 0
M  V30 13 C 2.3101 6.2079 0.0 0
M  V30 14 N 4.6201 7.5415 0.0 0
M  V30 15 C 1.5400 7.5415 0.0 0
M  V30 16 C 3.8501 8.8752 0.0 0
M  V30 17 N 2.3101 8.8752 0.0 0
M  V30 18 C 8.6886 5.5373 0.0 0
M  V30 19 C 9.7190 6.6819 0.0 0
M  V30 20 C 9.1644 4.0728 0.0 0
M  V30 21 C 11.2253 6.3617 0.0 0
M  V30 22 C 10.6707 3.7526 0.0 0
M  V30 23 C 11.7012 4.8970 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 11
M  V30 6 2 5 15
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 124-46-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2857047-48-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2857047-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34699522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Pharmacological Evaluation of Second-Generation
Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation
Rates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, Michael; Rossetti, Thomas; Ferreira, Jacob; Ghanem, Lubna;
Balbach, Melanie; Kaur, Navpreet; Levin, Lonny R.; Buck, Jochen; Kehr,
Maria; Coquille, Sandrine; van den Heuvel, Joop; Steegborn, Clemens;
Fushimi, Makoto; Finkin-Groner, Efrat; Myers, Robert W.; Kargman, Stacia;
Liverton, Nigel J.; Huggins, David J.; Meinke, Peter T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(22), 15208-15226

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Guanidine bicarbonate
CH5N3.CH2O3
124-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(Dimethylamino)-1-[1-ethyl-2-(trifluoromethyl)-1H-imidazol-5-yl]-2-pro...
C11H14F3N3O
893420-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8342 2.3932 0.0 0
M  V30 2 C 8.1679 3.1632 0.0 0
M  V30 3 O 6.8342 0.8532 0.0 0
M  V30 4 C 9.5017 2.3932 0.0 0
M  V30 5 N 10.8354 3.1632 0.0 0
M  V30 6 C 12.1690 2.3932 0.0 0
M  V30 7 C 10.8354 4.7033 0.0 0
M  V30 8 C 3.7734 1.0304 0.0 0
M  V30 9 C 4.9179 0.0000 0.0 0
M  V30 10 C 1.5316 3.5204 0.0 0
M  V30 11 F 1.6925 1.9888 0.0 0
M  V30 12 F 0.0000 3.3594 0.0 0
M  V30 13 F 1.3706 5.0519 0.0 0
M  V30 14 C 5.5005 3.1632 0.0 0
M  V30 15 N 4.0937 2.5369 0.0 0
M  V30 16 C 5.3396 4.6948 0.0 0
M  V30 17 C 3.0631 3.6813 0.0 0
M  V30 18 N 3.8331 5.0150 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 17
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[1-Ethyl-2-(trifluoromethyl)-1H-imidazol-5-yl]-2-pyrimidinamine
C10H10F3N5
893420-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7735 1.0304 0.0 0
M  V30 2 C 4.9179 0.0000 0.0 0
M  V30 3 C 1.5316 3.5204 0.0 0
M  V30 4 F 1.6925 1.9888 0.0 0
M  V30 5 F 0.0000 3.3594 0.0 0
M  V30 6 F 1.3706 5.0519 0.0 0
M  V30 7 N 10.8354 3.1632 0.0 0
M  V30 8 C 5.5005 3.1632 0.0 0
M  V30 9 N 4.0937 2.5369 0.0 0
M  V30 10 C 5.3396 4.6948 0.0 0
M  V30 11 C 3.0631 3.6813 0.0 0
M  V30 12 N 3.8331 5.0150 0.0 0
M  V30 13 C 6.8342 2.3932 0.0 0
M  V30 14 N 8.1680 3.1632 0.0 0
M  V30 15 C 6.8342 0.8532 0.0 0
M  V30 16 C 9.5017 2.3932 0.0 0
M  V30 17 C 8.1680 0.0832 0.0 0
M  V30 18 N 9.5017 0.8532 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 124-46-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 893420-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893420-42-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7263914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 111-96-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(3-Ethyl-2-trifluoromethyl-3H-imidazol-4-yl)-pyrimidin-2-ylamine
(E)-3-Dimethylamino-1-(3-ethyl-2-trifluoromethyl-3H-imidazol-4-yl)-propenone
(Method 44; 6.0 g, 0.023 mol) and guanidine carbonate (8.3 g, 0.046 mol)
were added to 2-methoxyethoxy ether (80 ml) and heated at 140°C for 2
days. The reaction was cooled and the solvent was removed in vacuo to
yield a yellow solid. Water (100 ml) was added and the system was
extracted with DCM (3 x 100 ml), dried and the solvent removed in vacuo
to yield a yellow solid. Purification by column chromatography on silica
using 0-5% MeOH in DCM gave the title compound as a yellow solid. Ether
(20 ml) followed by iso-hexane (50 ml) were added to yield an off white
solid which was filtered and dried, yield 5.9 g, 100% m/z 258.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-(4-(imidazol-4-yl)-pyrimidin-2-ylamino)benzamides as CDK
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, David; Finlay, Maurice Raymond; Green, Clive; Jones, Clifford
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006064251 A1 2006-06-22

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethyl 2-methoxypropanedioate
C6H10O5
5018-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 2.6675 3.0800 0.0 0
M  V30 3 C 5.3348 3.0800 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 O 1.3337 2.3100 0.0 0
M  V30 6 O 2.6675 4.6201 0.0 0
M  V30 7 O 6.6686 2.3100 0.0 0
M  V30 8 O 5.3348 4.6201 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 8.0022 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-hydroxy-5-methoxy-4(3H)-pyrimidinone
C5H7N3O3
98142-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 2.6674 0.0 0
M  V30 2 C 0.0000 4.0011 0.0 0
M  V30 3 O 2.3100 5.3349 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 N 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5018-30-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98142-98-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1136593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-23-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4,6-dichloro-5-methoxypyrimidin-2-amine (13b). EtOH (80 mL) under N2 was
carefully treated with sodium (2.8 g, 0.12 mmol) and the resulting
solution was heated to 80 °C, treated with guanidine carbonate (5.6 g, 31
mmol), stirred at 80 °C for 0.5 h, treated with dimethyl methoxymalonate
(10 g, 62 mmol) in EtOH (20 mL), heated at 80 °C for 2 h and allowed to
stand at room temperature over night. The solid was collected by
filtration, dissolved in water (50 mL) and acidified to pH 6 with acetic
acid. The resulting solid was collected by filtration, washed with water
and dried under vacuum to provide 5.14 g (>100 %) of
2-amino-5-methoxypyrimidine-4,6-diol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity Studies on a Series of a 2-Aminopyrimidine-Containing
Histamine H4 Receptor Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Altenbach, Robert J.; Adair, Ronald M.; Bettencourt, Brian M.; Black,
Lawrence A.; Fix-Stenzel, Shannon R.; Gopalakrishnan, Sujatha M.; Hsieh,
Gin C.; Liu, Huaqing; Marsh, Kennan C.; McPherson, Michael J.; Milicic,
Ivan; Miller, Thomas R.; Vortherms, Timothy A.; Warrior, Usha; Wetter,
Jill M.; Wishart, Neil; Witte, David G.; Honore, Prisca; Esbenshade,
Timothy A.; Hancock, Arthur A.; Brioni, Jorge D.; Cowart, Marlon D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(20), 6571-6580

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
5-(4-Nitrophenyl)-2-furancarboxylic acid
C11H7NO5
28123-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.5458 1.5317 0.0 0
M  V30 2 O 11.9526 2.1580 0.0 0
M  V30 3 O 10.3847 0.0000 0.0 0
M  V30 4 N 0.7700 3.2067 0.0 0 VAL=5
M  V30 5 O 0.0000 1.8731 0.0 0
M  V30 6 O 0.0000 4.5405 0.0 0
M  V30 7 C 6.9300 3.2067 0.0 0
M  V30 8 O 7.8352 1.9609 0.0 0
M  V30 9 C 7.8352 4.4528 0.0 0
M  V30 10 C 9.2998 2.4367 0.0 0
M  V30 11 C 9.2998 3.9767 0.0 0
M  V30 12 C 5.3900 3.2067 0.0 0
M  V30 13 C 4.6200 4.5405 0.0 0
M  V30 14 C 4.6200 1.8731 0.0 0
M  V30 15 C 3.0800 4.5405 0.0 0
M  V30 16 C 3.0800 1.8731 0.0 0
M  V30 17 C 2.3100 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Aminoiminomethyl)-5-(4-nitrophenyl)-2-furancarboxamide
C12H10N4O4
852146-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.5458 1.8104 0.0 0
M  V30 2 N 11.9526 2.4367 0.0 0
M  V30 3 O 10.3847 0.2789 0.0 0
M  V30 4 C 13.1984 1.5315 0.0 0
M  V30 5 N 13.0375 0.0000 0.0 0
M  V30 6 N 14.6054 2.1580 0.0 0
M  V30 7 N 0.7700 3.4856 0.0 0 VAL=5
M  V30 8 O 0.0000 2.1518 0.0 0
M  V30 9 O 0.0000 4.8193 0.0 0
M  V30 10 C 6.9300 3.4856 0.0 0
M  V30 11 O 7.8352 2.2396 0.0 0
M  V30 12 C 7.8352 4.7315 0.0 0
M  V30 13 C 9.2999 2.7156 0.0 0
M  V30 14 C 9.2999 4.2556 0.0 0
M  V30 15 C 5.3900 3.4856 0.0 0
M  V30 16 C 4.6200 2.1518 0.0 0
M  V30 17 C 4.6200 4.8193 0.0 0
M  V30 18 C 3.0800 2.1518 0.0 0
M  V30 19 C 3.0800 4.8193 0.0 0
M  V30 20 C 2.3100 3.4856 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 28123-73-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852146-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4888879
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method C. To a solution of the corresponding
furan-2-carboxylic acid (1.0 mmol) in THF (5 mL) was added
1,1'-carbonyldiimidazole (182 mg, 1.12 mmol), and the reaction mixture
was stirred at room temperature for 30 min, followed by an addition of a
2 M methanol solution of guanidine (3.0 mL, 6.0 mmol) and continuous
stirring at room temperature for 12 h. Brine (20 mL) was added, and the
mixture was extracted with ethyl acetate (30 mL x 3). The organic layer
was washed with 10% NaCl twice, dried (MgSO4), filtered, and concentrated
under reduced pressure. The residue was dissolved in acetone (4 mL), and
methanesulfonic acid (0.2 mL) was added. The resulting solution was
cooled to 0 °C, and the precipitates were filtered to yield the
acylguanidine methanesulfonate.
[5-(4-Nitrophenyl)furan-2-ylcarbonyl]guanidine, as yellow solid, yield
99%. mp 193-195 °C; 1H NMR (DMSO-d6) δ 7.08 (d, J = 3.6 Hz, 1H), 7.33 (d,
J = 3.6 Hz, 1H), 8.01 (dd, J = 2.1, 7.0 Hz, 1H), 7.96 (dd, J = 2.1, 7.0
Hz, 2H); MS 274 (M+); Anal. (C12H10N4O4) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (5-Arylfuran-2-ylcarbonyl)guanidines as Cardioprotectives through the
Inhibition of Na+/H+ Exchanger Isoform-1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Sunkyung; Yi, Kyu Yang; Hwang, Sun Kyung; Lee, Byung Ho; Yoo,
Sung-eun; Lee, Kyunghee
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(8), 2882-2891

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dibromo-4-ethoxy-α-(1-methoxypropylidene)benzeneacetonitrile
C14H15Br2NO2
805237-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 2.6673 3.8501 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 O 2.6673 5.3901 0.0 0
M  V30 6 N 4.0012 0.0000 0.0 0
M  V30 7 C 0.0000 3.8501 0.0 0
M  V30 8 C 1.3337 6.1601 0.0 0
M  V30 9 Br 9.3360 3.0801 0.0 0
M  V30 10 Br 6.6685 7.7002 0.0 0
M  V30 11 O 9.3360 6.1601 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 12.0033 6.1601 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 8.0022 3.8501 0.0 0
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 8.0022 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 3 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 9 17
M  V30 10 1 10 18
M  V30 11 1 11 12
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3,5-Dibromo-4-ethoxyphenyl)-6-ethyl-2,4-pyrimidinediamine
C14H16Br2N4O
410535-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3338 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 N 4.6201 6.6686 0.0 0
M  V30 4 Br 9.2401 1.3338 0.0 0
M  V30 5 Br 9.2401 6.6686 0.0 0
M  V30 6 O 10.7801 4.0011 0.0 0
M  V30 7 C 11.5501 5.3348 0.0 0
M  V30 8 C 13.0901 5.3348 0.0 0
M  V30 9 N 0.0000 4.0011 0.0 0
M  V30 10 C 6.1601 4.0011 0.0 0
M  V30 11 C 6.9301 2.6675 0.0 0
M  V30 12 C 6.9301 5.3348 0.0 0
M  V30 13 C 8.4701 2.6675 0.0 0
M  V30 14 C 8.4701 5.3348 0.0 0
M  V30 15 C 9.2401 4.0011 0.0 0
M  V30 16 C 4.6201 4.0011 0.0 0
M  V30 17 C 3.8500 2.6675 0.0 0
M  V30 18 C 3.8500 5.3348 0.0 0
M  V30 19 N 2.3100 2.6675 0.0 0
M  V30 20 N 2.3100 5.3348 0.0 0
M  V30 21 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 18
M  V30 4 1 4 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 9 21
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 805237-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 410535-94-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27380380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine (5, Pyr; R1 = R2 = R4 =
H, R3 = Cl, R5 = CH2CH3). A mixture of 4 (R1 = R2 = R4 = H, R3 = Cl, R5 =
CH2CH3) (0.66 g, 3 mmol) and guanidine (0.30 g, 5 mmol) in dry DMSO (5
mL) was heated at 80 °C for 5 min under N2. The reaction mixture was
poured into CH2Cl2 (100 mL) and was successively washed with water and
saturated aqueous sodium chloride solution, dried over MgSO4, filtered,
and evaporated to dryness under reduced pressure. Compound 5 (R1 = R2 =
R4 = H, R3 = Cl, R5 = CH2CH3) was crystallized from methanol to afford
white crystals (0.70 g, 94%). Compound 25; yield: 99%. Mp: 179.5-180 °C;
1H NMR (400 MHz) 0.98 (t, J = 7.5Hz, 3H, CH2CH3), 1.42 (t, J = 7.0 Hz,
3H, OCH2CH3),2.10 (q, J = 7.5 Hz, 2H, CH2CH3), 4.06 (q, J= 7.0 Hz, 2H,
OCH2CH3), 5.78 (s, 2H, NH2), 5.92 (s, 2H, NH2), 7.41 (s, 2H, ArH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of 2,4-Diaminopyrimidines as Antimalarials Based on
Inhibition of the S108N and C59R+S108N Mutants of Dihydrofolate Reductase
from Pyrimethamine-Resistant Plasmodium falciparum
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tarnchompoo, Bongkoch; Sirichaiwat, Chawanee; Phupong, Worrapong;
Intaraudom, Chakapong; Sirawaraporn, Worachart; Kamchonwongpaisan,
Sumalee; Vanichtanankul, Jarunee; Thebtaranonth, Yodhathai; Yuthavong,
Yongyuth
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(6), 1244-1252

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[[(3-cyanophenyl)methyl]methylamino]-3-oxobutanoate
C15H18N2O3
1493132-82-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 12.0035 3.0801 0.0 0
M  V30 7 O 10.6697 0.7700 0.0 0
M  V30 8 C 13.3372 2.3101 0.0 0
M  V30 9 O 14.6708 3.0801 0.0 0
M  V30 10 O 13.3372 0.7700 0.0 0
M  V30 11 C 16.0045 2.3101 0.0 0
M  V30 12 C 17.3383 3.0801 0.0 0
M  V30 13 C 1.3338 3.0801 0.0 0
M  V30 14 N 0.0000 3.8501 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 2.6675 2.3101 0.0 0
M  V30 19 C 4.0012 0.0000 0.0 0
M  V30 20 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 3 13 14
M  V30 14 1 13 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[(2-Amino-1,6-dihydro-6-oxo-4-pyrimidinyl)methyl]methylamino]methyl]benzo...
C14H15N5O
2231412-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 O 2.6673 0.0000 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 13.3370 4.6201 0.0 0
M  V30 8 N 14.6707 5.3901 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 N 2.6673 4.6201 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 N 1.3337 2.3101 0.0 0
M  V30 15 C 9.3358 3.8501 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 10.6697 1.5400 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 15
M  V30 6 2 5 12
M  V30 7 1 6 13
M  V30 8 3 7 8
M  V30 9 1 7 18
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493132-82-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2231412-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19524654
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl compounds, especially pyridyl, pyrimidinyl, and
triazinyl compounds, and their use in the treatment of lysosomal storage
diseases and synucleinopathies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garcia Collazo, Ana Maria; Barril Alonso, Xavier; Cubero Jorda, Elena;
Reves Vilaplana, Marc; Roberts, Richard Spurring
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018122775 A1 2018-07-05

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[[(4-ethylphenyl)methyl]methylamino]-3-oxobutanoate
C16H23NO3
2231412-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 12.0035 3.0801 0.0 0
M  V30 7 O 10.6697 0.7700 0.0 0
M  V30 8 C 13.3372 2.3101 0.0 0
M  V30 9 O 14.6708 3.0801 0.0 0
M  V30 10 O 13.3372 0.7700 0.0 0
M  V30 11 C 16.0045 2.3101 0.0 0
M  V30 12 C 17.3383 3.0801 0.0 0
M  V30 13 C 1.3338 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 2.6675 2.3101 0.0 0
M  V30 19 C 4.0012 0.0000 0.0 0
M  V30 20 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-[[[(4-ethylphenyl)methyl]methylamino]methyl]-4(3H)-pyrimidinone
C15H20N4O
2231412-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 O 2.6673 0.0000 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 13.3370 1.5400 0.0 0
M  V30 8 C 14.6707 2.3101 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 N 2.6673 4.6201 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 N 1.3337 2.3101 0.0 0
M  V30 15 C 9.3358 3.8501 0.0 0
M  V30 16 C 9.3358 2.3101 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 10.6697 1.5400 0.0 0
M  V30 19 C 12.0033 3.8501 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 15
M  V30 6 2 5 12
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2231412-79-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2231412-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19524655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl compounds, especially pyridyl, pyrimidinyl, and
triazinyl compounds, and their use in the treatment of lysosomal storage
diseases and synucleinopathies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garcia Collazo, Ana Maria; Barril Alonso, Xavier; Cubero Jorda, Elena;
Reves Vilaplana, Marc; Roberts, Richard Spurring
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018122775 A1 2018-07-05

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4R,5S)-4-[(3aS,4R,5S,7aS)-4-(Azidomethyl)octahydro-7a-methyl-1-methylene-1H-...
C32H54N4O2Si
2378528-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.3081 8.1708 0.0 0
M  V30 2 C 6.6519 8.7663 0.0 0
M  V30 3 N 6.6519 10.3063 0.0 0
M  V30 4 N 7.9855 11.0763 0.0 0 CHG=1 VAL=4
M  V30 5 N 9.3193 11.8463 0.0 0 CHG=-1
M  V30 6 C 5.5012 4.4136 0.0 0
M  V30 7 O 5.5012 2.8736 0.0 0
M  V30 8 Si 4.1674 2.1036 0.0 0
M  V30 9 C 2.8338 1.3336 0.0 0
M  V30 10 C 3.3974 3.4374 0.0 0
M  V30 11 C 4.9374 0.7700 0.0 0
M  V30 12 C 3.6038 0.0000 0.0 0
M  V30 13 C 1.5001 0.5636 0.0 0
M  V30 14 C 2.0638 2.6674 0.0 0
M  V30 15 C 10.8359 7.4936 0.0 0
M  V30 16 C 1.2440 7.3700 0.0 0
M  V30 17 O 10.8359 4.4136 0.0 0
M  V30 18 C 0.0000 8.7065 0.0 0
M  V30 19 C 5.3182 6.4563 0.0 0 CFG=1
M  V30 20 C 5.3182 7.9963 0.0 0 CFG=1
M  V30 21 C 3.9846 5.6863 0.0 0
M  V30 22 C 3.9846 8.7663 0.0 0 CFG=2
M  V30 23 C 2.6508 6.4563 0.0 0
M  V30 24 C 2.6508 7.9963 0.0 0 CFG=2
M  V30 25 C 3.6644 10.2726 0.0 0
M  V30 26 C 1.5064 9.0267 0.0 0
M  V30 27 C 2.1327 10.4337 0.0 0
M  V30 28 C 6.8348 6.7236 0.0 0 CFG=2
M  V30 29 C 6.8348 5.1836 0.0 0 CFG=1
M  V30 30 C 8.1685 7.4936 0.0 0
M  V30 31 C 8.1685 4.4136 0.0 0
M  V30 32 C 9.5021 6.7236 0.0 0
M  V30 33 C 9.5021 5.1836 0.0 0
M  V30 34 N 12.1695 6.7236 0.0 0
M  V30 35 C 13.5032 7.4936 0.0 0
M  V30 36 C 12.1695 5.1836 0.0 0
M  V30 37 C 14.8370 6.7236 0.0 0
M  V30 38 C 13.5032 4.4136 0.0 0
M  V30 39 C 14.8370 5.1836 0.0 0
M  V30 40 H 5.8449 5.0092 0.0 0
M  V30 41 H 5.2305 9.6715 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 28 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 2 3 4
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 29 6 CFG=3
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 2 15 32 CFG=2
M  V30 16 1 15 34
M  V30 17 1 24 16 CFG=1
M  V30 18 2 17 33
M  V30 19 2 18 26
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 28
M  V30 23 1 19 40 CFG=3
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 22 41 CFG=3
M  V30 29 1 23 24
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 19 20 22 24 28 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6R,7S)-6-[(3aS,4R,5S,7aS)-4-(Azidomethyl)octahydro-7a-methyl-1-methylene-1H-...
C28H46N6OSi
2378528-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 8.9919 0.0 0
M  V30 2 C 6.9106 5.3347 0.0 0
M  V30 3 O 7.6806 4.0009 0.0 0
M  V30 4 Si 6.9106 2.6673 0.0 0
M  V30 5 C 6.1406 1.3336 0.0 0
M  V30 6 C 8.2442 1.8973 0.0 0
M  V30 7 C 5.5768 3.4373 0.0 0
M  V30 8 C 7.4742 0.5636 0.0 0
M  V30 9 C 5.3706 0.0000 0.0 0
M  V30 10 C 4.8068 2.1036 0.0 0
M  V30 11 C 5.7308 9.6795 0.0 0
M  V30 12 N 4.9608 11.0132 0.0 0
M  V30 13 N 5.7308 12.3468 0.0 0 CHG=1 VAL=4
M  V30 14 N 6.5008 13.6804 0.0 0 CHG=-1
M  V30 15 C 1.7456 5.7662 0.0 0
M  V30 16 C 0.0000 6.3018 0.0 0
M  V30 17 N 13.8406 9.3356 0.0 0
M  V30 18 C 6.9106 8.0020 0.0 0 CFG=2
M  V30 19 C 7.6806 6.6684 0.0 0 CFG=1
M  V30 20 C 7.6806 9.3356 0.0 0
M  V30 21 C 9.2206 6.6684 0.0 0
M  V30 22 C 9.2206 9.3356 0.0 0
M  V30 23 C 9.9906 8.0020 0.0 0
M  V30 24 C 9.9906 10.6694 0.0 0
M  V30 25 N 11.5306 8.0020 0.0 0
M  V30 26 N 11.5306 10.6694 0.0 0
M  V30 27 C 12.3006 9.3356 0.0 0
M  V30 28 C 5.7308 7.0121 0.0 0 CFG=1
M  V30 29 C 4.9608 8.3457 0.0 0 CFG=1
M  V30 30 C 4.9608 5.6784 0.0 0
M  V30 31 C 3.4208 8.3457 0.0 0 CFG=2
M  V30 32 C 3.4208 5.6784 0.0 0
M  V30 33 C 2.6508 7.0121 0.0 0 CFG=2
M  V30 34 C 2.3904 9.4903 0.0 0
M  V30 35 C 1.1445 7.3322 0.0 0
M  V30 36 C 0.9834 8.8639 0.0 0
M  V30 37 H 6.9106 6.0222 0.0 0
M  V30 38 H 4.0473 9.7527 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 19 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 11 12
M  V30 12 1 29 11 CFG=3
M  V30 13 2 12 13
M  V30 14 2 13 14
M  V30 15 1 33 15 CFG=1
M  V30 16 2 16 35
M  V30 17 1 17 27
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 28
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 28 37 CFG=3
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 31 34
M  V30 37 1 31 38 CFG=3
M  V30 38 1 32 33
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 18 19 28 29 31 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378528-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378528-41-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21767590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indene derivatives useful in treating pain and inflammation and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harwig, Curtis; Pettigrew, Jeremy D.; Cross, Jennifer; Seenisamy,
Jeyaprakashnarayanan; Keregadde, Mahesh Narayan; Kher, Samir Satish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019195751 A1 2019-10-10

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-ethyl-4-methyl-β-oxo-1H-pyrazole-3-propanoate
C11H16N2O3
2732864-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6217 0.0 0
M  V30 2 C 7.5417 1.8517 0.0 0
M  V30 3 O 6.2079 4.1618 0.0 0
M  V30 4 C 8.8753 2.6217 0.0 0
M  V30 5 O 10.2090 1.8517 0.0 0
M  V30 6 O 8.8753 4.1618 0.0 0
M  V30 7 C 11.5427 2.6217 0.0 0
M  V30 8 C 12.8765 1.8517 0.0 0
M  V30 9 C 3.1472 3.9845 0.0 0
M  V30 10 C 0.9052 1.4946 0.0 0
M  V30 11 C 0.0000 0.2487 0.0 0
M  V30 12 C 4.8742 1.8517 0.0 0
M  V30 13 C 3.4674 2.4782 0.0 0
M  V30 14 N 4.7133 0.3202 0.0 0
M  V30 15 C 2.4368 1.3337 0.0 0
M  V30 16 N 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 13
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-(5-ethyl-4-methyl-1H-pyrazol-3-yl)-4(3H)-pyrimidinone
C10H13N5O
2732864-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0618 2.4873 0.0 0
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 N 2.6673 0.0000 0.0 0
M  V30 4 C 9.3038 4.9772 0.0 0
M  V30 5 C 10.2089 6.2231 0.0 0
M  V30 6 C 4.0010 3.8501 0.0 0
M  V30 7 C 2.6673 4.6201 0.0 0
M  V30 8 N 4.0010 2.3101 0.0 0
M  V30 9 C 1.3337 3.8501 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 N 1.3337 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 6.7417 3.9936 0.0 0
M  V30 14 N 5.4958 6.1517 0.0 0
M  V30 15 C 7.7721 5.1382 0.0 0
M  V30 16 N 7.0021 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2732864-56-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2732864-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24734427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM H4 antagonist compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Congreve, Miles Stuart; Fieldhouse, Charlotte; Swain, Nigel Alan;
Pickworth, Mark; Hannah, Duncan Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021214469 A1 2021-10-28

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Androstan-17-one, 3-hydroxy-16-[(4-nitrophenyl)methylene]-, (3α,5α,16E)-
C26H33NO4
503272-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 8.9699 0.0 0
M  V30 2 O 9.9426 9.3790 0.0 0
M  V30 3 C 11.9120 6.6684 0.0 0
M  V30 4 C 3.6025 6.6160 0.0 0
M  V30 5 O 0.0000 2.8184 0.0 0
M  V30 6 N 14.9920 1.3336 0.0 0 VAL=5
M  V30 7 O 14.2220 0.0000 0.0 0
M  V30 8 O 16.5320 1.3336 0.0 0
M  V30 9 C 8.0022 5.8984 0.0 0 CFG=2
M  V30 10 C 6.6684 5.1284 0.0 0 CFG=2
M  V30 11 C 8.0022 7.4384 0.0 0 CFG=1
M  V30 12 C 9.4667 5.4225 0.0 0
M  V30 13 C 5.3347 5.8984 0.0 0 CFG=2
M  V30 14 C 6.6684 3.5884 0.0 0
M  V30 15 C 9.4667 7.9143 0.0 0
M  V30 16 C 6.6684 8.2084 0.0 0
M  V30 17 C 10.3720 6.6684 0.0 0
M  V30 18 C 4.0011 5.1284 0.0 0 CFG=2
M  V30 19 C 5.3347 7.4384 0.0 0
M  V30 20 C 5.3347 2.8184 0.0 0
M  V30 21 C 4.0011 3.5884 0.0 0 CFG=2
M  V30 22 C 2.6674 5.8984 0.0 0
M  V30 23 C 2.6674 2.8184 0.0 0
M  V30 24 C 1.3336 5.1284 0.0 0
M  V30 25 C 1.3336 3.5884 0.0 0 CFG=2
M  V30 26 C 12.6820 5.3347 0.0 0
M  V30 27 C 11.9120 4.0011 0.0 0
M  V30 28 C 14.2220 5.3347 0.0 0
M  V30 29 C 12.6820 2.6674 0.0 0
M  V30 30 C 14.9920 4.0011 0.0 0
M  V30 31 C 14.2220 2.6674 0.0 0
M  V30 32 H 8.5540 4.4606 0.0 0
M  V30 33 H 7.7573 4.0394 0.0 0
M  V30 34 H 4.4514 7.1600 0.0 0
M  V30 35 H 4.0011 2.0484 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 2 2 15
M  V30 3 2 3 17
M  V30 4 1 3 26
M  V30 5 1 18 4 CFG=1
M  V30 6 1 25 5 CFG=3
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 31
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 32 CFG=3
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 10 33 CFG=1
M  V30 17 1 11 15
M  V30 18 1 11 16
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 13 19
M  V30 22 1 13 34 CFG=3
M  V30 23 1 14 20
M  V30 24 1 15 17
M  V30 25 1 16 19
M  V30 26 1 18 21
M  V30 27 1 18 22
M  V30 28 1 20 21
M  V30 29 1 21 23
M  V30 30 1 21 35 CFG=3
M  V30 31 1 22 24
M  V30 32 1 23 25
M  V30 33 1 24 25
M  V30 34 2 26 27
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 2 28 30
M  V30 38 2 29 31
M  V30 39 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 9 10 11 13 18 21 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5α)-2′-Amino-1′,6′-dihydro-6′-(4-nitrophenyl)androst-16-eno[17,16-d]pyrim...
C27H36N4O3
503272-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 1.9192 0.0 0
M  V30 2 C 3.6025 4.2731 0.0 0
M  V30 3 N 12.2511 0.0000 0.0 0
M  V30 4 O 0.0000 8.0707 0.0 0
M  V30 5 N 15.5244 9.0432 0.0 0 VAL=5
M  V30 6 O 17.0559 8.8823 0.0 0
M  V30 7 O 14.8979 10.4502 0.0 0
M  V30 8 C 8.0022 4.9907 0.0 0 CFG=1
M  V30 9 C 8.0022 3.4507 0.0 0 CFG=1
M  V30 10 C 6.6684 5.7607 0.0 0 CFG=2
M  V30 11 C 9.4667 5.4666 0.0 0
M  V30 12 C 9.4667 2.9748 0.0 0
M  V30 13 C 6.6684 2.6807 0.0 0
M  V30 14 C 5.3347 4.9907 0.0 0 CFG=1
M  V30 15 C 6.6684 7.3007 0.0 0
M  V30 16 C 10.3720 4.2207 0.0 0
M  V30 17 N 10.0932 1.5679 0.0 0
M  V30 18 C 5.3347 3.4507 0.0 0
M  V30 19 C 4.0011 5.7607 0.0 0 CFG=2
M  V30 20 C 5.3347 8.0707 0.0 0
M  V30 21 C 11.9035 4.0596 0.0 0 CFG=3
M  V30 22 C 11.6248 1.4070 0.0 0
M  V30 23 C 4.0011 7.3007 0.0 0 CFG=2
M  V30 24 C 2.6674 4.9907 0.0 0
M  V30 25 N 12.5300 2.6528 0.0 0
M  V30 26 C 2.6674 8.0707 0.0 0
M  V30 27 C 1.3336 5.7607 0.0 0
M  V30 28 C 1.3336 7.3007 0.0 0 CFG=2
M  V30 29 C 12.8087 5.3056 0.0 0
M  V30 30 C 12.1824 6.7124 0.0 0
M  V30 31 C 14.3402 5.1446 0.0 0
M  V30 32 C 13.0876 7.9583 0.0 0
M  V30 33 C 15.2455 6.3906 0.0 0
M  V30 34 C 14.6191 7.7974 0.0 0
M  V30 35 H 8.5540 6.4285 0.0 0
M  V30 36 H 7.7573 6.8496 0.0 0
M  V30 37 H 4.4514 3.7291 0.0 0
M  V30 38 H 4.0011 8.8407 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 19 2 CFG=3
M  V30 3 1 3 22
M  V30 4 1 28 4 CFG=1
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 34
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 35 CFG=1
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 10 36 CFG=3
M  V30 17 1 11 16
M  V30 18 2 12 16
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 14 18
M  V30 22 1 14 19
M  V30 23 1 14 37 CFG=1
M  V30 24 1 15 20
M  V30 25 1 16 21
M  V30 26 1 17 22
M  V30 27 1 19 23
M  V30 28 1 19 24
M  V30 29 1 20 23
M  V30 30 1 21 25
M  V30 31 1 21 29
M  V30 32 2 22 25
M  V30 33 1 23 26
M  V30 34 1 23 38 CFG=1
M  V30 35 1 24 27
M  V30 36 1 26 28
M  V30 37 1 27 28
M  V30 38 2 29 30
M  V30 39 1 29 31
M  V30 40 1 30 32
M  V30 41 2 31 33
M  V30 42 2 32 34
M  V30 43 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 8 9 10 14 19 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 503272-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 503272-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-12883974
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and pharmacological screening of some new pyrimidine and
cyclohexenone fused steroidal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amr, Abd El-Galil E.; Abdulla, M. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Heterocyclic Chemistry (2002), 12(2), 129-134

$RFMT $RIREG SCHEME38 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-3-buten-1-ol
C10H12O
936-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-3-buten-1-yl N-(aminoiminomethyl)carbamate
C12H15N3O2
2033151-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 O 5.3347 4.6200 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 N 8.0021 4.6200 0.0 0
M  V30 7 O 6.6684 2.3100 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 C 9.3358 3.8500 0.0 0
M  V30 10 N 9.3358 2.3100 0.0 0
M  V30 11 N 10.6694 4.6200 0.0 0
M  V30 12 C 2.6673 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6673 6.1600 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 936-58-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2033151-49-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-21148285
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective synthesis of cyclic guanidines by directed diamination of
unactivated alkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mailyan, Artur K.; Young, Kyle; Chen, Joanna L.; Reid, Bradley T.;
Zakarian, Armen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2016), 18(21), 5532-5535

$RFMT $RIREG SCHEME39 STEP1
$RXN



  3  2
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl alcohol
C7H8O
100-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[(2-Methoxyphenoxy)methyl]benzenemethanol
C15H16O3
18065-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 O 6.1600 6.6685 0.0 0
M  V30 5 O 1.5400 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.7800 6.6685 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 1 5 6
M  V30 7 1 5 8
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guaiacol
C7H8O2
90-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Diphenyl-2-pyrimidinamine
C16H13N3
40230-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 C 5.3348 4.6201 0.0 0
M  V30 4 N 6.6685 2.3101 0.0 0
M  V30 5 C 4.0012 3.8501 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 N 4.0012 2.3101 0.0 0
M  V30 8 C 8.0023 4.6201 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 C 8.0023 6.1601 0.0 0
M  V30 11 C 10.6697 4.6201 0.0 0
M  V30 12 C 9.3360 6.9302 0.0 0
M  V30 13 C 10.6697 6.1601 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 2.6673 6.1601 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 1.3337 6.9302 0.0 0
M  V30 19 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 8
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 14
M  V30 9 2 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-51-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 18065-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90-05-1
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 40230-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32737708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure tube used in stage 1, reaction conducted in the presence
of air
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transition-metal-free synthesis of pyrimidines from lignin β-O-4 segments
via a one-pot multi-component reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Bo; Guo, Tenglong; Li, Zhewei; Kuhn, Fritz E.; Lei, Ming; Zhao,
Zongbao K.; Xiao, Jianliang; Zhang, Jian; Xu, Dezhu; Zhang, Tao; Li,
Changzhi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2022), 13(1), 3365

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2-chloro-6-fluorobenzaldehyde
C7H3BrClFO
1114809-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 F 5.3348 4.6201 0.0 0
M  V30 5 Br 0.0000 1.5400 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 1.5400 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3338 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-5-chloro-2-quinazolinamine
C8H5BrClN3
1644663-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 4.0010 0.0 0
M  V30 2 Br 0.0000 1.3337 0.0 0
M  V30 3 N 8.4702 2.6673 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 N 6.1601 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 N 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1114809-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1644663-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38596370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridine sulfonamides as GCN2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Whitlock, Gavin; Fuchter, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023218195 A1 2023-11-16

$RFMT $RIREG SCHEME41 STEP1
$RXN



  3  1
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrapropylammonium hydroxide
C12H28N.HO
4499-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 5.5412 0.0 0 CHG=1 VAL=4
M  V30 2 C 2.6675 6.3112 0.0 0
M  V30 3 C 5.3348 4.7711 0.0 0
M  V30 4 C 4.7712 6.8748 0.0 0
M  V30 5 C 3.2311 4.2075 0.0 0
M  V30 6 C 1.3337 5.5412 0.0 0
M  V30 7 C 6.6687 5.5412 0.0 0
M  V30 8 C 4.0012 8.2087 0.0 0
M  V30 9 C 4.0012 2.8737 0.0 0
M  V30 10 C 0.0000 6.3112 0.0 0
M  V30 11 C 8.0023 4.7711 0.0 0
M  V30 12 C 4.7712 9.5423 0.0 0
M  V30 13 C 3.2311 1.5400 0.0 0
M  V30 14 O 4.0012 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Kemp's triacid
C12H18O6
79410-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 3.1941 0.8629 0.0 0
M  V30 5 C 2.2042 6.4769 0.0 0
M  V30 6 O 3.5378 7.2469 0.0 0
M  V30 7 O 0.8706 7.2469 0.0 0
M  V30 8 C 0.6876 5.2043 0.0 0
M  V30 9 C 6.0443 3.2546 0.0 0
M  V30 10 O 6.0443 1.7146 0.0 0
M  V30 11 O 7.3781 4.0246 0.0 0
M  V30 12 C 5.7006 5.2043 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 14 C 1.6775 3.4898 0.0 0
M  V30 15 C 4.1840 2.5775 0.0 0
M  V30 16 C 2.2042 4.9369 0.0 0 CFG=1
M  V30 17 C 4.7107 4.0246 0.0 0 CFG=2
M  V30 18 C 3.7208 5.2043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 13 4 CFG=3
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 16 5 CFG=1
M  V30 8 1 16 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 17 9 CFG=1
M  V30 12 1 17 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Propanaminium, N,N,N-tripropyl-, (1α,3α,5α)-1,3,5-trimethyl-1,3,5-cyclohexa...
C12H28N.C12H17O6.2CH5N3
1232674-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 19.8693 0.0 0
M  V30 2 N 2.6675 20.6393 0.0 0
M  V30 3 N 5.3348 20.6393 0.0 0
M  V30 4 N 4.0012 18.3293 0.0 0
M  V30 5 C 1.6459 11.0823 0.0 0
M  V30 6 O 0.3121 11.8523 0.0 0 CHG=-1
M  V30 7 O 1.6459 9.5423 0.0 0
M  V30 8 C 3.5062 10.4052 0.0 0
M  V30 9 C 2.5163 16.0193 0.0 0
M  V30 10 O 3.8499 16.7893 0.0 0
M  V30 11 O 1.1827 16.7893 0.0 0
M  V30 12 C 0.9997 14.7466 0.0 0
M  V30 13 C 6.3564 12.7970 0.0 0
M  V30 14 O 6.3564 11.2570 0.0 0
M  V30 15 O 7.6902 13.5670 0.0 0
M  V30 16 C 6.0127 14.7466 0.0 0
M  V30 17 C 2.9795 11.8523 0.0 0 CFG=1
M  V30 18 C 1.9896 13.0321 0.0 0
M  V30 19 C 4.4961 12.1198 0.0 0
M  V30 20 C 2.5163 14.4793 0.0 0 CFG=2
M  V30 21 C 5.0228 13.5670 0.0 0 CFG=1
M  V30 22 C 4.0329 14.7466 0.0 0
M  V30 23 N 4.0012 4.0012 0.0 0 CHG=1 VAL=4
M  V30 24 C 2.6675 4.7712 0.0 0
M  V30 25 C 5.3348 3.2311 0.0 0
M  V30 26 C 4.7712 5.3348 0.0 0
M  V30 27 C 3.2311 2.6675 0.0 0
M  V30 28 C 1.3337 4.0012 0.0 0
M  V30 29 C 6.6687 4.0012 0.0 0
M  V30 30 C 4.0012 6.6687 0.0 0
M  V30 31 C 4.0012 1.3337 0.0 0
M  V30 32 C 0.0000 4.7712 0.0 0
M  V30 33 C 8.0023 3.2311 0.0 0
M  V30 34 C 4.7712 8.0023 0.0 0
M  V30 35 C 3.2311 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 6 1 17 5 CFG=3
M  V30 7 1 17 8 CFG=1
M  V30 8 1 9 10
M  V30 9 2 9 11
M  V30 10 1 20 9 CFG=3
M  V30 11 1 20 12 CFG=1
M  V30 12 1 13 14
M  V30 13 2 13 15
M  V30 14 1 21 13 CFG=3
M  V30 15 1 21 16 CFG=1
M  V30 16 1 17 18
M  V30 17 1 17 19
M  V30 18 1 18 20
M  V30 19 1 19 21
M  V30 20 1 20 22
M  V30 21 1 21 22
M  V30 22 1 23 24
M  V30 23 1 23 25
M  V30 24 1 23 26
M  V30 25 1 23 27
M  V30 26 1 24 28
M  V30 27 1 25 29
M  V30 28 1 26 30
M  V30 29 1 27 31
M  V30 30 1 28 32
M  V30 31 1 29 33
M  V30 32 1 30 34
M  V30 33 1 31 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4499-86-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 79410-20-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1232674-91-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-5011632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controlled Aggregation of Multiple Guanidinium Ions through a
Hydrogen-Bonded Network Assembly with Deprotonated Forms of Kemp's
Triacid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Jie; Zang, Shuang-Quan; Mak, Thomas C. W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(17), 5078-5088,
S5078/1-S5078/10

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
4-Aminosalicylic acid
C7H7NO3
65-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-amino-2-hydroxy-, compd. with guanidine (1:1)
C7H7NO3.CH5N3
2973395-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4651 7.0810 0.0 0
M  V30 2 N 2.1314 7.8511 0.0 0
M  V30 3 N 4.7987 7.8511 0.0 0
M  V30 4 N 3.4651 5.5410 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 O 0.0000 4.0010 0.0 0
M  V30 7 O 0.0000 1.3337 0.0 0
M  V30 8 O 2.3101 0.0000 0.0 0
M  V30 9 N 6.9302 2.6673 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 3.0801 1.3337 0.0 0
M  V30 12 C 3.0801 4.0010 0.0 0
M  V30 13 C 4.6201 1.3337 0.0 0
M  V30 14 C 4.6201 4.0010 0.0 0
M  V30 15 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 6 1 5 10
M  V30 7 1 8 11
M  V30 8 1 9 15
M  V30 9 2 10 11
M  V30 10 1 10 12
M  V30 11 1 11 13
M  V30 12 2 12 14
M  V30 13 2 13 15
M  V30 14 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 65-49-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2973395-27-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37217161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Epoxy-amine systems with reactive guanidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Senchikhin, I. N.; Merkulova, M. S.; Sedishev, I. P.; Grammatikova, N.
E.; Uryupina, O. Ya.; Urodkova, E. K.; Zhavoronok, E. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Science, Series B: Polymer Chemistry (2023), 65(2), 133-143

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Salicylic acid
C7H6O3
69-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-hydroxy-, compd. with guanidine (1:1)
C7H6O3.CH5N3
38848-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6951 7.0810 0.0 0
M  V30 2 N 1.3614 7.8511 0.0 0
M  V30 3 N 4.0287 7.8511 0.0 0
M  V30 4 N 2.6951 5.5410 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 O 0.0000 4.0010 0.0 0
M  V30 7 O 0.0000 1.3337 0.0 0
M  V30 8 O 2.3101 0.0000 0.0 0
M  V30 9 C 2.3101 2.6673 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 3.0801 4.0010 0.0 0
M  V30 12 C 4.6201 1.3337 0.0 0
M  V30 13 C 4.6201 4.0010 0.0 0
M  V30 14 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 6 1 5 9
M  V30 7 1 8 10
M  V30 8 2 9 10
M  V30 9 1 9 11
M  V30 10 1 10 12
M  V30 11 2 11 13
M  V30 12 2 12 14
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 69-72-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 38848-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37217155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Epoxy-amine systems with reactive guanidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Senchikhin, I. N.; Merkulova, M. S.; Sedishev, I. P.; Grammatikova, N.
E.; Uryupina, O. Ya.; Urodkova, E. K.; Zhavoronok, E. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Science, Series B: Polymer Chemistry (2023), 65(2), 133-143

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Kemp's triacid
C12H18O6
79410-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 3.1941 0.8629 0.0 0
M  V30 5 C 2.2042 6.4769 0.0 0
M  V30 6 O 3.5378 7.2469 0.0 0
M  V30 7 O 0.8706 7.2469 0.0 0
M  V30 8 C 0.6876 5.2043 0.0 0
M  V30 9 C 6.0443 3.2546 0.0 0
M  V30 10 O 6.0443 1.7146 0.0 0
M  V30 11 O 7.3781 4.0246 0.0 0
M  V30 12 C 5.7006 5.2043 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 14 C 1.6775 3.4898 0.0 0
M  V30 15 C 4.1840 2.5775 0.0 0
M  V30 16 C 2.2042 4.9369 0.0 0 CFG=1
M  V30 17 C 4.7107 4.0246 0.0 0 CFG=2
M  V30 18 C 3.7208 5.2043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 13 4 CFG=3
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 16 5 CFG=1
M  V30 8 1 16 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 17 9 CFG=1
M  V30 12 1 17 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,3,5-Cyclohexanetricarboxylic acid, 1,3,5-trimethyl-, (1α,3α,5α)-, compd. wi...
C12H18O6.3CH5N3
1232674-89-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 1.3338 3.8501 0.0 0
M  V30 4 C 3.1941 4.7129 0.0 0
M  V30 5 C 2.2042 10.3270 0.0 0
M  V30 6 O 3.5378 11.0970 0.0 0
M  V30 7 O 0.8706 11.0970 0.0 0
M  V30 8 C 0.6876 9.0543 0.0 0
M  V30 9 C 6.0443 7.1047 0.0 0
M  V30 10 O 6.0443 5.5647 0.0 0
M  V30 11 O 7.3781 7.8747 0.0 0
M  V30 12 C 5.7006 9.0543 0.0 0
M  V30 13 C 2.6674 6.1601 0.0 0 CFG=2
M  V30 14 C 1.6775 7.3398 0.0 0
M  V30 15 C 4.1840 6.4275 0.0 0
M  V30 16 C 2.2042 8.7870 0.0 0 CFG=1
M  V30 17 C 4.7107 7.8747 0.0 0 CFG=2
M  V30 18 C 3.7208 9.0543 0.0 0
M  V30 19 C 3.6891 1.5400 0.0 0
M  V30 20 N 2.3554 2.3101 0.0 0
M  V30 21 N 5.0227 2.3101 0.0 0
M  V30 22 N 3.6891 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 13 4 CFG=3
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 16 5 CFG=1
M  V30 8 1 16 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 17 9 CFG=1
M  V30 12 1 17 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79410-20-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1232674-89-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-756738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends on stoichiometry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controlled Aggregation of Multiple Guanidinium Ions through a
Hydrogen-Bonded Network Assembly with Deprotonated Forms of Kemp's
Triacid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Jie; Zang, Shuang-Quan; Mak, Thomas C. W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(17), 5078-5088,
S5078/1-S5078/10

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Kemp's triacid
C12H18O6
79410-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 C 3.1941 0.8629 0.0 0
M  V30 5 C 2.2042 6.4769 0.0 0
M  V30 6 O 3.5378 7.2469 0.0 0
M  V30 7 O 0.8706 7.2469 0.0 0
M  V30 8 C 0.6876 5.2043 0.0 0
M  V30 9 C 6.0443 3.2546 0.0 0
M  V30 10 O 6.0443 1.7146 0.0 0
M  V30 11 O 7.3781 4.0246 0.0 0
M  V30 12 C 5.7006 5.2043 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 14 C 1.6775 3.4898 0.0 0
M  V30 15 C 4.1840 2.5775 0.0 0
M  V30 16 C 2.2042 4.9369 0.0 0 CFG=1
M  V30 17 C 4.7107 4.0246 0.0 0 CFG=2
M  V30 18 C 3.7208 5.2043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 13 4 CFG=3
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 16 5 CFG=1
M  V30 8 1 16 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 17 9 CFG=1
M  V30 12 1 17 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,3,5-Cyclohexanetricarboxylic acid, 1,3,5-trimethyl-, (1α,3α,5α)-, compd. wi...
C12H18O6.CH5N3
1233219-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 1.3338 3.8501 0.0 0
M  V30 4 C 3.1941 4.7129 0.0 0
M  V30 5 C 2.2042 10.3270 0.0 0
M  V30 6 O 3.5378 11.0970 0.0 0
M  V30 7 O 0.8706 11.0970 0.0 0
M  V30 8 C 0.6876 9.0543 0.0 0
M  V30 9 C 6.0443 7.1047 0.0 0
M  V30 10 O 6.0443 5.5647 0.0 0
M  V30 11 O 7.3781 7.8747 0.0 0
M  V30 12 C 5.7006 9.0543 0.0 0
M  V30 13 C 2.6674 6.1601 0.0 0 CFG=2
M  V30 14 C 1.6775 7.3398 0.0 0
M  V30 15 C 4.1840 6.4275 0.0 0
M  V30 16 C 2.2042 8.7870 0.0 0 CFG=1
M  V30 17 C 4.7107 7.8747 0.0 0 CFG=2
M  V30 18 C 3.7208 9.0543 0.0 0
M  V30 19 C 3.6891 1.5400 0.0 0
M  V30 20 N 2.3554 2.3101 0.0 0
M  V30 21 N 5.0227 2.3101 0.0 0
M  V30 22 N 3.6891 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 13 4 CFG=3
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 16 5 CFG=1
M  V30 8 1 16 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 17 9 CFG=1
M  V30 12 1 17 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79410-20-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1233219-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-9138385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends on stoichiometry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controlled Aggregation of Multiple Guanidinium Ions through a
Hydrogen-Bonded Network Assembly with Deprotonated Forms of Kemp's
Triacid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Jie; Zang, Shuang-Quan; Mak, Thomas C. W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(17), 5078-5088,
S5078/1-S5078/10

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Sulfosalicylic acid
C7H6O6S
97-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 O 6.6687 0.0000 0.0 0
M  V30 5 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 6 O 2.1037 4.4137 0.0 0
M  V30 7 O 0.5637 1.7464 0.0 0
M  V30 8 O 0.0000 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-hydroxy-5-sulfo-, compd. with guanidine (1:1)
C7H6O6S.CH5N3
156377-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 7.7001 0.0 0
M  V30 2 N 2.6675 8.4702 0.0 0
M  V30 3 N 5.3348 8.4702 0.0 0
M  V30 4 N 4.0012 6.1601 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 O 8.0023 2.3101 0.0 0
M  V30 7 O 6.6687 4.6201 0.0 0
M  V30 8 O 6.6687 0.0000 0.0 0
M  V30 9 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 10 O 2.1037 4.4137 0.0 0
M  V30 11 O 0.5637 1.7464 0.0 0
M  V30 12 O 0.0000 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6675 2.3101 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 6 1 5 13
M  V30 7 1 8 15
M  V30 8 2 9 10
M  V30 9 2 9 11
M  V30 10 1 9 12
M  V30 11 1 9 16
M  V30 12 2 13 14
M  V30 13 1 13 15
M  V30 14 1 14 16
M  V30 15 2 15 17
M  V30 16 2 16 18
M  V30 17 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 97-05-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 156377-67-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37217153
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Epoxy-amine systems with reactive guanidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Senchikhin, I. N.; Merkulova, M. S.; Sedishev, I. P.; Grammatikova, N.
E.; Uryupina, O. Ya.; Urodkova, E. K.; Zhavoronok, E. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Science, Series B: Polymer Chemistry (2023), 65(2), 133-143

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Sulfosalicylic acid
C7H6O6S
97-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 O 6.6687 0.0000 0.0 0
M  V30 5 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 6 O 2.1037 4.4137 0.0 0
M  V30 7 O 0.5637 1.7464 0.0 0
M  V30 8 O 0.0000 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-hydroxy-5-sulfo-, compd. with guanidine (1:2)
C7H6O6S.2CH5N3
1782936-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 7.7001 0.0 0
M  V30 2 N 2.6675 8.4702 0.0 0
M  V30 3 N 5.3348 8.4702 0.0 0
M  V30 4 N 4.0012 6.1601 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 O 8.0023 2.3101 0.0 0
M  V30 7 O 6.6687 4.6201 0.0 0
M  V30 8 O 6.6687 0.0000 0.0 0
M  V30 9 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 10 O 2.1037 4.4137 0.0 0
M  V30 11 O 0.5637 1.7464 0.0 0
M  V30 12 O 0.0000 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6675 2.3101 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 6 1 5 13
M  V30 7 1 8 15
M  V30 8 2 9 10
M  V30 9 2 9 11
M  V30 10 1 9 12
M  V30 11 1 9 16
M  V30 12 2 13 14
M  V30 13 1 13 15
M  V30 14 1 14 16
M  V30 15 2 15 17
M  V30 16 2 16 18
M  V30 17 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 97-05-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1782936-78-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37217156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Epoxy-amine systems with reactive guanidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Senchikhin, I. N.; Merkulova, M. S.; Sedishev, I. P.; Grammatikova, N.
E.; Uryupina, O. Ya.; Urodkova, E. K.; Zhavoronok, E. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Science, Series B: Polymer Chemistry (2023), 65(2), 133-143

$RFMT $RIREG SCHEME48 STEP1
$RXN



  3  1
$MOL
4′-Methoxyacetophenone
C9H10O2
100-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-4′-methoxychalcone
C16H13ClO2
6552-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 O 13.3370 4.6201 0.0 0
M  V30 6 C 14.6707 3.8501 0.0 0
M  V30 7 Cl 0.0000 4.6201 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 C 10.6697 1.5400 0.0 0
M  V30 10 C 9.3358 3.8501 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 12.0033 3.8501 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenyl)-2,6-bis(4-methoxyphenyl)pyridine
C25H20ClNO2
857500-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 14.6708 11.5503 0.0 0
M  V30 2 C 16.0046 10.7802 0.0 0
M  V30 3 O 1.3338 11.5503 0.0 0
M  V30 4 C 0.0000 10.7802 0.0 0
M  V30 5 Cl 8.0023 0.0000 0.0 0
M  V30 6 C 9.3360 8.4702 0.0 0
M  V30 7 N 8.0023 9.2402 0.0 0
M  V30 8 C 9.3360 6.9302 0.0 0
M  V30 9 C 6.6687 8.4702 0.0 0
M  V30 10 C 8.0023 6.1601 0.0 0
M  V30 11 C 6.6687 6.9302 0.0 0
M  V30 12 C 10.6698 9.2402 0.0 0
M  V30 13 C 12.0035 8.4702 0.0 0
M  V30 14 C 10.6698 10.7802 0.0 0
M  V30 15 C 13.3372 9.2402 0.0 0
M  V30 16 C 12.0035 11.5503 0.0 0
M  V30 17 C 13.3372 10.7802 0.0 0
M  V30 18 C 5.3348 9.2402 0.0 0
M  V30 19 C 5.3348 10.7802 0.0 0
M  V30 20 C 4.0012 8.4702 0.0 0
M  V30 21 C 4.0012 11.5503 0.0 0
M  V30 22 C 2.6675 9.2402 0.0 0
M  V30 23 C 2.6675 10.7802 0.0 0
M  V30 24 C 8.0023 4.6201 0.0 0
M  V30 25 C 6.6687 3.8501 0.0 0
M  V30 26 C 9.3360 3.8501 0.0 0
M  V30 27 C 6.6687 2.3101 0.0 0
M  V30 28 C 9.3360 2.3101 0.0 0
M  V30 29 C 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 1 3 23
M  V30 5 1 5 29
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 2 10 11
M  V30 14 1 10 24
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-06-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 6552-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 857500-67-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-5163725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-reagent, microwave irradiation (600W), no solvent,
mechanism studied
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave-assisted, solvent-free, three-component synthesis of
2,4,6-triarylpyridines from benign components
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zomordbakhsh, Shahab; Anaraki-Ardakani, Hossein; Zeeb, Mohsen; Sadeghi,
Mahdi; Mazraeh-Seffid, Manouchehr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2012), 36(3), 138-140

$RFMT $RIREG SCHEME49 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30176977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, CuO-nanoparticles prepared by supercritical
hydrothermal synthesis used as catalyst, catalyst recyclable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CuO nanoparticles, a mild and efficient reusable catalyst for the one-pot
synthesis of 4-amino-5-pyrimidin-ecarbonitriles under aqueous conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmadi, Seyed Javad; Sadjadi, Sodeh; Hosseinpour, Morteza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Diffusion and Defect Data--Solid State Data, Pt. A: Defect and Diffusion
Forum (2012), 326-328372-376

$RFMT $RIREG SCHEME49 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28588664
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, reusable catalyst,
alumina-supported potassium fluoride catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM KF/Al2O3: as a solid phase and recyclable basic catalyst for synthesis
mono and bis pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abaszadeh, Mehdi; Seifi, Mohammad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Iranian Journal of Chemistry & Chemical Engineering (2017), 36(1), 35-43

$RFMT $RIREG SCHEME50 STEP1
$RXN



  3  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxybenzaldehyde
C7H6O2
123-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Dimethylamino)-1-phenyl-2-propen-1-one
C11H13NO
1201-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 C 9.3358 1.5400 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-Amino-1,6-dihydro-6-(4-hydroxyphenyl)-5-pyrimidinyl]phenylmethanone
C17H15N3O2
2747886-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 5.3347 6.9300 0.0 0
M  V30 3 N 4.0011 0.0000 0.0 0
M  V30 4 O 10.6694 6.9300 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 N 5.3347 2.3100 0.0 0
M  V30 8 C 2.6673 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 N 2.6673 2.3100 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 C 8.0021 3.8500 0.0 0
M  V30 13 C 6.6684 6.1600 0.0 0
M  V30 14 C 9.3358 4.6200 0.0 0
M  V30 15 C 8.0021 6.9300 0.0 0
M  V30 16 C 9.3358 6.1600 0.0 0
M  V30 17 C 2.6673 6.9300 0.0 0
M  V30 18 C 2.6673 8.4700 0.0 0
M  V30 19 C 1.3336 6.1600 0.0 0
M  V30 20 C 1.3336 9.2400 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 22 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 17
M  V30 4 1 3 9
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-08-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1201-93-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2747886-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24765487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation, 400 W used, alternate method may
be used, Biginelli reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green Synthesis of Dihydropyrimidines and Pyridines Utilizing Biginelli
Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Zaydi, Khadijah M.; Al-Boqami, Modi; Elnagdi, Noha M. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2022), 42(10), 7298-7309

$RFMT $RIREG SCHEME51 STEP1
$RXN



  5  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenecarbohydrazonoyl chloride
C7H7ClN2
39950-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 Cl 5.3901 0.0000 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C27H28N6O5
3022925-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 2.6675 0.0 0
M  V30 2 O 5.9538 1.3337 0.0 0
M  V30 3 O 8.2638 2.6675 0.0 0
M  V30 4 C 6.7238 0.0000 0.0 0
M  V30 5 N 2.1037 5.3348 0.0 0
M  V30 6 C 1.3337 6.6685 0.0 0
M  V30 7 C 0.0000 5.8985 0.0 0
M  V30 8 C 0.5637 8.0023 0.0 0
M  V30 9 C 2.6673 7.4385 0.0 0
M  V30 10 C 3.6437 2.6675 0.0 0
M  V30 11 O 2.1037 2.6675 0.0 0
M  V30 12 O 4.4137 1.3337 0.0 0
M  V30 13 C 1.3337 1.3337 0.0 0
M  V30 14 O 12.3774 3.5854 0.0 0
M  V30 15 C 13.8837 3.9055 0.0 0
M  V30 16 N 6.7238 8.0023 0.0 0
M  V30 17 C 8.2554 8.1633 0.0 0
M  V30 18 C 6.0975 9.4091 0.0 0
M  V30 19 N 8.5757 9.6696 0.0 0
M  V30 20 N 7.2419 10.4396 0.0 0
M  V30 21 C 5.9538 6.6685 0.0 0
M  V30 22 N 6.7238 5.3348 0.0 0
M  V30 23 N 4.4137 6.6685 0.0 0
M  V30 24 C 5.9538 4.0012 0.0 0
M  V30 25 C 3.6437 5.3348 0.0 0
M  V30 26 C 4.4137 4.0012 0.0 0
M  V30 27 C 9.2859 7.0187 0.0 0
M  V30 28 C 10.7922 7.3390 0.0 0
M  V30 29 C 8.8101 5.5541 0.0 0
M  V30 30 C 11.8227 6.1945 0.0 0
M  V30 31 C 9.8405 4.4096 0.0 0
M  V30 32 C 11.3468 4.7299 0.0 0
M  V30 33 C 4.5910 9.7293 0.0 0
M  V30 34 C 3.5606 8.5849 0.0 0
M  V30 35 C 4.1151 11.1940 0.0 0
M  V30 36 C 2.0543 8.9051 0.0 0
M  V30 37 C 2.6088 11.5142 0.0 0
M  V30 38 C 1.5782 10.3697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 26
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 32
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21
M  V30 19 2 17 19
M  V30 20 1 17 27
M  V30 21 2 18 20
M  V30 22 1 18 33
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 39950-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3022925-79-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38650887
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green preparation of new pyrimidine triazole derivatives via one-pot
multicomponent reactions of guanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hezarcheshmeh, Nasrin Karami; Godarzbod, Farideh; Abdullah, Media Noori;
Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2024), 28(1), 217-228

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[3-(dimethylamino)-1-oxo-2-propen-1-yl]-4-(phenylmetho...
C23H28N2O4
1345693-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 O 5.3900 5.3347 0.0 0
M  V30 4 C 6.9300 2.6673 0.0 0
M  V30 5 N 7.7000 1.3336 0.0 0
M  V30 6 C 6.9300 0.0000 0.0 0
M  V30 7 C 9.2400 1.3336 0.0 0
M  V30 8 O 5.3900 8.0020 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 N 11.5500 8.0020 0.0 0
M  V30 11 C 12.3200 9.3358 0.0 0
M  V30 12 O 13.8600 9.3358 0.0 0
M  V30 13 O 11.5500 10.6694 0.0 0
M  V30 14 C 14.6300 10.6694 0.0 0
M  V30 15 C 13.2964 11.4394 0.0 0
M  V30 16 C 15.4000 12.0031 0.0 0
M  V30 17 C 15.9636 9.8994 0.0 0
M  V30 18 C 7.7000 6.6684 0.0 0
M  V30 19 C 6.9300 8.0020 0.0 0
M  V30 20 C 9.2400 6.6684 0.0 0
M  V30 21 C 7.7000 9.3358 0.0 0
M  V30 22 C 10.0100 8.0020 0.0 0
M  V30 23 C 9.2400 9.3358 0.0 0
M  V30 24 C 3.0800 9.3358 0.0 0
M  V30 25 C 2.3100 10.6694 0.0 0
M  V30 26 C 2.3100 8.0020 0.0 0
M  V30 27 C 0.7700 10.6694 0.0 0
M  V30 28 C 0.7700 8.0020 0.0 0
M  V30 29 C 0.0000 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 19
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-(2-amino-4-pyrimidinyl)-4-(phenylmethoxy)phenyl]carbamate
C22H24N4O3
1318802-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 N 11.5500 6.6684 0.0 0
M  V30 4 C 12.3200 8.0021 0.0 0
M  V30 5 O 13.8600 8.0021 0.0 0
M  V30 6 O 11.5500 9.3358 0.0 0
M  V30 7 C 14.6300 9.3358 0.0 0
M  V30 8 C 15.9636 8.5658 0.0 0
M  V30 9 C 15.4000 10.6694 0.0 0
M  V30 10 C 13.2964 10.1058 0.0 0
M  V30 11 N 7.7000 0.0000 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 7.7000 8.0021 0.0 0
M  V30 16 C 10.0100 6.6684 0.0 0
M  V30 17 C 9.2400 8.0021 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 N 7.7000 2.6673 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 6.9300 1.3336 0.0 0
M  V30 22 C 4.6200 2.6673 0.0 0
M  V30 23 N 5.3900 1.3336 0.0 0
M  V30 24 C 3.0800 8.0021 0.0 0
M  V30 25 C 2.3100 6.6684 0.0 0
M  V30 26 C 2.3100 9.3358 0.0 0
M  V30 27 C 0.7700 6.6684 0.0 0
M  V30 28 C 0.7700 9.3358 0.0 0
M  V30 29 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 24
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 21
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1345693-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1318802-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2643134
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Jinho; Kim, Kyoung-Hee; Jeong, Shinwu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(14), 4203-4205

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Dinitromethylene)-1-nitroimidazolidine
C4H5N5O6
140657-72-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5253 2.6217 0.0 0
M  V30 2 N 4.5253 4.1617 0.0 0 VAL=5
M  V30 3 N 5.8591 1.8517 0.0 0 VAL=5
M  V30 4 O 5.8591 4.9317 0.0 0
M  V30 5 O 3.1917 4.9317 0.0 0
M  V30 6 O 7.1927 2.6217 0.0 0
M  V30 7 O 5.8591 0.3117 0.0 0
M  V30 8 N 1.4647 3.9844 0.0 0 VAL=5
M  V30 9 O 0.0000 4.4603 0.0 0
M  V30 10 O 2.6091 5.0149 0.0 0
M  V30 11 C 3.1917 1.8517 0.0 0
M  V30 12 N 1.7849 2.4780 0.0 0
M  V30 13 N 3.0307 0.3202 0.0 0
M  V30 14 C 0.7543 1.3336 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 11
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 2 3 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 12
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine, compd. with 2-(dinitromethyl)-4,5-dihydro-1-nitro-1H-imidazole (1:1)
C4H5N5O6.CH5N3
1379459-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5253 6.4717 0.0 0
M  V30 2 N 4.5253 8.0117 0.0 0 VAL=5
M  V30 3 N 5.8591 5.7017 0.0 0 VAL=5
M  V30 4 O 5.8591 8.7817 0.0 0
M  V30 5 O 3.1917 8.7817 0.0 0
M  V30 6 O 7.1927 6.4717 0.0 0
M  V30 7 O 5.8591 4.1617 0.0 0
M  V30 8 N 1.4647 7.8345 0.0 0 VAL=5
M  V30 9 O 0.0000 8.3104 0.0 0
M  V30 10 O 2.6091 8.8649 0.0 0
M  V30 11 C 3.1917 5.7017 0.0 0
M  V30 12 N 1.7849 6.3281 0.0 0
M  V30 13 N 3.0307 4.1702 0.0 0
M  V30 14 C 0.7543 5.1837 0.0 0
M  V30 15 C 1.5243 3.8501 0.0 0
M  V30 16 C 3.5964 1.5400 0.0 0
M  V30 17 N 2.2627 2.3101 0.0 0
M  V30 18 N 4.9300 2.3101 0.0 0
M  V30 19 N 3.5964 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 2 3 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 12
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 140657-72-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1379459-34-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29327059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM safety
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-(Dinitromethylene)-1-nitro-1, 3-diazacyclopentane-Based Energetic Salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Jinhong; Zhou, Zhiming; Cao, Dan; Huang, Haifeng; Liang, Lixuan;
Wang, Kai; Zhang, Jun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Anorganische und Allgemeine Chemie (2012), 638(5),
811-820

$RFMT $RIREG SCHEME54 STEP1
$RXN



  3  1
$MOL
Diazomethane
CH2N2
334-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0 CHG=1 VAL=4
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 N 3.0800 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorocinnamic acid
C9H7ClO2
1615-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6675 1.5400 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R)-N-(Aminoiminomethyl)-2-(4-chlorophenyl)cyclopropanecarboxamide
C11H12ClN3O
230639-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2085 2.1037 0.0 0
M  V30 2 N 9.5424 1.3337 0.0 0
M  V30 3 O 8.2085 3.6437 0.0 0
M  V30 4 C 10.8760 2.1037 0.0 0
M  V30 5 N 10.8760 3.6437 0.0 0
M  V30 6 N 12.2097 1.3337 0.0 0
M  V30 7 Cl 0.0000 4.4137 0.0 0
M  V30 8 C 5.3348 1.3337 0.0 0 CFG=1
M  V30 9 C 6.8749 1.3337 0.0 0 CFG=1
M  V30 10 C 6.1048 0.0000 0.0 0
M  V30 11 C 4.0012 2.1037 0.0 0
M  V30 12 C 2.6673 1.3337 0.0 0
M  V30 13 C 4.0012 3.6437 0.0 0
M  V30 14 C 1.3337 2.1037 0.0 0
M  V30 15 C 2.6673 4.4137 0.0 0
M  V30 16 C 1.3337 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 334-88-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1615-02-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 230639-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-287-CAS-10759905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure A. General Procedure for Preparing
Arylcyclopropanecarboxyl Guanidines 3a-k from Cinnamic Acids or Esters.13
To a solution of the cinnamic acid or ester (0.5 mmol) in THF (10 mL)
were added Pd(OAc)2 (5 mg) and a cold (0°C) ethereal solution of
diazomethane (6 mL, freshly prepared from
1-methyl-3-nitro-1-nitrosoguanidine (MNNG, 74 mg, 4.5 mmol)) alternately
in small portions with continuous stirring during 10-15 min (the addition
of diazomethane was done in small portions just following each addition
of the palladium catalyst). It is noteworthy that the analytical HPLC
retention times and the TLC Rf values for the cinnamates and the
corresponding cyclopropyl esters are almost indistinguishable.
Furthermore, we could not observe the molecular ions (M + H)+ for the
cyclopropyl esters in LC/MS. Therefore, the progress of these reactions
was monitored by 1H NMR. Upon completion of the reaction, a few drops of
glacial acetic acid were added to quench excess diazomethane. The
reaction mixture was filtered through Celite, and the filtrate was
concentrated to give a thick dark brown residue. The crude cyclopropyl
esters thus prepared were dissolved in 0.5 mL of DMF and treated with a
solution of guanidine (148 mg, 2.5 mmol) in DMF (1 mL). The reaction
mixtures were stirred for 12 h at room temperature, diluted with water,
and extracted with EtOAc. The organic layer was dried over magnesium
sulfate and concentrated, and the residue was subjected to reversed-phase
preparative HPLC (ODS column/H2O-MeOH-TFA, 90:10:0.1 to 10:90:0.1
gradient) to afford the corresponding acyl guanidines as TFA salts. The
following compounds (3a-k) were prepared by the general procedure A
described above.
(±)-trans-N-(Aminoiminomethyl)-2-(4-chlorophenyl)-cyclopropanecarboxamide
(3d):. gummy solid (TFA salt, 38% yield). 1H NMR (500 MHz, CDCl3) δ 12.08
(brs, 1H), 8.54 (brs, 2H), 8.16 (brs, 2H), 7.26 (d, 2H, J = 8.2 Hz), 7.04
(d, 2H, J = 8.8 Hz), 2.63-2.61 (m, 1H), 2.04-2.02 (m, 1H), 1.75-1.72 (m,
1H), 1.45-1.43 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 174.91, 155.90,
137.10, 132.83, 128.74, 127.73, 27.97, 25.98, 18.66; HRMS (ESI) calcd for
C11H12ClN3O (M + H)+ 238.0748, found 238.0748; Anal. HPLC tR = 2.9 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylcyclopropanecarboxyl Guanidines as Novel, Potent, and Selective
Inhibitors of the Sodium Hydrogen Exchanger Isoform-1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmad, Saleem; Doweyko, Lidia M.; Dugar, Sundeep; Grazier, Nyeemah; Ngu,
Khehyong; Wu, Shung C.; Yost, Kenneth J.; Chen, Bang-Chi; Gougoutas, Jack
Z.; DiMarco, John D.; Lan, Shih-Jung; Gavin, Brian J.; Chen, Alice Y.;
Dorso, Charles R.; Serafino, Randy; Kirby, Mark; Atwal, Karnail S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2001), 44(20), 3302-3310

$RFMT $RIREG SCHEME55 STEP1
$RXN



  3  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloroisatin
C8H4ClNO2
17630-76-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 O 7.9110 2.7104 0.0 0
M  V30 3 Cl 0.0000 1.1704 0.0 0
M  V30 4 C 4.0011 1.9404 0.0 0
M  V30 5 C 4.0011 3.4804 0.0 0
M  V30 6 C 5.4658 1.4645 0.0 0
M  V30 7 C 2.6674 1.1704 0.0 0
M  V30 8 N 5.4658 3.9564 0.0 0
M  V30 9 C 2.6674 4.2504 0.0 0
M  V30 10 C 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 1.9404 0.0 0
M  V30 12 C 1.3338 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5′-chlorospiro[4H-indeno[1,2-d]pyrimidine-4,3′-[3H]indole]-2′,5(1′H,3...
C18H11ClN4O2
2271156-44-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0898 4.9995 0.0 0
M  V30 2 O 3.7827 5.8785 0.0 0
M  V30 3 N 8.1200 0.0000 0.0 0
M  V30 4 Cl 12.0006 3.4595 0.0 0
M  V30 5 C 6.5350 3.7536 0.0 0
M  V30 6 C 5.0286 3.4334 0.0 0
M  V30 7 C 7.9995 4.2295 0.0 0
M  V30 8 C 5.6298 4.9995 0.0 0
M  V30 9 N 7.5654 2.6091 0.0 0
M  V30 10 C 4.5527 1.9687 0.0 0
M  V30 11 C 3.7827 4.3385 0.0 0
M  V30 12 C 7.9995 5.7695 0.0 0
M  V30 13 C 9.3332 3.4595 0.0 0
M  V30 14 N 6.5350 6.2453 0.0 0
M  V30 15 C 7.0895 1.1445 0.0 0
M  V30 16 C 3.0127 1.9687 0.0 0
M  V30 17 N 5.5831 0.8244 0.0 0
M  V30 18 C 2.5368 3.4334 0.0 0
M  V30 19 C 9.3332 6.5395 0.0 0
M  V30 20 C 10.6670 4.2295 0.0 0
M  V30 21 C 1.9823 0.8244 0.0 0
M  V30 22 C 1.0304 3.7536 0.0 0
M  V30 23 C 10.6670 5.7695 0.0 0
M  V30 24 C 0.4759 1.1445 0.0 0
M  V30 25 C 0.0000 2.6091 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 11
M  V30 3 1 3 15
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 10 17
M  V30 17 1 11 18
M  V30 18 1 12 14
M  V30 19 2 12 19
M  V30 20 1 13 20
M  V30 21 2 15 17
M  V30 22 1 16 18
M  V30 23 2 16 21
M  V30 24 2 18 22
M  V30 25 1 19 23
M  V30 26 2 20 23
M  V30 27 1 21 24
M  V30 28 1 22 25
M  V30 29 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 17630-76-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271156-44-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29583211
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12017-35-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM nickel terephthalic acid supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, catalyst prepared and used, recyclable catalyst
used, reusable catalyst used, optimization study, optimized on
stoichiometry amount of catalyst, time and catalyst, solid supported
catalyst, nickel terephthalic acid support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM NiCo2O4@Ni(BDC) Nano-Porous Metal-Organic Framework as a Novel Catalyst
for the Synthesis of Spiro[indene[1,2-d]pyrimidine]-ones and
Investigation of Their Antimicrobial Activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Farhadi, Simin; Ghasemzadeh, Mohammad Ali; Aghaei, Seyyed Soheil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2019), 4(2), 729-736

$RFMT $RIREG SCHEME56 STEP1
$RXN



  3  1
$MOL
Diazomethane
CH2N2
334-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0 CHG=1 VAL=4
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 N 3.0800 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxycinnamic acid
C10H10O3
6099-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 9.3360 1.5400 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 8.0023 2.3101 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R)-N-(Aminoiminomethyl)-2-(3-methoxyphenyl)cyclopropanecarboxamide
C12H15N3O2
370867-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 2.6673 3.0801 0.0 0
M  V30 3 O 4.0012 0.7700 0.0 0
M  V30 4 C 1.3337 2.3101 0.0 0
M  V30 5 N 1.3337 0.7700 0.0 0
M  V30 6 N 0.0000 3.0801 0.0 0
M  V30 7 O 12.2097 3.0801 0.0 0
M  V30 8 C 13.5434 2.3101 0.0 0
M  V30 9 C 6.8749 3.0801 0.0 0 CFG=1
M  V30 10 C 5.3348 3.0801 0.0 0 CFG=1
M  V30 11 C 6.1048 4.4137 0.0 0
M  V30 12 C 8.2085 2.3101 0.0 0
M  V30 13 C 9.5422 3.0801 0.0 0
M  V30 14 C 8.2085 0.7700 0.0 0
M  V30 15 C 10.8760 2.3101 0.0 0
M  V30 16 C 9.5422 0.0000 0.0 0
M  V30 17 C 10.8760 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12 CFG=3
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 334-88-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6099-04-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 370867-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-287-CAS-6780895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure A. General Procedure for Preparing
Arylcyclopropanecarboxyl Guanidines 3a-k from Cinnamic Acids or Esters.13
To a solution of the cinnamic acid or ester (0.5 mmol) in THF (10 mL)
were added Pd(OAc)2 (5 mg) and a cold (0°C) ethereal solution of
diazomethane (6 mL, freshly prepared from
1-methyl-3-nitro-1-nitrosoguanidine (MNNG, 74 mg, 4.5 mmol)) alternately
in small portions with continuous stirring during 10-15 min (the addition
of diazomethane was done in small portions just following each addition
of the palladium catalyst). It is noteworthy that the analytical HPLC
retention times and the TLC Rf values for the cinnamates and the
corresponding cyclopropyl esters are almost indistinguishable.
Furthermore, we could not observe the molecular ions (M + H)+ for the
cyclopropyl esters in LC/MS. Therefore, the progress of these reactions
was monitored by 1H NMR. Upon completion of the reaction, a few drops of
glacial acetic acid were added to quench excess diazomethane. The
reaction mixture was filtered through Celite, and the filtrate was
concentrated to give a thick dark brown residue. The crude cyclopropyl
esters thus prepared were dissolved in 0.5 mL of DMF and treated with a
solution of guanidine (148 mg, 2.5 mmol) in DMF (1 mL). The reaction
mixtures were stirred for 12 h at room temperature, diluted with water,
and extracted with EtOAc. The organic layer was dried over magnesium
sulfate and concentrated, and the residue was subjected to reversed-phase
preparative HPLC (ODS column/H2O-MeOH-TFA, 90:10:0.1 to 10:90:0.1
gradient) to afford the corresponding acyl guanidines as TFA salts. The
following compounds (3a-k) were prepared by the general procedure A
described above.
(±)-trans-N-(Aminoiminomethyl)-2-(3-methoxyphenyl)-cyclopropanecarboxamide
(3f). white solid (TFA salt, 98% yield). 1H NMR (500 MHz, CDCl3) δ 12.04
(brs, 1H), 8.55 (brs, 2H), 8.15 (brs, 2H), 7.20 (t, 1H, 7.7 Hz, 8.2 Hz),
6.77 (d, 1H, J = 8.2 Hz), 6.69 (d, 1H, J = 7.7 Hz), 6.64 (s, 1H), 3.78
(s, 3H), 2.64-2.63 (m, 1H), 2.07-2.05 (m, 1H), 1.74-1.71 (m, 1H),
1.48-1.45 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 174.50, 159.82, 156.20,
140.21, 129.65, 118.57, 112.61, 111.94, 55.16, 28.69, 26.02, 18.89; HRMS
(ESI) calcd for C12H15N3O2 (M + H)+ 234.1243, found 234.1241; Anal. HPLC
tR = 2.6 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylcyclopropanecarboxyl Guanidines as Novel, Potent, and Selective
Inhibitors of the Sodium Hydrogen Exchanger Isoform-1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmad, Saleem; Doweyko, Lidia M.; Dugar, Sundeep; Grazier, Nyeemah; Ngu,
Khehyong; Wu, Shung C.; Yost, Kenneth J.; Chen, Bang-Chi; Gougoutas, Jack
Z.; DiMarco, John D.; Lan, Shih-Jung; Gavin, Brian J.; Chen, Alice Y.;
Dorso, Charles R.; Serafino, Randy; Kirby, Mark; Atwal, Karnail S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2001), 44(20), 3302-3310

$RFMT $RIREG SCHEME57 STEP1
$RXN



  3  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ninhydrin
C9H6O4
485-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.2334 0.0000 0.0 0
M  V30 2 O 0.5228 4.6949 0.0 0
M  V30 3 O 0.0000 2.4529 0.0 0
M  V30 4 O 1.0304 0.6682 0.0 0
M  V30 5 C 3.9437 2.6508 0.0 0
M  V30 6 C 3.1737 3.9845 0.0 0
M  V30 7 C 2.9132 1.5064 0.0 0
M  V30 8 C 5.4837 2.6508 0.0 0
M  V30 9 C 1.6674 3.6643 0.0 0
M  V30 10 C 3.9437 5.3183 0.0 0
M  V30 11 C 1.5063 2.1328 0.0 0
M  V30 12 C 6.2537 3.9845 0.0 0
M  V30 13 C 5.4837 5.3183 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Aminospiro[2H-indene-2,4′-[4H]indeno[1,2-d]pyrimidine]-1,3,5′(3′H)-trione
C19H11N3O3
1449786-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0203 1.7173 0.0 0
M  V30 2 O 5.7309 6.4121 0.0 0
M  V30 3 O 5.3709 7.2708 0.0 0
M  V30 4 N 6.0811 0.0000 0.0 0
M  V30 5 C 4.7475 3.8501 0.0 0
M  V30 6 C 6.0811 4.6201 0.0 0
M  V30 7 C 3.3405 3.2236 0.0 0
M  V30 8 C 4.5865 5.3816 0.0 0
M  V30 9 N 4.7475 2.3101 0.0 0
M  V30 10 C 7.4148 3.8501 0.0 0
M  V30 11 C 6.4013 6.1264 0.0 0
M  V30 12 C 2.3101 4.3682 0.0 0
M  V30 13 C 3.0801 5.7018 0.0 0
M  V30 14 C 6.0811 1.5400 0.0 0
M  V30 15 C 8.5594 4.8805 0.0 0
M  V30 16 N 7.4148 2.3101 0.0 0
M  V30 17 C 7.9329 6.2873 0.0 0
M  V30 18 C 0.7700 4.3682 0.0 0
M  V30 19 C 2.3101 7.0355 0.0 0
M  V30 20 C 10.0909 4.7196 0.0 0
M  V30 21 C 8.8381 7.5332 0.0 0
M  V30 22 C 0.0000 5.7018 0.0 0
M  V30 23 C 0.7700 7.0355 0.0 0
M  V30 24 C 10.9961 5.9655 0.0 0
M  V30 25 C 10.3698 7.3723 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 8
M  V30 3 2 3 11
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 13
M  V30 18 2 12 18
M  V30 19 2 13 19
M  V30 20 2 14 16
M  V30 21 1 15 17
M  V30 22 2 15 20
M  V30 23 2 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 2 22 23
M  V30 29 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 485-47-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1449786-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38554743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 500222-17-3
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM supported on graphene oxide
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, GO@mono-Arg malonate catalyst
prepared and used, no solvent, alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Nano-Size Inorganic-Bioorganic Hybrids Based on Graphene Oxide and
Arginine-Derived Ionic Liquids (GO@Mono-Arg Malonate and GO@di-Arg
Malonate): Versatile Catalysts to Prepare
Spiro[Indeno[1,2-d]Pyrimidineindoline]Ones,
Spiro[Indoline-Pyrimido[4,5-d]Pyrimidine]Ones, and
Dihydro-Spiro[Indoline-Pyrimidine]-Carboxylates under Solvent-Free
Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rezanezhad, Mitra; Nikoofar, Kobra; Molaei Yielzoleh, Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2024), 44(10), 6589-6614

$RFMT $RIREG SCHEME57 STEP1
$RXN



  3  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ninhydrin
C9H6O4
485-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.2334 0.0000 0.0 0
M  V30 2 O 0.5228 4.6949 0.0 0
M  V30 3 O 0.0000 2.4529 0.0 0
M  V30 4 O 1.0304 0.6682 0.0 0
M  V30 5 C 3.9437 2.6508 0.0 0
M  V30 6 C 3.1737 3.9845 0.0 0
M  V30 7 C 2.9132 1.5064 0.0 0
M  V30 8 C 5.4837 2.6508 0.0 0
M  V30 9 C 1.6674 3.6643 0.0 0
M  V30 10 C 3.9437 5.3183 0.0 0
M  V30 11 C 1.5063 2.1328 0.0 0
M  V30 12 C 6.2537 3.9845 0.0 0
M  V30 13 C 5.4837 5.3183 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Aminospiro[2H-indene-2,4′-[4H]indeno[1,2-d]pyrimidine]-1,3,5′(3′H)-trione
C19H11N3O3
1449786-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0203 1.7173 0.0 0
M  V30 2 O 5.7309 6.4121 0.0 0
M  V30 3 O 5.3709 7.2708 0.0 0
M  V30 4 N 6.0811 0.0000 0.0 0
M  V30 5 C 4.7475 3.8501 0.0 0
M  V30 6 C 6.0811 4.6201 0.0 0
M  V30 7 C 3.3405 3.2236 0.0 0
M  V30 8 C 4.5865 5.3816 0.0 0
M  V30 9 N 4.7475 2.3101 0.0 0
M  V30 10 C 7.4148 3.8501 0.0 0
M  V30 11 C 6.4013 6.1264 0.0 0
M  V30 12 C 2.3101 4.3682 0.0 0
M  V30 13 C 3.0801 5.7018 0.0 0
M  V30 14 C 6.0811 1.5400 0.0 0
M  V30 15 C 8.5594 4.8805 0.0 0
M  V30 16 N 7.4148 2.3101 0.0 0
M  V30 17 C 7.9329 6.2873 0.0 0
M  V30 18 C 0.7700 4.3682 0.0 0
M  V30 19 C 2.3101 7.0355 0.0 0
M  V30 20 C 10.0909 4.7196 0.0 0
M  V30 21 C 8.8381 7.5332 0.0 0
M  V30 22 C 0.0000 5.7018 0.0 0
M  V30 23 C 0.7700 7.0355 0.0 0
M  V30 24 C 10.9961 5.9655 0.0 0
M  V30 25 C 10.3698 7.3723 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 8
M  V30 3 2 3 11
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 13
M  V30 18 2 12 18
M  V30 19 2 13 19
M  V30 20 2 14 16
M  V30 21 1 15 17
M  V30 22 2 15 20
M  V30 23 2 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 2 22 23
M  V30 29 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 485-47-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1449786-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38554789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3020706-62-8
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM supported on graphene oxide
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, GO@di-Arg malonate catalyst
prepared and used, no solvent, alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Nano-Size Inorganic-Bioorganic Hybrids Based on Graphene Oxide and
Arginine-Derived Ionic Liquids (GO@Mono-Arg Malonate and GO@di-Arg
Malonate): Versatile Catalysts to Prepare
Spiro[Indeno[1,2-d]Pyrimidineindoline]Ones,
Spiro[Indoline-Pyrimido[4,5-d]Pyrimidine]Ones, and
Dihydro-Spiro[Indoline-Pyrimidine]-Carboxylates under Solvent-Free
Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rezanezhad, Mitra; Nikoofar, Kobra; Molaei Yielzoleh, Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2024), 44(10), 6589-6614

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2,4-Dichlorophenyl)methoxy]-3-methoxy-α-(1-methoxypropylidene)benzeneacet...
C20H19Cl2NO3
805236-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 6.6685 0.0 0
M  V30 5 O 0.7700 5.3347 0.0 0
M  V30 6 N 1.5400 1.3336 0.0 0
M  V30 7 C 2.3100 8.0021 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 O 7.7000 1.3336 0.0 0
M  V30 10 C 6.9300 0.0000 0.0 0
M  V30 11 O 9.2400 4.0011 0.0 0
M  V30 12 C 10.0100 5.3347 0.0 0
M  V30 13 Cl 11.5500 8.0021 0.0 0
M  V30 14 Cl 16.1700 5.3347 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 5.3900 2.6674 0.0 0
M  V30 17 C 5.3900 5.3347 0.0 0
M  V30 18 C 6.9300 2.6674 0.0 0
M  V30 19 C 6.9300 5.3347 0.0 0
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 12.3200 6.6685 0.0 0
M  V30 23 C 12.3200 4.0011 0.0 0
M  V30 24 C 13.8600 6.6685 0.0 0
M  V30 25 C 13.8600 4.0011 0.0 0
M  V30 26 C 14.6300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 3 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 11 12
M  V30 12 1 11 20
M  V30 13 1 12 21
M  V30 14 1 13 22
M  V30 15 1 14 26
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[4-[(2,4-Dichlorophenyl)methoxy]-3-methoxyphenyl]-6-ethyl-2,4-pyrimidinedia...
C20H20Cl2N4O2
410535-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6685 0.0 0
M  V30 2 C 3.8500 8.0021 0.0 0
M  V30 3 N 4.6200 1.3336 0.0 0
M  V30 4 O 9.2400 1.3336 0.0 0
M  V30 5 C 8.4700 0.0000 0.0 0
M  V30 6 N 0.0000 4.0011 0.0 0
M  V30 7 O 10.7800 4.0011 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 Cl 13.0900 8.0021 0.0 0
M  V30 10 Cl 17.7100 5.3347 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 N 2.3100 5.3347 0.0 0
M  V30 15 N 2.3100 2.6674 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 6.1600 4.0011 0.0 0
M  V30 18 C 6.9300 2.6674 0.0 0
M  V30 19 C 6.9300 5.3347 0.0 0
M  V30 20 C 8.4700 2.6674 0.0 0
M  V30 21 C 8.4700 5.3347 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 13.0900 5.3347 0.0 0
M  V30 24 C 13.8600 6.6685 0.0 0
M  V30 25 C 13.8600 4.0011 0.0 0
M  V30 26 C 15.4000 6.6685 0.0 0
M  V30 27 C 15.4000 4.0011 0.0 0
M  V30 28 C 16.1700 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 20
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 1 7 22
M  V30 9 1 8 23
M  V30 10 1 9 24
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 17
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 805236-76-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 410535-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25769096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine (5, Pyr; R1 = R2 = R4 =
H, R3 = Cl, R5 = CH2CH3). A mixture of 4 (R1 = R2 = R4 = H, R3 = Cl, R5 =
CH2CH3) (0.66 g, 3 mmol) and guanidine (0.30 g, 5 mmol) in dry DMSO (5
mL) was heated at 80 °C for 5 min under N2. The reaction mixture was
poured into CH2Cl2 (100 mL) and was successively washed with water and
saturated aqueous sodium chloride solution, dried over MgSO4, filtered,
and evaporated to dryness under reduced pressure. Compound 5 (R1 = R2 =
R4 = H, R3 = Cl, R5 = CH2CH3) was crystallized from methanol to afford
white crystals (0.70 g, 94%). Compound 24; yield: 98%. Mp: 228-229 °C; 1H
NMR (400 MHz) 0.97 (t, J = 7.5 Hz, 3H, CH2CH3), 2.13 (q, J = 7.5 Hz, 2H,
CH2CH3), 3.74 (s, 3H, OCH3) 5.12 (s, 2H, OCH2Ar) 5.46 (s, 2H, NH2), 5.80
(s, 2H, NH2), 6.67 (dd, J= 1.6, 8.1 Hz, 1H, ArH), 6.76 (d, J = 1.6 Hz,
1H, ArH), 7.08 (d, J= 8.2 Hz, 1H, ArH), 7.50 (dd, J= 2.0, 8.3 Hz, 1H,
ArH), 7.64 (d, J = 8.3 Hz, 1H, ArH), 7.69(d, J= 2.0Hz, 1H, ArH)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of 2,4-Diaminopyrimidines as Antimalarials Based on
Inhibition of the S108N and C59R+S108N Mutants of Dihydrofolate Reductase
from Pyrimethamine-Resistant Plasmodium falciparum
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tarnchompoo, Bongkoch; Sirichaiwat, Chawanee; Phupong, Worrapong;
Intaraudom, Chakapong; Sirawaraporn, Worachart; Kamchonwongpaisan,
Sumalee; Vanichtanankul, Jarunee; Thebtaranonth, Yodhathai; Yuthavong,
Yongyuth
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(6), 1244-1252

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(4-propylphenyl)-2-thiophenecarboxylate
C15H16O2S
884867-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6528 1.5317 0.0 0
M  V30 2 O 1.2459 2.1580 0.0 0
M  V30 3 O 2.8137 0.0000 0.0 0
M  V30 4 C 0.0000 1.2528 0.0 0
M  V30 5 C 12.4284 3.2067 0.0 0
M  V30 6 C 13.1984 4.5405 0.0 0
M  V30 7 C 14.7384 4.5405 0.0 0
M  V30 8 C 6.2684 3.2067 0.0 0
M  V30 9 S 5.3632 1.9609 0.0 0
M  V30 10 C 5.3632 4.4528 0.0 0
M  V30 11 C 3.8987 2.4367 0.0 0
M  V30 12 C 3.8987 3.9767 0.0 0
M  V30 13 C 7.8084 3.2067 0.0 0
M  V30 14 C 8.5784 1.8731 0.0 0
M  V30 15 C 8.5784 4.5405 0.0 0
M  V30 16 C 10.1184 1.8731 0.0 0
M  V30 17 C 10.1184 4.5405 0.0 0
M  V30 18 C 10.8884 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Aminoiminomethyl)-5-(4-propylphenyl)-2-thiophenecarboxamide
C15H17N3OS
884867-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 1.8104 0.0 0
M  V30 2 N 2.6528 2.4367 0.0 0
M  V30 3 O 4.2207 0.2789 0.0 0
M  V30 4 C 1.4069 1.5315 0.0 0
M  V30 5 N 1.5679 0.0000 0.0 0
M  V30 6 N 0.0000 2.1580 0.0 0
M  V30 7 C 13.8354 3.4856 0.0 0
M  V30 8 C 14.6054 4.8193 0.0 0
M  V30 9 C 16.1454 4.8193 0.0 0
M  V30 10 C 7.6754 3.4856 0.0 0
M  V30 11 S 6.7701 2.2396 0.0 0
M  V30 12 C 6.7701 4.7315 0.0 0
M  V30 13 C 5.3055 2.7156 0.0 0
M  V30 14 C 5.3055 4.2556 0.0 0
M  V30 15 C 9.2154 3.4856 0.0 0
M  V30 16 C 9.9854 2.1518 0.0 0
M  V30 17 C 9.9854 4.8193 0.0 0
M  V30 18 C 11.5254 2.1518 0.0 0
M  V30 19 C 11.5254 4.8193 0.0 0
M  V30 20 C 12.2954 3.4856 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 884867-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 884867-84-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13171661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure B for preparation of acyl
guanidines (1a-k, 3-4 and 6) To a solution of methyl ester (8a-k or 9a-b)
(1eq) in DMF was added a solution of guanidine (10 eq of 2M sol. in
MeOH). The reaction was allowed to stir at rt overnight. Brine was added
to the reaction mixture and the aqueous layer was extracted with EtOAc.
The combined organic extracts were washed with sat. aq. NaHCO3, dried
(MgSO4) and concentrated in vacuo. The crude product was purified on
silica gel using flash chromatography.
1-(2-(3-propylphenyl)thiophene-5-carbonyl)guanidine (1c), 98 %
yield.Purified by flash chromatography (10 % MeOH/CH2Cl2) 1H NMR
(MeOD-d4, 400 MHz) 0.89 (3H, t, J = 7.4 Hz, CH3), 1.59 (2H, m, CH2CH3),
2.55 (2H, t, J = 7.6 Hz, CH2), 7.17 (2H, d, J = 8.0 Hz, 2 × ArH), 7.29
(1H, d, J = 4.0 Hz, ArH), 7.52 (1H, d, J = 8.4 Hz, ArH), 7.69 (1H, d, J =
4.0 Hz, ArH) 13C NMR (MeOD-d4, 125 MHz) 14.4 (CH3), 20.9 (CH2), 25.6
(CH2), 124.4 (ArCH), 126.9 (2 × ArCH), 130.2 (2 × ArCH), 132.7 (ArC),
132.8 (ArCH), 141.7 (ArC), 144.6 (ArC), 151.5 (ArC), 162.8 (C=N), 172.9
(C=O) ESI-TOF calc. C15H17N3OS [M+H+]: 288.1165, found: 288.1167.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Superactivation of the Botulinum Neurotoxin Serotype A Light Chain
Metalloprotease: A New Wrinkle in Botulinum Neurotoxin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McAllister, Laura A.; Hixon, Mark S.; Kennedy, Jack P.; Dickerson, Tobin
J.; Janda, Kim D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2006), 128(13), 4176-4177

$RFMT $RIREG SCHEME60 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26202712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7447-39-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 856925-70-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound, silica-supported
1-(3-trimethoxysilylpropyl)3-methylimidazolium chloride-copper chloride
ionic liquid catalyst prepared and used, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic liquid attached to colloidal silica nanoparticles as catalyst for
the synthesis of pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shahbazi-Alavi, Hossein; Safaei-Ghomi, Javad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Nanoscience and Nanotechnology (2021), 17(2),
133-140

$RFMT $RIREG SCHEME60 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29792019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12052-28-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM amino-functionalized silica-coated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, ultrasound, sonicated at 40 W,
amino-functionalized silica-coated cobalt ferrite nanoparticles prepared
and used as catalyst, alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2,4-diamino-6-aryl-5-pyrimidinecarbonitrile promoted by
amino-functionalized CoFe2O4@SiO2 nanoparticles under conventional
heating, microwave and ultrasound irradiations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barkhordarion-Mohammadi, Samaneh; Safaei-Ghomi, Javad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2018), 73(1), 17-21

$RFMT $RIREG SCHEME60 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27317802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 66651-25-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, catalyst prepared and used, reusable catalyst
used, product formed via Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrimidines using nano-NiZr4(PO4)6 as a retrievable and
robust heterogeneous catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shahbazi-Alavi, Hossein; Safaei-Ghomi, Javad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nanochemistry Research (2020), 5(2), 141-147

$RFMT $RIREG SCHEME60 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28438997
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, green chemistry-solvent,
solid-supported catalyst, ultrasonic irradiation (40 W), recyclable
catalyst used, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasonic Accelerated Biginelli-Like Reaction by the Covalently Anchored
Copper-Isatoic Anhydride over the Modified Surface of Mesoporous SBA-15
to the Synthesis of Pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghomi, Javad Safaei; Bakhtiari, Atefeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2018), 3(44), 12704-12711

$RFMT $RIREG SCHEME60 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25816703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12017-35-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM nickel terephthalic acid supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, cobalt nickel oxide nanoparticles supported on
nickel terephthalic acid prepared and used as catalyst, optimization
study (optimized on catalyst, solvent and stoichiometry of catalyst),
reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly efficient synthesis of
2,4-diamino-6-arylpyrimidine-5-carbonitrile derivatives using
NiCo2O4@Ni(BDC) metal-organic frameworks as a novel and bifunctional
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghasemzadeh, Mohammad Ali; Azimi-Nasrabad, Mina; Farhadi, Simin;
Mirhosseini-Eshkevari, Boshra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2019), 900120935pp.

$RFMT $RIREG SCHEME61 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-bromophenyl)-5-pyrimidinecarbonitrile
C11H8BrN5
1072135-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Br 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072135-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26305669
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7447-39-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 856925-70-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound, silica-supported
1-(3-trimethoxysilylpropyl)3-methylimidazolium chloride-copper chloride
ionic liquid catalyst prepared and used, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic liquid attached to colloidal silica nanoparticles as catalyst for
the synthesis of pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shahbazi-Alavi, Hossein; Safaei-Ghomi, Javad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Nanoscience and Nanotechnology (2021), 17(2),
133-140

$RFMT $RIREG SCHEME61 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-bromophenyl)-5-pyrimidinecarbonitrile
C11H8BrN5
1072135-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Br 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072135-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30714924
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12052-28-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM amino-functionalized silica-coated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, ultrasound, sonicated at 40 W,
amino-functionalized silica-coated cobalt ferrite nanoparticles prepared
and used as catalyst, alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2,4-diamino-6-aryl-5-pyrimidinecarbonitrile promoted by
amino-functionalized CoFe2O4@SiO2 nanoparticles under conventional
heating, microwave and ultrasound irradiations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barkhordarion-Mohammadi, Samaneh; Safaei-Ghomi, Javad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2018), 73(1), 17-21

$RFMT $RIREG SCHEME61 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-bromophenyl)-5-pyrimidinecarbonitrile
C11H8BrN5
1072135-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Br 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072135-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27422849
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 66651-25-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, catalyst prepared and used, reusable catalyst
used, product formed via Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrimidines using nano-NiZr4(PO4)6 as a retrievable and
robust heterogeneous catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shahbazi-Alavi, Hossein; Safaei-Ghomi, Javad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nanochemistry Research (2020), 5(2), 141-147

$RFMT $RIREG SCHEME61 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-bromophenyl)-5-pyrimidinecarbonitrile
C11H8BrN5
1072135-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Br 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072135-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27826419
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 528818-81-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, microwave irradiation (100 W),
ionic liquid used (solvent)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave-assisted one-pot synthesis of functionalized pyrimidines using
ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raghuvanshi, Dushyant Singh; Singh, Krishna Nand
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2011), 48(3), 582-585

$RFMT $RIREG SCHEME62 STEP1
$RXN



  4  1
$MOL
Pimelic acid
C7H12O4
111-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 O 9.3360 0.0000 0.0 0
M  V30 11 O 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′-Aminoacetophenone
C8H9NO
99-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 N 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-[3-[2-Amino-6-(4-methoxyphenyl)-4-pyrimidinyl]phenyl]heptanediamide
C24H27N5O3
349489-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 0.0000 0.0 0
M  V30 2 N 14.6707 3.8501 0.0 0
M  V30 3 C 16.0045 4.6201 0.0 0
M  V30 4 C 17.3382 3.8501 0.0 0
M  V30 5 O 16.0045 6.1601 0.0 0
M  V30 6 C 18.6718 4.6201 0.0 0
M  V30 7 C 20.0055 3.8501 0.0 0
M  V30 8 C 21.3393 4.6201 0.0 0
M  V30 9 C 22.6730 3.8501 0.0 0
M  V30 10 C 24.0067 4.6201 0.0 0
M  V30 11 N 25.3403 3.8501 0.0 0
M  V30 12 O 24.0067 6.1601 0.0 0
M  V30 13 O 1.3337 6.9302 0.0 0
M  V30 14 C 0.0000 6.1601 0.0 0
M  V30 15 C 9.3358 3.8501 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 N 9.3358 2.3101 0.0 0
M  V30 18 C 6.6685 3.8501 0.0 0
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 N 6.6685 2.3101 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 23 C 10.6697 6.1601 0.0 0
M  V30 24 C 13.3370 4.6201 0.0 0
M  V30 25 C 12.0033 6.9302 0.0 0
M  V30 26 C 13.3370 6.1601 0.0 0
M  V30 27 C 5.3348 4.6201 0.0 0
M  V30 28 C 4.0010 3.8501 0.0 0
M  V30 29 C 5.3348 6.1601 0.0 0
M  V30 30 C 2.6673 4.6201 0.0 0
M  V30 31 C 4.0010 6.9302 0.0 0
M  V30 32 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 1 2 24
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 32
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 21
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 27
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 111-16-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-03-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 349489-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1861370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, first stage attachment to
TentaGel Rink Amide resin
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Symmetric building blocks and combinatorial functional group
transformation as versatile strategies in combinatorial chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fruchtel, Jorg Steffen; Pflugseder, Karin; Gstach, Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biotechnology and Bioengineering (2001), 71(2), 94-103

$RFMT $RIREG SCHEME63 STEP1
$RXN



  3  1
$MOL
tert-Butoxybis(dimethylamino)methane
C9H22N2O
5815-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 O 2.6675 1.5400 0.0 0
M  V30 3 N 4.0012 3.8501 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 C 1.3338 2.3101 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 6.6687 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 0.5638 0.9764 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 2.1038 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[2H-1-benzopyran-2,1′-cyclohexan]-3(4H)-one
C14H16O2
1190962-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 3.0800 2.6675 0.0 0
M  V30 3 C 3.8500 1.3338 0.0 0
M  V30 4 O 3.8500 4.0011 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 5.3901 1.3338 0.0 0
M  V30 8 C 5.3901 4.0011 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 6.1601 2.6675 0.0 0
M  V30 12 C 6.1601 5.3349 0.0 0
M  V30 13 C 0.0000 2.6675 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 15 C 7.7001 5.3349 0.0 0
M  V30 16 C 8.4701 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[5H-[1]benzopyrano[3,4-d]pyrimidine-5,1′-cyclohexan]-3-amine
C16H17N3O
1190961-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 5.3347 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 O 3.0800 2.6674 0.0 0
M  V30 5 C 3.8500 1.3338 0.0 0
M  V30 6 C 6.1600 2.6674 0.0 0
M  V30 7 C 4.6200 5.3347 0.0 0
M  V30 8 N 6.9300 4.0011 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 C 6.9300 1.3338 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 5.3900 6.6685 0.0 0
M  V30 14 C 7.7000 5.3347 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 6.1600 0.0000 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 N 6.9300 6.6685 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 20 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 1 9 12
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 1 11 16
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 2 14 18
M  V30 21 1 15 19
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5815-08-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190962-21-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190961-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14287201
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-23-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Spiro[chromeno[3,4-d]pyrimidine-5,1'-cyclohexan]-3-amine (6) A mixture of
spiro[chromene-2,1'-cyclohexan]-3(4H)-one (5) (0.52 g, 2.41 mmol) and
tert-butoxybis(dimethylamino)methane (0.75 ml, 3.61 mmol) was stirred at
reflux for 80 min. The temperature was lowered to 80 °C and n-propanol (6
mL), guanidine hydrochloride (1.2 g, 12.0 mmol), and sodium methoxide in
MeOH (4.37 M solution, 1.5 ml, 7.22 mmol) were added sequentially. The
resulting mixture was stirred at 80 °C overnight, then poured into ice
and saturated NaHCO3 aqueous solution, and extracted with EtOAc (2 X).
The combined organics were washed with brine (1 X), dried over Na2SO4 and
concentrated in vacuo to give crude
spiro[chromeno[3,4-d]pyrimidine-5,1'-cyclohexan]-3-amine (6) (0.67 g, 98%
yield) as a orange solid. Trituration with EtOAc/Hexanes gave the pure
spiro[chromeno[3,4-d]pyrimidine-5,1'-cyclohexan]-3-amine (6).
Spiro[chromeno[3,4-d]pyrimidine-5,1'-cyclohexan]-3-amine (6), yield 0.67
g, 98% 1H NMR (400 MHz, DMSO-d6) δ ppm 8.75 (1 H, s), 7.76 (1 H, dd,
J=7.8, 1.6 Hz), 7.17 (1 H, td, J=7.6, 1.6 Hz), 6.94 - 7.04 (2 H, m), 6.86
(2 H, br. s.), 1.49 - 1.87 (9 H, m), 1.20 - 1.30 (1 H, m). LCMS-ESI
(POS), M/Z, M+1: Found 268.1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell
cycle inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Connors, Richard V.; Dai, Kang; Eksterowicz, John; Fan, Pingchen; Fisher,
Benjamin; Fu, Jiasheng; Li, Kexue; Li, Zhihong; McGee, Lawrence R.;
Sharma, Rajiv; Wang, Xiaodong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009126584 A1 2009-10-15

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-one, 3-(2-chlorophenyl)-1-(1-hydroxy-2-naphthalenyl)-, (E)-
C19H13ClO2
125574-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 Cl 12.0033 0.0000 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 4.0010 1.5400 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 12.0033 1.5400 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 13.3370 2.3101 0.0 0
M  V30 21 C 12.0033 4.6201 0.0 0
M  V30 22 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 2 3 5
M  V30 6 1 5 17
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Amino-6-(2-chlorophenyl)-4-pyrimidinyl]-1-naphthalenol
C20H14ClN3O
1638508-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3359 2.3100 0.0 0
M  V30 2 N 5.3348 0.0000 0.0 0
M  V30 3 Cl 1.3337 2.3100 0.0 0
M  V30 4 C 8.0021 4.6201 0.0 0
M  V30 5 C 9.3359 3.8500 0.0 0
M  V30 6 C 8.0021 6.1601 0.0 0
M  V30 7 C 10.6695 4.6201 0.0 0
M  V30 8 C 9.3359 6.9301 0.0 0
M  V30 9 C 10.6695 6.1601 0.0 0
M  V30 10 C 12.0032 3.8500 0.0 0
M  V30 11 C 12.0032 6.9301 0.0 0
M  V30 12 C 13.3369 4.6201 0.0 0
M  V30 13 C 13.3369 6.1601 0.0 0
M  V30 14 C 6.6684 3.8500 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 N 6.6684 2.3100 0.0 0
M  V30 17 C 4.0010 3.8500 0.0 0
M  V30 18 C 5.3348 1.5400 0.0 0
M  V30 19 N 4.0010 2.3100 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 1.3337 3.8500 0.0 0
M  V30 22 C 2.6673 6.1601 0.0 0
M  V30 23 C 0.0000 4.6201 0.0 0
M  V30 24 C 1.3337 6.9301 0.0 0
M  V30 25 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 18
M  V30 3 1 3 21
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 125574-11-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1638508-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11073261
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (80W), no solvent, alternative
reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave initiated synthesis of pyrimidine analogues and study of their
antimicrobial properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lal, Kundan; Paliwal, L. J.; Bagade, M. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM American Journal of PharmTech Research (2014), 4(3), 646-656

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-(1-Hydroxy-2-naphthalenyl)-3-(4-methoxyphenyl)-2-propen-1-one
C20H16O3
125574-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.0000 0.0 0
M  V30 2 C 6.6687 1.5400 0.0 0
M  V30 3 C 8.0023 2.3101 0.0 0
M  V30 4 O 6.6687 0.0000 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 O 14.6708 4.6201 0.0 0
M  V30 7 C 16.0046 3.8501 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 1.3338 4.6201 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 18 C 10.6698 2.3101 0.0 0
M  V30 19 C 12.0035 1.5400 0.0 0
M  V30 20 C 10.6698 3.8501 0.0 0
M  V30 21 C 13.3372 2.3101 0.0 0
M  V30 22 C 12.0035 4.6201 0.0 0
M  V30 23 C 13.3372 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 2 3 5
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Amino-6-(4-methoxyphenyl)-4-pyrimidinyl]-1-naphthalenol
C21H17N3O2
210567-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 N 8.0023 0.0000 0.0 0
M  V30 3 O 14.6708 6.9302 0.0 0
M  V30 4 C 16.0046 6.1601 0.0 0
M  V30 5 C 6.6687 3.8501 0.0 0
M  V30 6 C 8.0023 4.6201 0.0 0
M  V30 7 N 6.6687 2.3101 0.0 0
M  V30 8 C 9.3360 3.8501 0.0 0
M  V30 9 C 8.0023 1.5400 0.0 0
M  V30 10 N 9.3360 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 16 C 2.6675 6.1601 0.0 0
M  V30 17 C 1.3338 3.8501 0.0 0
M  V30 18 C 1.3338 6.9302 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 20 C 0.0000 6.1601 0.0 0
M  V30 21 C 10.6698 4.6201 0.0 0
M  V30 22 C 10.6698 6.1601 0.0 0
M  V30 23 C 12.0035 3.8501 0.0 0
M  V30 24 C 12.0035 6.9302 0.0 0
M  V30 25 C 13.3372 4.6201 0.0 0
M  V30 26 C 13.3372 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 26
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 21
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 125574-12-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 210567-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1782036
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (80W), no solvent, alternative
reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave initiated synthesis of pyrimidine analogues and study of their
antimicrobial properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lal, Kundan; Paliwal, L. J.; Bagade, M. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM American Journal of PharmTech Research (2014), 4(3), 646-656

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(4-Chlorophenyl)-1-(1-hydroxy-2-naphthalenyl)-2-propen-1-one
C19H13ClO2
1352993-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 9.3358 1.5400 0.0 0
M  V30 6 Cl 14.6707 4.6201 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 4.0010 1.5400 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 19 C 12.0033 1.5400 0.0 0
M  V30 20 C 12.0033 4.6201 0.0 0
M  V30 21 C 13.3370 2.3101 0.0 0
M  V30 22 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 2 3 5
M  V30 6 1 5 17
M  V30 7 1 6 22
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Amino-6-(4-chlorophenyl)-4-pyrimidinyl]-1-naphthalenol
C20H14ClN3O
1638508-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 2.3101 0.0 0
M  V30 2 N 8.0022 0.0000 0.0 0
M  V30 3 Cl 14.6707 6.9302 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 8.0022 4.6201 0.0 0
M  V30 6 N 6.6685 2.3101 0.0 0
M  V30 7 C 9.3358 3.8501 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 N 9.3358 2.3101 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0010 3.8501 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 4.0010 6.9302 0.0 0
M  V30 15 C 2.6673 6.1601 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 19 C 0.0000 6.1601 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 10.6697 6.1601 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 23 C 12.0033 6.9302 0.0 0
M  V30 24 C 13.3370 4.6201 0.0 0
M  V30 25 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 8
M  V30 3 1 3 25
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 20
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 1 14 15
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352993-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1638508-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15109976
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (80W), no solvent, alternative
reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave initiated synthesis of pyrimidine analogues and study of their
antimicrobial properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lal, Kundan; Paliwal, L. J.; Bagade, M. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM American Journal of PharmTech Research (2014), 4(3), 646-656

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-[4-(Dimethylamino)phenyl]-1-(1-hydroxy-2-naphthalenyl)-2-propen-1-one
C21H19NO2
1353224-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1601 0.0 0
M  V30 2 C 6.6686 4.6201 0.0 0
M  V30 3 C 8.0022 3.8500 0.0 0
M  V30 4 O 6.6686 6.1601 0.0 0
M  V30 5 C 9.3359 4.6201 0.0 0
M  V30 6 N 14.6707 1.5400 0.0 0
M  V30 7 C 16.0045 2.3100 0.0 0
M  V30 8 C 14.6707 0.0000 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 1.3338 4.6201 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 1.3338 1.5400 0.0 0
M  V30 15 C 5.3348 3.8500 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 5.3348 2.3100 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 19 C 10.6697 3.8500 0.0 0
M  V30 20 C 10.6697 2.3100 0.0 0
M  V30 21 C 12.0034 4.6201 0.0 0
M  V30 22 C 12.0034 1.5400 0.0 0
M  V30 23 C 13.3370 3.8500 0.0 0
M  V30 24 C 13.3370 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 2 3 5
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Amino-6-[4-(dimethylamino)phenyl]-4-pyrimidinyl]-1-naphthalenol
C22H20N4O
210567-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 N 8.0022 0.0000 0.0 0
M  V30 3 N 14.6707 6.9301 0.0 0
M  V30 4 C 16.0045 6.1601 0.0 0
M  V30 5 C 14.6707 8.4701 0.0 0
M  V30 6 C 6.6686 3.8500 0.0 0
M  V30 7 C 8.0022 4.6201 0.0 0
M  V30 8 N 6.6686 2.3100 0.0 0
M  V30 9 C 9.3359 3.8500 0.0 0
M  V30 10 C 8.0022 1.5400 0.0 0
M  V30 11 N 9.3359 2.3100 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0011 3.8500 0.0 0
M  V30 14 C 5.3348 6.1601 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 4.0011 6.9301 0.0 0
M  V30 17 C 2.6675 6.1601 0.0 0
M  V30 18 C 1.3338 3.8500 0.0 0
M  V30 19 C 1.3338 6.9301 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 21 C 0.0000 6.1601 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 12.0034 3.8500 0.0 0
M  V30 24 C 10.6697 6.1601 0.0 0
M  V30 25 C 13.3370 4.6201 0.0 0
M  V30 26 C 12.0034 6.9301 0.0 0
M  V30 27 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 27
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 22
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353224-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 210567-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6491939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (80W), no solvent, alternative
reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave initiated synthesis of pyrimidine analogues and study of their
antimicrobial properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lal, Kundan; Paliwal, L. J.; Bagade, M. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM American Journal of PharmTech Research (2014), 4(3), 646-656

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]-3-[(3S)-3-fluoro-1-pyrrolidiny...
C15H17FN4O
1623126-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 1.3336 0.0 0
M  V30 2 N 4.3856 0.0000 0.0 0
M  V30 3 F 0.0000 5.6763 0.0 0
M  V30 4 C 9.7757 4.0011 0.0 0
M  V30 5 C 10.5457 5.3347 0.0 0
M  V30 6 O 10.5457 2.6674 0.0 0
M  V30 7 C 12.0857 5.3347 0.0 0
M  V30 8 N 12.8557 6.6685 0.0 0
M  V30 9 C 12.0857 8.0022 0.0 0
M  V30 10 C 14.3957 6.6685 0.0 0
M  V30 11 C 5.1556 4.0011 0.0 0
M  V30 12 C 5.9256 2.6674 0.0 0
M  V30 13 C 5.9256 5.3347 0.0 0
M  V30 14 N 7.4657 2.6674 0.0 0
M  V30 15 C 7.4657 5.3347 0.0 0
M  V30 16 C 8.2357 4.0011 0.0 0
M  V30 17 N 3.6156 4.0011 0.0 0
M  V30 18 C 2.7104 5.2470 0.0 0
M  V30 19 C 2.7104 2.7552 0.0 0
M  V30 20 C 1.2459 4.7711 0.0 0 CFG=1
M  V30 21 C 1.2459 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 12
M  V30 3 1 20 3 CFG=3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 2 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-(2-Amino-4-pyrimidinyl)-3-[(3S)-3-fluoro-1-pyrrolidinyl]-2-pyridinecarbonit...
C14H13FN6
1623126-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 1.3338 0.0 0
M  V30 2 N 8.4700 0.0000 0.0 0
M  V30 3 F 12.8557 5.6763 0.0 0
M  V30 4 N 0.0000 6.6685 0.0 0
M  V30 5 C 7.7000 4.0011 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 6.9300 5.3347 0.0 0
M  V30 8 N 5.3900 2.6674 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 N 9.2400 4.0011 0.0 0
M  V30 12 C 10.1453 2.7552 0.0 0
M  V30 13 C 10.1453 5.2470 0.0 0
M  V30 14 C 11.6098 3.2311 0.0 0
M  V30 15 C 11.6098 4.7711 0.0 0 CFG=1
M  V30 16 C 3.0800 4.0011 0.0 0
M  V30 17 N 2.3100 5.3347 0.0 0
M  V30 18 C 2.3100 2.6674 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 C 0.7700 2.6674 0.0 0
M  V30 21 N 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 15 3 CFG=1
M  V30 4 1 4 19
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 10 16
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1623126-88-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1623126-46-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3363429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine compounds useful in the treatment of diseases
mediated by IKKε and/or TBK1 mechanisms
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Newton, Gary Karl; Stewart, Mark Richard; Perrior, Trevor Robert; Crosby,
Stuart Richard; Hopkins, Anna; Negoita-Giras, Gabriel; Jenkins, Kerry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014128486 A1 2014-08-28

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-(1-Hydroxy-2-naphthalenyl)-3-(3-nitrophenyl)-2-propen-1-one
C19H13NO4
1638508-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 C 6.6686 1.5400 0.0 0
M  V30 3 C 8.0022 2.3100 0.0 0
M  V30 4 O 6.6686 0.0000 0.0 0
M  V30 5 C 9.3359 1.5400 0.0 0
M  V30 6 N 14.6707 1.5400 0.0 0 VAL=5
M  V30 7 O 14.6707 0.0000 0.0 0
M  V30 8 O 16.0045 2.3100 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 2.6675 3.8500 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 1.3338 1.5400 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 1.3338 4.6201 0.0 0
M  V30 15 C 5.3348 2.3100 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 5.3348 3.8500 0.0 0
M  V30 18 C 0.0000 3.8500 0.0 0
M  V30 19 C 10.6697 2.3100 0.0 0
M  V30 20 C 12.0034 1.5400 0.0 0
M  V30 21 C 10.6697 3.8500 0.0 0
M  V30 22 C 13.3370 2.3100 0.0 0
M  V30 23 C 12.0034 4.6201 0.0 0
M  V30 24 C 13.3370 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 2 3 5
M  V30 6 1 5 19
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 22
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Amino-6-(3-nitrophenyl)-4-pyrimidinyl]-1-naphthalenol
C20H14N4O3
1638508-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 N 8.0022 0.0000 0.0 0
M  V30 3 N 14.6707 3.8500 0.0 0 VAL=5
M  V30 4 O 16.0045 4.6201 0.0 0
M  V30 5 O 14.6707 2.3100 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 5.3348 6.1601 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0011 6.9301 0.0 0
M  V30 11 C 2.6675 6.1601 0.0 0
M  V30 12 C 1.3338 3.8500 0.0 0
M  V30 13 C 1.3338 6.9301 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 0.0000 6.1601 0.0 0
M  V30 16 C 6.6686 3.8500 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 N 6.6686 2.3100 0.0 0
M  V30 19 C 9.3359 3.8500 0.0 0
M  V30 20 C 8.0022 1.5400 0.0 0
M  V30 21 N 9.3359 2.3100 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 12.0034 3.8500 0.0 0
M  V30 24 C 10.6697 6.1601 0.0 0
M  V30 25 C 13.3370 4.6201 0.0 0
M  V30 26 C 12.0034 6.9301 0.0 0
M  V30 27 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 20
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 25
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1638508-40-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1638508-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12704565
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (80W), no solvent, alternative
reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave initiated synthesis of pyrimidine analogues and study of their
antimicrobial properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lal, Kundan; Paliwal, L. J.; Bagade, M. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM American Journal of PharmTech Research (2014), 4(3), 646-656

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,4E)-1-(1-Hydroxy-2-naphthalenyl)-5-phenyl-2,4-pentadien-1-one
C21H16O2
1638508-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 8.0021 2.3100 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 9.3358 1.5400 0.0 0
M  V30 6 C 10.6696 2.3100 0.0 0
M  V30 7 C 12.0032 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 1.3338 4.6200 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 5.3347 3.8500 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 18 C 13.3369 2.3100 0.0 0
M  V30 19 C 13.3369 3.8500 0.0 0
M  V30 20 C 14.6705 1.5400 0.0 0
M  V30 21 C 14.6705 4.6200 0.0 0
M  V30 22 C 16.0043 2.3100 0.0 0
M  V30 23 C 16.0043 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 2 3 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 7 18
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Amino-6-[(1E)-2-phenylethenyl]-4-pyrimidinyl]-1-naphthalenol
C22H17N3O
1638508-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 C 10.6696 4.6200 0.0 0
M  V30 3 C 12.0032 3.8500 0.0 0
M  V30 4 N 8.0021 0.0000 0.0 0
M  V30 5 C 6.6685 3.8500 0.0 0
M  V30 6 C 8.0021 4.6200 0.0 0
M  V30 7 N 6.6685 2.3100 0.0 0
M  V30 8 C 9.3358 3.8500 0.0 0
M  V30 9 C 8.0021 1.5400 0.0 0
M  V30 10 N 9.3358 2.3100 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 4.0011 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 C 2.6674 4.6200 0.0 0
M  V30 15 C 4.0011 6.9300 0.0 0
M  V30 16 C 2.6674 6.1600 0.0 0
M  V30 17 C 1.3338 3.8500 0.0 0
M  V30 18 C 1.3338 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 21 C 13.3369 4.6200 0.0 0
M  V30 22 C 13.3369 6.1600 0.0 0
M  V30 23 C 14.6705 3.8500 0.0 0
M  V30 24 C 14.6705 6.9300 0.0 0
M  V30 25 C 16.0043 4.6200 0.0 0
M  V30 26 C 16.0043 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 3
M  V30 3 1 2 8
M  V30 4 1 3 21
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 11
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1638508-41-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1638508-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13202207
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (80W), no solvent, alternative
reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave initiated synthesis of pyrimidine analogues and study of their
antimicrobial properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lal, Kundan; Paliwal, L. J.; Bagade, M. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM American Journal of PharmTech Research (2014), 4(3), 646-656

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-N-[(1E)-2-[2-(methylthio)benzoyl]-1-octen-1-yl]-N-phenylbenzenesulfo...
C29H33NO3S2
2154439-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 6.6684 0.0 0
M  V30 2 C 8.4700 5.3347 0.0 0
M  V30 3 S 10.7800 6.6684 0.0 0 VAL=6
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 O 10.7800 8.2084 0.0 0
M  V30 6 O 10.7800 5.1284 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 6.1600 6.6684 0.0 0
M  V30 9 O 4.6200 4.0011 0.0 0
M  V30 10 C 4.6200 6.6684 0.0 0
M  V30 11 C 3.8500 8.0021 0.0 0
M  V30 12 C 2.3100 8.0021 0.0 0
M  V30 13 C 1.5400 9.3358 0.0 0
M  V30 14 C 0.0000 9.3358 0.0 0
M  V30 15 S 4.6200 1.3336 0.0 0
M  V30 16 C 3.8500 0.0000 0.0 0
M  V30 17 C 16.9400 6.6684 0.0 0
M  V30 18 C 8.4700 8.0021 0.0 0
M  V30 19 C 9.2400 9.3358 0.0 0
M  V30 20 C 6.9300 8.0021 0.0 0
M  V30 21 C 8.4700 10.6694 0.0 0
M  V30 22 C 6.1600 9.3358 0.0 0
M  V30 23 C 6.9300 10.6694 0.0 0
M  V30 24 C 12.3200 6.6684 0.0 0
M  V30 25 C 13.0900 5.3347 0.0 0
M  V30 26 C 13.0900 8.0021 0.0 0
M  V30 27 C 14.6300 5.3347 0.0 0
M  V30 28 C 14.6300 8.0021 0.0 0
M  V30 29 C 15.4000 6.6684 0.0 0
M  V30 30 C 6.9300 2.6673 0.0 0
M  V30 31 C 6.1600 1.3336 0.0 0
M  V30 32 C 8.4700 2.6673 0.0 0
M  V30 33 C 6.9300 0.0000 0.0 0
M  V30 34 C 9.2400 1.3336 0.0 0
M  V30 35 C 8.4700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 2 2 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 3 24
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 2 7 9
M  V30 11 1 7 30
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 31
M  V30 19 1 17 29
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hexyl-4-[2-(methylthio)phenyl]-2-pyrimidinamine
C17H23N3S
2154439-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 5.3901 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 5.3901 0.0 0
M  V30 7 S 1.3337 3.0801 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 N 1.3337 7.7002 0.0 0
M  V30 10 C 4.0010 4.6201 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 N 2.6673 5.3901 0.0 0
M  V30 13 C 5.3348 6.9302 0.0 0
M  V30 14 C 2.6673 6.9302 0.0 0
M  V30 15 N 4.0010 7.7002 0.0 0
M  V30 16 C 4.0010 3.0801 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 2.6673 0.7700 0.0 0
M  V30 20 C 5.3348 0.7700 0.0 0
M  V30 21 C 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 16
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2154439-39-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2154439-93-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17903320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploiting rhodium-catalysed ynamide hydroacylation as a platform for
divergent heterocycle synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Straker, Robert N.; Majhail, Manjeet K.; Willis, Michael C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2017), 8(12), 7963-7968

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-(4-Chlorophenyl)-2,1-benzisoxazol-5-yl]-3-(dimethylamino)-2-propen-1-one
C18H15ClN2O2
337920-27-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1642 5.1454 0.0 0
M  V30 2 C 10.7042 5.1454 0.0 0
M  V30 3 O 8.3942 6.4791 0.0 0
M  V30 4 C 11.4742 6.4791 0.0 0
M  V30 5 N 13.0142 6.4791 0.0 0
M  V30 6 C 13.7842 7.8127 0.0 0
M  V30 7 C 13.7842 5.1454 0.0 0
M  V30 8 Cl 0.0000 6.2797 0.0 0
M  V30 9 C 6.0842 2.4780 0.0 0
M  V30 10 C 4.5778 2.1578 0.0 0
M  V30 11 C 6.8542 1.1444 0.0 0
M  V30 12 C 6.8542 3.8118 0.0 0
M  V30 13 O 4.4169 0.6263 0.0 0
M  V30 14 N 5.8237 0.0000 0.0 0
M  V30 15 C 8.3942 1.1444 0.0 0
M  V30 16 C 8.3942 3.8118 0.0 0
M  V30 17 C 9.1642 2.4780 0.0 0
M  V30 18 C 3.4334 3.1884 0.0 0
M  V30 19 C 1.9687 2.7124 0.0 0
M  V30 20 C 3.7536 4.6947 0.0 0
M  V30 21 C 0.8244 3.7430 0.0 0
M  V30 22 C 2.6091 5.7251 0.0 0
M  V30 23 C 1.1445 5.2492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 23
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 18
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 14
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-(4-Chlorophenyl)-2,1-benzisoxazol-5-yl]-2-pyrimidinamine
C17H11ClN4O
477845-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 6.2797 0.0 0
M  V30 2 N 13.0142 6.4791 0.0 0
M  V30 3 C 6.0842 2.4780 0.0 0
M  V30 4 C 4.5778 2.1578 0.0 0
M  V30 5 C 6.8542 1.1444 0.0 0
M  V30 6 C 6.8542 3.8118 0.0 0
M  V30 7 O 4.4169 0.6263 0.0 0
M  V30 8 N 5.8237 0.0000 0.0 0
M  V30 9 C 8.3942 1.1444 0.0 0
M  V30 10 C 8.3942 3.8118 0.0 0
M  V30 11 C 9.1642 2.4780 0.0 0
M  V30 12 C 3.4334 3.1884 0.0 0
M  V30 13 C 3.7536 4.6947 0.0 0
M  V30 14 C 1.9687 2.7124 0.0 0
M  V30 15 C 2.6091 5.7251 0.0 0
M  V30 16 C 0.8244 3.7430 0.0 0
M  V30 17 C 1.1445 5.2492 0.0 0
M  V30 18 C 9.1642 5.1454 0.0 0
M  V30 19 N 10.7042 5.1454 0.0 0
M  V30 20 C 8.3942 6.4791 0.0 0
M  V30 21 C 11.4742 6.4791 0.0 0
M  V30 22 C 9.1642 7.8127 0.0 0
M  V30 23 N 10.7042 7.8127 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 21
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 12
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 1 7 8
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 10 18
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 337920-27-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 477845-12-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4639571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-23-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A. 4-[3-(4-Chlorophenyl)-benzo[c]isoxazol-5-yl]-pyrimidin-2-ylamine:
To a mixture of sodium pellets (14 mg, 0.609 mmol) in methanol (1 mL) at
room temperature, was added guanidine hydrochloride (10 mg, 0.105 mmol)
and commercially available
1-[3-(4-chlorophenyl)-benzo[c]isoxazole-5-yl]-3-dimethylamino-propenone
(50 mg, 0.153 mmol). The reaction mixture was heated at 80° C for 18
hours. The mixture was cooled to room temperature and diluted with water
(6 mL). The granular precipitate was filtered, dissolved in
dichloromethane, then dried over magnesium sulfate. Purification by
silica gel chromatography (4:1 ethyl acetate/hexane) gave 4-
[3-(4-chlorophenyl)-benzo[c]isoxazol-5-yl]-pyrimidin-2-ylamine. Yellow
solid, yield 35 mg, 98%. 1H NMR (500 MHz, d6-DMSO) δ 8.68 (s, 1H), 8.35
(d, 1H), 8.25-8.19 (m, 3H), 7,82-7.80 (m, 1H), 7.78-7.72 (m, 2H), 7.4 (d,
1H), 6.79 (s, 1H) ppm. LC-MS (ES+) m/e= 323.04 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moon, Young Choon; Green, Jeremy; Davies, Robert; Choquette, Deb; Pierce,
Albert; Ledeboer, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002102800 A1 2002-12-27

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1,N2-Bis(2,2-dinitroethyl)-N1,N2-dinitro-1,2-ethanediamine
C6H10N8O12
41792-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 C 3.0800 2.6674 0.0 0
M  V30 3 N 3.0800 5.3347 0.0 0 VAL=5
M  V30 4 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 5 N 4.6200 2.6674 0.0 0
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 4.6200 5.3347 0.0 0
M  V30 8 O 0.0000 5.3347 0.0 0
M  V30 9 O 0.0000 2.6674 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 N 5.3900 1.3338 0.0 0 VAL=5
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 O 4.6200 0.0000 0.0 0
M  V30 14 O 6.9300 1.3336 0.0 0
M  V30 15 N 7.7000 5.3347 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 N 6.9300 6.6685 0.0 0 VAL=5
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 O 7.7000 8.0021 0.0 0
M  V30 20 O 5.3900 6.6685 0.0 0
M  V30 21 N 9.2400 2.6674 0.0 0 VAL=5
M  V30 22 N 11.5500 4.0011 0.0 0 VAL=5
M  V30 23 O 10.0100 1.3336 0.0 0
M  V30 24 O 7.7000 2.6674 0.0 0
M  V30 25 O 12.3200 2.6674 0.0 0
M  V30 26 O 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 2 21 23
M  V30 23 2 21 24
M  V30 24 2 22 25
M  V30 25 2 22 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine, compd. with N1,N2-bis(2,2-dinitroethyl)-N1,N2-dinitro-1,2-ethanedi...
C6H10N8O12.2CH5N3
1393741-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 7.8511 0.0 0
M  V30 2 C 3.0800 6.5175 0.0 0
M  V30 3 N 3.0800 9.1848 0.0 0 VAL=5
M  V30 4 N 0.7700 7.8511 0.0 0 VAL=5
M  V30 5 N 4.6200 6.5175 0.0 0
M  V30 6 O 2.3100 10.5186 0.0 0
M  V30 7 O 4.6200 9.1848 0.0 0
M  V30 8 O 0.0000 9.1848 0.0 0
M  V30 9 O 0.0000 6.5175 0.0 0
M  V30 10 C 5.3900 7.8511 0.0 0
M  V30 11 N 5.3900 5.1838 0.0 0 VAL=5
M  V30 12 C 6.9300 7.8511 0.0 0
M  V30 13 O 4.6200 3.8501 0.0 0
M  V30 14 O 6.9300 5.1837 0.0 0
M  V30 15 N 7.7000 9.1848 0.0 0
M  V30 16 C 9.2400 9.1848 0.0 0
M  V30 17 N 6.9300 10.5186 0.0 0 VAL=5
M  V30 18 C 10.0100 7.8511 0.0 0
M  V30 19 O 7.7000 11.8522 0.0 0
M  V30 20 O 5.3900 10.5186 0.0 0
M  V30 21 N 9.2400 6.5175 0.0 0 VAL=5
M  V30 22 N 11.5500 7.8511 0.0 0 VAL=5
M  V30 23 O 10.0100 5.1837 0.0 0
M  V30 24 O 7.7000 6.5175 0.0 0
M  V30 25 O 12.3200 6.5175 0.0 0
M  V30 26 O 12.3200 9.1848 0.0 0
M  V30 27 C 6.1600 1.5400 0.0 0
M  V30 28 N 4.8263 2.3101 0.0 0
M  V30 29 N 7.4937 2.3101 0.0 0
M  V30 30 N 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 2 21 23
M  V30 23 2 21 24
M  V30 24 2 22 25
M  V30 25 2 22 26
M  V30 26 2 27 28
M  V30 27 1 27 29
M  V30 28 1 27 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41792-58-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393741-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-15433568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Characteristics of Bis(2,
2-dinitroethyl-N-nitro)ethylenediamine-Based Energetic Salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Jinhong; Zhou, Zhiming; Huang, Haifeng; Cao, Dan; Liang, Lixuan;
Wang, Kai; Zhang, Jun; Zhao, Fen-Qui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Anorganische und Allgemeine Chemie (2012), 638(6),
957-964

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Androstan-17-one, 16-[(4-fluorophenyl)methylene]-3-hydroxy-, (3α,5α,16E)-
C26H33FO2
503272-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8289 0.4090 0.0 0
M  V30 2 O 5.0494 0.0000 0.0 0
M  V30 3 C 3.0800 2.7106 0.0 0
M  V30 4 C 11.6417 2.8549 0.0 0
M  V30 5 O 14.9920 6.5606 0.0 0
M  V30 6 F 0.0000 8.0453 0.0 0
M  V30 7 C 6.9898 3.4806 0.0 0 CFG=2
M  V30 8 C 8.3236 4.2506 0.0 0 CFG=2
M  V30 9 C 6.9898 1.9406 0.0 0 CFG=1
M  V30 10 C 5.5252 3.9564 0.0 0
M  V30 11 C 9.6572 3.4806 0.0 0 CFG=2
M  V30 12 C 8.3236 5.7906 0.0 0
M  V30 13 C 5.5252 1.4647 0.0 0
M  V30 14 C 8.3236 1.1706 0.0 0
M  V30 15 C 4.6200 2.7106 0.0 0
M  V30 16 C 10.9909 4.2506 0.0 0 CFG=2
M  V30 17 C 9.6572 1.9406 0.0 0
M  V30 18 C 9.6572 6.5606 0.0 0
M  V30 19 C 10.9909 5.7906 0.0 0 CFG=2
M  V30 20 C 12.3245 3.4806 0.0 0
M  V30 21 C 12.3245 6.5606 0.0 0
M  V30 22 C 13.6583 4.2506 0.0 0
M  V30 23 C 13.6583 5.7906 0.0 0 CFG=2
M  V30 24 C 2.3100 4.0442 0.0 0
M  V30 25 C 0.7700 4.0442 0.0 0
M  V30 26 C 3.0800 5.3779 0.0 0
M  V30 27 C 0.0000 5.3779 0.0 0
M  V30 28 C 2.3100 6.7117 0.0 0
M  V30 29 C 0.7700 6.7117 0.0 0
M  V30 30 H 6.1967 4.8007 0.0 0
M  V30 31 H 7.4402 5.5120 0.0 0
M  V30 32 H 10.5406 2.2190 0.0 0
M  V30 33 H 10.9909 7.3306 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 2 2 13
M  V30 3 2 3 15
M  V30 4 1 3 24
M  V30 5 1 16 4 CFG=1
M  V30 6 1 23 5 CFG=3
M  V30 7 1 6 29
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 30 CFG=3
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 31 CFG=1
M  V30 15 1 9 13
M  V30 16 1 9 14
M  V30 17 1 10 15
M  V30 18 1 11 16
M  V30 19 1 11 17
M  V30 20 1 11 32 CFG=3
M  V30 21 1 12 18
M  V30 22 1 13 15
M  V30 23 1 14 17
M  V30 24 1 16 19
M  V30 25 1 16 20
M  V30 26 1 18 19
M  V30 27 1 19 21
M  V30 28 1 19 33 CFG=3
M  V30 29 1 20 22
M  V30 30 1 21 23
M  V30 31 1 22 23
M  V30 32 2 24 25
M  V30 33 1 24 26
M  V30 34 1 25 27
M  V30 35 2 26 28
M  V30 36 2 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 7 8 9 11 16 19 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5α)-2′-Amino-6′-(4-fluorophenyl)-1′,6′-dihydroandrost-16-eno[17,16-d]pyri...
C27H36FN3O
503272-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3611 1.9190 0.0 0
M  V30 2 N 3.2731 0.0000 0.0 0
M  V30 3 C 12.1741 4.3648 0.0 0
M  V30 4 O 15.5242 8.0706 0.0 0
M  V30 5 F 0.0000 9.0432 0.0 0
M  V30 6 C 7.5222 3.4505 0.0 0 CFG=1
M  V30 7 C 7.5222 4.9905 0.0 0 CFG=1
M  V30 8 C 6.0575 2.9747 0.0 0
M  V30 9 C 8.8558 2.6805 0.0 0
M  V30 10 C 8.8558 5.7606 0.0 0 CFG=2
M  V30 11 C 6.0575 5.4666 0.0 0
M  V30 12 C 5.1522 4.2205 0.0 0
M  V30 13 N 5.4311 1.5679 0.0 0
M  V30 14 C 10.1895 3.4505 0.0 0
M  V30 15 C 10.1895 4.9905 0.0 0 CFG=1
M  V30 16 C 8.8558 7.3006 0.0 0
M  V30 17 C 3.6207 4.0596 0.0 0 CFG=3
M  V30 18 C 3.8996 1.4070 0.0 0
M  V30 19 C 11.5233 5.7606 0.0 0 CFG=2
M  V30 20 C 10.1895 8.0706 0.0 0
M  V30 21 N 2.9944 2.6528 0.0 0
M  V30 22 C 11.5233 7.3006 0.0 0 CFG=2
M  V30 23 C 12.8569 4.9905 0.0 0
M  V30 24 C 12.8569 8.0706 0.0 0
M  V30 25 C 14.1906 5.7606 0.0 0
M  V30 26 C 14.1906 7.3006 0.0 0 CFG=2
M  V30 27 C 2.7155 5.3055 0.0 0
M  V30 28 C 1.1840 5.1446 0.0 0
M  V30 29 C 3.3420 6.7124 0.0 0
M  V30 30 C 0.2787 6.3904 0.0 0
M  V30 31 C 2.4368 7.9583 0.0 0
M  V30 32 C 0.9052 7.7974 0.0 0
M  V30 33 H 6.7289 6.3106 0.0 0
M  V30 34 H 7.9725 7.0221 0.0 0
M  V30 35 H 11.0728 3.7291 0.0 0
M  V30 36 H 11.5233 8.8406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 2 18
M  V30 3 1 19 3 CFG=1
M  V30 4 1 26 4 CFG=3
M  V30 5 1 5 32
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 33 CFG=3
M  V30 12 2 8 12
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 10 34 CFG=1
M  V30 18 1 11 12
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 14 15
M  V30 22 1 15 19
M  V30 23 1 15 35 CFG=3
M  V30 24 1 16 20
M  V30 25 1 17 21
M  V30 26 1 17 27
M  V30 27 2 18 21
M  V30 28 1 19 22
M  V30 29 1 19 23
M  V30 30 1 20 22
M  V30 31 1 22 24
M  V30 32 1 22 36 CFG=3
M  V30 33 1 23 25
M  V30 34 1 24 26
M  V30 35 1 25 26
M  V30 36 2 27 28
M  V30 37 1 27 29
M  V30 38 1 28 30
M  V30 39 2 29 31
M  V30 40 2 30 32
M  V30 41 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 6 7 10 15 19 22 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 503272-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 503272-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-2231684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and pharmacological screening of some new pyrimidine and
cyclohexenone fused steroidal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amr, Abd El-Galil E.; Abdulla, M. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Heterocyclic Chemistry (2002), 12(2), 129-134

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-(1-Hydroxy-2-naphthalenyl)-3-(1-naphthalenyl)-2-propen-1-one
C23H16O2
574733-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 O 10.6697 0.7700 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 4.0010 3.0801 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 4.0010 4.6201 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 16 C 9.3358 3.0801 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 9.3358 4.6201 0.0 0
M  V30 19 C 12.0033 3.0801 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 12.0033 4.6201 0.0 0
M  V30 22 C 13.3370 2.3101 0.0 0
M  V30 23 C 13.3370 5.3901 0.0 0
M  V30 24 C 14.6707 3.0801 0.0 0
M  V30 25 C 14.6707 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 16
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Amino-6-(1-naphthalenyl)-4-pyrimidinyl]-1-naphthalenol
C24H17N3O
1638508-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 O 10.6697 2.3101 0.0 0
M  V30 3 C 4.0010 4.6201 0.0 0
M  V30 4 C 2.6673 3.8501 0.0 0
M  V30 5 C 4.0010 6.1601 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 6.9302 0.0 0
M  V30 9 C 1.3337 6.1601 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 8.0022 3.8501 0.0 0
M  V30 17 C 6.6685 1.5400 0.0 0
M  V30 18 N 8.0022 2.3101 0.0 0
M  V30 19 C 9.3358 4.6201 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 21 C 9.3358 6.1601 0.0 0
M  V30 22 C 12.0033 4.6201 0.0 0
M  V30 23 C 10.6697 6.9302 0.0 0
M  V30 24 C 12.0033 6.1601 0.0 0
M  V30 25 C 13.3370 3.8501 0.0 0
M  V30 26 C 13.3370 6.9302 0.0 0
M  V30 27 C 14.6707 4.6201 0.0 0
M  V30 28 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 9
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 22 25
M  V30 28 1 23 24
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 574733-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1638508-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4076931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (80W), no solvent, alternative
reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave initiated synthesis of pyrimidine analogues and study of their
antimicrobial properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lal, Kundan; Paliwal, L. J.; Bagade, M. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM American Journal of PharmTech Research (2014), 4(3), 646-656

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-(2-deoxy-β-D-erythro-pentofuranosyl)-4-nitro-1H-imidazole
C8H10BrN3O5
657408-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Br 2.7394 2.4451 0.0 0
M  V30 2 C 9.8357 2.7104 0.0 0
M  V30 3 O 10.6057 4.0442 0.0 0
M  V30 4 O 7.8663 0.0000 0.0 0
M  V30 5 N 0.7702 5.1556 0.0 0 VAL=5
M  V30 6 O 0.0000 6.4893 0.0 0
M  V30 7 O 0.0000 3.8220 0.0 0
M  V30 8 C 5.9258 3.4804 0.0 0 CFG=1
M  V30 9 O 7.3905 3.9563 0.0 0
M  V30 10 C 5.9258 1.9404 0.0 0
M  V30 11 C 8.2957 2.7104 0.0 0 CFG=2
M  V30 12 C 7.3905 1.4645 0.0 0 CFG=2
M  V30 13 N 4.6799 4.3856 0.0 0
M  V30 14 C 3.2152 3.9098 0.0 0
M  V30 15 C 4.6799 5.9256 0.0 0
M  V30 16 C 2.3102 5.1556 0.0 0
M  V30 17 N 3.2152 6.4015 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 11 2 CFG=3
M  V30 4 1 12 4 CFG=1
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13 CFG=3
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[1-(2-Deoxy-β-D-erythro-pentofuranosyl)-4-nitro-1H-imidazol-5-yl]guanidine
C9H14N6O5
657408-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 2.7394 2.6091 0.0 0
M  V30 2 C 3.7698 1.4645 0.0 0
M  V30 3 N 3.2939 0.0000 0.0 0
M  V30 4 N 5.2762 1.7847 0.0 0
M  V30 5 N 0.7700 5.3195 0.0 0 VAL=5
M  V30 6 O 0.0000 3.9858 0.0 0
M  V30 7 O 0.0000 6.6531 0.0 0
M  V30 8 C 9.8357 2.8743 0.0 0
M  V30 9 O 10.6057 4.2080 0.0 0
M  V30 10 O 7.8663 0.1639 0.0 0
M  V30 11 N 4.6799 4.5495 0.0 0
M  V30 12 C 3.2152 4.0736 0.0 0
M  V30 13 C 4.6799 6.0895 0.0 0
M  V30 14 C 2.3102 5.3195 0.0 0
M  V30 15 N 3.2152 6.5653 0.0 0
M  V30 16 C 5.9258 3.6443 0.0 0 CFG=1
M  V30 17 O 7.3905 4.1203 0.0 0
M  V30 18 C 5.9258 2.1043 0.0 0
M  V30 19 C 8.2957 2.8743 0.0 0 CFG=2
M  V30 20 C 7.3905 1.6284 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 8 9
M  V30 9 1 19 8 CFG=3
M  V30 10 1 20 10 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 16 11 CFG=3
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 657408-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 657408-24-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29116619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Guanidino-4-nitroimidazole-β-2’-deoxy-D-ribofuranose (5) Guanidine
hydrochloride (77.4 mg, 0.810 mmol) was dissolved in 1.62 mL of 0.5 M
NaOMe in MeOH. The solution was stirred, evaporated to dryness, and
redissolved in 5 mL of absolute EtOH. To this solution was added 50.0 mg
(0.162 mmol) of 4, and the reaction refluxed for 2 h. The solvent was
subsequently evaporated and the residue adsorbed onto silica (0.5 g) by
suspending in MeOH and then evaporating to dryness. The dried silica was
suspended in CHCl3 and charged to a silica column prepared in CHCl3.
Elution with 15-30% MeOH in CHCl3 gave 5 as a bright yellow, very
hygroscopic solid (45 mg, 98%, by UV-vis spectrophotometry). Rf = 0.24
(30% MeOH:CH2Cl2). 1H NMR (D2O, 500 MHz): δ = 7.73 (1H, s), 6.08 (1H, t,
J = 6.7 Hz), 4.52 (1H, dt, J = 4.0, 6.3 Hz), 4.03 (1H, m), 3.77 (1H, dd,
J = 3.7, 12.5 Hz), 3.69 (1H, dd, J = 5.2, 12.5 Hz), 2.60 (1H, m), 2.46
(1H, ddd, J = 4.3, 6.6, 14.1 Hz); 13C NMR (CD3OD, 125.8 MHz): δ = 160.0,
143.4, 135.0, 132.2, 89.1, 85.5, 72.4, 63.1, 41.8; UV-vis (H2O, pH 7)
λmax (log ε): 230 nm (4.13), 380 nm (3.82); ESI-HRMS calc’d for C9H14N6O5
[(M+Na+)] 309.0918, found 309.0917.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Synthesis of DNA Containing the Guanine Oxidation-Nitration
Product 5-Guanidino-4-nitroimidazole: Generation by a Postsynthetic
Substitution Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neeley, William L.; Henderson, Paul T.; Essigmann, John M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(2), 245-248

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
11H-Dibenz[b,f][1,4]oxathiepin-8-carboxylic acid, 10,10-dioxide
C14H10O5S
887508-01-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7768 5.3504 0.0 0
M  V30 2 O 3.9046 5.7776 0.0 0
M  V30 3 C 9.7779 4.2000 0.0 0
M  V30 4 O 11.1116 3.4300 0.0 0
M  V30 5 O 9.7779 5.7400 0.0 0
M  V30 6 C 5.7768 1.8899 0.0 0
M  V30 7 C 5.7768 3.4300 0.0 0
M  V30 8 O 4.5728 0.9297 0.0 0
M  V30 9 C 7.1106 1.1199 0.0 0
M  V30 10 S 4.5728 4.3902 0.0 0 VAL=6
M  V30 11 C 7.1106 4.2000 0.0 0
M  V30 12 C 3.0714 1.2724 0.0 0
M  V30 13 C 8.4443 1.8899 0.0 0
M  V30 14 C 3.0714 4.0473 0.0 0
M  V30 15 C 8.4443 3.4300 0.0 0
M  V30 16 C 2.4032 2.6599 0.0 0
M  V30 17 C 2.2039 0.0000 0.0 0
M  V30 18 C 0.8675 2.7750 0.0 0
M  V30 19 C 0.6681 0.1150 0.0 0
M  V30 20 C 0.0000 1.5026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
11H-Dibenz[b,f][1,4]oxathiepin-8-carboxamide, N-(aminoiminomethyl)-, 10,10-di...
C15H13N3O4S
887504-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7769 5.3503 0.0 0
M  V30 2 O 3.9047 5.7775 0.0 0
M  V30 3 C 9.7780 4.1999 0.0 0
M  V30 4 N 11.1116 3.4299 0.0 0
M  V30 5 O 9.7780 5.7399 0.0 0
M  V30 6 C 12.4453 4.1999 0.0 0
M  V30 7 N 13.7791 3.4299 0.0 0
M  V30 8 N 12.4453 5.7399 0.0 0
M  V30 9 C 5.7769 1.8899 0.0 0
M  V30 10 C 5.7769 3.4299 0.0 0
M  V30 11 O 4.5729 0.9297 0.0 0
M  V30 12 C 7.1105 1.1199 0.0 0
M  V30 13 C 7.1105 4.1999 0.0 0
M  V30 14 S 4.5729 4.3901 0.0 0 VAL=6
M  V30 15 C 3.0714 1.2724 0.0 0
M  V30 16 C 8.4443 1.8899 0.0 0
M  V30 17 C 8.4443 3.4299 0.0 0
M  V30 18 C 3.0714 4.0473 0.0 0
M  V30 19 C 2.4033 2.6599 0.0 0
M  V30 20 C 2.2039 0.0000 0.0 0
M  V30 21 C 0.8676 2.7749 0.0 0
M  V30 22 C 0.6682 0.1150 0.0 0
M  V30 23 C 0.0000 1.5026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 887508-01-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 887504-05-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3166656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-23-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(10,10-Dioxo-10,11-dihydro-5-oxa-10lambda*6*-thia-dibenzo[a.d]cycloheptene-8-carbonyl)-guanidine,
methanesulfonic acid salt. 1,1-Carbonyldiimidazole (0.2g, 1.2mmol) was
added in an atmosphere of N2 to a solution of Example 1i (0.25g,
0.86mmol) in dry DMF (5mL). The reaction mixture was stirred for 1h and
subsequently added dropwise with stirring to guanidine (generated as
given below from its hydrochloride) in methanol (10mL). The reaction
mixture was stirred for 1h, concentrated, treated with water, extracted
with ethyl acetate, washed with brine, dried and purified using flash
chromatography (silica gel, CHCl3MeOH) to obtain the acyl guanidine
(0.28g, 98%);.
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated reactant in stage 1, product was converted to mesylate
salt in 58% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tricyclic guanidine derivatives as sodium-proton exchange inhibitors and
their preparation, pharmaceutical compositions and use for treatment of
various diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lal, Bansi; Bal-Tembe, Swati; Ghosh, Usha; Jain, Arun Kumar; More,
Tulsidas; Ghate, Anil; Trivedi, Jacqueline; Parikh, Sapna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006051476 A1 2006-05-18

$RFMT $RIREG SCHEME78 STEP1
$RXN



  3  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-bromophenyl)-5-pyrimidinecarbonitrile
C11H8BrN5
1072135-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Br 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072135-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26152424
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12018-18-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasonic irradiation (65W, 20KHz), catalyst prepared
and used, catalyst can be recycled and reused
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel(II) Chromite Nanoparticles: An Eco-Friendly and Reusable Catalyst
for Synthesis of 2,4-Diamino-6-aryl-pyrimidine-5-yl Cyanides under
Ultrasonic Radiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saeedi, Bahareh; Abdolmohammadi, Shahrzad; Mirjafary, Zohreh;
Kia-Kojoori, Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2021), 24(3),
455-464

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Cinnamoylbenzimidazole
C16H12N2O
20224-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 C 7.4148 2.3101 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 8.7485 1.5400 0.0 0
M  V30 5 C 2.3101 2.8281 0.0 0
M  V30 6 C 3.0801 4.1618 0.0 0
M  V30 7 N 3.3405 1.6836 0.0 0
M  V30 8 C 0.7700 2.8281 0.0 0
M  V30 9 N 4.5864 3.8416 0.0 0
M  V30 10 C 2.3101 5.4955 0.0 0
M  V30 11 C 4.7475 2.3101 0.0 0
M  V30 12 C 0.0000 4.1618 0.0 0
M  V30 13 C 0.7700 5.4955 0.0 0
M  V30 14 C 10.0823 2.3101 0.0 0
M  V30 15 C 10.0823 3.8501 0.0 0
M  V30 16 C 11.4160 1.5400 0.0 0
M  V30 17 C 11.4160 4.6201 0.0 0
M  V30 18 C 12.7496 2.3101 0.0 0
M  V30 19 C 12.7496 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 11
M  V30 14 1 10 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1H-Benzimidazol-2-yl)-6-phenyl-2-pyrimidinamine
C17H13N5
132308-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 N 9.4091 3.9936 0.0 0
M  V30 4 N 8.1633 6.1517 0.0 0
M  V30 5 C 10.4396 5.1382 0.0 0
M  V30 6 C 9.6696 6.4718 0.0 0
M  V30 7 C 11.9796 5.1382 0.0 0
M  V30 8 C 10.4396 7.8055 0.0 0
M  V30 9 C 12.7496 6.4718 0.0 0
M  V30 10 C 11.9796 7.8055 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 5.3348 1.5400 0.0 0
M  V30 16 N 4.0012 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20224-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132308-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16726595
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 105-53-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM NaOH reagent may also be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anti bacterial activity of aryl
thiazolidin-4-one/azetidin-2-one derivatives from pyrimido-benzimidazole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhaskar, P.; Gullapelli, Kumaraswamy; Muralikrishna, T.; Brahmeshwari, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Journal of Pharmacy and Pharmaceutical Sciences (2014), 3(11),
1041-1050, 10 pp.

$RFMT $RIREG SCHEME80 STEP1
$RXN



  3  1
$MOL
2-Thiophenecarboxaldehyde
C5H4OS
98-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-1,3-dioxane-4,6-dione
C6H8O4
2033-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 O 1.5166 2.3101 0.0 0
M  V30 7 O 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5,6-dihydro-6-(2-thienyl)-4(3H)-pyrimidinone
C8H9N3OS
2102926-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7721 4.6200 0.0 0
M  V30 2 N 5.1046 0.0000 0.0 0
M  V30 3 C 3.7710 3.8500 0.0 0
M  V30 4 C 5.1046 4.6200 0.0 0
M  V30 5 N 3.7710 2.3100 0.0 0
M  V30 6 C 6.4384 3.8500 0.0 0
M  V30 7 C 5.1046 1.5400 0.0 0
M  V30 8 N 6.4384 2.3100 0.0 0
M  V30 9 C 2.4374 4.6200 0.0 0
M  V30 10 C 2.2764 6.1515 0.0 0
M  V30 11 S 1.0304 3.9935 0.0 0
M  V30 12 C 0.7700 6.4717 0.0 0
M  V30 13 C 0.0000 5.1381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-03-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2102926-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17235599
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon nanotube supported
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst (carbon nanotube supported
titanium oxide used as catalyst), Knoevenagel condensation followed by
Michael addition and then intramolecular cyclization, no solvent,
catalyst prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Eco-Friendly and Highly Efficient Synthesis of Pyrimidinones Using a
TiO2-CNTs Nanocomposite Catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khalilian, Shahin; Abdolmohammadi, Shahrzad; Nematolahi, Fereshteh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Organic Chemistry (2017), 14(5), 361-367

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Bis[(4-chlorophenyl)methylene]-1-methyl-4-piperidinone
C20H17Cl2NO
104169-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 8.0023 0.0000 0.0 0
M  V30 3 C 10.6698 1.5400 0.0 0
M  V30 4 C 8.0023 6.1601 0.0 0
M  V30 5 Cl 0.0000 4.6201 0.0 0
M  V30 6 Cl 16.0046 4.6201 0.0 0
M  V30 7 C 6.6687 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 6.6687 3.8501 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 N 8.0023 4.6201 0.0 0
M  V30 12 C 9.3360 3.8501 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 2.6675 1.5400 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 1.3338 2.3101 0.0 0
M  V30 18 C 1.3338 3.8501 0.0 0
M  V30 19 C 12.0035 2.3101 0.0 0
M  V30 20 C 12.0035 3.8501 0.0 0
M  V30 21 C 13.3372 1.5400 0.0 0
M  V30 22 C 13.3372 4.6201 0.0 0
M  V30 23 C 14.6708 2.3101 0.0 0
M  V30 24 C 14.6708 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7 CFG=2
M  V30 2 1 1 13
M  V30 3 2 2 8
M  V30 4 2 3 10 CFG=2
M  V30 5 1 3 19
M  V30 6 1 4 11
M  V30 7 1 5 18
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenyl)-8-[(4-chlorophenyl)methylene]-1,4,5,6,7,8-hexahydro-6-meth...
C21H20Cl2N4
753407-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 3.8500 0.0 0
M  V30 2 C 8.0022 8.4701 0.0 0
M  V30 3 N 6.6686 0.0000 0.0 0
M  V30 4 Cl 0.0000 6.9301 0.0 0
M  V30 5 Cl 16.0045 6.9301 0.0 0
M  V30 6 C 6.6686 4.6201 0.0 0
M  V30 7 C 8.0022 3.8500 0.0 0
M  V30 8 C 5.3348 3.8500 0.0 0
M  V30 9 C 6.6686 6.1601 0.0 0
M  V30 10 C 9.3359 4.6201 0.0 0
M  V30 11 N 8.0022 2.3100 0.0 0
M  V30 12 N 5.3348 2.3100 0.0 0
M  V30 13 N 8.0022 6.9301 0.0 0
M  V30 14 C 9.3359 6.1601 0.0 0
M  V30 15 C 6.6686 1.5400 0.0 0
M  V30 16 C 4.0011 4.6201 0.0 0
M  V30 17 C 2.6675 3.8500 0.0 0
M  V30 18 C 4.0011 6.1601 0.0 0
M  V30 19 C 1.3338 4.6201 0.0 0
M  V30 20 C 2.6675 6.9301 0.0 0
M  V30 21 C 1.3338 6.1601 0.0 0
M  V30 22 C 12.0034 4.6201 0.0 0
M  V30 23 C 13.3370 3.8500 0.0 0
M  V30 24 C 12.0034 6.1601 0.0 0
M  V30 25 C 14.6707 4.6201 0.0 0
M  V30 26 C 13.3370 6.9301 0.0 0
M  V30 27 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10 CFG=2
M  V30 2 1 1 22
M  V30 3 1 2 13
M  V30 4 1 3 15
M  V30 5 1 4 21
M  V30 6 1 5 27
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 16
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 14
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104169-80-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 753407-72-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-9649537
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 919-30-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM zeolite MCM-41-functionalized propanamine
$DTYPE RXN:VAR(1):NOTES
$DATUM recyclable catalyst, no solvent, optimization study, optimized on
catalyst, time, temperature and solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of (Fe2O3)-MCM-41-nPrNH2 magnetically recoverable
nanocatalyst for the synthesis of phenylpyrido[4,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rostamizadeh, Shahnaz; Shadjou, Nasrin; Isapoor, Elyass; Hasanzadeh,
Mohammad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Nanoscience and Nanotechnology (2013), 13(7), 4925-4933

$RFMT $RIREG SCHEME82 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-1,6-dihydro-6-oxo-5-pyrimidinecarbonitrile
C11H7ClN4O
878489-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 2 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878489-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31372504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 111-40-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with fullerene
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 99685-96-8
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM reaction product wth diethylenetriamine
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, diethylenetriamine functionalized fullerene catalyst
prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fullerene-C60/NH2 : A recyclable heterogeneous catalyst for the green
synthesis of chromene and pyrimidine derivatives and antibacterial
evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mirza-Aghayan, Maryam; Mohammadi, Marzieh; Boukherroub, Rabah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2022), 59(6), 1102-1115

$RFMT $RIREG SCHEME83 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26445755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of
4-Amino-5-pyrimidinecarbonitriles A mixture of aldehyde 1 (1 mmol),
malononitrile 2 (1 mmol), amidine hydrochloride or guanidinum carbonate
(1 mmol), and ZnO nanoparticles (0.1 mmol) in H2O (5 mL) was stirred for
15 min [the progress of the reaction was monitored by thin-layer
chromatography (TLC) using n-hexane/ethyl acetate as an eluent (2:3)].
Upon completion of the reaction, the reaction mixture was filtered to
isolate the solid product. Then the solid product was diluted with
chloroform, and the catalyst was removed by simple centrifugation (the
catalyst is not soluble in chloroform). After evaporation of solvent,
more purification was obtained by recrystallization from ethanol. Table
3. Entry f, yield 98% Mp (°C) Observed (lit.)[13]: 231 (229-231)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnO nanoparticles, a mild and efficient reusable catalyst for the one-pot
synthesis of 4-amino-5-pyrimidinecarbonitriles under aqueous conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hekmatshoar, Rahim; Kenary, Ghodsieh Nanva; Sadjadi, Sodeh; Beheshtiha,
Yahya S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(13), 2007-2013

$RFMT $RIREG SCHEME84 STEP1
$RXN



  3  1
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1,6-dihydro-4-(3-nitrophenyl)-6-oxo-5-pyrimidinecarbonitrile
C11H7N5O3
1160740-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 N 9.3358 3.8500 0.0 0 VAL=5
M  V30 6 O 9.3358 2.3100 0.0 0
M  V30 7 O 10.6694 4.6200 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 N 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 N 1.3336 2.3100 0.0 0
M  V30 14 C 5.3347 4.6200 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 5.3347 6.1600 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 2 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1160740-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31372507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 111-40-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with fullerene
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 99685-96-8
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM reaction product wth diethylenetriamine
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, diethylenetriamine functionalized fullerene catalyst
prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fullerene-C60/NH2 : A recyclable heterogeneous catalyst for the green
synthesis of chromene and pyrimidine derivatives and antibacterial
evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mirza-Aghayan, Maryam; Mohammadi, Marzieh; Boukherroub, Rabah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2022), 59(6), 1102-1115

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-3,5-bis[(4-nitrophenyl)methylene]-4-piperidinone
C20H17N3O5
571931-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0035 1.5400 0.0 0
M  V30 2 O 9.3360 0.0000 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 9.3360 6.1601 0.0 0
M  V30 5 N 17.3383 4.6201 0.0 0 VAL=5
M  V30 6 O 17.3383 6.1601 0.0 0
M  V30 7 O 18.6720 3.8501 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 9 O 0.0000 3.8501 0.0 0
M  V30 10 O 1.3337 6.1601 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 10.6697 3.8501 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 N 9.3360 4.6201 0.0 0
M  V30 16 C 8.0023 3.8501 0.0 0
M  V30 17 C 13.3372 2.3101 0.0 0
M  V30 18 C 13.3372 3.8501 0.0 0
M  V30 19 C 14.6708 1.5400 0.0 0
M  V30 20 C 14.6708 4.6201 0.0 0
M  V30 21 C 16.0045 2.3101 0.0 0
M  V30 22 C 16.0045 3.8501 0.0 0
M  V30 23 C 5.3348 2.3101 0.0 0
M  V30 24 C 5.3348 3.8501 0.0 0
M  V30 25 C 4.0012 1.5400 0.0 0
M  V30 26 C 4.0012 4.6201 0.0 0
M  V30 27 C 2.6675 2.3101 0.0 0
M  V30 28 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11 CFG=2
M  V30 2 1 1 17
M  V30 3 2 2 12
M  V30 4 2 3 14 CFG=2
M  V30 5 1 3 23
M  V30 6 1 4 15
M  V30 7 2 5 6
M  V30 8 2 5 7
M  V30 9 1 5 22
M  V30 10 2 8 9
M  V30 11 2 8 10
M  V30 12 1 8 28
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4,5,6,7,8-Hexahydro-6-methyl-4-(4-nitrophenyl)-8-[(4-nitrophenyl)methylene]...
C21H20N6O4
1450888-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0034 3.8500 0.0 0
M  V30 2 C 9.3359 8.4701 0.0 0
M  V30 3 N 8.0022 0.0000 0.0 0
M  V30 4 N 1.3337 6.9301 0.0 0 VAL=5
M  V30 5 O 0.0000 6.1601 0.0 0
M  V30 6 O 1.3337 8.4701 0.0 0
M  V30 7 N 17.3381 6.9301 0.0 0 VAL=5
M  V30 8 O 18.6718 6.1601 0.0 0
M  V30 9 O 17.3381 8.4701 0.0 0
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 C 9.3359 3.8500 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 8.0022 6.1601 0.0 0
M  V30 14 C 10.6695 4.6201 0.0 0
M  V30 15 N 9.3359 2.3100 0.0 0
M  V30 16 N 6.6684 2.3100 0.0 0
M  V30 17 N 9.3359 6.9301 0.0 0
M  V30 18 C 10.6695 6.1601 0.0 0
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 4.0011 3.8500 0.0 0
M  V30 22 C 5.3348 6.1601 0.0 0
M  V30 23 C 2.6675 4.6201 0.0 0
M  V30 24 C 4.0011 6.9301 0.0 0
M  V30 25 C 2.6675 6.1601 0.0 0
M  V30 26 C 13.3370 4.6201 0.0 0
M  V30 27 C 13.3370 6.1601 0.0 0
M  V30 28 C 14.6707 3.8500 0.0 0
M  V30 29 C 14.6707 6.9301 0.0 0
M  V30 30 C 16.0043 4.6201 0.0 0
M  V30 31 C 16.0043 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14 CFG=2
M  V30 2 1 1 26
M  V30 3 1 2 17
M  V30 4 1 3 19
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 25
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 31
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 20
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 17 18
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 571931-01-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1450888-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-4777782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 919-30-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM zeolite MCM-41-functionalized propanamine
$DTYPE RXN:VAR(1):NOTES
$DATUM recyclable catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of (Fe2O3)-MCM-41-nPrNH2 magnetically recoverable
nanocatalyst for the synthesis of phenylpyrido[4,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rostamizadeh, Shahnaz; Shadjou, Nasrin; Isapoor, Elyass; Hasanzadeh,
Mohammad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Nanoscience and Nanotechnology (2013), 13(7), 4925-4933

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
3,5-Bis[(2-chlorophenyl)methylene]-1-methyl-4-piperidinone
C20H17Cl2NO
67288-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 O 6.6685 6.1601 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 Cl 1.3337 6.1601 0.0 0
M  V30 6 Cl 12.0033 6.1601 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 6.6685 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 N 6.6685 1.5400 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 12.0033 4.6201 0.0 0
M  V30 21 C 10.6697 2.3101 0.0 0
M  V30 22 C 13.3370 3.8501 0.0 0
M  V30 23 C 12.0033 1.5400 0.0 0
M  V30 24 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7 CFG=2
M  V30 2 1 1 13
M  V30 3 2 2 8
M  V30 4 2 3 10 CFG=2
M  V30 5 1 3 19
M  V30 6 1 4 11
M  V30 7 1 5 14
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Chlorophenyl)-8-[(2-chlorophenyl)methylene]-1,4,5,6,7,8-hexahydro-6-meth...
C21H20Cl2N4
67288-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 3.8500 0.0 0
M  V30 2 C 6.6684 8.4701 0.0 0
M  V30 3 N 5.3348 0.0000 0.0 0
M  V30 4 Cl 1.3337 2.3100 0.0 0
M  V30 5 Cl 12.0032 2.3100 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 6.6684 3.8500 0.0 0
M  V30 8 C 4.0010 3.8500 0.0 0
M  V30 9 C 5.3348 6.1601 0.0 0
M  V30 10 C 8.0021 4.6201 0.0 0
M  V30 11 N 6.6684 2.3100 0.0 0
M  V30 12 N 4.0010 2.3100 0.0 0
M  V30 13 N 6.6684 6.9301 0.0 0
M  V30 14 C 8.0021 6.1601 0.0 0
M  V30 15 C 5.3348 1.5400 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 3.8500 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 20 C 1.3337 6.9301 0.0 0
M  V30 21 C 0.0000 6.1601 0.0 0
M  V30 22 C 10.6695 4.6201 0.0 0
M  V30 23 C 12.0032 3.8500 0.0 0
M  V30 24 C 10.6695 6.1601 0.0 0
M  V30 25 C 13.3369 4.6201 0.0 0
M  V30 26 C 12.0032 6.9301 0.0 0
M  V30 27 C 13.3369 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10 CFG=2
M  V30 2 1 1 22
M  V30 3 1 2 13
M  V30 4 1 3 15
M  V30 5 1 4 17
M  V30 6 1 5 23
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 16
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 14
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 67288-79-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67288-80-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-13919202
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 919-30-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM zeolite MCM-41-functionalized propanamine
$DTYPE RXN:VAR(1):NOTES
$DATUM recyclable catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of (Fe2O3)-MCM-41-nPrNH2 magnetically recoverable
nanocatalyst for the synthesis of phenylpyrido[4,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rostamizadeh, Shahnaz; Shadjou, Nasrin; Isapoor, Elyass; Hasanzadeh,
Mohammad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Nanoscience and Nanotechnology (2013), 13(7), 4925-4933

$RFMT $RIREG SCHEME87 STEP1
$RXN



  3  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1,6-dihydro-4-(4-methylphenyl)-6-oxo-5-pyrimidinecarbonitrile
C12H10N4O
86700-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 C 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 2 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86700-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13246029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM 3-aminopropylated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical procedure for the synthesis of
2-amino-5-cyano-6-hydroxy-4-aryl pyrimidine derivatives. A solution of
aliphatic, aromatic or heterocyclic aldehyde (1 mmol), ethyl cyanoacetate
(1 mmol) and NH2-SBA-15 (0.3 g, 60 mol %) in 2 mL ethanol was stirred
mechanically for at least 10 min, then guanidinium carbonate (1 mmol) was
added to the above reaction mixture and refluxed for appropriate time as
indicated in Table 3. After the completion of reaction, the reaction
mixture was poured into ice-cooled water and neutralized by 0.1 N HCl
aqueous solutions. The mixture was filtered and washed with water. For
further purification, the product was recrystallized from ethanol.
2-Amino-4-hydroxy-6-(p-tolyl)pyrimidine-5-carbonitrile 4c. Yield: 98%,
time: 1.30 h. m.p.: 329 °C; 1H NMR (DMSO-d6, 80 MHz): δ = 2.36 (s, 3H,
CH3), 7.24-7.76 (m, 6H, 4CH arom & 2H NH2), 11.56 (br. s, 1H, OH); 13C
NMR (DMSO-d6, 125 MHz): δ = 21.8, 85.2, 118.2, 129.1, 129.6, 134.5,
141.8, 157.2, 162.6, 172.1; MS (E. I) (70 eV): m/z (%) 226 (74) (M+), 198
(31), 184 (82), 169 (7), 156 (20), 116 (17), 91 (24), 65 (21), 43 (100);
IR (KBr): 3402, 3142, 2212, 1691, 1641, 1575, 1489, 1408, 1253 cm-1;
Anal. calcd. for C12H10N4O: C, 63.71; H, 4.46; N, 24.76 %. Found: C,
63.14; H, 4.47; N, 24.36 %.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, Amino-functionalized
SBA-15 catalyst prepared and used, Knoevenagel condensation followed by
Michael addition, recyclable catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amino-functionalized SBA-15 catalyzed one-step synthesis of
2-amino-5-cyano-4-hydroxy-6-aryl pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mirza-Aghayan, M.; Mohammadian, N.; Abolghasemi Malakshah, M.;
Boukherroub, R.; Tarlani, A. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2013), 10(3), 559-563

$RFMT $RIREG SCHEME88 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28750814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the preparation of
4-amino-5-Pyrimidinecarbonitriles A mixture of aldehyde 1 (1 mmol),
malononitrile (1 mmol), amidine hydrochloride or guanidinum carbonate 3
(1 mmol) and CuO microspheres (0.1 mmol) in 5 cm3 H2O was stirred for 15
min, the progress of the reaction being monitored by TLC using
n-hexane/ethyl acetate (2:3) as eluent. Upon completion of the reaction,
the reaction mixture was filtered to isolate the solid product. The solid
product was dissolved in chloroform and the catalyst was then removed by
simple filtration. After evaporation of the solvent, the products were
purified by recrystallization from ethanol.Table 4 Synthesis of
4-amino-5-pyrimidinecarbonitriles 4 Compound 4a Table 4 Synthesis of
4-amino-5-pyrimidinecarbonitriles 4 Compound 4f Yield 98%. M.p./°C
229-230, Lit. m.p./°C [14] 229-231
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Granulated copper oxide nanocatalyst, a mild and efficient reusable
catalyst for the one-pot synthesis of 4-amino-5-pyrimidinecarbonitriles
under aqueous conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmadi, Seyed Javad; Sadjadi, Sodeh; Hosseinpour, Morteza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2011), 142(11), 1163-1168

$RFMT $RIREG SCHEME89 STEP1
$RXN



  3  1
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1,6-dihydro-4-(4-nitrophenyl)-6-oxo-5-pyrimidinecarbonitrile
C11H7N5O3
1229519-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 N 9.3358 6.9300 0.0 0 VAL=5
M  V30 6 O 9.3358 8.4700 0.0 0
M  V30 7 O 10.6694 6.1600 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 N 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 N 1.3336 2.3100 0.0 0
M  V30 14 C 5.3347 4.6200 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 5.3347 6.1600 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 2 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1229519-41-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8941313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM 3-aminopropylated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical procedure for the synthesis of
2-amino-5-cyano-6-hydroxy-4-aryl pyrimidine derivatives. A solution of
aliphatic, aromatic or heterocyclic aldehyde (1 mmol), ethyl cyanoacetate
(1 mmol) and NH2-SBA-15 (0.3 g, 60 mol %) in 2 mL ethanol was stirred
mechanically for at least 10 min, then guanidinium carbonate (1 mmol) was
added to the above reaction mixture and refluxed for appropriate time as
indicated in Table 3. After the completion of reaction, the reaction
mixture was poured into ice-cooled water and neutralized by 0.1 N HCl
aqueous solutions. The mixture was filtered and washed with water. For
further purification, the product was recrystallized from ethanol.
2-Amino-4-hydroxy-6-(4-nitrophenyl)pyrimidine-5-carbonitrile 4e. Yield:
98%, time: 1.30 h. m.p.: 247 °C; 1H NMR (DMSO-d6, 400 MHz): δ = 6.95 (br.
s, 1H, OH), 7.80 (br. s, 2H, NH2), 8.01 (d, 2H, 2CH arom), 8.36 (d, 2H,
2CH arom); 13C NMR (DMSO-d6, 125 MHz): δ = 84.00, 117.17, 123.29, 130.10,
143.02, 149.05, 157.22, 161.97, 170.06; MS (E. I) (70 eV): m/z (%) 257
(8) (M+), 215 (10), 46 (15), 44 (35), 43 (55), 30 (100), 28 (88); IR
(KBr): 3734, 3593, 3338, 2360, 2206, 1672, 1516, 1348, 1253, 1107, 1045
cm-1; Anal. calcd. for C11H7N5O3: C, 51.37; H, 2.74; N, 27.23 %. Found:
C, 51.44; H, 2.71; N, 27.19 %.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, Amino-functionalized
SBA-15 catalyst prepared and used, Knoevenagel condensation followed by
Michael addition, recyclable catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amino-functionalized SBA-15 catalyzed one-step synthesis of
2-amino-5-cyano-4-hydroxy-6-aryl pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mirza-Aghayan, M.; Mohammadian, N.; Abolghasemi Malakshah, M.;
Boukherroub, R.; Tarlani, A. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2013), 10(3), 559-563

$RFMT $RIREG SCHEME90 STEP1
$RXN



  3  1
$MOL
1-Tetralone
C10H10O
529-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Bromophenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine
C18H14BrN3
931386-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 Br 12.0033 6.9302 0.0 0
M  V30 3 C 4.0012 3.8501 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 N 4.0012 2.3101 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 5.3348 6.1601 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 N 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 6.9302 0.0 0
M  V30 14 C 1.3337 6.9302 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 9.3360 3.8501 0.0 0
M  V30 20 C 9.3360 6.9302 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 22
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 17
M  V30 13 1 8 13
M  V30 14 1 9 13
M  V30 15 2 9 14
M  V30 16 1 10 15
M  V30 17 2 11 12
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 529-34-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 931386-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3427767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile synthesis of pyrimidine and quinazoline
derivatives via one-pot three-component reaction under solvent-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rong, Liangce; Han, Hongxia; Wang, Haiying; Jiang, Hong; Tu, Shuajiang;
Shi, Daqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2009), 46(2), 152-157

$RFMT $RIREG SCHEME91 STEP1
$RXN



  5  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenecarbohydrazonoyl chloride
C7H7ClN2
39950-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 Cl 5.3901 0.0000 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Pyrimidinedicarboxylic acid, 6-[(1,1-dimethylethyl)amino]-2-(3,5-diphenyl...
C26H26N6O4
3022925-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 5.3348 0.0 0
M  V30 2 O 1.5400 4.0012 0.0 0
M  V30 3 O 1.5400 6.6685 0.0 0
M  V30 4 C 0.0000 4.0012 0.0 0
M  V30 5 N 6.9302 2.6675 0.0 0
M  V30 6 C 8.4702 2.6675 0.0 0
M  V30 7 C 8.4702 1.1275 0.0 0
M  V30 8 C 10.0102 2.6675 0.0 0
M  V30 9 C 8.4702 4.2075 0.0 0
M  V30 10 C 3.8501 2.6675 0.0 0
M  V30 11 O 4.6201 1.3337 0.0 0
M  V30 12 O 2.3101 2.6675 0.0 0
M  V30 13 C 3.8501 0.0000 0.0 0
M  V30 14 N 6.9302 8.0023 0.0 0
M  V30 15 C 8.4619 8.1633 0.0 0
M  V30 16 C 6.3038 9.4091 0.0 0
M  V30 17 N 8.7820 9.6696 0.0 0
M  V30 18 N 7.4482 10.4396 0.0 0
M  V30 19 C 6.1601 6.6685 0.0 0
M  V30 20 N 4.6201 6.6685 0.0 0
M  V30 21 N 6.9302 5.3348 0.0 0
M  V30 22 C 3.8501 5.3348 0.0 0
M  V30 23 C 6.1601 4.0012 0.0 0
M  V30 24 C 4.6201 4.0012 0.0 0
M  V30 25 C 9.4923 7.0187 0.0 0
M  V30 26 C 10.9986 7.3390 0.0 0
M  V30 27 C 9.0164 5.5541 0.0 0
M  V30 28 C 12.0292 6.1945 0.0 0
M  V30 29 C 10.0469 4.4096 0.0 0
M  V30 30 C 11.5532 4.7299 0.0 0
M  V30 31 C 4.7975 9.7293 0.0 0
M  V30 32 C 4.3215 11.1940 0.0 0
M  V30 33 C 3.7669 8.5849 0.0 0
M  V30 34 C 2.8152 11.5142 0.0 0
M  V30 35 C 2.2606 8.9051 0.0 0
M  V30 36 C 1.7847 10.3697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 24
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19
M  V30 17 2 15 17
M  V30 18 1 15 25
M  V30 19 2 16 18
M  V30 20 1 16 31
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 39950-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3022925-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38650884
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, optimization study, optimized on solvent and time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green preparation of new pyrimidine triazole derivatives via one-pot
multicomponent reactions of guanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hezarcheshmeh, Nasrin Karami; Godarzbod, Farideh; Abdullah, Media Noori;
Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2024), 28(1), 217-228

$RFMT $RIREG SCHEME92 STEP1
$RXN



  6  1
$MOL
5-Methylisatin
C9H7NO2
608-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 O 7.9110 2.7104 0.0 0
M  V30 3 C 0.0000 1.1704 0.0 0
M  V30 4 C 4.0011 1.9404 0.0 0
M  V30 5 C 4.0011 3.4804 0.0 0
M  V30 6 C 5.4658 1.4645 0.0 0
M  V30 7 C 2.6674 1.1704 0.0 0
M  V30 8 N 5.4658 3.9564 0.0 0
M  V30 9 C 2.6674 4.2504 0.0 0
M  V30 10 C 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 1.9404 0.0 0
M  V30 12 C 1.3338 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl bromopyruvate
C5H7BrO3
70-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 Br 0.0000 2.3100 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzaldehyde
C8H5NO
105-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C42H35N7O7
2719837-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 62 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8206 11.8511 0.0 0
M  V30 2 O 9.1927 12.5501 0.0 0
M  V30 3 O 6.5290 12.6898 0.0 0
M  V30 4 C 9.2733 14.0881 0.0 0
M  V30 5 C 7.9818 14.9268 0.0 0
M  V30 6 C 12.2353 14.9201 0.0 0
M  V30 7 N 12.2353 16.4601 0.0 0
M  V30 8 C 5.6390 11.4530 0.0 0
M  V30 9 O 4.5664 12.5581 0.0 0
M  V30 10 O 7.1324 11.8292 0.0 0
M  V30 11 C 4.9873 14.0394 0.0 0
M  V30 12 O 7.8446 1.4068 0.0 0
M  V30 13 C 8.4709 0.0000 0.0 0
M  V30 14 C 2.6314 10.3023 0.0 0
M  V30 15 O 1.1895 9.7611 0.0 0
M  V30 16 O 2.8837 11.8215 0.0 0
M  V30 17 C 0.0000 10.7392 0.0 0
M  V30 18 C 6.6477 2.5747 0.0 0
M  V30 19 N 10.9894 7.8549 0.0 0
M  V30 20 C 12.2353 8.7601 0.0 0
M  V30 21 C 11.4653 6.3904 0.0 0
M  V30 22 N 13.4812 7.8549 0.0 0
M  V30 23 N 13.0053 6.3904 0.0 0
M  V30 24 C 9.5247 8.3309 0.0 0
M  V30 25 N 8.3804 7.3004 0.0 0
M  V30 26 N 9.2046 9.8372 0.0 0
M  V30 27 C 6.9157 7.7762 0.0 0
M  V30 28 C 7.7400 10.3131 0.0 0
M  V30 29 C 6.5955 9.2827 0.0 0
M  V30 30 C 5.9376 6.5867 0.0 0
M  V30 31 C 5.2181 9.9715 0.0 0
M  V30 32 C 4.3978 6.6098 0.0 0
M  V30 33 C 6.6876 5.2417 0.0 0
M  V30 34 C 3.8209 9.3241 0.0 0
M  V30 35 N 3.4558 7.8281 0.0 0
M  V30 36 C 3.6079 5.2877 0.0 0
M  V30 37 C 5.8977 3.9198 0.0 0
M  V30 38 C 4.3579 3.9427 0.0 0
M  V30 39 C 12.2353 10.3001 0.0 0
M  V30 40 C 13.5689 11.0701 0.0 0
M  V30 41 C 10.9017 11.0701 0.0 0
M  V30 42 C 13.5689 12.6101 0.0 0
M  V30 43 C 10.9017 12.6101 0.0 0
M  V30 44 C 12.2353 13.3801 0.0 0
M  V30 45 C 10.5601 5.1445 0.0 0
M  V30 46 C 9.0286 5.3055 0.0 0
M  V30 47 C 11.1866 3.7376 0.0 0
M  V30 48 C 8.1233 4.0596 0.0 0
M  V30 49 C 10.2813 2.4917 0.0 0
M  V30 50 C 8.7497 2.6527 0.0 0
M  V30 51 C 14.9459 8.3309 0.0 0
M  V30 52 C 16.0902 7.3004 0.0 0
M  V30 53 C 15.2660 9.8372 0.0 0
M  V30 54 C 17.5549 7.7762 0.0 0
M  V30 55 C 16.7306 10.3131 0.0 0
M  V30 56 C 17.8751 9.2827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 28
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 3 6 7
M  V30 7 1 6 44
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 31
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 50
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 34
M  V30 17 1 15 17
M  V30 18 1 18 37
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 24
M  V30 22 1 20 22
M  V30 23 1 20 39
M  V30 24 2 21 23
M  V30 25 1 21 45
M  V30 26 1 22 23
M  V30 27 1 22 51
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 27 30
M  V30 34 2 28 29
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 30 33
M  V30 38 2 31 34
M  V30 39 1 32 35
M  V30 40 2 32 36
M  V30 41 1 33 37
M  V30 42 1 34 35
M  V30 43 1 36 38
M  V30 44 2 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 2 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 49
M  V30 55 2 48 50
M  V30 56 1 49 50
M  V30 57 2 51 52
M  V30 58 1 51 53
M  V30 59 1 52 54
M  V30 60 2 53 55
M  V30 61 2 54 56
M  V30 62 1 55 56
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 608-05-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-23-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 105-07-7
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2719837-60-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24291241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, (iron/copper/zinc)oxide
supported on carbon nanotubes catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fe3O4/CuO/ZnO@MWCNT MNCs as an efficient organometallic nanocatalyst
promoted synthesis of new 1,2,4-triazolpyrimidoazepine derivatives:
Investigation of antioxidant and antimicrobial activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirangi, Hannaneh Sadat; Varasteh Moradi, Ali; Ahmadi Golsefidi, Maziar;
Hossaini, Zinatossadat; Jalilian, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Organometallic Chemistry (2022), 36(1), e6460

$RFMT $RIREG SCHEME93 STEP1
$RXN



  5  1
$MOL
1H-Indene-1,2,3-trione
C9H4O3
938-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl bromoacetate
C4H7BrO2
105-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Br 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxaldehyde
C5H4OS
98-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Indeno[2,1-d]pyrimidine-4-carboxylic acid, 2-[1,5-dihydro-3-(4-methoxyphen...
C33H25N5O4S
2858811-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8614 11.7798 0.0 0
M  V30 2 O 4.5278 12.5498 0.0 0
M  V30 3 O 7.1951 12.5498 0.0 0
M  V30 4 C 4.5278 14.0898 0.0 0
M  V30 5 C 3.1941 14.8598 0.0 0
M  V30 6 O 2.5872 5.9892 0.0 0
M  V30 7 O 4.1120 1.5064 0.0 0
M  V30 8 C 4.4321 0.0000 0.0 0
M  V30 9 N 8.5289 7.1598 0.0 0
M  V30 10 C 9.9357 7.7861 0.0 0
M  V30 11 C 8.6898 5.6283 0.0 0
M  V30 12 N 10.9661 6.6417 0.0 0
M  V30 13 N 10.1961 5.3081 0.0 0
M  V30 14 C 7.1951 7.9298 0.0 0
M  V30 15 N 5.8614 7.1598 0.0 0
M  V30 16 N 7.1951 9.4698 0.0 0
M  V30 17 C 4.5278 7.9298 0.0 0
M  V30 18 C 5.8614 10.2398 0.0 0
M  V30 19 C 4.5278 9.4698 0.0 0
M  V30 20 C 3.0631 7.4539 0.0 0
M  V30 21 C 3.0631 9.9457 0.0 0
M  V30 22 C 2.1579 8.6998 0.0 0
M  V30 23 C 2.4368 11.3526 0.0 0
M  V30 24 C 0.6263 8.8607 0.0 0
M  V30 25 C 0.9052 11.5136 0.0 0
M  V30 26 C 0.0000 10.2677 0.0 0
M  V30 27 C 10.2558 9.2926 0.0 0
M  V30 28 C 9.2254 10.4369 0.0 0
M  V30 29 S 11.6628 9.9189 0.0 0
M  V30 30 C 9.9954 11.7707 0.0 0
M  V30 31 C 11.5017 11.4504 0.0 0
M  V30 32 C 7.5454 4.5977 0.0 0
M  V30 33 C 6.0807 5.0737 0.0 0
M  V30 34 C 7.8656 3.0914 0.0 0
M  V30 35 C 4.9363 4.0431 0.0 0
M  V30 36 C 6.7211 2.0610 0.0 0
M  V30 37 C 5.2565 2.5369 0.0 0
M  V30 38 C 12.4978 6.8027 0.0 0
M  V30 39 C 13.4030 5.5568 0.0 0
M  V30 40 C 13.1241 8.2096 0.0 0
M  V30 41 C 14.9345 5.7177 0.0 0
M  V30 42 C 14.6556 8.3706 0.0 0
M  V30 43 C 15.5609 7.1247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 20
M  V30 7 1 7 8
M  V30 8 1 7 37
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 10 27
M  V30 14 2 11 13
M  V30 15 1 11 32
M  V30 16 1 12 13
M  V30 17 1 12 38
M  V30 18 1 14 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 17 20
M  V30 24 2 18 19
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 1 21 22
M  V30 28 2 21 23
M  V30 29 2 22 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 2 30 31
M  V30 38 2 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 37
M  V30 44 2 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 42
M  V30 48 2 41 43
M  V30 49 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 938-24-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-36-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 98-03-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2858811-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34651292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with CuO and ZnO, supported on MWCNT MNCs
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, recyclable and reusable
catalyst used, carbon nanotube support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fe3O4/CuO/ZnO@MWCNT MNCs Promoted the Green Synthesis of
Indenopyrimidin-1,2,4-Triazoles as Hybrid Molecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aghaei-Meybodi, Zahra; Mirabi, Ali; Khandan, Samira; Azizi, Bayan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(8), 7319-7342

$RFMT $RIREG SCHEME94 STEP1
$RXN



  6  1
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl bromopyruvate
C5H7BrO3
70-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 Br 0.0000 2.3100 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetaldehyde
C2H4O
75-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenylbenzenecarbohydrazonoyl chloride
C13H11ClN2
15424-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 4.0012 0.0000 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 8.0023 2.3101 0.0 0
M  V30 12 C 8.0023 3.8501 0.0 0
M  V30 13 C 9.3360 1.5400 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-(4-methoxyphenyl)benzenecarbohydrazonoyl chloride
C15H15ClN2O2
2808427-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 Cl 6.6687 0.0000 0.0 0
M  V30 4 N 9.3360 1.5400 0.0 0
M  V30 5 O 1.3338 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 O 14.6708 4.6201 0.0 0
M  V30 8 C 16.0046 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 10.6698 2.3101 0.0 0
M  V30 16 C 10.6698 3.8501 0.0 0
M  V30 17 C 12.0035 1.5400 0.0 0
M  V30 18 C 12.0035 4.6201 0.0 0
M  V30 19 C 13.3372 2.3101 0.0 0
M  V30 20 C 13.3372 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[2-[1,5-dihydro-1,3-bis(4-methoxyphenyl)-5-methyl-4H-1,2,4-triazol-4-...
C44H38N8O5
2808427-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 65 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4619 11.8186 0.0 0
M  V30 2 O 9.6063 10.7881 0.0 0
M  V30 3 O 8.7820 13.3249 0.0 0
M  V30 4 C 11.0710 11.2639 0.0 0
M  V30 5 C 11.3911 12.7704 0.0 0
M  V30 6 C 12.0235 10.8578 0.0 0
M  V30 7 O 9.5776 1.2459 0.0 0
M  V30 8 C 10.4828 0.0000 0.0 0
M  V30 9 O 19.0852 11.8051 0.0 0
M  V30 10 C 20.4190 11.0351 0.0 0
M  V30 11 C 6.9972 11.3426 0.0 0
M  V30 12 N 6.6770 12.8491 0.0 0
M  V30 13 O 5.6635 10.5726 0.0 0
M  V30 14 N 5.1455 13.0100 0.0 0
M  V30 15 C 4.5192 11.6032 0.0 0
M  V30 16 C 7.6237 9.9358 0.0 0
M  V30 17 C 6.7184 8.6900 0.0 0
M  V30 18 N 9.1552 9.7749 0.0 0
M  V30 19 C 7.3448 7.2830 0.0 0
M  V30 20 N 5.1869 8.5289 0.0 0
M  V30 21 C 9.7815 8.3679 0.0 0
M  V30 22 C 6.2004 6.2526 0.0 0
M  V30 23 N 8.8765 7.1221 0.0 0
M  V30 24 C 4.8667 7.0226 0.0 0
M  V30 25 C 6.2004 4.7126 0.0 0
M  V30 26 C 3.5329 6.2526 0.0 0
M  V30 27 C 4.8667 3.9426 0.0 0
M  V30 28 C 3.5329 4.7126 0.0 0
M  V30 29 C 7.7076 13.9934 0.0 0
M  V30 30 C 9.2139 13.6733 0.0 0
M  V30 31 C 7.2316 15.4581 0.0 0
M  V30 32 C 10.2443 14.8178 0.0 0
M  V30 33 C 8.2621 16.6025 0.0 0
M  V30 34 C 9.7684 16.2823 0.0 0
M  V30 35 C 3.0127 11.2830 0.0 0
M  V30 36 C 2.5369 9.8183 0.0 0
M  V30 37 C 1.9823 12.4274 0.0 0
M  V30 38 C 1.0306 9.4982 0.0 0
M  V30 39 C 0.4760 12.1072 0.0 0
M  V30 40 C 0.0000 10.6425 0.0 0
M  V30 41 N 11.3132 8.2070 0.0 0
M  V30 42 C 12.0832 6.8734 0.0 0
M  V30 43 C 12.3436 9.3514 0.0 0
M  V30 44 N 13.5895 7.1935 0.0 0
M  V30 45 N 13.7504 8.7251 0.0 0
M  V30 46 C 11.4567 5.4664 0.0 0
M  V30 47 C 9.9252 5.3055 0.0 0
M  V30 48 C 12.3620 4.2205 0.0 0
M  V30 49 C 9.2989 3.8985 0.0 0
M  V30 50 C 11.7356 2.8137 0.0 0
M  V30 51 C 10.2041 2.6527 0.0 0
M  V30 52 C 15.0842 9.4951 0.0 0
M  V30 53 C 16.4179 8.7251 0.0 0
M  V30 54 C 15.0842 11.0351 0.0 0
M  V30 55 C 17.7515 9.4951 0.0 0
M  V30 56 C 16.4179 11.8051 0.0 0
M  V30 57 C 17.7515 11.0351 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 43
M  V30 7 1 7 8
M  V30 8 1 7 51
M  V30 9 1 9 10
M  V30 10 1 9 57
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 16
M  V30 14 1 12 14
M  V30 15 1 12 29
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 15 35
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 1 21 23
M  V30 28 1 21 41
M  V30 29 1 22 24
M  V30 30 2 22 25
M  V30 31 2 24 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 2 27 28
M  V30 35 2 29 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 2 31 33
M  V30 39 2 32 34
M  V30 40 1 33 34
M  V30 41 2 35 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 2 37 39
M  V30 45 2 38 40
M  V30 46 1 39 40
M  V30 47 1 41 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 1 42 46
M  V30 51 1 43 45
M  V30 52 1 44 45
M  V30 53 1 45 52
M  V30 54 2 46 47
M  V30 55 1 46 48
M  V30 56 1 47 49
M  V30 57 2 48 50
M  V30 58 2 49 51
M  V30 59 1 50 51
M  V30 60 2 52 53
M  V30 61 1 52 54
M  V30 62 1 53 55
M  V30 63 2 54 56
M  V30 64 2 55 57
M  V30 65 1 56 57
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-23-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 75-07-0
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 15424-14-3
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 2808427-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2808427-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33458181
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, baker's yeast catalyst used (stage 1),
optimization study, optimized on catalyst, solvent, time, temperature and
stoichiometry of catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Baker's Yeast Promoted One-Pot Synthesis of New
1,2,4-Triazolpyrimido-1,3,4-Oxadiazoles: Investigation of Antioxidant and
Antimicrobial Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mashal, Neda; Azizian, Javad; Larijani, Kambiz; Nematollahi, Fereshteh;
Azizian, Homa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(5), 4478-4495

$RFMT $RIREG SCHEME95 STEP1
$RXN



  6  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitroisatin
C8H4N2O4
611-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2753 0.3694 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 O 9.2446 3.0800 0.0 0
M  V30 6 C 5.3347 2.3100 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.7994 1.8341 0.0 0
M  V30 10 N 6.7994 4.3259 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 7.7046 3.0800 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl bromopyruvate
C5H7BrO3
70-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 Br 0.0000 2.3100 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetaldehyde
C2H4O
75-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-N-(4-methylphenyl)benzenecarbohydrazonoyl chloride
C15H15ClN2
78841-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 Cl 5.3348 0.0000 0.0 0
M  V30 4 N 8.0022 1.5400 0.0 0
M  V30 5 C 0.0000 4.6201 0.0 0
M  V30 6 C 13.3370 4.6201 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 9.3360 2.3101 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 1.5400 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-(4-methoxyphenyl)benzenecarbohydrazonoyl chloride
C15H15ClN2O2
2808427-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 Cl 6.6687 0.0000 0.0 0
M  V30 4 N 9.3360 1.5400 0.0 0
M  V30 5 O 1.3338 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 O 14.6708 4.6201 0.0 0
M  V30 8 C 16.0046 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 10.6698 2.3101 0.0 0
M  V30 16 C 10.6698 3.8501 0.0 0
M  V30 17 C 12.0035 1.5400 0.0 0
M  V30 18 C 12.0035 4.6201 0.0 0
M  V30 19 C 13.3372 2.3101 0.0 0
M  V30 20 C 13.3372 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[2-[1,5-dihydro-1,3-bis(4-methoxyphenyl)-5-methyl-4H-1,2,4-triazol-4-...
C46H41N9O7
2808427-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  62 70 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9682 11.8185 0.0 0
M  V30 2 O 11.1125 10.7881 0.0 0
M  V30 3 O 10.2883 13.3249 0.0 0
M  V30 4 C 12.5772 11.2639 0.0 0
M  V30 5 C 12.8974 12.7704 0.0 0
M  V30 6 C 13.5297 10.8578 0.0 0
M  V30 7 C 12.3051 17.4267 0.0 0
M  V30 8 N 6.3729 2.4026 0.0 0 VAL=5
M  V30 9 O 5.0392 1.6326 0.0 0
M  V30 10 O 7.7067 1.6326 0.0 0
M  V30 11 C 0.0000 10.3224 0.0 0
M  V30 12 O 11.0839 1.2459 0.0 0
M  V30 13 C 11.9891 0.0000 0.0 0
M  V30 14 O 20.5914 11.8051 0.0 0
M  V30 15 C 21.9251 11.0351 0.0 0
M  V30 16 C 8.5035 11.3426 0.0 0
M  V30 17 N 8.1833 12.8491 0.0 0
M  V30 18 O 7.1698 10.5726 0.0 0
M  V30 19 N 6.6518 13.0100 0.0 0
M  V30 20 C 6.0254 11.6032 0.0 0
M  V30 21 C 9.1299 9.9358 0.0 0
M  V30 22 C 8.2247 8.6900 0.0 0
M  V30 23 N 10.6615 9.7747 0.0 0
M  V30 24 C 8.8510 7.2830 0.0 0
M  V30 25 N 6.6930 8.5289 0.0 0
M  V30 26 C 11.2878 8.3679 0.0 0
M  V30 27 C 7.7067 6.2526 0.0 0
M  V30 28 N 10.3826 7.1221 0.0 0
M  V30 29 C 6.3729 7.0226 0.0 0
M  V30 30 C 7.7067 4.7126 0.0 0
M  V30 31 C 5.0392 6.2526 0.0 0
M  V30 32 C 6.3729 3.9426 0.0 0
M  V30 33 C 5.0392 4.7126 0.0 0
M  V30 34 C 9.2137 13.9934 0.0 0
M  V30 35 C 8.7379 15.4581 0.0 0
M  V30 36 C 10.7201 13.6733 0.0 0
M  V30 37 C 9.7684 16.6025 0.0 0
M  V30 38 C 11.7506 14.8176 0.0 0
M  V30 39 C 11.2747 16.2823 0.0 0
M  V30 40 C 4.5190 11.2829 0.0 0
M  V30 41 C 4.0431 9.8183 0.0 0
M  V30 42 C 3.4886 12.4274 0.0 0
M  V30 43 C 2.5367 9.4982 0.0 0
M  V30 44 C 1.9821 12.1072 0.0 0
M  V30 45 C 1.5063 10.6425 0.0 0
M  V30 46 N 12.8193 8.2070 0.0 0
M  V30 47 C 13.5893 6.8732 0.0 0
M  V30 48 C 13.8499 9.3514 0.0 0
M  V30 49 N 15.0958 7.1935 0.0 0
M  V30 50 N 15.2567 8.7251 0.0 0
M  V30 51 C 12.9630 5.4664 0.0 0
M  V30 52 C 11.4315 5.3055 0.0 0
M  V30 53 C 13.8682 4.2205 0.0 0
M  V30 54 C 10.8050 3.8985 0.0 0
M  V30 55 C 13.2418 2.8136 0.0 0
M  V30 56 C 11.7102 2.6527 0.0 0
M  V30 57 C 16.5904 9.4951 0.0 0
M  V30 58 C 16.5904 11.0351 0.0 0
M  V30 59 C 17.9242 8.7251 0.0 0
M  V30 60 C 17.9242 11.8051 0.0 0
M  V30 61 C 19.2578 9.4951 0.0 0
M  V30 62 C 19.2578 11.0351 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 48
M  V30 7 1 7 39
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 32
M  V30 11 1 11 45
M  V30 12 1 12 13
M  V30 13 1 12 56
M  V30 14 1 14 15
M  V30 15 1 14 62
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21
M  V30 19 1 17 19
M  V30 20 1 17 34
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 20 40
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 2 24 28
M  V30 31 1 25 29
M  V30 32 1 26 28
M  V30 33 1 26 46
M  V30 34 1 27 29
M  V30 35 2 27 30
M  V30 36 2 29 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 33
M  V30 40 2 34 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 2 36 38
M  V30 44 2 37 39
M  V30 45 1 38 39
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 52 1 46 47
M  V30 53 1 46 48
M  V30 54 2 47 49
M  V30 55 1 47 51
M  V30 56 1 48 50
M  V30 57 1 49 50
M  V30 58 1 50 57
M  V30 59 2 51 52
M  V30 60 1 51 53
M  V30 61 1 52 54
M  V30 62 2 53 55
M  V30 63 2 54 56
M  V30 64 1 55 56
M  V30 65 2 57 58
M  V30 66 1 57 59
M  V30 67 1 58 60
M  V30 68 2 59 61
M  V30 69 2 60 62
M  V30 70 1 61 62
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-09-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-23-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 75-07-0
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 78841-14-2
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 2808427-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2808427-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33458192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, baker's yeast catalyst used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Baker's Yeast Promoted One-Pot Synthesis of New
1,2,4-Triazolpyrimido-1,3,4-Oxadiazoles: Investigation of Antioxidant and
Antimicrobial Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mashal, Neda; Azizian, Javad; Larijani, Kambiz; Nematollahi, Fereshteh;
Azizian, Homa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(5), 4478-4495

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2:5,6-Dianhydro-3,4-O-(1-methylethylidene)-L-iditol
C9H14O4
63699-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5167 0.6368 0.0 0
M  V30 2 C 3.4767 0.0000 0.0 0
M  V30 3 C 2.8504 3.8985 0.0 0 CFG=1
M  V30 4 C 4.3149 3.4226 0.0 0 CFG=1
M  V30 5 O 1.9452 2.6526 0.0 0
M  V30 6 O 4.3149 1.8826 0.0 0
M  V30 7 C 2.8504 1.4068 0.0 0
M  V30 8 C 1.5167 4.6685 0.0 0 CFG=1
M  V30 9 C 0.5268 3.4889 0.0 0
M  V30 10 O 0.0000 4.9360 0.0 0
M  V30 11 C 5.8466 3.2617 0.0 0 CFG=1
M  V30 12 C 6.2710 4.7421 0.0 0
M  V30 13 O 7.3409 3.6342 0.0 0
M  V30 14 H 3.0912 5.4196 0.0 0
M  V30 15 H 4.6351 4.9291 0.0 0
M  V30 16 H 2.0434 6.1156 0.0 0
M  V30 17 H 5.9539 1.7254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 3 14 CFG=1
M  V30 7 1 4 6
M  V30 8 1 4 11
M  V30 9 1 4 15 CFG=3
M  V30 10 1 5 7
M  V30 11 1 6 7
M  V30 12 1 8 9
M  V30 13 1 8 10 CFG=3
M  V30 14 1 8 16
M  V30 15 1 9 10
M  V30 16 1 11 12 CFG=1
M  V30 17 1 11 13
M  V30 18 1 11 17
M  V30 19 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 4 8 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,4S,10S,10aR)-7-Amino-3a,5,8,9,10,10a-hexahydro-2,2-dimethyl-4H-1,3-dioxo...
C10H19N3O4
206655-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.7342 6.5669 0.0 0
M  V30 2 O 3.7342 0.0000 0.0 0
M  V30 3 C 0.0000 2.2530 0.0 0
M  V30 4 C 0.0000 4.3138 0.0 0
M  V30 5 N 9.4211 3.2834 0.0 0
M  V30 6 C 3.5143 4.0534 0.0 0 CFG=1
M  V30 7 C 3.5143 2.5134 0.0 0 CFG=1
M  V30 8 O 2.0496 4.5293 0.0 0
M  V30 9 C 4.5042 5.2331 0.0 0 CFG=1
M  V30 10 O 2.0496 2.0376 0.0 0
M  V30 11 C 4.5042 1.3338 0.0 0 CFG=1
M  V30 12 C 1.1444 3.2834 0.0 0
M  V30 13 C 6.0208 5.5006 0.0 0
M  V30 14 C 6.0208 1.0663 0.0 0
M  V30 15 N 7.3544 4.7306 0.0 0
M  V30 16 N 7.3544 1.8363 0.0 0
M  V30 17 C 7.8811 3.2834 0.0 0
M  V30 18 H 3.0897 5.5338 0.0 0
M  V30 19 H 3.0897 1.0330 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 11 2 CFG=3
M  V30 3 1 3 12
M  V30 4 1 4 12
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 18 CFG=1
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 19 CFG=3
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 10 12
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 6 7 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63699-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 206655-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-2193512
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of C2-symmetric guanidino-sugars as potent inhibitors of
glycosidases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le Merrer, Y.; Gauzy, L.; Gravier-Pelletier, C.; Depezay, J.-C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2000), 8(2), 307-320

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2:5,6-Dianhydro-3,4-O-isopropylidene-D-mannitol
C9H14O4
63700-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5167 0.6368 0.0 0
M  V30 2 C 3.4767 0.0000 0.0 0
M  V30 3 C 2.8504 3.8985 0.0 0 CFG=1
M  V30 4 C 4.3149 3.4226 0.0 0 CFG=1
M  V30 5 O 1.9452 2.6526 0.0 0
M  V30 6 O 4.3149 1.8826 0.0 0
M  V30 7 C 2.8504 1.4068 0.0 0
M  V30 8 C 1.5167 4.6685 0.0 0 CFG=2
M  V30 9 C 0.5268 3.4889 0.0 0
M  V30 10 O 0.0000 4.9360 0.0 0
M  V30 11 C 5.8466 3.2617 0.0 0 CFG=2
M  V30 12 C 6.2710 4.7421 0.0 0
M  V30 13 O 7.3409 3.6342 0.0 0
M  V30 14 H 3.0912 5.4196 0.0 0
M  V30 15 H 4.6351 4.9291 0.0 0
M  V30 16 H 2.0434 6.1156 0.0 0
M  V30 17 H 5.9539 1.7254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 3 14 CFG=1
M  V30 7 1 4 6
M  V30 8 1 4 11
M  V30 9 1 4 15 CFG=3
M  V30 10 1 5 7
M  V30 11 1 6 7
M  V30 12 1 8 9
M  V30 13 1 8 10 CFG=1
M  V30 14 1 8 16
M  V30 15 1 9 10
M  V30 16 1 11 12 CFG=3
M  V30 17 1 11 13
M  V30 18 1 11 17
M  V30 19 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 4 8 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,4R,10R,10aR)-7-Amino-3a,5,8,9,10,10a-hexahydro-2,2-dimethyl-4H-1,3-dioxo...
C10H19N3O4
206655-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.7342 6.5669 0.0 0
M  V30 2 O 3.7342 0.0000 0.0 0
M  V30 3 C 0.0000 2.2530 0.0 0
M  V30 4 C 0.0000 4.3138 0.0 0
M  V30 5 N 9.4211 3.2834 0.0 0
M  V30 6 C 3.5143 4.0534 0.0 0 CFG=1
M  V30 7 C 3.5143 2.5134 0.0 0 CFG=1
M  V30 8 O 2.0496 4.5293 0.0 0
M  V30 9 C 4.5042 5.2331 0.0 0 CFG=2
M  V30 10 O 2.0496 2.0376 0.0 0
M  V30 11 C 4.5042 1.3338 0.0 0 CFG=2
M  V30 12 C 1.1444 3.2834 0.0 0
M  V30 13 C 6.0208 5.5006 0.0 0
M  V30 14 C 6.0208 1.0663 0.0 0
M  V30 15 N 7.3544 4.7306 0.0 0
M  V30 16 N 7.3544 1.8363 0.0 0
M  V30 17 C 7.8811 3.2834 0.0 0
M  V30 18 H 3.0897 5.5338 0.0 0
M  V30 19 H 3.0897 1.0330 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 11 2 CFG=1
M  V30 3 1 3 12
M  V30 4 1 4 12
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 18 CFG=1
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 19 CFG=3
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 10 12
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 6 7 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63700-05-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 206655-87-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-99883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of C2-symmetric guanidino-sugars as potent inhibitors of
glycosidases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le Merrer, Y.; Gauzy, L.; Gravier-Pelletier, C.; Depezay, J.-C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2000), 8(2), 307-320

$RFMT $RIREG SCHEME98 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Chloroacetophenone
C8H7ClO
99-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenyl)-6-phenyl-2-pyrimidinamine
C16H12ClN3
59807-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 Cl 12.0033 6.9302 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 N 6.6685 2.3101 0.0 0
M  V30 6 C 4.0012 3.8501 0.0 0
M  V30 7 C 5.3348 1.5400 0.0 0
M  V30 8 N 4.0012 2.3101 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 8.0022 6.1601 0.0 0
M  V30 11 C 9.3360 3.8501 0.0 0
M  V30 12 C 9.3360 6.9302 0.0 0
M  V30 13 C 10.6697 4.6201 0.0 0
M  V30 14 C 10.6697 6.1601 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 19 C 1.3337 6.9302 0.0 0
M  V30 20 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 15
M  V30 10 2 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-91-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59807-18-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33784596
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2638568-78-0
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, solid-supported catalyst,
catalyst prepared and used, recyclable catalyst, no solvent, ionic liquid
used (catalyst), alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic Liquid-Coated Nanoparticles (CaO@SiO2@BAIL): A Bi-Functional and
Environmentally Benign Catalyst for Green Synthesis of Pyridine,
Pyrimidine, and Pyrazoline Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sameri, Fatemeh; Bodaghifard, Mohammad Ali; Mobinikhaledi, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2022), 42(7), 4700-4716

$RFMT $RIREG SCHEME99 STEP1
$RXN



  3  1
$MOL
tert-Butoxybis(dimethylamino)methane
C9H22N2O
5815-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 O 2.6675 1.5400 0.0 0
M  V30 3 N 4.0012 3.8501 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 C 1.3338 2.3101 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 6.6687 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 0.5638 0.9764 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 2.1038 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Bromo-1H-indol-3-yl)-2-(2-methoxyethoxy)ethanone
C13H14BrNO3
1202768-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 3.1059 0.0 0
M  V30 2 C 7.0871 3.8760 0.0 0
M  V30 3 O 5.7534 1.5659 0.0 0
M  V30 4 O 8.4208 3.1059 0.0 0
M  V30 5 C 9.7544 3.8760 0.0 0
M  V30 6 C 11.0882 3.1059 0.0 0
M  V30 7 O 12.4219 3.8760 0.0 0
M  V30 8 C 13.7556 3.1059 0.0 0
M  V30 9 Br 0.5546 0.0000 0.0 0
M  V30 10 C 3.0128 3.2495 0.0 0
M  V30 11 C 4.4196 3.8760 0.0 0
M  V30 12 C 1.9823 4.3940 0.0 0
M  V30 13 C 2.5369 1.7849 0.0 0
M  V30 14 C 4.2587 5.4075 0.0 0
M  V30 15 N 2.7523 5.7277 0.0 0
M  V30 16 C 0.4759 4.0739 0.0 0
M  V30 17 C 1.0304 1.4647 0.0 0
M  V30 18 C 0.0000 2.6091 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(5-Bromo-1H-indol-3-yl)-5-(2-methoxyethoxy)-2-pyrimidinamine
C15H15BrN4O2
1202768-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.9565 5.0543 0.0 0
M  V30 2 C 9.2902 5.8244 0.0 0
M  V30 3 C 10.6238 5.0543 0.0 0
M  V30 4 O 11.9576 5.8244 0.0 0
M  V30 5 C 13.2913 5.0543 0.0 0
M  V30 6 Br 0.0000 2.1051 0.0 0
M  V30 7 N 2.6217 8.1344 0.0 0
M  V30 8 C 5.2890 3.5143 0.0 0
M  V30 9 C 4.0432 2.6091 0.0 0
M  V30 10 C 6.5351 2.6091 0.0 0
M  V30 11 C 4.5190 1.1445 0.0 0
M  V30 12 C 2.5369 2.9293 0.0 0
M  V30 13 N 6.0591 1.1445 0.0 0
M  V30 14 C 3.4886 0.0000 0.0 0
M  V30 15 C 1.5063 1.7849 0.0 0
M  V30 16 C 1.9823 0.3202 0.0 0
M  V30 17 C 5.2890 5.0543 0.0 0
M  V30 18 C 6.6229 5.8244 0.0 0
M  V30 19 N 3.9554 5.8244 0.0 0
M  V30 20 C 6.6229 7.3644 0.0 0
M  V30 21 C 3.9554 7.3644 0.0 0
M  V30 22 N 5.2890 8.1344 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 15
M  V30 7 1 7 21
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5815-08-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1202768-87-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1202768-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15440434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-23-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
4-(5-Bromo-1H-indol-3-yl)-5-(2-methoxyethoxy)-2-pyrimidinamine A.313.
1-(5-Bromo-1H-indol-3-yl)-2-(2-methoxyethoxy)ethanone A.312 (4.0 g, 12.8
mmol) was treated neat with t-BuOCH(NMe2)2 (2.0 eq., 4.47 g) at 105 °C
under N2 for 1.5 h. The mixture was cooled before n-PrOH (35 mL),
guanidine hydrochloride (5.0 eq., 6.2 g), and MeONa (5.53 M in methanol)
(3.0 eq., 7.5 mL) were added sequentially. The resulting mixture was
stirred at 95°C for 24 h. Upon workup, the mixture was cooled and poured
into ice and saturated NaHCO3 aqueous solution and extracted with ethyl
acetate (3×). The combined organics were washed with brine (2×), dried
over anhydrous Na2SO4, and concentrated in vacuo.
4-(5-bromo-1H-indol-3-yl)-5-(2-methoxyethoxy)-2-pyrimidinamine A.313 (4.5
g, 97% yield) as a light yellow solid. 1H NMR (400 MHz, DMSO-d6) δ ppm
11.84 (1 H, s), 8.94 (1 H, d, J= 1.8 Hz), 8.44 (1 H, s), 8.05 (1 H, s),
7.41 (1 H, d, J= 8.4 Hz), 7.30 (1 H, dd, J= 8.6, 2.0 Hz), 6.14 (2 H, s),
4.12-4.21 (2 H, m), 3.71-3.77 (2 H, m), 3.36 (3 H, s). LCMS-ESI (POS),
M/Z, M+1: Found 363.0 and 364.9.
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkynyl alcohols as kinase inhibitors and their preparation,
pharmaceutical compositions and use in the treatment of inflammation and
inflammatory disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Guoqing; Cushing, Timothy D.; Fisher, Benjamin; He, Xiao; Li,
Kexue; Li, Zhihong; McGee, Lawrence R.; Pattaropong, Vatee; Faulder,
Paul; Seganish, Jennifer L.; Shin, Youngsook
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009158011 A1 2009-12-30

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H35N5O6
2642159-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.6869 4.8514 0.0 0
M  V30 2 N 10.3530 5.6214 0.0 0
M  V30 3 O 11.6869 3.3114 0.0 0
M  V30 4 C 9.0194 4.8514 0.0 0
M  V30 5 N 7.6857 5.6214 0.0 0
M  V30 6 N 9.0194 3.3114 0.0 0
M  V30 7 C 6.3519 4.8514 0.0 0
M  V30 8 O 6.3519 3.3114 0.0 0
M  V30 9 C 14.7475 3.4886 0.0 0
M  V30 10 O 16.2122 3.0128 0.0 0
M  V30 11 O 13.6031 2.4582 0.0 0
M  V30 12 C 16.5324 1.5063 0.0 0
M  V30 13 C 18.0387 1.8265 0.0 0
M  V30 14 C 16.8526 0.0000 0.0 0
M  V30 15 C 15.0261 1.1861 0.0 0
M  V30 16 C 3.2912 3.4886 0.0 0
M  V30 17 O 1.8265 3.0128 0.0 0
M  V30 18 O 4.4356 2.4582 0.0 0
M  V30 19 C 1.5063 1.5063 0.0 0
M  V30 20 C 3.0126 1.1861 0.0 0
M  V30 21 C 1.1861 0.0000 0.0 0
M  V30 22 C 0.0000 1.8265 0.0 0
M  V30 23 C 13.0205 5.6214 0.0 0 CFG=2
M  V30 24 N 14.4273 4.9949 0.0 0
M  V30 25 C 13.1815 7.1530 0.0 0
M  V30 26 C 15.4579 6.1395 0.0 0
M  V30 27 C 14.6879 7.4732 0.0 0
M  V30 28 C 5.0182 5.6214 0.0 0 CFG=2
M  V30 29 N 3.6114 4.9949 0.0 0
M  V30 30 C 4.8573 7.1530 0.0 0
M  V30 31 C 2.5808 6.1395 0.0 0
M  V30 32 C 3.3508 7.4732 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 7 8
M  V30 9 1 28 7 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 29
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2642159-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23548347
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1314-56-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-carbamate protected amino acid derived guanidine organocatalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Taie, Zahraa S.; Anderson, Joseph M.; Bischoff, Laura; Christensen,
Jeppe; Coles, Simon J.; Froom, Richard; Gibbard, Mari E.; Jones, Leigh
F.; de Kleijne, Frank F. J.; Murphy, Patrick J.; Thompson, Emma C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2021), 89132093

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-[2,3-Dihydro-6-(3-nitrophenyl)imidazo[2,1-b]thiazol-5-yl]-3-(dimethyla...
C16H16N4O3S
1807473-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 5.0883 0.0 0
M  V30 2 C 9.4586 4.7679 0.0 0
M  V30 3 O 7.4762 6.5528 0.0 0
M  V30 4 C 10.4890 5.9125 0.0 0
M  V30 5 N 11.9955 5.5923 0.0 0
M  V30 6 C 13.0259 6.7367 0.0 0
M  V30 7 C 12.4713 4.1276 0.0 0
M  V30 8 N 0.7700 6.7721 0.0 0 VAL=5
M  V30 9 O 0.0000 5.4385 0.0 0
M  V30 10 O 0.0000 8.1058 0.0 0
M  V30 11 C 5.3901 4.1047 0.0 0
M  V30 12 C 6.9217 3.9437 0.0 0
M  V30 13 N 4.7638 2.6978 0.0 0
M  V30 14 N 7.2419 2.4374 0.0 0
M  V30 15 C 5.9082 1.6674 0.0 0
M  V30 16 C 8.3864 1.4068 0.0 0
M  V30 17 S 6.2284 0.1609 0.0 0
M  V30 18 C 7.7599 0.0000 0.0 0
M  V30 19 C 4.6201 5.4385 0.0 0
M  V30 20 C 3.0801 5.4385 0.0 0
M  V30 21 C 5.3901 6.7721 0.0 0
M  V30 22 C 2.3101 6.7721 0.0 0
M  V30 23 C 4.6201 8.1058 0.0 0
M  V30 24 C 3.0801 8.1058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 19
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2,3-Dihydro-6-(3-nitrophenyl)imidazo[2,1-b]thiazol-5-yl]-2-pyrimidinamine
C15H12N6O2S
1807473-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.9953 5.5923 0.0 0
M  V30 2 N 0.7700 6.7721 0.0 0 VAL=5
M  V30 3 O 0.0000 8.1058 0.0 0
M  V30 4 O 0.0000 5.4385 0.0 0
M  V30 5 C 6.9217 3.9437 0.0 0
M  V30 6 C 5.3901 4.1047 0.0 0
M  V30 7 N 7.2419 2.4374 0.0 0
M  V30 8 N 4.7636 2.6978 0.0 0
M  V30 9 C 5.9082 1.6674 0.0 0
M  V30 10 C 8.3863 1.4068 0.0 0
M  V30 11 S 6.2284 0.1609 0.0 0
M  V30 12 C 7.7599 0.0000 0.0 0
M  V30 13 C 7.9521 5.0883 0.0 0
M  V30 14 N 9.4586 4.7679 0.0 0
M  V30 15 C 7.4762 6.5528 0.0 0
M  V30 16 C 10.4890 5.9125 0.0 0
M  V30 17 C 8.5067 7.6974 0.0 0
M  V30 18 N 10.0131 7.3771 0.0 0
M  V30 19 C 4.6201 5.4385 0.0 0
M  V30 20 C 3.0801 5.4385 0.0 0
M  V30 21 C 5.3901 6.7721 0.0 0
M  V30 22 C 2.3101 6.7721 0.0 0
M  V30 23 C 4.6201 8.1058 0.0 0
M  V30 24 C 3.0801 8.1058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 6 19
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 8 9
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807473-98-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807473-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-24757392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
2,3-dihydroimidazo[2,1-b]thiazoles as dual EGFR and IGF1R inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gadekar, Pradip K.; Urunkar, Ganesh; Roychowdhury, Abhijit; Sharma,
Rajiv; Bose, Julie; Khanna, Smriti; Damre, Anagha; Sarveswari, S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2021), 115105151

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-[2,3-Dihydro-6-(3-nitrophenyl)imidazo[2,1-b]thiazol-5-yl]-3-(dimethyla...
C16H16N4O3S
1807473-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 5.0883 0.0 0
M  V30 2 C 9.4586 4.7679 0.0 0
M  V30 3 O 7.4762 6.5528 0.0 0
M  V30 4 C 10.4890 5.9125 0.0 0
M  V30 5 N 11.9955 5.5923 0.0 0
M  V30 6 C 13.0259 6.7367 0.0 0
M  V30 7 C 12.4713 4.1276 0.0 0
M  V30 8 N 0.7700 6.7721 0.0 0 VAL=5
M  V30 9 O 0.0000 5.4385 0.0 0
M  V30 10 O 0.0000 8.1058 0.0 0
M  V30 11 C 5.3901 4.1047 0.0 0
M  V30 12 C 6.9217 3.9437 0.0 0
M  V30 13 N 4.7638 2.6978 0.0 0
M  V30 14 N 7.2419 2.4374 0.0 0
M  V30 15 C 5.9082 1.6674 0.0 0
M  V30 16 C 8.3864 1.4068 0.0 0
M  V30 17 S 6.2284 0.1609 0.0 0
M  V30 18 C 7.7599 0.0000 0.0 0
M  V30 19 C 4.6201 5.4385 0.0 0
M  V30 20 C 3.0801 5.4385 0.0 0
M  V30 21 C 5.3901 6.7721 0.0 0
M  V30 22 C 2.3101 6.7721 0.0 0
M  V30 23 C 4.6201 8.1058 0.0 0
M  V30 24 C 3.0801 8.1058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 19
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2,3-Dihydro-6-(3-nitrophenyl)imidazo[2,1-b]thiazol-5-yl]-2-pyrimidinamine
C15H12N6O2S
1807473-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.9953 5.5923 0.0 0
M  V30 2 N 0.7700 6.7721 0.0 0 VAL=5
M  V30 3 O 0.0000 8.1058 0.0 0
M  V30 4 O 0.0000 5.4385 0.0 0
M  V30 5 C 6.9217 3.9437 0.0 0
M  V30 6 C 5.3901 4.1047 0.0 0
M  V30 7 N 7.2419 2.4374 0.0 0
M  V30 8 N 4.7636 2.6978 0.0 0
M  V30 9 C 5.9082 1.6674 0.0 0
M  V30 10 C 8.3863 1.4068 0.0 0
M  V30 11 S 6.2284 0.1609 0.0 0
M  V30 12 C 7.7599 0.0000 0.0 0
M  V30 13 C 7.9521 5.0883 0.0 0
M  V30 14 N 9.4586 4.7679 0.0 0
M  V30 15 C 7.4762 6.5528 0.0 0
M  V30 16 C 10.4890 5.9125 0.0 0
M  V30 17 C 8.5067 7.6974 0.0 0
M  V30 18 N 10.0131 7.3771 0.0 0
M  V30 19 C 4.6201 5.4385 0.0 0
M  V30 20 C 3.0801 5.4385 0.0 0
M  V30 21 C 5.3901 6.7721 0.0 0
M  V30 22 C 2.3101 6.7721 0.0 0
M  V30 23 C 4.6201 8.1058 0.0 0
M  V30 24 C 3.0801 8.1058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 6 19
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 8 9
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807473-98-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807473-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1120123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted heterocyclic amine derivatives as multikinase
inhibitors for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roychowdhury, Abhijit; Sharma, Rajiv; Gadekar, Pradip Keshavrao; Urunkar,
Ganesh Devidas; Seelaboyina, Balapadmasree; Deka, Nabajyoti; Dawange,
Mahesh Balasaheb; B-Rao, Chandrika; Khanna, Smriti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015128698 A1 2015-09-03

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl 2-formylbutanedioate
C6H8O5
202999-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 C 4.6201 2.6675 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 O 5.3901 4.0011 0.0 0
M  V30 6 O 5.3901 1.3338 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 6.9301 4.0011 0.0 0
M  V30 10 O 0.0000 2.6675 0.0 0
M  V30 11 O 0.0000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3,4-dihydro-4-oxo-5-pyrimidineacetic acid
C6H7N3O3
85301-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 6.1600 5.3349 0.0 0
M  V30 4 O 8.4700 4.0011 0.0 0
M  V30 5 O 4.6200 0.0000 0.0 0
M  V30 6 N 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 N 2.3100 1.3338 0.0 0
M  V30 11 N 2.3100 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 8
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 202999-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85301-38-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15926121
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Peptide nucleic acids antisense to mRNA or rRNA as antibacterial or
bacteriostatic antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nielsen, Peter E.; Good, Liam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6734161 B1 2004-05-11

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl 2-formylbutanedioate
C6H8O5
202999-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 C 4.6201 2.6675 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 O 5.3901 4.0011 0.0 0
M  V30 6 O 5.3901 1.3338 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 6.9301 4.0011 0.0 0
M  V30 10 O 0.0000 2.6675 0.0 0
M  V30 11 O 0.0000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3,4-dihydro-4-oxo-5-pyrimidineacetic acid
C6H7N3O3
85301-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 6.1600 5.3349 0.0 0
M  V30 4 O 8.4700 4.0011 0.0 0
M  V30 5 O 4.6200 0.0000 0.0 0
M  V30 6 N 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 N 2.3100 1.3338 0.0 0
M  V30 11 N 2.3100 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 8
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 202999-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85301-38-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9693600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Peptide nucleic acids with Nα-(2-aminoethyl)-histidine backbones having
enhanced binding affinity and sequence specificity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nielsen, Peter E.; Egholm, Michael; Berg, Rolf H.; Buchardt, Ole
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6710164 B1 2004-03-23

$RFMT $RIREG SCHEME103 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethylbenzaldehyde
C9H10O
22927-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 4.6201 4.0010 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(2-ethylphenyl)-5H-indeno[1,2-d]pyrimidin-5-one
C19H15N3O
2254844-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.8703 6.6519 0.0 0
M  V30 2 N 3.8500 0.0000 0.0 0
M  V30 3 C 1.5400 4.0011 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 7.1904 5.1455 0.0 0
M  V30 9 C 8.4363 2.9876 0.0 0
M  V30 10 N 6.1600 1.3336 0.0 0
M  V30 11 N 3.8500 2.6674 0.0 0
M  V30 12 C 8.5974 4.5191 0.0 0
M  V30 13 C 9.6822 2.0824 0.0 0
M  V30 14 C 4.6200 1.3336 0.0 0
M  V30 15 C 10.0042 5.1455 0.0 0
M  V30 16 C 11.0891 2.7087 0.0 0
M  V30 17 C 11.2500 4.2404 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 4.6200 6.6685 0.0 0
M  V30 21 C 1.5400 6.6685 0.0 0
M  V30 22 C 3.8500 8.0022 0.0 0
M  V30 23 C 2.3100 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 18
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 2 11 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 22927-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2254844-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29670782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 697740-91-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, Knoevenagel condensation followed by Michael addition,
cyclization, isomerization and then aromatization, catalyst prepared and
used, reusable catalyst, recyclable catalyst upto six cycles
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of supra molecular self-assembled Nickel(II)
coordination complex in synthesis of indeno-pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gangu, Kranthi Kumar; Maddila, Suresh; Mukkamala, Saratchandra Babu;
Jonnalagadda, Sreekantha B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2019), 158464-470

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2,4-Dichlorophenyl)-1-(2,5-dichloro-3-thienyl)-2-propen-1-one
C13H6Cl4OS
2641183-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3320 5.3026 0.0 0
M  V30 2 C 4.8721 5.3026 0.0 0
M  V30 3 O 2.5620 6.6363 0.0 0
M  V30 4 C 5.6421 6.6363 0.0 0
M  V30 5 Cl 0.0000 4.9524 0.0 0
M  V30 6 Cl 2.2049 0.0000 0.0 0
M  V30 7 Cl 7.1821 9.3037 0.0 0
M  V30 8 Cl 11.8022 6.6363 0.0 0
M  V30 9 C 2.5620 3.9688 0.0 0
M  V30 10 C 1.0304 3.8079 0.0 0
M  V30 11 C 3.1885 2.5620 0.0 0
M  V30 12 S 0.7103 2.3016 0.0 0
M  V30 13 C 2.0439 1.5316 0.0 0
M  V30 14 C 7.1821 6.6363 0.0 0
M  V30 15 C 7.9521 7.9700 0.0 0
M  V30 16 C 7.9521 5.3026 0.0 0
M  V30 17 C 9.4922 7.9700 0.0 0
M  V30 18 C 9.4922 5.3026 0.0 0
M  V30 19 C 10.2622 6.6363 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 10
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 1 8 19
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,4-Dichlorophenyl)-6-(2,5-dichloro-3-thienyl)-2-pyrimidinamine
C14H7Cl4N3S
2641182-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.9526 0.0 0
M  V30 2 Cl 2.2049 0.0000 0.0 0
M  V30 3 N 2.5620 9.3038 0.0 0
M  V30 4 Cl 7.1821 9.3039 0.0 0
M  V30 5 Cl 11.8022 6.6364 0.0 0
M  V30 6 C 2.5620 3.9690 0.0 0
M  V30 7 C 3.1885 2.5621 0.0 0
M  V30 8 C 1.0304 3.8080 0.0 0
M  V30 9 C 2.0439 1.5317 0.0 0
M  V30 10 S 0.7103 2.3017 0.0 0
M  V30 11 C 3.3320 5.3028 0.0 0
M  V30 12 C 4.8720 5.3028 0.0 0
M  V30 13 N 2.5620 6.6364 0.0 0
M  V30 14 C 5.6421 6.6364 0.0 0
M  V30 15 C 3.3320 7.9701 0.0 0
M  V30 16 N 4.8720 7.9701 0.0 0
M  V30 17 C 7.1821 6.6364 0.0 0
M  V30 18 C 7.9521 7.9701 0.0 0
M  V30 19 C 7.9521 5.3028 0.0 0
M  V30 20 C 9.4921 7.9701 0.0 0
M  V30 21 C 9.4921 5.3028 0.0 0
M  V30 22 C 10.2621 6.6364 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 15
M  V30 4 1 4 18
M  V30 5 1 5 22
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2641183-08-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2641182-97-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23474961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel pyrimidine derivatives from 2,5-dichloro-3-acetylthienyl chalcones
as antifungal, antitubercular and cytotoxic agents: design, synthesis,
biological activity and docking study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lokesh, Bontha Venkata Subrahmanya; Rajendra Prasad, Y.; Shaik, Afzal
Basha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Chemistry (2019), 31(6), 1212-1220

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Androstan-17-one, 3-hydroxy-16-[(4-methylphenyl)methylene]-, (3α,5α,16E)-
C27H36O2
503272-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8289 0.4090 0.0 0
M  V30 2 O 5.0494 0.0000 0.0 0
M  V30 3 C 3.0800 2.7106 0.0 0
M  V30 4 C 11.6417 2.8549 0.0 0
M  V30 5 O 14.9920 6.5606 0.0 0
M  V30 6 C 0.0000 8.0453 0.0 0
M  V30 7 C 6.9898 3.4806 0.0 0 CFG=2
M  V30 8 C 8.3236 4.2506 0.0 0 CFG=2
M  V30 9 C 6.9898 1.9406 0.0 0 CFG=1
M  V30 10 C 5.5252 3.9564 0.0 0
M  V30 11 C 9.6572 3.4806 0.0 0 CFG=2
M  V30 12 C 8.3236 5.7906 0.0 0
M  V30 13 C 5.5252 1.4647 0.0 0
M  V30 14 C 8.3236 1.1706 0.0 0
M  V30 15 C 4.6200 2.7106 0.0 0
M  V30 16 C 10.9909 4.2506 0.0 0 CFG=2
M  V30 17 C 9.6572 1.9406 0.0 0
M  V30 18 C 9.6572 6.5606 0.0 0
M  V30 19 C 10.9909 5.7906 0.0 0 CFG=2
M  V30 20 C 12.3245 3.4806 0.0 0
M  V30 21 C 12.3245 6.5606 0.0 0
M  V30 22 C 13.6583 4.2506 0.0 0
M  V30 23 C 13.6583 5.7906 0.0 0 CFG=2
M  V30 24 C 2.3100 4.0442 0.0 0
M  V30 25 C 3.0800 5.3779 0.0 0
M  V30 26 C 0.7700 4.0442 0.0 0
M  V30 27 C 2.3100 6.7117 0.0 0
M  V30 28 C 0.0000 5.3779 0.0 0
M  V30 29 C 0.7700 6.7117 0.0 0
M  V30 30 H 6.1967 4.8007 0.0 0
M  V30 31 H 7.4402 5.5120 0.0 0
M  V30 32 H 10.5406 2.2190 0.0 0
M  V30 33 H 10.9909 7.3306 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 2 2 13
M  V30 3 2 3 15
M  V30 4 1 3 24
M  V30 5 1 16 4 CFG=1
M  V30 6 1 23 5 CFG=3
M  V30 7 1 6 29
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 30 CFG=3
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 31 CFG=1
M  V30 15 1 9 13
M  V30 16 1 9 14
M  V30 17 1 10 15
M  V30 18 1 11 16
M  V30 19 1 11 17
M  V30 20 1 11 32 CFG=3
M  V30 21 1 12 18
M  V30 22 1 13 15
M  V30 23 1 14 17
M  V30 24 1 16 19
M  V30 25 1 16 20
M  V30 26 1 18 19
M  V30 27 1 19 21
M  V30 28 1 19 33 CFG=3
M  V30 29 1 20 22
M  V30 30 1 21 23
M  V30 31 1 22 23
M  V30 32 2 24 25
M  V30 33 1 24 26
M  V30 34 1 25 27
M  V30 35 2 26 28
M  V30 36 2 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 7 8 9 11 16 19 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5α)-2′-Amino-1′,6′-dihydro-6′-(4-methylphenyl)androst-16-eno[17,16-d]pyri...
C28H39N3O
503272-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3611 1.9190 0.0 0
M  V30 2 N 3.2731 0.0000 0.0 0
M  V30 3 C 12.1741 4.3648 0.0 0
M  V30 4 O 15.5242 8.0706 0.0 0
M  V30 5 C 0.0000 9.0432 0.0 0
M  V30 6 C 7.5222 3.4505 0.0 0 CFG=1
M  V30 7 C 7.5222 4.9905 0.0 0 CFG=1
M  V30 8 C 6.0575 2.9747 0.0 0
M  V30 9 C 8.8558 2.6805 0.0 0
M  V30 10 C 8.8558 5.7606 0.0 0 CFG=2
M  V30 11 C 6.0575 5.4666 0.0 0
M  V30 12 C 5.1522 4.2205 0.0 0
M  V30 13 N 5.4311 1.5679 0.0 0
M  V30 14 C 10.1895 3.4505 0.0 0
M  V30 15 C 10.1895 4.9905 0.0 0 CFG=1
M  V30 16 C 8.8558 7.3006 0.0 0
M  V30 17 C 3.6207 4.0596 0.0 0 CFG=3
M  V30 18 C 3.8996 1.4070 0.0 0
M  V30 19 C 11.5233 5.7606 0.0 0 CFG=2
M  V30 20 C 10.1895 8.0706 0.0 0
M  V30 21 N 2.9944 2.6528 0.0 0
M  V30 22 C 11.5233 7.3006 0.0 0 CFG=2
M  V30 23 C 12.8569 4.9905 0.0 0
M  V30 24 C 12.8569 8.0706 0.0 0
M  V30 25 C 14.1906 5.7606 0.0 0
M  V30 26 C 14.1906 7.3006 0.0 0 CFG=2
M  V30 27 C 2.7155 5.3055 0.0 0
M  V30 28 C 1.1840 5.1446 0.0 0
M  V30 29 C 3.3420 6.7124 0.0 0
M  V30 30 C 0.2787 6.3904 0.0 0
M  V30 31 C 2.4368 7.9583 0.0 0
M  V30 32 C 0.9052 7.7974 0.0 0
M  V30 33 H 6.7289 6.3106 0.0 0
M  V30 34 H 7.9725 7.0221 0.0 0
M  V30 35 H 11.0728 3.7291 0.0 0
M  V30 36 H 11.5233 8.8406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 2 18
M  V30 3 1 19 3 CFG=1
M  V30 4 1 26 4 CFG=3
M  V30 5 1 5 32
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 33 CFG=3
M  V30 12 2 8 12
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 10 34 CFG=1
M  V30 18 1 11 12
M  V30 19 1 12 17
M  V30 20 1 13 18
M  V30 21 1 14 15
M  V30 22 1 15 19
M  V30 23 1 15 35 CFG=3
M  V30 24 1 16 20
M  V30 25 1 17 21
M  V30 26 1 17 27
M  V30 27 2 18 21
M  V30 28 1 19 22
M  V30 29 1 19 23
M  V30 30 1 20 22
M  V30 31 1 22 24
M  V30 32 1 22 36 CFG=3
M  V30 33 1 23 25
M  V30 34 1 24 26
M  V30 35 1 25 26
M  V30 36 2 27 28
M  V30 37 1 27 29
M  V30 38 1 28 30
M  V30 39 2 29 31
M  V30 40 2 30 32
M  V30 41 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 6 7 10 15 19 22 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 503272-69-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 503272-38-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-8621309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and pharmacological screening of some new pyrimidine and
cyclohexenone fused steroidal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amr, Abd El-Galil E.; Abdulla, M. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Heterocyclic Chemistry (2002), 12(2), 129-134

$RFMT $RIREG SCHEME106 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(αS)-α-[(1R)-1-Methyl-2-propen-1-yl]benzenepropanol
C13H18O
83173-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0 CFG=2
M  V30 4 C 8.0023 2.3101 0.0 0 CFG=2
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 8.0023 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S)-2-Methyl-1-(2-phenylethyl)-3-buten-1-yl N-(aminoiminomethyl)carba...
C15H21N3O2
2033151-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 5.3347 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 5.3900 1.3336 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 N 2.3100 6.6685 0.0 0
M  V30 10 O 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 0.0000 0.0 0
M  V30 12 C 0.7700 6.6685 0.0 0
M  V30 13 N 0.0000 5.3347 0.0 0
M  V30 14 N 0.0000 8.0021 0.0 0
M  V30 15 C 9.2400 5.3347 0.0 0
M  V30 16 C 10.0100 6.6685 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 11.5500 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8 CFG=3
M  V30 8 1 5 15
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 1 9 12
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83173-74-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2033151-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-21153974
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective synthesis of cyclic guanidines by directed diamination of
unactivated alkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mailyan, Artur K.; Young, Kyle; Chen, Joanna L.; Reid, Bradley T.;
Zakarian, Armen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2016), 18(21), 5532-5535

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(1,3-Butadiyne-1,4-diyl)bis[3-chlorobenzene]
C16H8Cl2
80221-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3901 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 C 8.0022 3.8501 0.0 0
M  V30 4 C 9.3358 3.0801 0.0 0
M  V30 5 Cl 0.0000 5.3901 0.0 0
M  V30 6 Cl 14.6707 3.0801 0.0 0
M  V30 7 C 4.0010 6.1601 0.0 0
M  V30 8 C 2.6673 5.3901 0.0 0
M  V30 9 C 4.0010 7.7002 0.0 0
M  V30 10 C 1.3337 6.1601 0.0 0
M  V30 11 C 2.6673 8.4702 0.0 0
M  V30 12 C 1.3337 7.7002 0.0 0
M  V30 13 C 10.6697 2.3101 0.0 0
M  V30 14 C 12.0033 3.0801 0.0 0
M  V30 15 C 10.6697 0.7700 0.0 0
M  V30 16 C 13.3370 2.3101 0.0 0
M  V30 17 C 12.0033 0.0000 0.0 0
M  V30 18 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 4 13
M  V30 6 1 5 10
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-Amino-6-(3-chlorophenyl)-4-pyrimidinyl](3-chlorophenyl)methanone
C17H11Cl2N3O
1778684-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 4.6201 0.0 0
M  V30 2 O 9.3358 6.1601 0.0 0
M  V30 3 N 6.6685 0.0000 0.0 0
M  V30 4 Cl 0.0000 3.8501 0.0 0
M  V30 5 Cl 14.6707 4.6201 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 N 5.3348 2.3101 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 N 8.0022 2.3101 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 4.0010 6.1601 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 2.6673 6.9302 0.0 0
M  V30 17 C 1.3337 6.1601 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 10.6697 2.3101 0.0 0
M  V30 21 C 13.3370 3.8501 0.0 0
M  V30 22 C 12.0033 1.5400 0.0 0
M  V30 23 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 18
M  V30 4 1 3 10
M  V30 5 1 4 15
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 12
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 80221-18-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1778684-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26233838
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, sealed tube used, selective oxidation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The synthesis of carbonyl 2-amino-pyrimidines via tandem regioselective
heterocyclization of 1,3-diynes with guanidine and selective oxidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Liang; Zhao, Mingzhu; Zhao, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2015), 51(45),
9370-9373

$RFMT $RIREG SCHEME108 STEP1
$RXN



  3  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-nitrophenyl)-5-pyrimidinecarbonitrile
C11H8N6O2
1632171-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 N 9.3358 6.9300 0.0 0 VAL=5
M  V30 6 O 9.3358 8.4700 0.0 0
M  V30 7 O 10.6694 6.1600 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 N 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 N 1.3336 2.3100 0.0 0
M  V30 14 C 5.3347 4.6200 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 5.3347 6.1600 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1632171-89-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30370383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12018-18-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasonic irradiation (65W, 20KHz), catalyst prepared
and used, catalyst can be recycled and reused
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel(II) Chromite Nanoparticles: An Eco-Friendly and Reusable Catalyst
for Synthesis of 2,4-Diamino-6-aryl-pyrimidine-5-yl Cyanides under
Ultrasonic Radiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saeedi, Bahareh; Abdolmohammadi, Shahrzad; Mirjafary, Zohreh;
Kia-Kojoori, Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2021), 24(3),
455-464

$RFMT $RIREG SCHEME108 STEP1
$RXN



  3  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-nitrophenyl)-5-pyrimidinecarbonitrile
C11H8N6O2
1632171-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 N 9.3358 6.9300 0.0 0 VAL=5
M  V30 6 O 9.3358 8.4700 0.0 0
M  V30 7 O 10.6694 6.1600 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 N 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 N 1.3336 2.3100 0.0 0
M  V30 14 C 5.3347 4.6200 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 5.3347 6.1600 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1632171-89-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29892920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst (TiO2 nanoparticles supported
on silica shells), Knoevenagel addition followed by Michael addition and
then intermolecular cyclization, no solvent, catalyst prepared and used,
reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A green approach for an efficient preparation of
2,4-diamino-6-aryl-5-pyrimidinecarbonitriles using a TiO2-SiO2
nanocomposite catalyst under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rabiei, Ahmad; Abdolmohammadi, Shahrzad; Shafaei, Faezeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2017), 72(4), 241-247

$RFMT $RIREG SCHEME109 STEP1
$RXN



  3  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-1,3-dioxane-4,6-dione
C6H8O4
2033-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 O 1.5166 2.3101 0.0 0
M  V30 7 O 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-(4-bromophenyl)-5,6-dihydro-4(3H)-pyrimidinone
C10H10BrN3O
937180-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 N 2.6674 0.0000 0.0 0
M  V30 3 Br 9.3358 6.9300 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 N 4.0011 2.3100 0.0 0
M  V30 7 C 1.3336 3.8500 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 N 1.3336 2.3100 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 5.3347 6.1600 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 6.6684 6.9300 0.0 0
M  V30 14 C 8.0021 4.6200 0.0 0
M  V30 15 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 937180-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17235579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon nanotube supported
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst (carbon nanotube supported
titanium oxide used as catalyst), Knoevenagel condensation followed by
Michael addition and then intramolecular cyclization, no solvent,
catalyst prepared and used, recyclable catalyst upto 4 cycles,
optimization study, optimized on solvent, optimized on temperature,
optimized on time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Eco-Friendly and Highly Efficient Synthesis of Pyrimidinones Using a
TiO2-CNTs Nanocomposite Catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khalilian, Shahin; Abdolmohammadi, Shahrzad; Nematolahi, Fereshteh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Organic Chemistry (2017), 14(5), 361-367

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2,5-Dichlorophenyl)-1-(4-methoxyphenyl)-2-propen-1-one
C16H12Cl2O2
1393687-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 O 6.6685 6.1601 0.0 0
M  V30 5 Cl 1.3337 6.1601 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 O 12.0033 1.5400 0.0 0
M  V30 8 C 13.3370 2.3101 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 19 C 9.3360 1.5400 0.0 0
M  V30 20 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 15
M  V30 6 1 5 10
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,5-Dichlorophenyl)-6-(4-methoxyphenyl)-2-pyrimidinamine
C17H13Cl2N3O
1354938-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.3336 2.3100 0.0 0
M  V30 2 N 5.3347 0.0000 0.0 0
M  V30 3 Cl 1.3336 8.4700 0.0 0
M  V30 4 O 12.0031 6.9300 0.0 0
M  V30 5 C 13.3367 6.1600 0.0 0
M  V30 6 C 4.0009 3.8500 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 N 4.0009 2.3100 0.0 0
M  V30 9 C 6.6684 3.8500 0.0 0
M  V30 10 C 5.3347 1.5400 0.0 0
M  V30 11 N 6.6684 2.3100 0.0 0
M  V30 12 C 2.6673 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6673 6.1600 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 0.0000 6.1600 0.0 0
M  V30 18 C 8.0020 4.6200 0.0 0
M  V30 19 C 8.0020 6.1600 0.0 0
M  V30 20 C 9.3358 3.8500 0.0 0
M  V30 21 C 9.3358 6.9300 0.0 0
M  V30 22 C 10.6694 4.6200 0.0 0
M  V30 23 C 10.6694 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 10
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1393687-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1354938-13-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3702468
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of chalcone derivatives (0.01 mol),
guanidine nitrate (0.015 mole, 1.83 g) and 25% sodium methoxide solution
in methanol (28 mL) was refluxed for 6 h. After the completion of
reaction, the resultant mixture was cooled to room temperature.
Precipitated compound was filtered, washed with water, dried, and
crystallized from methanol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Azatricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaen-6-yl)-3-(dimethyl...
C20H22N2O
1449040-78-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2022 4.6197 0.0 0
M  V30 2 C 9.5360 3.8497 0.0 0
M  V30 3 O 8.2022 6.1597 0.0 0
M  V30 4 C 10.8696 4.6197 0.0 0
M  V30 5 N 12.2033 3.8497 0.0 0
M  V30 6 C 13.5369 4.6197 0.0 0
M  V30 7 C 12.2033 2.3097 0.0 0
M  V30 8 C 6.8686 3.8497 0.0 0
M  V30 9 C 5.5340 4.6200 0.0 0
M  V30 10 N 6.8684 2.3097 0.0 0
M  V30 11 C 4.2094 3.8502 0.0 0
M  V30 12 C 5.5343 6.1600 0.0 0
M  V30 13 C 5.5335 1.5400 0.0 0
M  V30 14 C 4.2093 2.3102 0.0 0
M  V30 15 C 1.3353 6.1606 0.0 0
M  V30 16 C 5.5332 0.0000 0.0 0
M  V30 17 C 1.3350 4.6206 0.0 0
M  V30 18 C 1.3343 0.0006 0.0 0
M  V30 19 C 0.0002 3.8509 0.0 0
M  V30 20 C 2.6694 3.8505 0.0 0
M  V30 21 C 1.3346 1.5406 0.0 0
M  V30 22 C 0.0000 2.3109 0.0 0
M  V30 23 C 2.6693 2.3105 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 14
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(5-Azatricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaen-6-yl)-2-pyrimidin...
C19H18N4
1449040-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.2033 3.8497 0.0 0
M  V30 2 C 6.8686 3.8497 0.0 0
M  V30 3 C 5.5340 4.6200 0.0 0
M  V30 4 N 6.8684 2.3097 0.0 0
M  V30 5 C 4.2094 3.8502 0.0 0
M  V30 6 C 5.5343 6.1600 0.0 0
M  V30 7 C 5.5335 1.5400 0.0 0
M  V30 8 C 4.2093 2.3102 0.0 0
M  V30 9 C 1.3353 6.1606 0.0 0
M  V30 10 C 5.5332 0.0000 0.0 0
M  V30 11 C 1.3350 4.6206 0.0 0
M  V30 12 C 1.3343 0.0006 0.0 0
M  V30 13 C 0.0002 3.8509 0.0 0
M  V30 14 C 2.6694 3.8505 0.0 0
M  V30 15 C 1.3346 1.5406 0.0 0
M  V30 16 C 0.0000 2.3109 0.0 0
M  V30 17 C 2.6693 2.3105 0.0 0
M  V30 18 C 8.2023 4.6197 0.0 0
M  V30 19 N 9.5360 3.8497 0.0 0
M  V30 20 C 8.2023 6.1597 0.0 0
M  V30 21 C 10.8696 4.6197 0.0 0
M  V30 22 C 9.5360 6.9297 0.0 0
M  V30 23 N 10.8696 6.1597 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 8
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 2 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1449040-78-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1449040-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13553699
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Planar Chiral N-Heterocyclic-Substituted Pyridinophanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kramer, Joshua J. P.; Nieger, Martin; Brase, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2013), 2013(3), 541-549

$RFMT $RIREG SCHEME112 STEP1
$RXN



  4  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tosylmethyl isocyanide
C9H9NO2S
36635-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 1.3337 0.0 0 VAL=6
M  V30 2 C 6.6685 0.5637 0.0 0
M  V30 3 O 4.5648 0.0000 0.0 0
M  V30 4 O 6.1048 2.6673 0.0 0
M  V30 5 N 8.0023 1.3337 0.0 0 CHG=1 VAL=4
M  V30 6 C 9.3360 2.1037 0.0 0 CHG=-1
M  V30 7 C 0.0000 4.4137 0.0 0
M  V30 8 C 4.0012 2.1037 0.0 0
M  V30 9 C 2.6675 1.3337 0.0 0
M  V30 10 C 4.0012 3.6437 0.0 0
M  V30 11 C 1.3337 2.1037 0.0 0
M  V30 12 C 2.6675 4.4137 0.0 0
M  V30 13 C 1.3337 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4E)-5-(3-Chlorophenyl)-1,1-bis(methylthio)-1,4-pentadien-3-one
C13H13ClOS2
1636155-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 2.6673 3.0801 0.0 0
M  V30 5 O 4.0012 0.7700 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 S 1.3337 0.7700 0.0 0
M  V30 8 S 0.0000 3.0801 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 0.0000 4.6201 0.0 0
M  V30 11 Cl 12.0033 2.3101 0.0 0
M  V30 12 C 8.0022 3.0801 0.0 0
M  V30 13 C 9.3360 2.3101 0.0 0
M  V30 14 C 8.0022 4.6201 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 11 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanol
CH4O
67-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(3-Chlorophenyl)-1H-pyrrol-3-yl]-6-methoxy-2-pyrimidinamine
C15H13ClN4O
1636155-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 5.1046 0.0 0
M  V30 2 C 0.0000 6.4384 0.0 0
M  V30 3 N 5.3900 7.7721 0.0 0
M  V30 4 Cl 11.9951 3.9248 0.0 0
M  V30 5 C 5.3900 2.4374 0.0 0
M  V30 6 C 6.9215 2.2764 0.0 0
M  V30 7 C 4.7635 1.0304 0.0 0
M  V30 8 C 7.2417 0.7700 0.0 0
M  V30 9 N 5.9081 0.0000 0.0 0
M  V30 10 C 4.6200 3.7710 0.0 0
M  V30 11 C 3.0800 3.7710 0.0 0
M  V30 12 N 5.3900 5.1046 0.0 0
M  V30 13 C 2.3100 5.1046 0.0 0
M  V30 14 C 4.6200 6.4384 0.0 0
M  V30 15 N 3.0800 6.4384 0.0 0
M  V30 16 C 7.9519 3.4208 0.0 0
M  V30 17 C 9.4584 3.1006 0.0 0
M  V30 18 C 7.4761 4.8855 0.0 0
M  V30 19 C 10.4888 4.2450 0.0 0
M  V30 20 C 8.5065 6.0299 0.0 0
M  V30 21 C 10.0129 5.7097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 14
M  V30 4 1 4 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36635-61-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1636155-19-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1636155-31-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-013-CAS-16707580
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient one-pot multicomponent strategy for the synthesis of
6-pyrrolylpyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dhanalakshmi, Pandi; Shanmugam, Sivakumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(56), 29493-29501

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4′-Dimethoxychalcone
C17H16O3
2373-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 O 1.3338 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 O 14.6708 4.6201 0.0 0
M  V30 8 C 16.0046 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 10.6698 2.3101 0.0 0
M  V30 16 C 10.6698 3.8501 0.0 0
M  V30 17 C 12.0035 1.5400 0.0 0
M  V30 18 C 12.0035 4.6201 0.0 0
M  V30 19 C 13.3372 2.3101 0.0 0
M  V30 20 C 13.3372 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Bis(4-methoxyphenyl)-2-pyrimidinamine
C18H17N3O2
125968-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 0.0000 0.0 0
M  V30 2 O 1.3338 6.9302 0.0 0
M  V30 3 C 0.0000 6.1601 0.0 0
M  V30 4 O 14.6708 6.9302 0.0 0
M  V30 5 C 16.0046 6.1601 0.0 0
M  V30 6 C 6.6687 3.8501 0.0 0
M  V30 7 C 8.0023 4.6201 0.0 0
M  V30 8 N 6.6687 2.3101 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 N 9.3360 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 2.6675 6.1601 0.0 0
M  V30 18 C 10.6698 4.6201 0.0 0
M  V30 19 C 12.0035 3.8501 0.0 0
M  V30 20 C 10.6698 6.1601 0.0 0
M  V30 21 C 13.3372 4.6201 0.0 0
M  V30 22 C 12.0035 6.9302 0.0 0
M  V30 23 C 13.3372 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2373-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 125968-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12848890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of chalcone derivatives (0.01 mol),
guanidine nitrate (0.015 mole, 1.83 g) and 25% sodium methoxide solution
in methanol (28 mL) was refluxed for 6 h. After the completion of
reaction, the resultant mixture was cooled to room temperature.
Precipitated compound was filtered, washed with water, dried, and
crystallized from methanol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Fluorophenyl)-1-(4-methoxyphenyl)-2-propen-1-one
C16H13FO2
2965-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 O 13.3370 4.6201 0.0 0
M  V30 6 C 14.6707 3.8501 0.0 0
M  V30 7 F 0.0000 4.6201 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 C 10.6697 1.5400 0.0 0
M  V30 10 C 9.3358 3.8501 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 12.0033 3.8501 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Fluorophenyl)-6-(4-methoxyphenyl)-2-pyrimidinamine
C17H14FN3O
332951-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 O 13.3370 6.9302 0.0 0
M  V30 3 C 14.6707 6.1601 0.0 0
M  V30 4 F 0.0000 6.9302 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 8.0022 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 9.3358 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 9.3358 6.1601 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 10.6697 6.9302 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 4.0010 6.1601 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2965-63-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332951-09-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3455493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of chalcone derivatives (0.01 mol),
guanidine nitrate (0.015 mole, 1.83 g) and 25% sodium methoxide solution
in methanol (28 mL) was refluxed for 6 h. After the completion of
reaction, the resultant mixture was cooled to room temperature.
Precipitated compound was filtered, washed with water, dried, and
crystallized from methanol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Methoxyphenyl)-1-(4-methoxyphenyl)-2-propen-1-one
C17H16O3
52182-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 6.6687 1.5400 0.0 0
M  V30 4 O 6.6687 0.0000 0.0 0
M  V30 5 O 14.6708 1.5400 0.0 0
M  V30 6 C 16.0046 2.3101 0.0 0
M  V30 7 O 1.3338 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 C 10.6698 2.3101 0.0 0
M  V30 10 C 12.0035 1.5400 0.0 0
M  V30 11 C 10.6697 3.8501 0.0 0
M  V30 12 C 13.3372 2.3101 0.0 0
M  V30 13 C 12.0035 4.6201 0.0 0
M  V30 14 C 13.3372 3.8501 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 4.0012 1.5400 0.0 0
M  V30 18 C 4.0012 4.6201 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3-Methoxyphenyl)-6-(4-methoxyphenyl)-2-pyrimidinamine
C18H17N3O2
1226780-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 0.0000 0.0 0
M  V30 2 O 1.3338 6.9302 0.0 0
M  V30 3 C 0.0000 6.1601 0.0 0
M  V30 4 O 14.6708 3.8501 0.0 0
M  V30 5 C 16.0046 4.6201 0.0 0
M  V30 6 C 6.6687 3.8501 0.0 0
M  V30 7 C 8.0023 4.6201 0.0 0
M  V30 8 N 6.6687 2.3101 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 C 8.0023 1.5400 0.0 0
M  V30 11 N 9.3360 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 5.3348 6.1601 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 4.0012 6.9302 0.0 0
M  V30 17 C 2.6675 6.1601 0.0 0
M  V30 18 C 10.6698 4.6201 0.0 0
M  V30 19 C 12.0035 3.8501 0.0 0
M  V30 20 C 10.6698 6.1601 0.0 0
M  V30 21 C 13.3372 4.6201 0.0 0
M  V30 22 C 12.0035 6.9302 0.0 0
M  V30 23 C 13.3372 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52182-14-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1226780-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1597920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of chalcone derivatives (0.01 mol),
guanidine nitrate (0.015 mole, 1.83 g) and 25% sodium methoxide solution
in methanol (28 mL) was refluxed for 6 h. After the completion of
reaction, the resultant mixture was cooled to room temperature.
Precipitated compound was filtered, washed with water, dried, and
crystallized from methanol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Methoxyphenyl)-3-(4-nitrophenyl)-2-propen-1-one
C16H13NO4
6552-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 0.0000 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 14.6708 4.6201 0.0 0
M  V30 6 C 16.0046 3.8501 0.0 0
M  V30 7 N 1.3338 4.6201 0.0 0 VAL=5
M  V30 8 O 1.3338 6.1601 0.0 0
M  V30 9 O 0.0000 3.8501 0.0 0
M  V30 10 C 10.6698 2.3101 0.0 0
M  V30 11 C 12.0035 1.5400 0.0 0
M  V30 12 C 10.6698 3.8501 0.0 0
M  V30 13 C 13.3372 2.3101 0.0 0
M  V30 14 C 12.0035 4.6201 0.0 0
M  V30 15 C 13.3372 3.8501 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 4.0012 1.5400 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenyl)-6-(4-nitrophenyl)-2-pyrimidinamine
C17H14N4O3
935854-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 0.0000 0.0 0
M  V30 2 N 1.3338 6.9302 0.0 0 VAL=5
M  V30 3 O 0.0000 6.1601 0.0 0
M  V30 4 O 1.3338 8.4702 0.0 0
M  V30 5 O 14.6708 6.9302 0.0 0
M  V30 6 C 16.0046 6.1601 0.0 0
M  V30 7 C 6.6687 3.8501 0.0 0
M  V30 8 C 8.0023 4.6201 0.0 0
M  V30 9 N 6.6687 2.3101 0.0 0
M  V30 10 C 9.3360 3.8501 0.0 0
M  V30 11 C 8.0023 1.5400 0.0 0
M  V30 12 N 9.3360 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 4.0012 6.9302 0.0 0
M  V30 18 C 2.6675 6.1601 0.0 0
M  V30 19 C 10.6698 4.6201 0.0 0
M  V30 20 C 12.0035 3.8501 0.0 0
M  V30 21 C 10.6698 6.1601 0.0 0
M  V30 22 C 13.3372 4.6201 0.0 0
M  V30 23 C 12.0035 6.9302 0.0 0
M  V30 24 C 13.3372 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 19
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6552-67-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 935854-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14709460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of chalcone derivatives (0.01 mol),
guanidine nitrate (0.015 mole, 1.83 g) and 25% sodium methoxide solution
in methanol (28 mL) was refluxed for 6 h. After the completion of
reaction, the resultant mixture was cooled to room temperature.
Precipitated compound was filtered, washed with water, dried, and
crystallized from methanol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-4′-methoxychalcone
C16H13ClO2
6552-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 O 13.3370 4.6201 0.0 0
M  V30 6 C 14.6707 3.8501 0.0 0
M  V30 7 Cl 0.0000 4.6201 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 C 10.6697 1.5400 0.0 0
M  V30 10 C 9.3358 3.8501 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 12.0033 3.8501 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenyl)-6-(4-methoxyphenyl)-2-pyrimidinamine
C17H14ClN3O
186885-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 O 13.3370 6.9302 0.0 0
M  V30 3 C 14.6707 6.1601 0.0 0
M  V30 4 Cl 0.0000 6.9302 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 8.0022 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 9.3358 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 9.3358 6.1601 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 10.6697 6.9302 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 4.0010 6.1601 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6552-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 186885-94-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1307073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of chalcone derivatives (0.01 mol),
guanidine nitrate (0.015 mole, 1.83 g) and 25% sodium methoxide solution
in methanol (28 mL) was refluxed for 6 h. After the completion of
reaction, the resultant mixture was cooled to room temperature.
Precipitated compound was filtered, washed with water, dried, and
crystallized from methanol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-4′-methoxychalcone
C16H13ClO2
6552-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 O 13.3370 4.6201 0.0 0
M  V30 6 C 14.6707 3.8501 0.0 0
M  V30 7 Cl 0.0000 4.6201 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 C 10.6697 1.5400 0.0 0
M  V30 10 C 9.3358 3.8501 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 12.0033 3.8501 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenyl)-6-(4-methoxyphenyl)-2-pyrimidinamine
C17H14ClN3O
186885-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 O 13.3370 6.9302 0.0 0
M  V30 3 C 14.6707 6.1601 0.0 0
M  V30 4 Cl 0.0000 6.9302 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 8.0022 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 9.3358 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 9.3358 6.1601 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 10.6697 6.9302 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 4.0010 6.1601 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6552-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 186885-94-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4296335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17194-00-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, ultrasound, alternative preparation gave lower
yield (solution phase-MWI,solid phase-MWI), reaction with anhydrous K2CO3
gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-amino-4,6-diarylpyrimidines using inorganic solid support
under microwave and ultrasound irradiation and their antibacterial
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choudhary, Prakash C.; Sharma, Hari Om; Punjabi, Pinki B.; Verma, B. L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Heterocyclic Chemistry (2011), 20(3), 209-212

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Methoxyphenyl)-3-(3-nitrophenyl)-2-propen-1-one
C16H13NO4
68063-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 0.0000 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 14.6708 4.6201 0.0 0
M  V30 6 C 16.0046 3.8501 0.0 0
M  V30 7 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3338 0.0000 0.0 0
M  V30 10 C 10.6698 2.3101 0.0 0
M  V30 11 C 12.0035 1.5400 0.0 0
M  V30 12 C 10.6698 3.8501 0.0 0
M  V30 13 C 13.3372 2.3101 0.0 0
M  V30 14 C 12.0035 4.6201 0.0 0
M  V30 15 C 13.3372 3.8501 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 4.0012 1.5400 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenyl)-6-(3-nitrophenyl)-2-pyrimidinamine
C17H14N4O3
1219134-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 0.0000 0.0 0
M  V30 2 N 1.3338 3.8501 0.0 0 VAL=5
M  V30 3 O 1.3338 2.3101 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 O 14.6708 6.9302 0.0 0
M  V30 6 C 16.0046 6.1601 0.0 0
M  V30 7 C 6.6687 3.8501 0.0 0
M  V30 8 C 8.0023 4.6201 0.0 0
M  V30 9 N 6.6687 2.3101 0.0 0
M  V30 10 C 9.3360 3.8501 0.0 0
M  V30 11 C 8.0023 1.5400 0.0 0
M  V30 12 N 9.3360 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 4.0012 6.9302 0.0 0
M  V30 18 C 2.6675 6.1601 0.0 0
M  V30 19 C 10.6698 4.6201 0.0 0
M  V30 20 C 12.0035 3.8501 0.0 0
M  V30 21 C 10.6698 6.1601 0.0 0
M  V30 22 C 13.3372 4.6201 0.0 0
M  V30 23 C 12.0035 6.9302 0.0 0
M  V30 24 C 13.3372 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 19
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 68063-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1219134-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12556437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of chalcone derivatives (0.01 mol),
guanidine nitrate (0.015 mole, 1.83 g) and 25% sodium methoxide solution
in methanol (28 mL) was refluxed for 6 h. After the completion of
reaction, the resultant mixture was cooled to room temperature.
Precipitated compound was filtered, washed with water, dried, and
crystallized from methanol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Bromophenyl)-1-(4-methoxyphenyl)-2-propen-1-one
C16H13BrO2
92873-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 O 13.3370 4.6201 0.0 0
M  V30 6 C 14.6707 3.8501 0.0 0
M  V30 7 Br 0.0000 4.6201 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 C 10.6697 1.5400 0.0 0
M  V30 10 C 9.3358 3.8501 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 12.0033 3.8501 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Bromophenyl)-6-(4-methoxyphenyl)-2-pyrimidinamine
C17H14BrN3O
1226780-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 O 13.3370 6.9302 0.0 0
M  V30 3 C 14.6707 6.1601 0.0 0
M  V30 4 Br 0.0000 6.9302 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 8.0022 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 9.3358 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 9.3358 6.1601 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 10.6697 6.9302 0.0 0
M  V30 16 C 12.0033 6.1601 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 4.0010 6.1601 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92873-00-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1226780-77-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14979099
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A mixture of chalcone derivatives (0.01 mol),
guanidine nitrate (0.015 mole, 1.83 g) and 25% sodium methoxide solution
in methanol (28 mL) was refluxed for 6 h. After the completion of
reaction, the resultant mixture was cooled to room temperature.
Precipitated compound was filtered, washed with water, dried, and
crystallized from methanol.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Methoxychalcone
C16H14O2
959-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenyl)-6-phenyl-2-pyrimidinamine
C17H15N3O
59807-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 O 12.0033 6.9302 0.0 0
M  V30 3 C 13.3370 6.1601 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 N 6.6685 2.3101 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 N 4.0010 2.3101 0.0 0
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 C 9.3360 3.8501 0.0 0
M  V30 12 C 8.0022 6.1601 0.0 0
M  V30 13 C 10.6697 4.6201 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 C 10.6697 6.1601 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 1.3337 6.9302 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 21 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 959-23-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59807-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10443735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A mixture of chalcone derivatives (0.01 mol), guanidine nitrate (0.015
mole, 1.83 g) and 25% sodium methoxide solution in methanol (28 mL) was
refluxed for 6 h. After the completion of reaction, the resultant mixture
was cooled to room temperature. Precipitated compound was filtered,
washed with water, dried, and crystallized from methanol. Pyrimidine
derivatives 6 with 88-97% yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antimicrobial activity of thiazole,
benzothiazole and pyrimidine derivatives bearing sydnone moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Asundaria, S. T.; Patel, K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2012), 45(12), 725-731

$RFMT $RIREG SCHEME121 STEP1
$RXN



  3  1
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1,6-dihydro-4-(4-methoxyphenyl)-6-oxo-5-pyrimidinecarbonitrile
C12H10N4O2
273940-80-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 O 9.3358 6.9300 0.0 0
M  V30 6 C 10.6694 6.1600 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6673 4.6200 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 13 C 5.3347 4.6200 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 2 3 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 273940-80-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31372513
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 111-40-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with fullerene
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 99685-96-8
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM reaction product wth diethylenetriamine
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, diethylenetriamine functionalized fullerene catalyst
prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fullerene-C60/NH2 : A recyclable heterogeneous catalyst for the green
synthesis of chromene and pyrimidine derivatives and antibacterial
evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mirza-Aghayan, Maryam; Mohammadi, Marzieh; Boukherroub, Rabah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2022), 59(6), 1102-1115

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Azido-6-methyl-2-phenyl-4H-1-benzopyran-4-one
C16H11N3O2
2219355-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 1.3336 0.0 0 CHG=1 VAL=4
M  V30 3 N 6.1600 0.0000 0.0 0 CHG=-1
M  V30 4 O 7.7000 2.6674 0.0 0
M  V30 5 C 11.5500 6.6685 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 O 5.3900 6.6685 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 6.9300 6.6685 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 C 7.7000 8.0021 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 9.2400 8.0021 0.0 0
M  V30 15 C 10.0100 6.6685 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 9
M  V30 5 1 5 15
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol, 2-(2-amino-5-azido-6-phenyl-4-pyrimidinyl)-4-methyl-
C17H14N6O
2163000-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.1601 0.0 0
M  V30 2 N 6.6684 6.9301 0.0 0 CHG=1 VAL=4
M  V30 3 N 8.0022 7.7001 0.0 0 CHG=-1
M  V30 4 O 1.3337 2.3100 0.0 0
M  V30 5 N 5.3348 0.0000 0.0 0
M  V30 6 C 1.3337 8.4701 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 6.6684 3.8500 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 N 6.6684 2.3100 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 15 C 2.6673 6.1601 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 1.3337 6.9301 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 C 8.0022 4.6201 0.0 0
M  V30 20 C 8.0022 6.1601 0.0 0
M  V30 21 C 9.3359 3.8500 0.0 0
M  V30 22 C 9.3359 6.9301 0.0 0
M  V30 23 C 10.6695 4.6201 0.0 0
M  V30 24 C 10.6695 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 14
M  V30 5 1 5 11
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 19
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2219355-09-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2163000-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22096077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 174501-64-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, green chemistry, inert, optimization study, reusable
catalyst, optimized on solvent, temperature and time, ionic liquid used
as catalyst and solvent, alternate conventional method gave 80% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and molecular docking studies of azido-pyrimidine
analogues as anti-bacterial and anti-fungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Longadge, Nitin K.; Rahatgaonkar, Anjali M.; Saraf, Binda. D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical and Pharmaceutical Research (2016), 8(3), 807-822

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[(3-bromophenyl)methyl]-3-methyl-2-oxocyclohexanecarboxylate
C16H19BrO3
937250-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5698 3.0112 0.0 0
M  V30 2 C 6.5698 4.9910 0.0 0
M  V30 3 O 5.3900 1.3338 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 O 0.7700 1.3338 0.0 0
M  V30 6 O 3.0800 0.0000 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 Br 11.8235 2.0849 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 3.0800 2.6674 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 8.0169 3.5378 0.0 0
M  V30 16 C 9.1966 2.5481 0.0 0
M  V30 17 C 8.2843 5.0544 0.0 0
M  V30 18 C 10.6437 3.0748 0.0 0
M  V30 19 C 9.7314 5.5813 0.0 0
M  V30 20 C 10.9112 4.5914 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 9
M  V30 4 2 3 10
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 1 5 7
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-8-[(3-bromophenyl)methyl]-5,6,7,8-tetrahydro-8-methyl-4(3H)-quinazoli...
C16H18BrN3O
937250-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8515 4.8873 0.0 0
M  V30 2 C 5.8615 3.1729 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Br 11.8645 3.0629 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 5.3349 4.6200 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 5.3349 6.1600 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 1.3338 3.8500 0.0 0
M  V30 13 C 2.6674 1.5400 0.0 0
M  V30 14 C 4.0011 6.9300 0.0 0
M  V30 15 N 1.3338 2.3100 0.0 0
M  V30 16 C 7.8412 3.7077 0.0 0
M  V30 17 C 9.3580 3.9752 0.0 0
M  V30 18 C 7.3145 2.2606 0.0 0
M  V30 19 C 10.3477 2.7954 0.0 0
M  V30 20 C 8.3044 1.0809 0.0 0
M  V30 21 C 9.8210 1.3483 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 16
M  V30 3 1 2 7
M  V30 4 2 3 12
M  V30 5 1 4 13
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 937250-32-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 937250-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11126105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Amino-8-(3-bromobenzyl)-8-methyl-5,6,7,8-tetrahydroquinazolin-4(3H)-one
(Scheme #5, U). To
methy13-(3-bromobenzyl)-3-methyl-2-oxocyc1ohexanecarboxylate (1.86 g,
5.48 mmol) was added ethanol (20.0 mL), guanidine carbonate (0.987 g,
5.48 mmol), and the reaction was refluxed. After 18 h the organic solvent
was removed under reduced pressure and the resulting solids triturated
with water (50 mL). The white precipitate was filtered and dried under
high vacuum at 50 °C to give the title compound (1.85 g, 97% yield). 1H
NMR (300 MHz, DMSO-d 6/TFA-d) δ1.21 (s, 3H), 1.31 - 1.41 (m, 1H), 1.57 -
1.77 (m, 3H), 2.18- 2.27 (m, 2H), 2.95 (s, 2H), 7.41-7.50 (m, 2H), 7.19
-7.31 (m, 2H), m/z (APCI+) M+1 (348); tR = 1.91 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 2-aminopyrimidin-4-ones for treating or
preventing Aβ-related pathologies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Albert, Jeffrey; Andisik, Donald; Edwards, Phil; Sylvester, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007058580 A1 2007-05-24

$RFMT $RIREG SCHEME124 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone
C6H10O
108-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(8E)-4-(4-Chlorophenyl)-8-[(4-chlorophenyl)methylene]-5,6,7,8-tetrahydro-2-qu...
C21H17Cl2N3
1173717-52-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6698 3.8501 0.0 0
M  V30 2 N 6.6687 0.0000 0.0 0
M  V30 3 Cl 0.0000 6.9302 0.0 0
M  V30 4 Cl 16.0046 6.9302 0.0 0
M  V30 5 C 6.6687 4.6201 0.0 0
M  V30 6 C 8.0023 3.8501 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 6.6687 6.1601 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 N 8.0023 2.3101 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 8.0023 6.9302 0.0 0
M  V30 13 C 9.3360 6.1601 0.0 0
M  V30 14 C 6.6687 1.5400 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 2.6675 3.8501 0.0 0
M  V30 17 C 4.0012 6.1601 0.0 0
M  V30 18 C 1.3338 4.6201 0.0 0
M  V30 19 C 2.6675 6.9302 0.0 0
M  V30 20 C 1.3338 6.1601 0.0 0
M  V30 21 C 12.0035 4.6201 0.0 0
M  V30 22 C 13.3372 3.8501 0.0 0
M  V30 23 C 12.0035 6.1601 0.0 0
M  V30 24 C 14.6708 4.6201 0.0 0
M  V30 25 C 13.3372 6.9302 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 1 21
M  V30 3 1 2 14
M  V30 4 1 3 20
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 7 15
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 11 14
M  V30 17 1 12 13
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-94-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1173717-52-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-554-CAS-12286421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, stereoselective, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile synthesis of pyrimidine and quinazoline
derivatives via one-pot three-component reaction under solvent-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rong, Liangce; Han, Hongxia; Wang, Haiying; Jiang, Hong; Tu, Shuajiang;
Shi, Daqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2009), 46(2), 152-157

$RFMT $RIREG SCHEME125 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Tetralone
C10H10O
529-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine
C18H14ClN3
97145-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 Cl 12.0033 6.9302 0.0 0
M  V30 3 C 4.0012 3.8501 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 N 4.0012 2.3101 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 5.3348 6.1601 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 N 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 6.9302 0.0 0
M  V30 14 C 1.3337 6.9302 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 9.3360 3.8501 0.0 0
M  V30 20 C 9.3360 6.9302 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 22
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 17
M  V30 13 1 8 13
M  V30 14 1 9 13
M  V30 15 2 9 14
M  V30 16 1 10 15
M  V30 17 2 11 12
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 529-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 97145-64-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5569160
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile synthesis of pyrimidine and quinazoline
derivatives via one-pot three-component reaction under solvent-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rong, Liangce; Han, Hongxia; Wang, Haiying; Jiang, Hong; Tu, Shuajiang;
Shi, Daqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2009), 46(2), 152-157

$RFMT $RIREG SCHEME126 STEP1
$RXN



  3  1
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Tetralone
C10H10O
529-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dihydro-4-(4-methoxyphenyl)benzo[h]quinazolin-2-amine
C19H17N3O
97145-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 O 12.0032 6.9301 0.0 0
M  V30 3 C 13.3369 6.1601 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 C 4.0010 3.8500 0.0 0
M  V30 6 C 6.6684 3.8500 0.0 0
M  V30 7 C 5.3348 6.1601 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 N 4.0010 2.3100 0.0 0
M  V30 10 N 6.6684 2.3100 0.0 0
M  V30 11 C 4.0010 6.9301 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 3.8500 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 1.3337 6.9301 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 0.0000 6.1601 0.0 0
M  V30 18 C 8.0021 4.6201 0.0 0
M  V30 19 C 8.0021 6.1601 0.0 0
M  V30 20 C 9.3359 3.8500 0.0 0
M  V30 21 C 9.3359 6.9301 0.0 0
M  V30 22 C 10.6695 4.6201 0.0 0
M  V30 23 C 10.6695 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 18
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 2 10 14
M  V30 16 1 11 12
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 529-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 97145-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5274573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile synthesis of pyrimidine and quinazoline
derivatives via one-pot three-component reaction under solvent-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rong, Liangce; Han, Hongxia; Wang, Haiying; Jiang, Hong; Tu, Shuajiang;
Shi, Daqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2009), 46(2), 152-157

$RFMT $RIREG SCHEME127 STEP1
$RXN



  3  1
$MOL
Ethyl benzoylacetate
C11H12O3
94-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-benzoyl-5,6-dihydro-6-phenyl-4(3H)-pyrimidinone
C17H15N3O2
1696387-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 O 4.6200 6.6685 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 N 2.3100 0.0000 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 N 2.3100 2.6674 0.0 0
M  V30 9 N 4.6200 1.3336 0.0 0
M  V30 10 C 3.0800 1.3336 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 0.0000 6.6685 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 17
M  V30 4 2 3 7
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 94-02-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1696387-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-2439764
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave irradiation (180W), regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Unexpected One-pot Synthesis of Novel 2-Aminopyrimidine-4-ones under
Microwave Irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kefayati, Hassan; Mirfarhadi, Seyyedeh Mina; Kazemi-Rad, Reyhaneh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Chinese Chemical Society (Weinheim, Germany) (2015),
62(2), 107-111

$RFMT $RIREG SCHEME128 STEP1
$RXN



  3  1
$MOL
Acetophenone
C8H8O
98-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)chalcone
C17H17NO
1030-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 O 4.0010 6.1601 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 12.0033 1.5400 0.0 0
M  V30 6 C 13.3370 2.3101 0.0 0
M  V30 7 C 12.0033 0.0000 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 9.3360 1.5400 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,6-Diphenyl-4-pyridinyl)-N,N-dimethylbenzenamine
C25H22N2
29312-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0031 10.0100 0.0 0
M  V30 2 C 13.3367 9.2400 0.0 0
M  V30 3 C 12.0031 11.5500 0.0 0
M  V30 4 C 6.6684 6.9300 0.0 0
M  V30 5 C 6.6684 5.3900 0.0 0
M  V30 6 C 5.3347 7.7000 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 4.0009 6.9300 0.0 0
M  V30 9 N 4.0009 5.3900 0.0 0
M  V30 10 C 8.0020 7.7000 0.0 0
M  V30 11 C 8.0020 9.2400 0.0 0
M  V30 12 C 9.3358 6.9300 0.0 0
M  V30 13 C 9.3358 10.0100 0.0 0
M  V30 14 C 10.6694 7.7000 0.0 0
M  V30 15 C 10.6694 9.2400 0.0 0
M  V30 16 C 5.3347 3.0800 0.0 0
M  V30 17 C 6.6684 2.3100 0.0 0
M  V30 18 C 4.0009 2.3100 0.0 0
M  V30 19 C 6.6684 0.7700 0.0 0
M  V30 20 C 4.0009 0.7700 0.0 0
M  V30 21 C 5.3347 0.0000 0.0 0
M  V30 22 C 2.6673 7.7000 0.0 0
M  V30 23 C 1.3336 6.9300 0.0 0
M  V30 24 C 2.6673 9.2400 0.0 0
M  V30 25 C 0.0000 7.7000 0.0 0
M  V30 26 C 1.3336 10.0100 0.0 0
M  V30 27 C 0.0000 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 1 8 22
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-86-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1030-27-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29312-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-11893871
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-reagent, microwave irradiation (600W), no solvent,
mechanism studied
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave-assisted, solvent-free, three-component synthesis of
2,4,6-triarylpyridines from benign components
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zomordbakhsh, Shahab; Anaraki-Ardakani, Hossein; Zeeb, Mohsen; Sadeghi,
Mahdi; Mazraeh-Seffid, Manouchehr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2012), 36(3), 138-140

$RFMT $RIREG SCHEME129 STEP1
$RXN



  3  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-methylphenyl)-5-pyrimidinecarbonitrile
C12H11N5
107199-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 C 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107199-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28562825
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, CuO-nanoparticles prepared by supercritical
hydrothermal synthesis used as catalyst, catalyst recyclable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CuO nanoparticles, a mild and efficient reusable catalyst for the one-pot
synthesis of 4-amino-5-pyrimidin-ecarbonitriles under aqueous conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmadi, Seyed Javad; Sadjadi, Sodeh; Hosseinpour, Morteza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Diffusion and Defect Data--Solid State Data, Pt. A: Defect and Diffusion
Forum (2012), 326-328372-376

$RFMT $RIREG SCHEME129 STEP1
$RXN



  3  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-methylphenyl)-5-pyrimidinecarbonitrile
C12H11N5
107199-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 C 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107199-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25264883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, reusable catalyst,
alumina-supported potassium fluoride catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM KF/Al2O3: as a solid phase and recyclable basic catalyst for synthesis
mono and bis pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abaszadeh, Mehdi; Seifi, Mohammad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Iranian Journal of Chemistry & Chemical Engineering (2017), 36(1), 35-43

$RFMT $RIREG SCHEME130 STEP1
$RXN



  5  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenecarbohydrazonoyl chloride
C7H7ClN2
39950-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 Cl 5.3901 0.0000 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C27H28N6O4
3022925-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.9724 3.8501 0.0 0
M  V30 2 C 1.6387 4.6201 0.0 0
M  V30 3 C 2.4087 5.9537 0.0 0
M  V30 4 C 0.3051 5.3901 0.0 0
M  V30 5 C 0.8687 3.2864 0.0 0
M  V30 6 C 8.3072 3.8501 0.0 0
M  V30 7 O 8.3072 2.3100 0.0 0
M  V30 8 O 9.6408 4.6201 0.0 0
M  V30 9 C 9.6408 1.5400 0.0 0
M  V30 10 C 5.6399 2.3100 0.0 0
M  V30 11 O 4.3061 1.5400 0.0 0
M  V30 12 O 6.9735 1.5400 0.0 0
M  V30 13 C 4.3061 0.0000 0.0 0
M  V30 14 C 12.7443 7.4717 0.0 0
M  V30 15 N 5.6399 8.4701 0.0 0
M  V30 16 C 6.8857 9.3753 0.0 0
M  V30 17 C 4.3940 9.3753 0.0 0
M  V30 18 N 6.4099 10.8399 0.0 0
M  V30 19 N 4.8699 10.8399 0.0 0
M  V30 20 C 5.6399 6.9301 0.0 0
M  V30 21 N 4.3061 6.1601 0.0 0
M  V30 22 N 6.9735 6.1601 0.0 0
M  V30 23 C 4.3061 4.6201 0.0 0
M  V30 24 C 6.9735 4.6201 0.0 0
M  V30 25 C 5.6399 3.8501 0.0 0
M  V30 26 C 8.3503 8.8993 0.0 0
M  V30 27 C 8.6706 7.3930 0.0 0
M  V30 28 C 9.4948 9.9299 0.0 0
M  V30 29 C 10.1352 6.9172 0.0 0
M  V30 30 C 10.9594 9.4540 0.0 0
M  V30 31 C 11.2797 7.9476 0.0 0
M  V30 32 C 2.9293 8.8993 0.0 0
M  V30 33 C 1.7849 9.9299 0.0 0
M  V30 34 C 2.6091 7.3930 0.0 0
M  V30 35 C 0.3202 9.4540 0.0 0
M  V30 36 C 1.1444 6.9172 0.0 0
M  V30 37 C 0.0000 7.9476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 25
M  V30 13 1 11 13
M  V30 14 1 14 31
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 1 16 26
M  V30 20 2 17 19
M  V30 21 1 17 32
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 39950-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3022925-86-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38650896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green preparation of new pyrimidine triazole derivatives via one-pot
multicomponent reactions of guanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hezarcheshmeh, Nasrin Karami; Godarzbod, Farideh; Abdullah, Media Noori;
Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2024), 28(1), 217-228

$RFMT $RIREG SCHEME131 STEP1
$RXN



  5  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl propiolate
C4H4O2
922-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 3.8500 1.3336 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenecarbohydrazonoyl chloride
C7H7ClN2
39950-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 Cl 5.3901 0.0000 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H26N6O2
3022925-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.3071 3.0800 0.0 0
M  V30 2 C 8.3071 1.5400 0.0 0
M  V30 3 C 6.7671 1.5400 0.0 0
M  V30 4 C 8.3071 0.0000 0.0 0
M  V30 5 C 9.8471 1.5400 0.0 0
M  V30 6 C 2.9724 3.0800 0.0 0
M  V30 7 O 2.9724 1.5400 0.0 0
M  V30 8 O 1.6387 3.8500 0.0 0
M  V30 9 C 1.6387 0.7700 0.0 0
M  V30 10 C 12.7441 6.7016 0.0 0
M  V30 11 N 5.6398 7.7000 0.0 0
M  V30 12 C 6.8856 8.6052 0.0 0
M  V30 13 C 4.3939 8.6052 0.0 0
M  V30 14 N 6.4098 10.0698 0.0 0
M  V30 15 N 4.8698 10.0698 0.0 0
M  V30 16 C 5.6398 6.1600 0.0 0
M  V30 17 N 6.9734 5.3900 0.0 0
M  V30 18 N 4.3060 5.3900 0.0 0
M  V30 19 C 6.9734 3.8500 0.0 0
M  V30 20 C 4.3060 3.8500 0.0 0
M  V30 21 C 5.6398 3.0800 0.0 0
M  V30 22 C 8.3502 8.1292 0.0 0
M  V30 23 C 9.4947 9.1598 0.0 0
M  V30 24 C 8.6705 6.6229 0.0 0
M  V30 25 C 10.9593 8.6839 0.0 0
M  V30 26 C 10.1350 6.1471 0.0 0
M  V30 27 C 11.2796 7.1775 0.0 0
M  V30 28 C 2.9292 8.1292 0.0 0
M  V30 29 C 2.6091 6.6229 0.0 0
M  V30 30 C 1.7849 9.1598 0.0 0
M  V30 31 C 1.1444 6.1471 0.0 0
M  V30 32 C 0.3202 8.6839 0.0 0
M  V30 33 C 0.0000 7.1775 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 1 10 27
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 16
M  V30 14 2 12 14
M  V30 15 1 12 22
M  V30 16 2 13 15
M  V30 17 1 13 28
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 922-67-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 39950-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3022925-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38650889
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green preparation of new pyrimidine triazole derivatives via one-pot
multicomponent reactions of guanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hezarcheshmeh, Nasrin Karami; Godarzbod, Farideh; Abdullah, Media Noori;
Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2024), 28(1), 217-228

$RFMT $RIREG SCHEME132 STEP1
$RXN



  3  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Methylacetophenone
C9H10O
122-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-4′-methylchalcone
C17H16O2
6552-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 0.0000 4.6201 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 14.6707 3.8501 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 4.0010 3.8501 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 9.3358 2.3101 0.0 0
M  V30 15 C 10.6697 1.5400 0.0 0
M  V30 16 C 9.3358 3.8501 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 14
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenyl)-2,6-bis(4-methylphenyl)pyridine
C26H23NO
75573-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3370 11.5503 0.0 0
M  V30 2 C 14.6707 10.7802 0.0 0
M  V30 3 C 0.0000 11.5503 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 8.0022 8.4702 0.0 0
M  V30 6 C 6.6685 9.2402 0.0 0
M  V30 7 C 8.0022 6.9302 0.0 0
M  V30 8 C 5.3348 8.4702 0.0 0
M  V30 9 C 6.6685 6.1601 0.0 0
M  V30 10 N 5.3348 6.9302 0.0 0
M  V30 11 C 9.3358 9.2402 0.0 0
M  V30 12 C 10.6697 8.4702 0.0 0
M  V30 13 C 9.3358 10.7802 0.0 0
M  V30 14 C 12.0033 9.2402 0.0 0
M  V30 15 C 10.6697 11.5503 0.0 0
M  V30 16 C 12.0033 10.7802 0.0 0
M  V30 17 C 4.0010 9.2402 0.0 0
M  V30 18 C 4.0010 10.7802 0.0 0
M  V30 19 C 2.6673 8.4702 0.0 0
M  V30 20 C 2.6673 11.5503 0.0 0
M  V30 21 C 1.3337 9.2402 0.0 0
M  V30 22 C 1.3337 10.7802 0.0 0
M  V30 23 C 6.6685 4.6201 0.0 0
M  V30 24 C 5.3348 3.8501 0.0 0
M  V30 25 C 8.0022 3.8501 0.0 0
M  V30 26 C 5.3348 2.3101 0.0 0
M  V30 27 C 8.0022 2.3101 0.0 0
M  V30 28 C 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 22
M  V30 4 1 4 28
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 2 9 10
M  V30 13 1 9 23
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-00-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 6552-66-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 75573-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-12174734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-reagent, microwave irradiation (600W), no solvent,
mechanism studied
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave-assisted, solvent-free, three-component synthesis of
2,4,6-triarylpyridines from benign components
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zomordbakhsh, Shahab; Anaraki-Ardakani, Hossein; Zeeb, Mohsen; Sadeghi,
Mahdi; Mazraeh-Seffid, Manouchehr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2012), 36(3), 138-140

$RFMT $RIREG SCHEME133 STEP1
$RXN



  5  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanal
C3H6O
123-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenecarbohydrazonoyl chloride
C7H7ClN2
39950-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 Cl 5.3901 0.0000 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Pyrimidinedicarboxylic acid, 6-[(1,1-dimethylethyl)amino]-2-(3-ethyl-5-ph...
C22H26N6O4
3022925-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5911 9.7293 0.0 0
M  V30 2 C 4.1151 11.1939 0.0 0
M  V30 3 C 6.7238 2.6673 0.0 0
M  V30 4 O 5.9538 1.3337 0.0 0
M  V30 5 O 8.2638 2.6673 0.0 0
M  V30 6 C 6.7238 0.0000 0.0 0
M  V30 7 N 2.1037 5.3348 0.0 0
M  V30 8 C 1.3337 6.6685 0.0 0
M  V30 9 C 2.6675 7.4385 0.0 0
M  V30 10 C 0.5637 8.0022 0.0 0
M  V30 11 C 0.0000 5.8985 0.0 0
M  V30 12 C 3.6437 2.6673 0.0 0
M  V30 13 O 2.1037 2.6673 0.0 0
M  V30 14 O 4.4137 1.3337 0.0 0
M  V30 15 C 1.3337 1.3337 0.0 0
M  V30 16 N 6.7238 8.0022 0.0 0
M  V30 17 C 8.2555 8.1631 0.0 0
M  V30 18 C 6.0975 9.4091 0.0 0
M  V30 19 N 8.5757 9.6696 0.0 0
M  V30 20 N 7.2420 10.4396 0.0 0
M  V30 21 C 5.9538 6.6685 0.0 0
M  V30 22 N 6.7238 5.3348 0.0 0
M  V30 23 N 4.4137 6.6685 0.0 0
M  V30 24 C 5.9538 4.0010 0.0 0
M  V30 25 C 3.6437 5.3348 0.0 0
M  V30 26 C 4.4137 4.0010 0.0 0
M  V30 27 C 9.2859 7.0187 0.0 0
M  V30 28 C 8.8101 5.5540 0.0 0
M  V30 29 C 10.7922 7.3389 0.0 0
M  V30 30 C 9.8405 4.4096 0.0 0
M  V30 31 C 11.8228 6.1945 0.0 0
M  V30 32 C 11.3470 4.7298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 24
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 26
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21
M  V30 19 2 17 19
M  V30 20 1 17 27
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-38-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 39950-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3022925-84-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38650895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green preparation of new pyrimidine triazole derivatives via one-pot
multicomponent reactions of guanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hezarcheshmeh, Nasrin Karami; Godarzbod, Farideh; Abdullah, Media Noori;
Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2024), 28(1), 217-228

$RFMT $RIREG SCHEME134 STEP1
$RXN



  3  1
$MOL
Diazomethane
CH2N2
334-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0 CHG=1 VAL=4
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 N 3.0800 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorocinnamic acid
C9H7ClO2
3752-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 Cl 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R)-N-(Aminoiminomethyl)-2-(2-chlorophenyl)cyclopropanecarboxamide
C11H12ClN3O
370867-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8747 2.3100 0.0 0
M  V30 2 N 8.2084 1.5400 0.0 0
M  V30 3 O 6.8747 3.8500 0.0 0
M  V30 4 C 9.5421 2.3100 0.0 0
M  V30 5 N 9.5421 3.8500 0.0 0
M  V30 6 N 10.8758 1.5400 0.0 0
M  V30 7 Cl 1.3336 0.0000 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 9 C 5.5411 1.5400 0.0 0 CFG=1
M  V30 10 C 4.7711 0.2064 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 1.3336 1.5400 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 334-88-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3752-25-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 370867-71-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-287-CAS-6501177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure A. General Procedure for Preparing
Arylcyclopropanecarboxyl Guanidines 3a-k from Cinnamic Acids or Esters.13
To a solution of the cinnamic acid or ester (0.5 mmol) in THF (10 mL)
were added Pd(OAc)2 (5 mg) and a cold (0°C) ethereal solution of
diazomethane (6 mL, freshly prepared from
1-methyl-3-nitro-1-nitrosoguanidine (MNNG, 74 mg, 4.5 mmol)) alternately
in small portions with continuous stirring during 10-15 min (the addition
of diazomethane was done in small portions just following each addition
of the palladium catalyst). It is noteworthy that the analytical HPLC
retention times and the TLC Rf values for the cinnamates and the
corresponding cyclopropyl esters are almost indistinguishable.
Furthermore, we could not observe the molecular ions (M + H)+ for the
cyclopropyl esters in LC/MS. Therefore, the progress of these reactions
was monitored by 1H NMR. Upon completion of the reaction, a few drops of
glacial acetic acid were added to quench excess diazomethane. The
reaction mixture was filtered through Celite, and the filtrate was
concentrated to give a thick dark brown residue. The crude cyclopropyl
esters thus prepared were dissolved in 0.5 mL of DMF and treated with a
solution of guanidine (148 mg, 2.5 mmol) in DMF (1 mL). The reaction
mixtures were stirred for 12 h at room temperature, diluted with water,
and extracted with EtOAc. The organic layer was dried over magnesium
sulfate and concentrated, and the residue was subjected to reversed-phase
preparative HPLC (ODS column/H2O-MeOH-TFA, 90:10:0.1 to 10:90:0.1
gradient) to afford the corresponding acyl guanidines as TFA salts. The
following compounds (3a-k) were prepared by the general procedure A
described above.
(±)-trans-N-(Aminoiminomethyl)-2-(2-chlorophenyl)-cyclopropanecarboxamide
(3b):. white solid (TFA salt, 96% yield). 1H NMR (500 MHz, CDCl3) δ 12.29
(brs, 1H), 8.85 (brs, 2H), 7.95 (brs, 2H), 7.38-7.36 (m, 1H), 7.22-7.20
(m, 2H), 7.10-7.08 (m, 1H), 2.85-2.82 (m, 1H), 2.01-1.99 (m, 1H),
1.79-1.77 (m, 1H), 1.53-1.52 (m, 1H); 13C NMR (125 MHz, CD3OD) δ 174.78,
155.49, 136.68, 135.41, 129.20, 128.47, 127.61, 127.17, 26.23, 24.97,
15.70; HRMS (ESI) calcd for C11H12ClN3O (M + H)+ 238.0748, found
238.0738; Anal. HPLC tR = 2.7 min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylcyclopropanecarboxyl Guanidines as Novel, Potent, and Selective
Inhibitors of the Sodium Hydrogen Exchanger Isoform-1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmad, Saleem; Doweyko, Lidia M.; Dugar, Sundeep; Grazier, Nyeemah; Ngu,
Khehyong; Wu, Shung C.; Yost, Kenneth J.; Chen, Bang-Chi; Gougoutas, Jack
Z.; DiMarco, John D.; Lan, Shih-Jung; Gavin, Brian J.; Chen, Alice Y.;
Dorso, Charles R.; Serafino, Randy; Kirby, Mark; Atwal, Karnail S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2001), 44(20), 3302-3310

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluorobenzoic acid
C7H6FNO2
446-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoroquinazolin-4(3H)-one
C8H5FN2O
16499-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 F 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-544-CAS-15587738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and docking studies of afatinib analogs bearing
cinnamamide moiety as potent EGFR inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tu, Yuanbiao; OuYang, Yiqiang; Xu, Shan; Zhu, Yan; Li, Gen; Sun, Chao;
Zheng, Pengwu; Zhu, Wufu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(7), 1495-1503

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-9-Acridinyl-3-oxobutanamide
C17H14N2O2
943415-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 5.3900 0.0 0
M  V30 2 C 6.6684 4.6200 0.0 0
M  V30 3 C 8.0021 5.3900 0.0 0
M  V30 4 O 6.6684 3.0800 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 C 10.6694 5.3900 0.0 0
M  V30 7 O 9.3358 3.0800 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6673 5.3900 0.0 0
M  V30 13 N 1.3336 3.0800 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 5.3347 0.7700 0.0 0
M  V30 16 C 1.3336 4.6200 0.0 0
M  V30 17 C 2.6673 6.9300 0.0 0
M  V30 18 C 4.0011 0.0000 0.0 0
M  V30 19 C 0.0000 5.3900 0.0 0
M  V30 20 C 1.3336 7.7000 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 2 13 16
M  V30 18 2 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,5-Dihydro-2-imino-6-methyl-4-pyrimidinyl)-9-acridinamine
C18H15N5
1852487-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 2.3100 0.0 0
M  V30 2 C 10.6694 2.3100 0.0 0
M  V30 3 N 8.0021 6.9300 0.0 0
M  V30 4 C 4.0011 3.0800 0.0 0
M  V30 5 C 2.6673 2.3100 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 1.3336 3.0800 0.0 0
M  V30 8 C 2.6673 0.7700 0.0 0
M  V30 9 C 2.6673 5.3900 0.0 0
M  V30 10 C 5.3347 5.3900 0.0 0
M  V30 11 N 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 2.6673 6.9300 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 17 C 4.0011 7.7000 0.0 0
M  V30 18 C 6.6684 3.0800 0.0 0
M  V30 19 C 8.0021 2.3100 0.0 0
M  V30 20 N 6.6684 4.6200 0.0 0
M  V30 21 C 9.3358 3.0800 0.0 0
M  V30 22 C 8.0021 5.3900 0.0 0
M  V30 23 N 9.3358 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 1 18 CFG=2
M  V30 3 1 2 21
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 2 8 13
M  V30 14 2 9 11
M  V30 15 1 9 14
M  V30 16 2 10 15
M  V30 17 2 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 943415-89-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1852487-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2816295
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (800 W)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of heterocycles containing pyrimidine-acridine rings by
microwave irradiation, antimicrobial study and its comparison with
classical heating
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawle, Pravin R.; Deohate, Pradip P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Indian Chemical Society (2015), 92(6), 925-928

$RFMT $RIREG SCHEME137 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1,6-dihydro-6-oxo-4-phenyl-5-pyrimidinecarbonitrile
C11H8N4O
81066-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.1600 0.0 0
M  V30 2 N 5.3347 7.7000 0.0 0
M  V30 3 O 8.0021 4.6200 0.0 0
M  V30 4 N 5.3347 0.0000 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 N 4.0011 2.3100 0.0 0
M  V30 8 C 6.6685 3.8500 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 N 6.6685 2.3100 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 1.3336 3.8500 0.0 0
M  V30 13 C 2.6674 6.1600 0.0 0
M  V30 14 C 0.0000 4.6200 0.0 0
M  V30 15 C 1.3336 6.9300 0.0 0
M  V30 16 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 81066-94-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20222387
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, green chemistry-solvent,
solid-supported catalyst, ultrasonic irradiation (40 W), recyclable
catalyst used, catalyst prepared and used, optimization study, optimized
on catalyst, optimized on solvent, optimized on stoichiometry of
catalyst, optimized on power
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasonic Accelerated Biginelli-Like Reaction by the Covalently Anchored
Copper-Isatoic Anhydride over the Modified Surface of Mesoporous SBA-15
to the Synthesis of Pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghomi, Javad Safaei; Bakhtiari, Atefeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2018), 3(44), 12704-12711

$RFMT $RIREG SCHEME138 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-5H-indeno[1,2-d]pyrimidin-5-one
C17H10ClN3O
713514-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6253 7.2708 0.0 0
M  V30 2 N 4.9150 0.0000 0.0 0
M  V30 3 Cl 11.5835 6.9302 0.0 0
M  V30 4 C 4.9150 4.6201 0.0 0
M  V30 5 C 3.5812 3.8501 0.0 0
M  V30 6 C 6.2487 3.8501 0.0 0
M  V30 7 C 4.5948 6.1264 0.0 0
M  V30 8 C 2.4368 4.8805 0.0 0
M  V30 9 N 3.5812 2.3101 0.0 0
M  V30 10 N 6.2487 2.3101 0.0 0
M  V30 11 C 3.0631 6.2873 0.0 0
M  V30 12 C 0.9052 4.7196 0.0 0
M  V30 13 C 4.9150 1.5400 0.0 0
M  V30 14 C 2.1580 7.5332 0.0 0
M  V30 15 C 0.0000 5.9655 0.0 0
M  V30 16 C 0.6263 7.3723 0.0 0
M  V30 17 C 7.5824 4.6201 0.0 0
M  V30 18 C 8.9162 3.8501 0.0 0
M  V30 19 C 7.5824 6.1601 0.0 0
M  V30 20 C 10.2498 4.6201 0.0 0
M  V30 21 C 8.9162 6.9302 0.0 0
M  V30 22 C 10.2498 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 13
M  V30 3 1 3 22
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 17
M  V30 11 1 7 11
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 2 10 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 713514-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22633260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, liquid glass used as catalyst, alternative reaction
conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Liquid Glass Catalyzed Three-Component Preparation of
2-Amino-4-Aryl-5H-Indeno[1,2-d]Pyrimidin-5-One Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fazlinia, Abbas; Sheikh, Setareh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2020), 40(5), 1362-1366

$RFMT $RIREG SCHEME138 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)-5H-indeno[1,2-d]pyrimidin-5-one
C17H10ClN3O
713514-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6253 7.2708 0.0 0
M  V30 2 N 4.9150 0.0000 0.0 0
M  V30 3 Cl 11.5835 6.9302 0.0 0
M  V30 4 C 4.9150 4.6201 0.0 0
M  V30 5 C 3.5812 3.8501 0.0 0
M  V30 6 C 6.2487 3.8501 0.0 0
M  V30 7 C 4.5948 6.1264 0.0 0
M  V30 8 C 2.4368 4.8805 0.0 0
M  V30 9 N 3.5812 2.3101 0.0 0
M  V30 10 N 6.2487 2.3101 0.0 0
M  V30 11 C 3.0631 6.2873 0.0 0
M  V30 12 C 0.9052 4.7196 0.0 0
M  V30 13 C 4.9150 1.5400 0.0 0
M  V30 14 C 2.1580 7.5332 0.0 0
M  V30 15 C 0.0000 5.9655 0.0 0
M  V30 16 C 0.6263 7.3723 0.0 0
M  V30 17 C 7.5824 4.6201 0.0 0
M  V30 18 C 8.9162 3.8501 0.0 0
M  V30 19 C 7.5824 6.1601 0.0 0
M  V30 20 C 10.2498 4.6201 0.0 0
M  V30 21 C 8.9162 6.9302 0.0 0
M  V30 22 C 10.2498 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 13
M  V30 3 1 3 22
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 17
M  V30 11 1 7 11
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 2 10 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 713514-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25167375
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 697740-91-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, Knoevenagel condensation followed by Michael addition,
cyclization, isomerization and then aromatization, catalyst prepared and
used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of supra molecular self-assembled Nickel(II)
coordination complex in synthesis of indeno-pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gangu, Kranthi Kumar; Maddila, Suresh; Mukkamala, Saratchandra Babu;
Jonnalagadda, Sreekantha B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2019), 158464-470

$RFMT $RIREG SCHEME139 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzaldehyde
C7H5FO
456-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(3-fluorophenyl)-5-pyrimidinecarbonitrile
C11H8FN5
1140184-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 F 9.3358 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 456-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1140184-74-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28585290
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 10035-06-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the preparation of
pyrimidine and pyrimidinone derivatives A mixture of the aldehyde (2
mmol), amidines hydrochloride (2 mmol), malononitrile or ethyl
cyanoacetate (2 mmol), Bi(NO3)3•5H2O (5 mol%) and a catalytic amount of
Et3N in CH3CN (5 mL) was refluxed with stirring for the times reported in
Table 1. The progress of the reaction was monitored by thin-layer
chromatography (TLC), and hexane/ethyl acetate was used as an eluent.
After completion of the reaction, the catalyst was separated from the
reaction mixture by centrifugation. The excess acetonitrile was removed
by evaporation and then was poured into icecold water; the crude product
was filtered, dried, and recrystallized from 96 % ethanol.
6-Oxo-2,4-diphenyl-1,6-dihydro-5-pyrimidinecarbonitrile (5a) Compd. no.:
4o. Yield: 96%.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, recyclable catalyst, Knoevenagel addition
followed by Michael addition, alternative reaction conditions shown,
reaction can also be carried out under thermal conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapid three-component synthesis of pyrimidine and pyrimidinone
derivatives in the presence of Bi(NO3)3.5H2O as a mild and highly
efficient catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zahedifar, Moahboobeh; Sheibani, Hassan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2015), 41(1), 105-111

$RFMT $RIREG SCHEME139 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzaldehyde
C7H5FO
456-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(3-fluorophenyl)-5-pyrimidinecarbonitrile
C11H8FN5
1140184-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 F 9.3358 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 456-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1140184-74-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28666010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1309-48-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of
Pyrimidine and Pyrimidinone Derivatives A mixture of the aldehyde (2
mmol), amidines hydrochloride (2 mmol), malononitrile or ethyl
cyanoacetate (2 mmol), and MgO (0.25 g) in CH3CN (5 mL) was refluxed with
stirring for the time reported in Table 1. The progress of the reaction
was monitored by thin-layer chromatography (TLC), and hexane/ethyl
acetate was used as an eluent). After completion of the reaction, the
catalyst was separated from the reaction mixture by centrifugation. The
excess acetonitrile was removed by evaporation and then was poured into
ice-cold water; the crude product was filtered, dried, and recrystallized
from 96% ethanol. 4o, yield 96%.
$DTYPE RXN:VAR(1):NOTES
$DATUM multicomponent reaction, Michael addition, alternative preparation gave
lower yield, Knoevenagel reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Three-component synthesis of pyrimidine and pyrimidinone derivatives in
the presence of high-surface-area MgO, a highly effective heterogeneous
base catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheibani, Hassan; Seifi, Mohammad; Bazgir, Ayoob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(6), 1055-1064

$RFMT $RIREG SCHEME140 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzaldehyde
C7H5FO
459-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 F 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-fluorophenyl)-5-pyrimidinecarbonitrile
C11H8FN5
1103416-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 F 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 459-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1103416-12-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27016554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 528818-81-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, microwave irradiation (100 W),
ionic liquid used (solvent)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave-assisted one-pot synthesis of functionalized pyrimidines using
ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raghuvanshi, Dushyant Singh; Singh, Krishna Nand
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2011), 48(3), 582-585

$RFMT $RIREG SCHEME141 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5-Trimethoxybenzaldehyde
C10H12O4
86-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3100 0.0 0
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9301 0.0 0
M  V30 7 C 6.6686 5.3901 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarbonitrile, 2,4-diamino-6-(3,4,5-trimethoxyphenyl)-
C14H15N5O3
1312798-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 6.1600 0.0 0
M  V30 2 N 8.0021 7.7000 0.0 0
M  V30 3 N 10.6694 4.6200 0.0 0
M  V30 4 N 8.0021 0.0000 0.0 0
M  V30 5 O 4.0011 8.4700 0.0 0
M  V30 6 C 2.6673 9.2400 0.0 0
M  V30 7 O 1.3336 3.8500 0.0 0
M  V30 8 C 1.3336 2.3100 0.0 0
M  V30 9 O 1.3336 6.9300 0.0 0
M  V30 10 C 0.0000 6.1600 0.0 0
M  V30 11 C 6.6684 3.8500 0.0 0
M  V30 12 C 8.0021 4.6200 0.0 0
M  V30 13 N 6.6684 2.3100 0.0 0
M  V30 14 C 9.3358 3.8500 0.0 0
M  V30 15 C 8.0021 1.5400 0.0 0
M  V30 16 N 9.3358 2.3100 0.0 0
M  V30 17 C 5.3347 4.6200 0.0 0
M  V30 18 C 5.3347 6.1600 0.0 0
M  V30 19 C 4.0011 3.8500 0.0 0
M  V30 20 C 4.0011 6.9300 0.0 0
M  V30 21 C 2.6673 4.6200 0.0 0
M  V30 22 C 2.6673 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 12
M  V30 3 1 3 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 7 8
M  V30 8 1 7 21
M  V30 9 1 9 10
M  V30 10 1 9 22
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 17
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86-81-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1312798-20-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29533794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 528818-81-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, microwave irradiation (100 W),
ionic liquid used (solvent)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave-assisted one-pot synthesis of functionalized pyrimidines using
ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raghuvanshi, Dushyant Singh; Singh, Krishna Nand
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2011), 48(3), 582-585

$RFMT $RIREG SCHEME142 STEP1
$RXN



  4  1
$MOL
Pimelic acid
C7H12O4
111-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 O 9.3360 0.0000 0.0 0
M  V30 11 O 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′-Aminoacetophenone
C8H9NO
99-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 N 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetamidobenzaldehyde
C9H9NO2
122-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 3.0801 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 1.3337 0.7700 0.0 0
M  V30 4 O 0.0000 3.0801 0.0 0
M  V30 5 C 8.0023 0.0000 0.0 0
M  V30 6 O 9.3360 0.7700 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-[3-[6-[4-(Acetylamino)phenyl]-2-amino-4-pyrimidinyl]phenyl]heptanediamide
C25H28N6O3
349489-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 0.0000 0.0 0
M  V30 2 N 2.6675 6.9302 0.0 0
M  V30 3 C 1.3338 6.1601 0.0 0
M  V30 4 C 1.3338 4.6201 0.0 0
M  V30 5 O 0.0000 6.9302 0.0 0
M  V30 6 N 16.0046 3.8501 0.0 0
M  V30 7 C 17.3383 4.6201 0.0 0
M  V30 8 C 18.6720 3.8501 0.0 0
M  V30 9 O 17.3383 6.1601 0.0 0
M  V30 10 C 20.0057 4.6201 0.0 0
M  V30 11 C 21.3395 3.8501 0.0 0
M  V30 12 C 22.6731 4.6201 0.0 0
M  V30 13 C 24.0068 3.8501 0.0 0
M  V30 14 C 25.3405 4.6201 0.0 0
M  V30 15 N 26.6743 3.8501 0.0 0
M  V30 16 O 25.3405 6.1601 0.0 0
M  V30 17 C 8.0023 3.8501 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 19 N 8.0023 2.3101 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 21 C 9.3360 1.5400 0.0 0
M  V30 22 N 10.6697 2.3101 0.0 0
M  V30 23 C 6.6687 4.6201 0.0 0
M  V30 24 C 6.6687 6.1601 0.0 0
M  V30 25 C 5.3348 3.8501 0.0 0
M  V30 26 C 5.3348 6.9302 0.0 0
M  V30 27 C 4.0012 4.6201 0.0 0
M  V30 28 C 4.0012 6.1601 0.0 0
M  V30 29 C 12.0035 4.6201 0.0 0
M  V30 30 C 13.3372 3.8501 0.0 0
M  V30 31 C 12.0035 6.1601 0.0 0
M  V30 32 C 14.6708 4.6201 0.0 0
M  V30 33 C 13.3372 6.9302 0.0 0
M  V30 34 C 14.6708 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 3
M  V30 3 1 2 28
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 32
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 17 23
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 29
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 111-16-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-03-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 122-85-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 349489-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14926743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, first stage attachment to
TentaGel Rink Amide resin
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Symmetric building blocks and combinatorial functional group
transformation as versatile strategies in combinatorial chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fruchtel, Jorg Steffen; Pflugseder, Karin; Gstach, Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biotechnology and Bioengineering (2001), 71(2), 94-103

$RFMT $RIREG SCHEME143 STEP1
$RXN



  3  1
$MOL
tert-Butoxybis(dimethylamino)methane
C9H22N2O
5815-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 O 2.6675 1.5400 0.0 0
M  V30 3 N 4.0012 3.8501 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 C 1.3338 2.3101 0.0 0
M  V30 6 C 5.3348 4.6201 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 6.6687 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 0.5638 0.9764 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 2.1038 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Fluorospiro[2H-1-benzopyran-2,1′-cyclohexan]-3(4H)-one
C14H15FO2
1190962-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 6.6687 0.0 0
M  V30 2 F 3.0801 0.0000 0.0 0
M  V30 3 C 5.3901 4.0012 0.0 0
M  V30 4 O 4.6201 2.6675 0.0 0
M  V30 5 C 4.6201 5.3348 0.0 0
M  V30 6 C 6.1601 5.3348 0.0 0
M  V30 7 C 6.1601 2.6675 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 3.0801 5.3348 0.0 0
M  V30 10 C 7.7002 5.3348 0.0 0
M  V30 11 C 7.7002 2.6675 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 C 2.3101 1.3338 0.0 0
M  V30 14 C 8.4702 4.0012 0.0 0
M  V30 15 C 0.7700 4.0012 0.0 0
M  V30 16 C 0.7700 1.3338 0.0 0
M  V30 17 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 12
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluorospiro[5H-[1]benzopyrano[3,4-d]pyrimidine-5,1′-cyclohexan]-3-amine
C16H16FN3O
1190961-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 3.0801 0.0 0
M  V30 2 F 0.0000 5.3901 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0
M  V30 4 C 5.3348 3.8501 0.0 0
M  V30 5 O 2.6675 3.8501 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 N 6.6685 3.0801 0.0 0
M  V30 10 C 2.6675 5.3901 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 C 4.0012 6.1601 0.0 0
M  V30 14 C 6.6685 6.1601 0.0 0
M  V30 15 C 8.0023 3.8501 0.0 0
M  V30 16 C 1.3337 6.1601 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 4.0012 7.7002 0.0 0
M  V30 19 N 8.0023 5.3901 0.0 0
M  V30 20 C 1.3337 7.7002 0.0 0
M  V30 21 C 2.6675 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 13
M  V30 16 2 10 16
M  V30 17 1 11 17
M  V30 18 1 12 17
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 2 15 19
M  V30 22 1 16 20
M  V30 23 1 18 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5815-08-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190962-30-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190961-50-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2057315
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-23-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 7-Fluorospiro[chromeno[3,4-d]pyrimidine-5,1'-cyclohexan]-3-amine (37) A
solution of 8-fluorospiro[chromene-2,1'-cyclohexan]-3(4H)-one (40) (1.84
g, 7.85 mmol) in tert-butoxy-bis(dimethylamino)methane (3.57 ml, 17.3
mmol) was heated at reflux for 40 min. After brief cooling, n-propanol
(35 mL), guanidine hydrochloride (4.50 g, 47.1 mmol), and sodium
methoxide in MeOH (4.37 M) (5.39 ml, 23.6 mmol) were added sequentially.
The resulting mixture was stirred at 75 °C overnight. Upon workup, the
mixture was poured into ice and saturated NaHCO3 aqueous solution and
extracted with EtOAc (2 X). The combined organics were washed with brine
(2 X), dried over Na2SO4, and concentrated in vacuo to give the crude
7-fluorospiro[chromeno[3,4-d]pyrimidine-5,1'-cyclohexan]-3-amine (37)
(2.15 g, 95.9% yield).
7-Fluorospiro[chromeno[3,4-d]pyrimidine-5,1'-cyclohexan]-3-amine (37),
yield 2.15 g, 95.9% 1H NMR (500 MHz, DMSO-d6) δ ppm 8.78 (1 H, s), 7.59
(1 H, d, J=7.8 Hz), 7.07 - 7.14 (1 H, m), 6.94 - 7.03 (3 H, m), 1.56 -
1.89 (9 H, m), 1.20 - 1.33 (1 H, m). LCMS-ESI (POS), M/Z, M+1: Found
286.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell
cycle inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Connors, Richard V.; Dai, Kang; Eksterowicz, John; Fan, Pingchen; Fisher,
Benjamin; Fu, Jiasheng; Li, Kexue; Li, Zhihong; McGee, Lawrence R.;
Sharma, Rajiv; Wang, Xiaodong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009126584 A1 2009-10-15

$RFMT $RIREG SCHEME144 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(3,4-dimethoxyphenyl)-5H-indeno[1,2-d]pyrimidin-5-one
C19H15N3O3
1631962-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6403 4.0176 0.0 0
M  V30 2 N 4.6200 10.6695 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 O 2.3100 1.3337 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 6.9301 6.6684 0.0 0
M  V30 8 C 7.7001 8.0022 0.0 0
M  V30 9 C 5.3901 6.6684 0.0 0
M  V30 10 C 7.9605 5.5240 0.0 0
M  V30 11 C 9.2064 7.6819 0.0 0
M  V30 12 N 6.9301 9.3359 0.0 0
M  V30 13 N 4.6200 8.0022 0.0 0
M  V30 14 C 9.3674 6.1504 0.0 0
M  V30 15 C 10.4522 8.5871 0.0 0
M  V30 16 C 5.3901 9.3359 0.0 0
M  V30 17 C 10.7743 5.5240 0.0 0
M  V30 18 C 11.8592 7.9608 0.0 0
M  V30 19 C 12.0201 6.4293 0.0 0
M  V30 20 C 4.6200 5.3348 0.0 0
M  V30 21 C 3.0800 5.3348 0.0 0
M  V30 22 C 5.3901 4.0011 0.0 0
M  V30 23 C 2.3100 4.0011 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 3.0800 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 1 3 23
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1631962-11-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24126745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-23-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 20667-12-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, catalyst prepared and used,
Michael addition, zirconium oxide (ZrO2) supported catalyst used,
catalyst can be recycled and reused
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ag2O on ZrO2 as a recyclable catalyst for multicomponent synthesis of
indenopyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhaskaruni, Sandeep V. H. S.; Maddila, Suresh; van Zyl, Werner E.;
Jonnalagadda, Sreekantha B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2018), 23(7), 1648/1-1648/14

$RFMT $RIREG SCHEME145 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzaldehyde
C8H8O2
135-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(2-methoxyphenyl)-5H-indeno[1,2-d]pyrimidin-5-one
C18H13N3O2
713514-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.8703 6.6519 0.0 0
M  V30 2 N 3.8500 0.0000 0.0 0
M  V30 3 O 1.5400 4.0011 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 7.1904 5.1455 0.0 0
M  V30 9 C 8.4363 2.9876 0.0 0
M  V30 10 N 6.1600 1.3336 0.0 0
M  V30 11 N 3.8500 2.6674 0.0 0
M  V30 12 C 8.5974 4.5191 0.0 0
M  V30 13 C 9.6822 2.0824 0.0 0
M  V30 14 C 4.6200 1.3336 0.0 0
M  V30 15 C 10.0042 5.1455 0.0 0
M  V30 16 C 11.0891 2.7087 0.0 0
M  V30 17 C 11.2500 4.2404 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 4.6200 6.6685 0.0 0
M  V30 21 C 1.5400 6.6685 0.0 0
M  V30 22 C 3.8500 8.0022 0.0 0
M  V30 23 C 2.3100 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 18
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 2 11 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 135-02-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 713514-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24126746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-23-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 20667-12-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, catalyst prepared and used,
optimization study, optimized on stiochiometric amount of catalyst,
solvent and time, Michael addition, zirconium oxide (ZrO2) supported
catalyst used, catalyst can be recycled and reused
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ag2O on ZrO2 as a recyclable catalyst for multicomponent synthesis of
indenopyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhaskaruni, Sandeep V. H. S.; Maddila, Suresh; van Zyl, Werner E.;
Jonnalagadda, Sreekantha B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2018), 23(7), 1648/1-1648/14

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanedioic acid, 2-(2-propyn-1-yl)-, 1,3-diethyl ester
C10H14O4
17920-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 O 6.9300 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 O 2.3100 5.3347 0.0 0
M  V30 8 O 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 7.7000 6.6685 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 3 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-hydroxy-5-(2-propyn-1-yl)-4(3H)-pyrimidinone
C7H7N3O2
81887-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 N 1.3337 2.3100 0.0 0
M  V30 11 N 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 3 2 3
M  V30 4 2 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17920-23-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 81887-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3834931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Amino-5-(prop-2-yn-1-yl)pyrimidine-4,6-diol (A6). It was obtained as a
white solid; yield: 33.47 g (96 %). m.p. >250 °C; 1H NMR (DMSO-d6): δ =
10.55 (2H, bs, 2 × OH), 6.79 (2H, bs, NH2), 2.95 (2H, d, J(1,3') = 2.6,
H-1'), 2.43 (1H, t, J(3',1') = 2.6, H-3'); 13C NMR (DMSO-d6): δ = 163.69
(C-4 and 6), 152.69 (C-2), 89.05 (C-2'), 84.97 (C-5), 68.02 (C-3'), 12.06
(C-1'); Anal. Calcd. for C7H7N3O2 + 0.5H2O: C, 48.28; H, 4.63; N, 24.13.
Found: C, 48.09; H, 4.33; N, 24.23.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of ethanol in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5-Substituted 2-amino-4,6-dihydroxypyrimidines and
2-amino-4,6-dichloropyrimidines. Synthesis and inhibitory effects on
immune-activated nitric oxide production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jansa, Petr; Holy, Antonin; Dracinsky, Martin; Kolman, Viktor; Janeba,
Zlatko; Kostecka, Petra; Kmonickova, Eva; Zidek, Zdenek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Medicinal Chemistry Research (2014), 23(10), 4482-4490

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanedioic acid, 2-(2-propyn-1-yl)-, 1,3-diethyl ester
C10H14O4
17920-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 O 6.9300 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 O 2.3100 5.3347 0.0 0
M  V30 8 O 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 7.7000 6.6685 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 3 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-hydroxy-5-(2-propyn-1-yl)-4(3H)-pyrimidinone
C7H7N3O2
81887-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 N 1.3337 2.3100 0.0 0
M  V30 11 N 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 3 2 3
M  V30 4 2 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17920-23-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 81887-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3861698
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-23-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 1: Preparation of 5-substituted
2-amino-4,6-dihydroxypyrimidines In 300 ml of absolute ethanol, 12.9 g
(0.56 mol) of metallic podium were dissolved under inert gas (argon)
while being intensively mixed with a shaft stirrer. The reaction vessel
was equipped with a condensation cooler with a chlorocalcium stopper in
order to prevent the pressure of the reaction mixture from increasing
because of the massive generation of hydrogen and fast heating of the
solvent, which shifts even to boiling. After all the sodium was dissolved
and the reaction mixture was cooled to room temperature, 21.02 g (0.22
mol) of guanidine hydrochloride were added under intensive stirring,
followed by 0.2 mol of the respective monosubstituted malonic acid
diester (e.g. 43.26 g of diethyl butylammonate. The reaction mixture was
further intensively stirred due to the production of the solid product,
which is so massive that after 2 hours it already practically precludes
stirring. After another 2 hours, 200 ml of absolute ethanol were added
and the reaction mixture was heated to the boiling point for one hour
while being stirred. Afterward, ca 200-300 ml of ethanol were evaporated
on a vacuum rotary evaporator and 500 ml of water were added to the
reaction mixture. After stirring, the product (in the form of sodium
salt) was partially dissolved. This suspensions was subsequently
neutralized by by adding ethanoic acid dropwise, causing an immediate
separation of the desired product in the form of a sediment. This was
subsequently refluxed for 10 minutes and then cooled to laboratory
temperature. This refluxing and cooling was repeated twice more, with the
yield being a well-filterable solid product. Having been drained and
rinsed with 2×50 ml of water, 2×50 ml of ethanol and 2×50 ml of acetone,
the product was dried in a vacuum drier at 60° C. and under 0.1 mbar for
2 days. The obtained purity of the product prepared in this manner is
sufficient for the following reaction and based on analyses contains only
crystalline water. 2-amino-4,6-dihydroxy-5-methyl-pyrimidine (1)
2-amino-4,6-dihydroxy-5-(prop-2-yn-1-yl)pyrimidine (6) Yield: 33.47 g
(96% of the theor. yield). m.p. &gt;250° C. 1H NMR (DMSO-d6): 10.55 bs,
2H, (2×OH); 6.79 bs, 2H, (NH2); 2.95 d, 2H, J(1,3′)=2.6 (H-1′); 2.43 t,
1H, J(3′,1′)=2.6 (H-3′). 13C NMR (DMSO-d6): 163.69 (C-4 and 6); 152.69
(C-2); 89.05 (C-2′); 84.97 (C-5); 68.02 (C-3′); 12.06 (C-1′). For
C7H7N3O2+0.5 H2O: calculated: 48.28% C, 4.63% H, 24.13% N. found: 48.09%
C, 4.33% H, 24.23% N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine compounds inhibiting the formation of nitric
oxide and prostaglandin E2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jansa, Petr; Holy, Antonin; Zidek, Zdenek; Kmonickova, Eva; Janeba,
Zlatko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012116666 A1 2012-09-07

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorobenzylidene)malononitrile
C10H5ClN2
1867-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 C 6.1600 1.3338 0.0 0
M  V30 5 N 10.0100 2.6674 0.0 0
M  V30 6 N 5.3900 0.0000 0.0 0
M  V30 7 Cl 0.0000 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 3 3 5
M  V30 6 3 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1867-38-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27611901
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1309-48-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of
Pyrimidine and Pyrimidinone Derivatives A mixture of the aldehyde (2
mmol), amidines hydrochloride (2 mmol), malononitrile or ethyl
cyanoacetate (2 mmol), and MgO (0.25 g) in CH3CN (5 mL) was refluxed with
stirring for the time reported in Table 1. The progress of the reaction
was monitored by thin-layer chromatography (TLC), and hexane/ethyl
acetate was used as an eluent). After completion of the reaction, the
catalyst was separated from the reaction mixture by centrifugation. The
excess acetonitrile was removed by evaporation and then was poured into
ice-cold water; the crude product was filtered, dried, and recrystallized
from 96% ethanol. 4i, yield 97%.
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Three-component synthesis of pyrimidine and pyrimidinone derivatives in
the presence of high-surface-area MgO, a highly effective heterogeneous
base catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheibani, Hassan; Seifi, Mohammad; Bazgir, Ayoob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(6), 1055-1064

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorobenzylidene)malononitrile
C10H5ClN2
1867-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 C 6.1600 1.3338 0.0 0
M  V30 5 N 10.0100 2.6674 0.0 0
M  V30 6 N 5.3900 0.0000 0.0 0
M  V30 7 Cl 0.0000 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 3 3 5
M  V30 6 3 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
99973-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1867-38-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99973-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27851953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 10035-06-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the preparation of
pyrimidine and pyrimidinone derivatives A mixture of the aldehyde (2
mmol), amidines hydrochloride (2 mmol), malononitrile or ethyl
cyanoacetate (2 mmol), Bi(NO3)3•5H2O (5 mol%) and a catalytic amount of
Et3N in CH3CN (5 mL) was refluxed with stirring for the times reported in
Table 1. The progress of the reaction was monitored by thin-layer
chromatography (TLC), and hexane/ethyl acetate was used as an eluent.
After completion of the reaction, the catalyst was separated from the
reaction mixture by centrifugation. The excess acetonitrile was removed
by evaporation and then was poured into icecold water; the crude product
was filtered, dried, and recrystallized from 96 % ethanol.
6-Oxo-2,4-diphenyl-1,6-dihydro-5-pyrimidinecarbonitrile (5a) Compound:
4i. Yield: 94%.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, recyclable catalyst, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapid three-component synthesis of pyrimidine and pyrimidinone
derivatives in the presence of Bi(NO3)3.5H2O as a mild and highly
efficient catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zahedifar, Moahboobeh; Sheibani, Hassan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2015), 41(1), 105-111

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,4-Dichloro-7-isoquinolinyl)benzonitrile
C16H8Cl2N2
223671-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.3337 6.1601 0.0 0
M  V30 2 Cl 1.3337 0.0000 0.0 0
M  V30 3 C 10.6695 3.8500 0.0 0
M  V30 4 N 12.0032 3.0800 0.0 0
M  V30 5 C 2.6673 3.8500 0.0 0
M  V30 6 C 2.6673 2.3100 0.0 0
M  V30 7 C 4.0011 4.6201 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 N 0.0000 3.8500 0.0 0
M  V30 13 C 5.3348 2.3100 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 6.6684 4.6201 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 6.6684 6.1601 0.0 0
M  V30 18 C 9.3359 4.6201 0.0 0
M  V30 19 C 8.0021 6.9301 0.0 0
M  V30 20 C 9.3359 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 3 3 4
M  V30 4 1 3 18
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Chloro-7-(3-cyanophenyl)-1-isoquinolinyl]guanidine
C17H12ClN5
223670-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 6.1601 0.0 0
M  V30 2 C 1.3337 6.9302 0.0 0
M  V30 3 N 1.3337 8.4702 0.0 0
M  V30 4 N 0.0000 6.1601 0.0 0
M  V30 5 Cl 2.6673 0.0000 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 N 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 N 1.3337 3.8501 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3360 3.8501 0.0 0
M  V30 20 C 8.0022 6.1601 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 9.3360 6.9302 0.0 0
M  V30 23 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 3 6 7
M  V30 7 1 6 21
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 17
M  V30 18 1 15 16
M  V30 19 1 15 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 223671-44-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 223670-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13109587
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (4-Chloro-7-(3-cyanophenyl)isoquinolin-1-yl)quanidine (VIII) (i) A
stirred suspension of guanidine hydrochloride (3.8 kg, 39.8 mol) and
KOtBu (4.28 kg, 38.1 mol) in DME (17.6 L) was heated to reflux under N2
for 1 hour. The gum containing solution was cooled to room temperature,
diluted with NMP (8.8 L) and 1,4-dichloro-7-(3-cyanophenyl)isoquinoline
(4.4 kg, 14.7 mol) was added as a solid. The mixture was heated at reflux
overnight, cooled to room temperature, filtered through a pad of celite
and the pad washed with DME (4.4 L). Water (35.2 L) was added to the
filtrate. The resultant slurry was stirred for 2 hour and the solid
collected by filtration. The solid was washed with water (4.4 L) and
dried in vacuo at 50°C to give
(4-chloro-7-(3-cyanophenyl)isoquinolin-1-yl)guanidine (4.55 kg, 14.1 mol,
96%) as a green solid
(4-Chloro-7-(3-cyanophenyl)isoquinolin-1-yl)quanidine, Yield (4.55 kg,
14.1 mol, 96%) Mp >300°C 1H (DMSO-d6, 300MHz) δ 8.97 (1H, d), 8.19 (1H,
t) 8.13 (1H, dd), 8.08 (1H, d), 8.00 (1H, s), 7.95 (1H, d), 7.86 (1H,
br.d), 7.72 (1H, t) ppm.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative prepn. gave lower yields
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine for
pharmaceutical use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bruckner, Anne; Butters, Michael; Fish, Paul Vincent; Fitzgerald, Michael
Paul; Macrae, Julie Ann; Newbury, Trevor Jack; Storey, Richard Anthony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002036571 A1 2002-05-10

$RFMT $RIREG SCHEME149 STEP1
$RXN



  3  1
$MOL
Dimethylformamide
C3H7NO
68-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dihydro-3,9,10,11-tetramethoxy-5H-dibenzo[a,c]cyclohepten-5-one
C19H20O5
226221-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6686 6.9505 0.0 0
M  V30 2 C 6.6686 8.4905 0.0 0
M  V30 3 O 4.0012 8.4905 0.0 0
M  V30 4 C 2.6675 9.2605 0.0 0
M  V30 5 O 7.1248 0.0000 0.0 0
M  V30 6 O 1.3338 6.9505 0.0 0
M  V30 7 C 0.0000 6.1804 0.0 0
M  V30 8 O 11.2727 3.0497 0.0 0
M  V30 9 C 12.3202 4.1786 0.0 0
M  V30 10 C 5.3348 4.6404 0.0 0
M  V30 11 C 6.7684 4.0777 0.0 0
M  V30 12 C 5.3348 6.1804 0.0 0
M  V30 13 C 4.0012 3.8704 0.0 0
M  V30 14 C 7.2224 2.6062 0.0 0
M  V30 15 C 7.8160 5.2067 0.0 0
M  V30 16 C 4.0012 6.9505 0.0 0
M  V30 17 C 2.6675 4.6404 0.0 0
M  V30 18 C 3.7717 2.3476 0.0 0
M  V30 19 C 8.7238 2.2635 0.0 0
M  V30 20 C 6.3548 1.3337 0.0 0
M  V30 21 C 9.3173 4.8640 0.0 0
M  V30 22 C 2.6675 6.1804 0.0 0
M  V30 23 C 4.8191 1.2186 0.0 0
M  V30 24 C 9.7713 3.3924 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 2 5 20
M  V30 6 1 6 7
M  V30 7 1 6 22
M  V30 8 1 8 9
M  V30 9 1 8 24
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 13 18
M  V30 18 2 14 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 2 16 22
M  V30 22 1 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 23
M  V30 26 2 21 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,11,12,13-Tetramethoxy-9H-dibenzo[4,5:6,7]cyclohepta[1,2-d]pyrimidin-6-amine
C21H21N3O4
568598-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 3.5085 0.0 0
M  V30 2 C 2.6673 2.7385 0.0 0
M  V30 3 O 1.3337 5.0485 0.0 0
M  V30 4 C 0.0000 5.8185 0.0 0
M  V30 5 O 1.3337 8.1286 0.0 0
M  V30 6 C 1.3337 9.6686 0.0 0
M  V30 7 O 9.6812 1.4717 0.0 0
M  V30 8 C 9.2274 0.0000 0.0 0
M  V30 9 N 12.6473 7.6308 0.0 0
M  V30 10 C 5.3348 5.8185 0.0 0
M  V30 11 C 6.5388 4.8583 0.0 0
M  V30 12 C 5.3348 7.3586 0.0 0
M  V30 13 C 4.0010 5.0485 0.0 0
M  V30 14 C 8.0402 5.2010 0.0 0
M  V30 15 C 6.0848 3.3867 0.0 0
M  V30 16 C 6.5388 8.3188 0.0 0
M  V30 17 C 4.0010 8.1286 0.0 0
M  V30 18 C 2.6673 5.8185 0.0 0
M  V30 19 C 8.7084 6.5885 0.0 0
M  V30 20 C 9.0877 4.0721 0.0 0
M  V30 21 C 7.1323 2.2578 0.0 0
M  V30 22 C 8.0402 7.9761 0.0 0
M  V30 23 C 2.6673 7.3586 0.0 0
M  V30 24 N 10.2441 6.4735 0.0 0
M  V30 25 C 8.6337 2.6005 0.0 0
M  V30 26 C 8.9077 9.2485 0.0 0
M  V30 27 C 11.1116 7.7459 0.0 0
M  V30 28 N 10.4434 9.1334 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 5 6
M  V30 6 1 5 23
M  V30 7 1 7 8
M  V30 8 1 7 25
M  V30 9 1 9 27
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 2 14 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 17 23
M  V30 23 2 18 23
M  V30 24 1 19 22
M  V30 25 2 19 24
M  V30 26 1 20 25
M  V30 27 2 21 25
M  V30 28 2 22 26
M  V30 29 1 24 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 226221-77-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 568598-03-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15437945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 5815-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7440-23-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel B-ring modified allocolchicinoids of the NCME series: design,
synthesis, antimicrotubule activity and cytotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bergemann, Silke; Brecht, Rene; Buttner, Frank; Guenard, Daniel; Gust,
Ronald; Seitz, Gunther; Stubbs, Milton T.; Thoret, Sylviane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2003), 11(7), 1269-1281

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenoic acid, 2-cyano-3-(4-methoxyphenyl)-, ethyl ester
C13H13NO3
2286-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 C 8.0022 3.8501 0.0 0
M  V30 5 O 10.6697 2.3101 0.0 0
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 N 8.0022 5.3901 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 13.3370 2.3101 0.0 0
M  V30 10 O 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0010 1.5400 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 3 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1,6-dihydro-4-(4-methoxyphenyl)-6-oxo-5-pyrimidinecarbonitrile
C12H10N4O2
273940-80-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 O 9.3358 6.9300 0.0 0
M  V30 6 C 10.6694 6.1600 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6673 4.6200 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 13 C 5.3347 4.6200 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 2 3 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2286-29-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 273940-80-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10237088
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrogen bridgehead compounds, facile synthesis of bioactive
cyanopyrimido[1,2-a]pyrimidinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abdel-Megid, Mohamed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmazie (2000), 55(4), 263-268

$RFMT $RIREG SCHEME151 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-3-(1H-Imidazol-1-yl)-1-(4-methoxyphenyl)-3-phenyl-2-propen-1-one
C19H16N2O2
2674106-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.9098 0.0 0
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 O 6.6685 2.3698 0.0 0
M  V30 5 O 12.0033 6.9899 0.0 0
M  V30 6 C 13.3370 6.2199 0.0 0
M  V30 7 N 4.0010 2.3698 0.0 0
M  V30 8 C 2.7551 1.4646 0.0 0
M  V30 9 C 5.2470 1.4646 0.0 0
M  V30 10 C 3.2310 0.0000 0.0 0
M  V30 11 N 4.7710 0.0000 0.0 0
M  V30 12 C 2.6673 4.6799 0.0 0
M  V30 13 C 2.6673 6.2199 0.0 0
M  V30 14 C 1.3337 3.9098 0.0 0
M  V30 15 C 1.3337 6.9899 0.0 0
M  V30 16 C 0.0000 4.6799 0.0 0
M  V30 17 C 0.0000 6.2199 0.0 0
M  V30 18 C 8.0022 4.6799 0.0 0
M  V30 19 C 9.3360 3.9098 0.0 0
M  V30 20 C 8.0022 6.2199 0.0 0
M  V30 21 C 10.6697 4.6799 0.0 0
M  V30 22 C 9.3360 6.9899 0.0 0
M  V30 23 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 1 3 18
M  V30 7 1 5 6
M  V30 8 1 5 23
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(1H-Imidazol-1-yl)-1-(4-methoxyphenyl)-3-phenyl-2-propen-1-one
C19H16N2O2
2674106-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 4.6201 0.0 0
M  V30 2 C 5.1048 5.3901 0.0 0
M  V30 3 C 6.4384 4.6201 0.0 0
M  V30 4 O 6.4384 3.0801 0.0 0
M  V30 5 O 11.7733 7.7002 0.0 0
M  V30 6 C 13.1069 6.9302 0.0 0
M  V30 7 N 2.4373 5.3901 0.0 0
M  V30 8 C 1.0304 4.7638 0.0 0
M  V30 9 C 2.2763 6.9217 0.0 0
M  V30 10 C 0.0000 5.9082 0.0 0
M  V30 11 N 0.7700 7.2419 0.0 0
M  V30 12 C 3.7711 3.0801 0.0 0
M  V30 13 C 5.1048 2.3101 0.0 0
M  V30 14 C 2.4373 2.3101 0.0 0
M  V30 15 C 5.1048 0.7700 0.0 0
M  V30 16 C 2.4373 0.7700 0.0 0
M  V30 17 C 3.7711 0.0000 0.0 0
M  V30 18 C 7.7721 5.3901 0.0 0
M  V30 19 C 9.1059 4.6201 0.0 0
M  V30 20 C 7.7721 6.9302 0.0 0
M  V30 21 C 10.4396 5.3901 0.0 0
M  V30 22 C 9.1059 7.7002 0.0 0
M  V30 23 C 10.4396 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 1 3 18
M  V30 7 1 5 6
M  V30 8 1 5 23
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenyl)-6-phenyl-2-pyrimidinamine
C17H15N3O
59807-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 O 12.0033 6.9302 0.0 0
M  V30 3 C 13.3370 6.1601 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 N 6.6685 2.3101 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 N 4.0010 2.3101 0.0 0
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 C 9.3360 3.8501 0.0 0
M  V30 12 C 8.0022 6.1601 0.0 0
M  V30 13 C 10.6697 4.6201 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 C 10.6697 6.1601 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 1.3337 6.9302 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 21 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2674106-65-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2674106-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59807-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24003027
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal-free cascade synthesis of unsymmetrical 2-aminopyrimidines from
imidazolate enaminones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cui, Xue; Ma, Jianting; Zeng, Tingting; Xu, Junyu; Li, Youbin; Wang,
Xuesong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2021), 11(39), 24247-24253

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Cyclopropylmethyl)-6,7-dimethoxy-α-[(phenylamino)methylene]-4-benzofuranpr...
C24H24N2O3
394736-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.8281 2.3100 0.0 0
M  V30 2 C 2.8281 0.7700 0.0 0
M  V30 3 C 8.1628 5.3900 0.0 0
M  V30 4 C 9.4964 4.6200 0.0 0
M  V30 5 C 10.8301 5.3900 0.0 0
M  V30 6 C 9.4964 3.0800 0.0 0
M  V30 7 N 12.1638 4.6200 0.0 0
M  V30 8 N 9.4964 1.5400 0.0 0
M  V30 9 O 5.4953 0.7700 0.0 0
M  V30 10 C 6.8291 0.0000 0.0 0
M  V30 11 C 2.8736 8.3912 0.0 0
M  V30 12 C 4.1617 4.6200 0.0 0
M  V30 13 C 5.4953 5.3900 0.0 0
M  V30 14 C 4.1617 3.0800 0.0 0
M  V30 15 O 3.0173 5.6506 0.0 0
M  V30 16 C 6.8291 4.6200 0.0 0
M  V30 17 C 5.1752 6.8964 0.0 0
M  V30 18 C 5.4953 2.3100 0.0 0
M  V30 19 C 3.6436 7.0574 0.0 0
M  V30 20 C 6.8291 3.0800 0.0 0
M  V30 21 C 1.3336 8.3912 0.0 0
M  V30 22 C 0.0000 9.1612 0.0 0
M  V30 23 C 0.0000 7.6212 0.0 0
M  V30 24 C 13.4975 5.3900 0.0 0
M  V30 25 C 14.8311 4.6200 0.0 0
M  V30 26 C 13.4975 6.9300 0.0 0
M  V30 27 C 16.1648 5.3900 0.0 0
M  V30 28 C 14.8311 7.7000 0.0 0
M  V30 29 C 16.1648 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 2 4 5 CFG=2
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 3 6 8
M  V30 9 1 7 24
M  V30 10 1 9 10
M  V30 11 1 9 18
M  V30 12 1 11 19
M  V30 13 1 11 21
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[2-(Cyclopropylmethyl)-6,7-dimethoxy-4-benzofuranyl]methyl]-2,4-pyrimidine...
C19H22N4O3
394735-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0
M  V30 2 O 9.2400 1.3336 0.0 0
M  V30 3 C 8.4700 0.0000 0.0 0
M  V30 4 C 12.2410 6.6228 0.0 0
M  V30 5 O 6.1600 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 N 4.6200 9.3358 0.0 0
M  V30 8 N 0.0000 6.6684 0.0 0
M  V30 9 C 8.4700 5.3347 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 9.5006 6.4792 0.0 0
M  V30 13 C 8.4700 2.6674 0.0 0
M  V30 14 O 10.7464 4.3212 0.0 0
M  V30 15 C 6.1600 4.0011 0.0 0
M  V30 16 C 10.9074 5.8528 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 4.6200 6.6684 0.0 0
M  V30 19 C 3.8500 8.0021 0.0 0
M  V30 20 C 3.8500 5.3347 0.0 0
M  V30 21 N 2.3100 8.0021 0.0 0
M  V30 22 N 2.3100 5.3347 0.0 0
M  V30 23 C 1.5400 6.6684 0.0 0
M  V30 24 C 13.5748 5.8528 0.0 0
M  V30 25 C 14.3448 4.5191 0.0 0
M  V30 26 C 15.1148 5.8528 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 4 16
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 5 17
M  V30 9 1 7 19
M  V30 10 1 8 23
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 2 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394736-31-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 394735-83-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27521627
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure J: Cyclisation with
guanidine Under argon, to a solution of guanidine hydrochloride (3 eq.)
in potassium tert-butoxide (3 eq.) were added and stirred for 15 min. The
fine precipitate was filtrated through celite under argon and the
filtrate was added to a solution of compound XVII (1 eq.) in ethanol. The
reaction mixture was stirred under reflux conditions for 8h. After
cooling the reaction to r.t and then to -20°C compound I precipitated.
5-(6,7-Dimethoxy-2-cyclopropylmethybenzofuran-4-y)-pyrimidine-2,4-diamine
(1.16 g, 96%) was obtained as a white-yellow precipitate by reacting
guanidine hydrochloride (1.37 g, 14.44 mmol), potassium tert-butoxide
(1.62 g, 14.44 mmol) and 3-
anilino-2-(6,7-dimethoxy-2-cyclopropylmethybenzofuran-4-y)acrylonitrile
(1.87 g, 4.81 mmol). MNR CD3OD 500 MHz δ in ppm J in Hz: 6.95-7.35 (m,
1H, Ar), 6.78 (s, 1H, Ar) 6.44 (s, 1H, Ar), 4.03 (s, 3H, OMe), 3.85 (s,
3H, OMe), 3.81 (s, 2H, CH2), 2.66 (d, 2H, J = 6.8), 1.14- 1.04 (m, 1H),
0.59-0.54 (m, 2H), 0.28-0.25 (m, 2H). MS ISP: 397 (M+Na, 25%), 355 (M+H,
100%). HPLC purity RP C18 Dicovery: 98%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzofuran-containing 2,4-diamino-5-substituted-pyrimidine derivatives
and their preparation and use as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burri, Kaspar; Greiveldinger-Poenaru, Sorana; Islam, Khalid
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002010156 A1 2002-02-07

$RFMT $RIREG SCHEME153 STEP1
$RXN



  3  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzaldehyde
C7H5ClO
587-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(3-chlorophenyl)-5H-indeno[1,2-d]pyrimidin-5-one
C17H10ClN3O
1631962-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6253 7.2708 0.0 0
M  V30 2 N 4.9150 0.0000 0.0 0
M  V30 3 Cl 11.5835 3.8501 0.0 0
M  V30 4 C 4.9150 4.6201 0.0 0
M  V30 5 C 3.5812 3.8501 0.0 0
M  V30 6 C 6.2487 3.8501 0.0 0
M  V30 7 C 4.5948 6.1264 0.0 0
M  V30 8 C 2.4368 4.8805 0.0 0
M  V30 9 N 3.5812 2.3101 0.0 0
M  V30 10 N 6.2487 2.3101 0.0 0
M  V30 11 C 3.0631 6.2873 0.0 0
M  V30 12 C 0.9052 4.7196 0.0 0
M  V30 13 C 4.9150 1.5400 0.0 0
M  V30 14 C 2.1580 7.5332 0.0 0
M  V30 15 C 0.0000 5.9655 0.0 0
M  V30 16 C 0.6263 7.3723 0.0 0
M  V30 17 C 7.5824 4.6201 0.0 0
M  V30 18 C 8.9162 3.8501 0.0 0
M  V30 19 C 7.5824 6.1601 0.0 0
M  V30 20 C 10.2498 4.6201 0.0 0
M  V30 21 C 8.9162 6.9302 0.0 0
M  V30 22 C 10.2498 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 13
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 17
M  V30 11 1 7 11
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 2 10 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 587-04-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1631962-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25990112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 697740-91-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, Knoevenagel condensation followed by Michael addition,
cyclization, isomerization and then aromatization, catalyst prepared and
used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of supra molecular self-assembled Nickel(II)
coordination complex in synthesis of indeno-pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gangu, Kranthi Kumar; Maddila, Suresh; Mukkamala, Saratchandra Babu;
Jonnalagadda, Sreekantha B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2019), 158464-470

$RFMT $RIREG SCHEME153 STEP1
$RXN



  3  1
$MOL
3-Chlorobenzaldehyde
C7H5ClO
587-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(3-chlorophenyl)-5H-indeno[1,2-d]pyrimidin-5-one
C17H10ClN3O
1631962-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6253 7.2708 0.0 0
M  V30 2 N 4.9150 0.0000 0.0 0
M  V30 3 Cl 11.5835 3.8501 0.0 0
M  V30 4 C 4.9150 4.6201 0.0 0
M  V30 5 C 3.5812 3.8501 0.0 0
M  V30 6 C 6.2487 3.8501 0.0 0
M  V30 7 C 4.5948 6.1264 0.0 0
M  V30 8 C 2.4368 4.8805 0.0 0
M  V30 9 N 3.5812 2.3101 0.0 0
M  V30 10 N 6.2487 2.3101 0.0 0
M  V30 11 C 3.0631 6.2873 0.0 0
M  V30 12 C 0.9052 4.7196 0.0 0
M  V30 13 C 4.9150 1.5400 0.0 0
M  V30 14 C 2.1580 7.5332 0.0 0
M  V30 15 C 0.0000 5.9655 0.0 0
M  V30 16 C 0.6263 7.3723 0.0 0
M  V30 17 C 7.5824 4.6201 0.0 0
M  V30 18 C 8.9162 3.8501 0.0 0
M  V30 19 C 7.5824 6.1601 0.0 0
M  V30 20 C 10.2498 4.6201 0.0 0
M  V30 21 C 8.9162 6.9302 0.0 0
M  V30 22 C 10.2498 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 13
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 17
M  V30 11 1 7 11
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 2 10 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 587-04-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1631962-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3905273
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure: 1,3 indandione (3mmol) and
4-chloro benzaldehyde (3 mmol) in 5 ml ethanol were taken in 50ml round
bottom flask. To this 5ml of 4 % aqueous NaOH solution was added and
reaction was magnetically stirred at room temperature till completion of
Knoevenagel product, after which successive addition of guanidine
hydrochloride (4.5mmol) was carried and reaction mixture was subjected in
oil bath at reflux. Finally after completion of reaction the resultant
reaction mixture was poured on crushed ice and stirred continuously until
the desired 2-amino-4-(phenyl)-5-H-indeno [1,2-d] pyrimidine-5-one was
precipitated. The obtained product was isolated by simple filtration
followed by washing with cold water. The reaction progress of both
intermediate Knoevenagel and the final desired product were confirmed by
TLC monitoring and desired product was analyzed by spectroscopic
investigation.
2-Amino-4-(3-chlorophenyl)-5H-indeno[1,2-d]-pyrimidine-5-one (Table 2,
entry B). Orange solid; wt, 0.89 g. Mp, 240 °C (decompose). IR (KBr, ν
max, cm-1): 3302, 3175, 1639, 1506, 768, 728. H1 NMR (DMSO-d 6, 300 MHz,
δ): 6.87 (s, 1H, Ar-H), 7.05-7.09 (m, 1H, Ar-H), 7.12-7.20 (br. s,
2H,-NH2), 7.44-8.04 (m, 6H, Ar-H). 13C NMR (δ): 111.37, 117.22, 117.53,
121.27, 123.33, 128.42, 129.36, 129.51, 129.64, 130.63, 132.80, 133.32,
134.06, 136.77, 138.05, 140.12, 140.42, 158.68, 163.48, 165.41, 176.31,
187.70. ESI-MS m/z: 309.10, 311.00 (M+ + 1). Anal. Calcd for C17H10ClN3O:
C, 66.35%; H, 3.28%; N, 13.65%. Found: C, 66.48%; H, 3.36%; N, 13.69%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, green chemistry, Knoevenagel condensation in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Trouble-Free Multicomponent Method for Combinatorial Synthesis of
2-Amino-4-phenyl-5-H-indeno[1,2-d]pyrimidine-5-one and Their Screening
against Cancer Cell Lines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patravale, Ajinkya A.; Gore, Anil H.; Patil, Dipti R.; Kolekar, Govind
B.; Deshmukh, Madhukar B.; Anbhule, Prashant V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Industrial & Engineering Chemistry Research (2014), 53(42), 16568-16578

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-one, 3-(dimethylamino)-1-(3,4,5-trimethoxyphenyl)-, (E)-
C14H19NO4
67382-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 N 10.6697 4.6201 0.0 0
M  V30 6 C 12.0033 5.3901 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 O 4.0012 0.7700 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 1.3337 5.3901 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 O 1.3337 2.3101 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 4.0012 5.3901 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 2.6673 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4,5-Trimethoxyphenyl)-2-pyrimidinamine
C13H15N3O3
1783453-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 5.3901 0.0 0
M  V30 2 C 1.3337 6.9301 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 N 10.6695 4.6201 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 C 0.0000 3.0800 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 4.0011 5.3901 0.0 0
M  V30 10 C 5.3348 3.0800 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 2.6673 3.0800 0.0 0
M  V30 14 C 6.6684 5.3901 0.0 0
M  V30 15 N 8.0022 4.6201 0.0 0
M  V30 16 C 6.6684 6.9301 0.0 0
M  V30 17 C 9.3359 5.3901 0.0 0
M  V30 18 C 8.0022 7.7001 0.0 0
M  V30 19 N 9.3359 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67382-36-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1783453-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36399716
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of diaryl heterocyclic
derivatives targeting tubulin polymerization with potent anticancer
activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Gang; Wu, Jia-Qiang; Cai, Xiaojia; Guan, Wen; Zeng, Zhijun; Ou,
Yanghui; Wu, Xiaoyun; Li, Jiayu; Fang, Xiangxiang; Liu, Jinling; Zhang,
Yali; Wang, Huamin; Yin, Canqiang; Yao, Hongliang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 252115284

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylthio)phenylmethylene]-4-(1-propen-1-yl)-1H-indene-1,3(2H)-dione
C20H16O2S
713515-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.9521 3.0176 0.0 0
M  V30 2 C 9.9091 5.6684 0.0 0
M  V30 3 C 11.2428 6.4384 0.0 0
M  V30 4 C 12.5766 5.6684 0.0 0
M  V30 5 O 3.2573 5.7282 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 S 5.3900 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 7.2419 5.6684 0.0 0
M  V30 10 C 5.9081 6.4384 0.0 0
M  V30 11 C 6.9217 4.1620 0.0 0
M  V30 12 C 8.5755 6.4384 0.0 0
M  V30 13 C 4.7637 5.4079 0.0 0
M  V30 14 C 5.9081 7.9784 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 8.5755 7.9784 0.0 0
M  V30 17 C 7.2419 8.7484 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 1.3336 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 1.3336 0.0 0
M  V30 23 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 3 CFG=2
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 2 6 15 CFG=2
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-phenyl-6-(1-propen-1-yl)-5H-indeno[1,2-d]pyrimidin-5-one
C20H15N3O
713515-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2708 4.6245 0.0 0
M  V30 2 N 0.0000 5.3347 0.0 0
M  V30 3 C 8.9401 7.4653 0.0 0
M  V30 4 C 10.1861 8.3706 0.0 0
M  V30 5 C 11.5929 7.7441 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 3.8500 6.6684 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 6.1263 5.6549 0.0 0
M  V30 10 C 4.8804 7.8129 0.0 0
M  V30 11 N 2.3100 6.6684 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 6.2874 7.1864 0.0 0
M  V30 14 C 4.7195 9.3445 0.0 0
M  V30 15 C 1.5400 5.3347 0.0 0
M  V30 16 C 7.5333 8.0917 0.0 0
M  V30 17 C 5.9654 10.2497 0.0 0
M  V30 18 C 7.3723 9.6234 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 C 3.8500 1.3336 0.0 0
M  V30 21 C 6.1600 2.6674 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 23 C 6.9300 1.3336 0.0 0
M  V30 24 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 15
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 713515-53-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 713515-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12977394
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, other analogs also prepared
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylindenopyridines and arylindenopyrimidines as adenosine
A2a receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heintzelman, Geoffrey R.; Rupert, Kenneth C.; Bullington, James L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM South Africa, ZA2006003486 A 2009-02-25

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylthio)phenylmethylene]-4-(1-propen-1-yl)-1H-indene-1,3(2H)-dione
C20H16O2S
713515-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.9521 3.0176 0.0 0
M  V30 2 C 9.9091 5.6684 0.0 0
M  V30 3 C 11.2428 6.4384 0.0 0
M  V30 4 C 12.5766 5.6684 0.0 0
M  V30 5 O 3.2573 5.7282 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 S 5.3900 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 7.2419 5.6684 0.0 0
M  V30 10 C 5.9081 6.4384 0.0 0
M  V30 11 C 6.9217 4.1620 0.0 0
M  V30 12 C 8.5755 6.4384 0.0 0
M  V30 13 C 4.7637 5.4079 0.0 0
M  V30 14 C 5.9081 7.9784 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 8.5755 7.9784 0.0 0
M  V30 17 C 7.2419 8.7484 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 1.3336 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 1.3336 0.0 0
M  V30 23 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 3 CFG=2
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 2 6 15 CFG=2
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-phenyl-6-(1-propen-1-yl)-5H-indeno[1,2-d]pyrimidin-5-one
C20H15N3O
713515-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2708 4.6245 0.0 0
M  V30 2 N 0.0000 5.3347 0.0 0
M  V30 3 C 8.9401 7.4653 0.0 0
M  V30 4 C 10.1861 8.3706 0.0 0
M  V30 5 C 11.5929 7.7441 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 3.8500 6.6684 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 6.1263 5.6549 0.0 0
M  V30 10 C 4.8804 7.8129 0.0 0
M  V30 11 N 2.3100 6.6684 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 6.2874 7.1864 0.0 0
M  V30 14 C 4.7195 9.3445 0.0 0
M  V30 15 C 1.5400 5.3347 0.0 0
M  V30 16 C 7.5333 8.0917 0.0 0
M  V30 17 C 5.9654 10.2497 0.0 0
M  V30 18 C 7.3723 9.6234 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 C 3.8500 1.3336 0.0 0
M  V30 21 C 6.1600 2.6674 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 23 C 6.9300 1.3336 0.0 0
M  V30 24 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 15
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 713515-53-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 713515-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14690068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Solid guanidine hydrochloride (1.5 g, 15.3 mmol) was added to a solution
of the thioenol ether (4.9 g, 15.3 mmol) and K2CO3 (2.6 g, 19.1 mmol) in
30 mL of DMF and the solution was heated to 80°C. After 6 h at 80°C, the
solution was diluted with EtOAc and washed with water and brine. The
organic layer was dried over Na2SO4, concentrated, and purified by column
chromatography eluting with 40 % EtOAc in hexanes to give 4.6 g (96%) of
the pyrimidine regioisomers 11 as yellow solids. MS m/z 314 (M+H).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, product is a mixture of isomers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylindenopyridines and arylindenopyrimidines and their
use as adenosine A2a receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heintzelman, Geoffrey R.; Bullington, James L.; Rupert, Kenneth C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005042500 A1 2005-05-12

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylthio)phenylmethylene]-4-(1-propen-1-yl)-1H-indene-1,3(2H)-dione
C20H16O2S
713515-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.9521 3.0176 0.0 0
M  V30 2 C 9.9091 5.6684 0.0 0
M  V30 3 C 11.2428 6.4384 0.0 0
M  V30 4 C 12.5766 5.6684 0.0 0
M  V30 5 O 3.2573 5.7282 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 S 5.3900 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 7.2419 5.6684 0.0 0
M  V30 10 C 5.9081 6.4384 0.0 0
M  V30 11 C 6.9217 4.1620 0.0 0
M  V30 12 C 8.5755 6.4384 0.0 0
M  V30 13 C 4.7637 5.4079 0.0 0
M  V30 14 C 5.9081 7.9784 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 8.5755 7.9784 0.0 0
M  V30 17 C 7.2419 8.7484 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 1.3336 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 1.3336 0.0 0
M  V30 23 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 3 CFG=2
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 2 6 15 CFG=2
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-phenyl-6-(1-propen-1-yl)-5H-indeno[1,2-d]pyrimidin-5-one
C20H15N3O
713515-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2708 4.6245 0.0 0
M  V30 2 N 0.0000 5.3347 0.0 0
M  V30 3 C 8.9401 7.4653 0.0 0
M  V30 4 C 10.1861 8.3706 0.0 0
M  V30 5 C 11.5929 7.7441 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 3.8500 6.6684 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 6.1263 5.6549 0.0 0
M  V30 10 C 4.8804 7.8129 0.0 0
M  V30 11 N 2.3100 6.6684 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 6.2874 7.1864 0.0 0
M  V30 14 C 4.7195 9.3445 0.0 0
M  V30 15 C 1.5400 5.3347 0.0 0
M  V30 16 C 7.5333 8.0917 0.0 0
M  V30 17 C 5.9654 10.2497 0.0 0
M  V30 18 C 7.3723 9.6234 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 C 3.8500 1.3336 0.0 0
M  V30 21 C 6.1600 2.6674 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 23 C 6.9300 1.3336 0.0 0
M  V30 24 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 15
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 713515-53-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 713515-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15355594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylindenopyridines and arylindenopyrimidines as adenosine
A2a receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heintzelman, Geoffrey R.; Bullington, James Lawrence; Rupert, Kenneth C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040127510 A1 2004-07-01

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
Guanidine hydrochloride
CH5N3.ClH
50-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 2.6673 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 Cl 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αZ)-4-Bromo-α-[(dimethylamino)methylene]benzeneacetaldehyde
C11H12BrNO
85907-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 6.6684 3.0800 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 8.0022 0.7700 0.0 0
M  V30 7 C 9.3359 3.0800 0.0 0
M  V30 8 Br 0.0000 5.3901 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 1.3337 3.0800 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Bromophenyl)-2-pyrimidinamine
C10H8BrN3
31483-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 10.7802 1.3337 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 3.8501 0.0000 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 1.5400 1.3337 0.0 0
M  V30 9 C 6.1601 1.3337 0.0 0
M  V30 10 C 6.9302 2.6673 0.0 0
M  V30 11 C 6.9302 0.0000 0.0 0
M  V30 12 N 8.4702 2.6673 0.0 0
M  V30 13 N 8.4702 0.0000 0.0 0
M  V30 14 C 9.2402 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 14
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85907-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31483-56-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1675215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2. 5-(4-bromophenyl)pyrimidin-2-amine. A mixture of
(Z)-2-(4-bromophenyl)-3-(dimethylamino)acrylaldehyde (1.27 g, 5 mmol),
guanidine hydrochloride (0.525 g, 5.5 mmol) and potassium carbonate (1.38
g, 10 mmol) in ethanol (10 mL) was heated at 80°C overnight. After
cooling, the reaction mixture was filtered, washed with methanol and
water, and dried under high vacuum to give the desired product (1.2 g,
96%). LCMS: (M+H) = 249.9/251.9.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazotriazines and imidazopyrimidines as kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhuo, Jincong; Metcalf, Brian; Xu, Meizhong; He, Chunhong; Zhang, Colin;
Qian, Ding-Quan; Burns, David M.; Li, Yunlong; Yao, Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008064157 A1 2008-05-29

$RFMT $RIREG SCHEME157 STEP1
$RXN



  3  1
$MOL
4-Cyanobenzaldehyde
C8H5NO
105-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-1,3-dioxane-4,6-dione
C6H8O4
2033-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 O 1.5166 2.3101 0.0 0
M  V30 7 O 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Amino-1,4,5,6-tetrahydro-6-oxo-4-pyrimidinyl)benzonitrile
C11H10N4O
1239918-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 5.3349 0.0 0
M  V30 2 N 0.0000 0.0000 0.0 0
M  V30 3 C 9.2400 2.6674 0.0 0
M  V30 4 N 10.7800 2.6674 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 N 2.3100 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 N 0.0000 2.6674 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 5.3900 1.3338 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 3 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 105-07-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1239918-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17235586
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon nanotube supported
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst (carbon nanotube supported
titanium oxide used as catalyst), Knoevenagel condensation followed by
Michael addition and then intramolecular cyclization, no solvent,
catalyst prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Eco-Friendly and Highly Efficient Synthesis of Pyrimidinones Using a
TiO2-CNTs Nanocomposite Catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khalilian, Shahin; Abdolmohammadi, Shahrzad; Nematolahi, Fereshteh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Organic Chemistry (2017), 14(5), 361-367

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3β)-16-[(2-Chlorophenyl)methylene]-3-hydroxyandrost-5-en-17-one
C26H31ClO2
1095785-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8289 0.4090 0.0 0
M  V30 2 O 5.0494 0.0000 0.0 0
M  V30 3 C 3.0800 2.7106 0.0 0
M  V30 4 C 11.3894 2.7631 0.0 0
M  V30 5 Cl 0.0000 2.7106 0.0 0
M  V30 6 O 14.9920 6.5606 0.0 0
M  V30 7 C 6.9898 3.4806 0.0 0 CFG=2
M  V30 8 C 8.3236 4.2506 0.0 0 CFG=2
M  V30 9 C 6.9898 1.9406 0.0 0 CFG=1
M  V30 10 C 5.5252 3.9564 0.0 0
M  V30 11 C 9.6572 3.4806 0.0 0 CFG=2
M  V30 12 C 8.3236 5.7906 0.0 0
M  V30 13 C 5.5252 1.4647 0.0 0
M  V30 14 C 8.3236 1.1706 0.0 0
M  V30 15 C 4.6200 2.7106 0.0 0
M  V30 16 C 10.9909 4.2506 0.0 0 CFG=2
M  V30 17 C 9.6572 1.9406 0.0 0
M  V30 18 C 9.6572 6.5606 0.0 0
M  V30 19 C 10.9909 5.7906 0.0 0
M  V30 20 C 12.3245 3.4806 0.0 0
M  V30 21 C 12.3245 6.5606 0.0 0
M  V30 22 C 13.6583 4.2506 0.0 0
M  V30 23 C 13.6583 5.7906 0.0 0 CFG=1
M  V30 24 C 2.3100 4.0442 0.0 0
M  V30 25 C 0.7700 4.0442 0.0 0
M  V30 26 C 3.0800 5.3779 0.0 0
M  V30 27 C 0.0000 5.3779 0.0 0
M  V30 28 C 2.3100 6.7117 0.0 0
M  V30 29 C 0.7700 6.7117 0.0 0
M  V30 30 H 6.4380 4.9183 0.0 0
M  V30 31 H 7.2347 5.3395 0.0 0
M  V30 32 H 10.5406 2.2190 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 2 2 13
M  V30 3 2 3 15 CFG=2
M  V30 4 1 3 24
M  V30 5 1 16 4 CFG=1
M  V30 6 1 5 25
M  V30 7 1 23 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 30 CFG=3
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 31 CFG=1
M  V30 15 1 9 13
M  V30 16 1 9 14
M  V30 17 1 10 15
M  V30 18 1 11 16
M  V30 19 1 11 17
M  V30 20 1 11 32 CFG=3
M  V30 21 1 12 18
M  V30 22 1 13 15
M  V30 23 1 14 17
M  V30 24 1 16 19
M  V30 25 1 16 20
M  V30 26 2 18 19
M  V30 27 1 19 21
M  V30 28 1 20 22
M  V30 29 1 21 23
M  V30 30 1 22 23
M  V30 31 2 24 25
M  V30 32 1 24 26
M  V30 33 1 25 27
M  V30 34 2 26 28
M  V30 35 2 27 29
M  V30 36 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 7 8 9 11 16 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3β)-2′-Amino-6′-(2-chlorophenyl)androsta-5,16-dieno[17,16-d]pyridimidin-3-ol
C27H32ClN3O
2294831-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9828 8.3188 0.0 0
M  V30 2 C 10.3738 8.6071 0.0 0
M  V30 3 N 0.4829 7.9367 0.0 0
M  V30 4 Cl 0.0000 3.3420 0.0 0
M  V30 5 O 15.1281 7.0729 0.0 0
M  V30 6 C 6.6581 5.7391 0.0 0 CFG=1
M  V30 7 C 5.8881 7.0729 0.0 0 CFG=1
M  V30 8 C 8.1981 5.7391 0.0 0 CFG=2
M  V30 9 C 5.6275 4.5948 0.0 0
M  V30 10 C 4.3816 6.7528 0.0 0
M  V30 11 C 6.6581 8.4066 0.0 0
M  V30 12 C 8.9681 7.0729 0.0 0 CFG=1
M  V30 13 C 8.9681 4.4055 0.0 0
M  V30 14 C 4.2207 5.2211 0.0 0
M  V30 15 N 3.1358 7.6578 0.0 0
M  V30 16 C 8.1981 8.4066 0.0 0
M  V30 17 C 10.5081 7.0729 0.0 0 CFG=2
M  V30 18 C 10.5081 4.4055 0.0 0
M  V30 19 C 2.8137 4.5948 0.0 0
M  V30 20 C 1.7288 7.0315 0.0 0
M  V30 21 C 11.2781 5.7391 0.0 0
M  V30 22 C 11.2781 8.4066 0.0 0
M  V30 23 N 1.5679 5.5000 0.0 0
M  V30 24 C 12.8181 5.7391 0.0 0
M  V30 25 C 12.8181 8.4066 0.0 0
M  V30 26 C 13.5881 7.0729 0.0 0 CFG=1
M  V30 27 C 2.6528 3.0632 0.0 0
M  V30 28 C 1.2460 2.4367 0.0 0
M  V30 29 C 3.8987 2.1580 0.0 0
M  V30 30 C 1.0849 0.9052 0.0 0
M  V30 31 C 3.7377 0.6265 0.0 0
M  V30 32 C 2.3308 0.0000 0.0 0
M  V30 33 H 6.6311 4.1994 0.0 0
M  V30 34 H 8.0638 4.2051 0.0 0
M  V30 35 H 9.1022 8.6071 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=3
M  V30 2 1 17 2 CFG=3
M  V30 3 1 3 20
M  V30 4 1 4 28
M  V30 5 1 26 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 33 CFG=1
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 34 CFG=3
M  V30 15 1 9 14
M  V30 16 1 10 14
M  V30 17 2 10 15
M  V30 18 1 11 16
M  V30 19 1 12 16
M  V30 20 1 12 17
M  V30 21 1 12 35 CFG=1
M  V30 22 1 13 18
M  V30 23 2 14 19
M  V30 24 1 15 20
M  V30 25 1 17 21
M  V30 26 1 17 22
M  V30 27 2 18 21
M  V30 28 1 19 23
M  V30 29 1 19 27
M  V30 30 2 20 23
M  V30 31 1 21 24
M  V30 32 1 22 25
M  V30 33 1 24 26
M  V30 34 1 25 26
M  V30 35 2 27 28
M  V30 36 1 27 29
M  V30 37 1 28 30
M  V30 38 2 29 31
M  V30 39 2 30 32
M  V30 40 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 6 7 8 12 17 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1095785-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2294831-98-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20103761
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Steroidal[17,16-d]pyrimidines derived from dehydroepiandrosterone: A
convenient synthesis, antiproliferation activity, structure-activity
relationships, and role of heterocyclic moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ke, Shaoyong; Shi, Liqiao; Zhang, Zhigang; Yang, Ziwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Scientific Reports (2017), 744439pp.

$RFMT $RIREG SCHEME159 STEP1
$RXN



  3  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-methoxyphenyl)-5-pyrimidinecarbonitrile
C12H11N5O
107199-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 O 9.3358 6.9300 0.0 0
M  V30 6 C 10.6694 6.1600 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6673 4.6200 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 13 C 5.3347 4.6200 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107199-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30267097
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12018-18-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasonic irradiation (65W, 20KHz), catalyst prepared
and used, catalyst can be recycled and reused
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel(II) Chromite Nanoparticles: An Eco-Friendly and Reusable Catalyst
for Synthesis of 2,4-Diamino-6-aryl-pyrimidine-5-yl Cyanides under
Ultrasonic Radiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saeedi, Bahareh; Abdolmohammadi, Shahrzad; Mirjafary, Zohreh;
Kia-Kojoori, Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2021), 24(3),
455-464

$RFMT $RIREG SCHEME159 STEP1
$RXN



  3  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-methoxyphenyl)-5-pyrimidinecarbonitrile
C12H11N5O
107199-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1600 0.0 0
M  V30 2 N 2.6673 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 O 9.3358 6.9300 0.0 0
M  V30 6 C 10.6694 6.1600 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6673 4.6200 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 13 C 5.3347 4.6200 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107199-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30835282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst (TiO2 nanoparticles supported
on silica shells), Knoevenagel addition followed by Michael addition and
then intermolecular cyclization, no solvent, catalyst prepared and used,
reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A green approach for an efficient preparation of
2,4-diamino-6-aryl-5-pyrimidinecarbonitriles using a TiO2-SiO2
nanocomposite catalyst under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rabiei, Ahmad; Abdolmohammadi, Shahrzad; Shafaei, Faezeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2017), 72(4), 241-247

$RFMT $RIREG SCHEME160 STEP1
$RXN



  3  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzaldehyde
C7H5ClO
587-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(3-chlorophenyl)-5-pyrimidinecarbonitrile
C11H8ClN5
1132094-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Cl 9.3358 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 587-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1132094-27-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30492036
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12018-18-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasonic irradiation (65W, 20KHz), catalyst prepared
and used, catalyst can be recycled and reused
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel(II) Chromite Nanoparticles: An Eco-Friendly and Reusable Catalyst
for Synthesis of 2,4-Diamino-6-aryl-pyrimidine-5-yl Cyanides under
Ultrasonic Radiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saeedi, Bahareh; Abdolmohammadi, Shahrzad; Mirjafary, Zohreh;
Kia-Kojoori, Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2021), 24(3),
455-464

$RFMT $RIREG SCHEME161 STEP1
$RXN



  3  1
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitroisatin
C8H4N2O4
611-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2753 0.3694 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 O 9.2446 3.0800 0.0 0
M  V30 6 C 5.3347 2.3100 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.7994 1.8341 0.0 0
M  V30 10 N 6.7994 4.3259 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 7.7046 3.0800 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Amino-7′,8′-dihydro-7′,7′-dimethyl-5-nitrospiro[3H-indole-3,4′(3′H)-quinaz...
C17H17N5O4
2415289-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.2070 8.3955 0.0 0
M  V30 2 O 4.2598 6.6684 0.0 0
M  V30 3 N 6.5698 0.0000 0.0 0
M  V30 4 N 12.6248 5.2443 0.0 0 VAL=5
M  V30 5 O 12.3046 3.7380 0.0 0
M  V30 6 O 14.0895 5.7202 0.0 0
M  V30 7 C 0.0000 3.0112 0.0 0
M  V30 8 C 0.0000 4.9910 0.0 0
M  V30 9 C 6.5698 5.3347 0.0 0
M  V30 10 C 4.2598 4.0011 0.0 0
M  V30 11 C 8.8713 6.8294 0.0 0
M  V30 12 C 6.7133 8.0753 0.0 0
M  V30 13 N 6.5698 2.6673 0.0 0
M  V30 14 C 3.4898 2.6673 0.0 0
M  V30 15 C 3.4898 5.3347 0.0 0
M  V30 16 C 9.1915 8.3357 0.0 0
M  V30 17 C 10.0157 5.7989 0.0 0
M  V30 18 N 7.8578 9.1057 0.0 0
M  V30 19 C 5.7998 1.3336 0.0 0
M  V30 20 N 4.2598 1.3336 0.0 0
M  V30 21 C 1.9498 2.6673 0.0 0
M  V30 22 C 1.9498 5.3347 0.0 0
M  V30 23 C 10.6562 8.8116 0.0 0
M  V30 24 C 11.4804 6.2747 0.0 0
M  V30 25 C 1.1798 4.0011 0.0 0
M  V30 26 C 11.8006 7.7812 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 15
M  V30 3 1 3 19
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 24
M  V30 7 1 7 25
M  V30 8 1 8 25
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 15 22
M  V30 22 1 16 18
M  V30 23 2 16 23
M  V30 24 1 17 24
M  V30 25 2 19 20
M  V30 26 1 21 25
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 2 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 611-09-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2415289-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28587259
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1309-38-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM KIT-6 mesoporous silica-coated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, catalyst prepared and used,
recyclable catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aqueous-Mediated green synthesis of novel spiro[indole-quinazoline]
derivatives using kit-6 mesoporous silica coated Fe3O4 nanoparticles as
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abdolmohammadi, Shahrzad; Shariati, Shahab; Fard, Narges Elmi; Samani,
Amir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2020), 57(7), 2729-2737

$RFMT $RIREG SCHEME162 STEP1
$RXN



  3  1
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H18N4O2
2415289-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2015 7.9519 0.0 0
M  V30 2 O 5.5177 6.9300 0.0 0
M  V30 3 N 4.1840 0.0000 0.0 0
M  V30 4 C 0.0000 5.8925 0.0 0
M  V30 5 C 0.9899 7.6071 0.0 0
M  V30 6 C 6.8513 4.6200 0.0 0
M  V30 7 C 4.1840 4.6200 0.0 0
M  V30 8 C 9.5919 4.7635 0.0 0
M  V30 9 C 8.3460 6.9215 0.0 0
M  V30 10 N 5.5177 2.3100 0.0 0
M  V30 11 C 2.8502 3.8500 0.0 0
M  V30 12 C 4.1840 6.1600 0.0 0
M  V30 13 C 10.6223 5.9081 0.0 0
M  V30 14 C 10.0677 3.2990 0.0 0
M  V30 15 N 9.8523 7.2417 0.0 0
M  V30 16 C 4.1840 1.5400 0.0 0
M  V30 17 N 2.8502 2.3100 0.0 0
M  V30 18 C 1.5166 4.6200 0.0 0
M  V30 19 C 2.8502 6.9300 0.0 0
M  V30 20 C 12.1287 5.5879 0.0 0
M  V30 21 C 11.5742 2.9788 0.0 0
M  V30 22 C 1.5166 6.1600 0.0 0
M  V30 23 C 12.6046 4.1232 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 12
M  V30 3 1 3 16
M  V30 4 1 4 22
M  V30 5 1 5 22
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 11 18
M  V30 18 1 12 19
M  V30 19 1 13 15
M  V30 20 2 13 20
M  V30 21 1 14 21
M  V30 22 2 16 17
M  V30 23 1 18 22
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2415289-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26215372
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1309-38-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM KIT-6 mesoporous silica-coated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, catalyst prepared and used,
recyclable catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aqueous-Mediated green synthesis of novel spiro[indole-quinazoline]
derivatives using kit-6 mesoporous silica coated Fe3O4 nanoparticles as
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abdolmohammadi, Shahrzad; Shariati, Shahab; Fard, Narges Elmi; Samani,
Amir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2020), 57(7), 2729-2737

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Aminophenyl)-3-(2-furanyl)-2-propen-1-one
C13H11NO2
15462-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 9.4969 3.8416 0.0 0
M  V30 14 O 10.7428 1.6837 0.0 0
M  V30 15 C 11.0032 4.1618 0.0 0
M  V30 16 C 11.7733 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Aminophenyl)-6-(2-furanyl)-2-pyrimidinamine
C14H12N4O
1391979-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1048 0.0000 0.0 0
M  V30 2 N 11.7733 6.9302 0.0 0
M  V30 3 C 6.4384 3.8501 0.0 0
M  V30 4 C 5.1048 4.6201 0.0 0
M  V30 5 N 6.4384 2.3101 0.0 0
M  V30 6 C 3.7711 3.8501 0.0 0
M  V30 7 C 5.1048 1.5400 0.0 0
M  V30 8 N 3.7711 2.3101 0.0 0
M  V30 9 C 7.7722 4.6201 0.0 0
M  V30 10 C 7.7722 6.1601 0.0 0
M  V30 11 C 9.1059 3.8501 0.0 0
M  V30 12 C 9.1059 6.9302 0.0 0
M  V30 13 C 10.4396 4.6201 0.0 0
M  V30 14 C 10.4396 6.1601 0.0 0
M  V30 15 C 2.4373 4.6201 0.0 0
M  V30 16 C 2.2763 6.1517 0.0 0
M  V30 17 O 1.0304 3.9938 0.0 0
M  V30 18 C 0.7700 6.4718 0.0 0
M  V30 19 C 0.0000 5.1382 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 15
M  V30 10 2 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15462-52-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1391979-43-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32170100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound, alternate conventional heating may be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green synthesis, characterization, biological evaluation and docking
study of some pyrazoline and pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Ghulikah, H. A.; El-Azab, A. S.; Al-Saleem, M. S.; Al-Towayan, M. S.;
Al-Issa, S. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research Journal of Chemistry and Environment (2021), 25(12), 88-97

$RFMT $RIREG SCHEME164 STEP1
$RXN



  3  1
$MOL
Furfural
C5H4O2
98-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-1,3-dioxane-4,6-dione
C6H8O4
2033-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 O 1.5166 2.3101 0.0 0
M  V30 7 O 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-(2-furanyl)-5,6-dihydro-4(3H)-pyrimidinone
C8H9N3O2
2102926-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7721 4.6200 0.0 0
M  V30 2 N 5.1046 0.0000 0.0 0
M  V30 3 C 3.7710 3.8500 0.0 0
M  V30 4 C 5.1046 4.6200 0.0 0
M  V30 5 N 3.7710 2.3100 0.0 0
M  V30 6 C 6.4384 3.8500 0.0 0
M  V30 7 C 5.1046 1.5400 0.0 0
M  V30 8 N 6.4384 2.3100 0.0 0
M  V30 9 C 2.4374 4.6200 0.0 0
M  V30 10 C 2.2764 6.1515 0.0 0
M  V30 11 O 1.0304 3.9935 0.0 0
M  V30 12 C 0.7700 6.4717 0.0 0
M  V30 13 C 0.0000 5.1381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-01-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2102926-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17235595
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon nanotube supported
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst (carbon nanotube supported
titanium oxide used as catalyst), Knoevenagel condensation followed by
Michael addition and then intramolecular cyclization, no solvent,
catalyst prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Eco-Friendly and Highly Efficient Synthesis of Pyrimidinones Using a
TiO2-CNTs Nanocomposite Catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khalilian, Shahin; Abdolmohammadi, Shahrzad; Nematolahi, Fereshteh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Organic Chemistry (2017), 14(5), 361-367

$RFMT $RIREG SCHEME165 STEP1
$RXN



  3  1
$MOL
1,3-Cyclohexanedione
C6H8O2
504-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0800 0.0 0
M  V30 2 O 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine nitrate
CH5N3.HNO3
506-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitroisatin
C8H4N2O4
611-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2753 0.3694 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 O 9.2446 3.0800 0.0 0
M  V30 6 C 5.3347 2.3100 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.7994 1.8341 0.0 0
M  V30 10 N 6.7994 4.3259 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 7.7046 3.0800 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Amino-7′,8′-dihydro-5-nitrospiro[3H-indole-3,4′(3′H)-quinazoline]-2,5′(1H,...
C15H13N5O4
2415289-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0274 8.3955 0.0 0
M  V30 2 O 3.0800 6.6684 0.0 0
M  V30 3 N 5.3900 0.0000 0.0 0
M  V30 4 N 11.4451 5.2443 0.0 0 VAL=5
M  V30 5 O 12.9098 5.7202 0.0 0
M  V30 6 O 11.1250 3.7380 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 7.6917 6.8294 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 5.5337 8.0753 0.0 0
M  V30 11 N 5.3900 2.6673 0.0 0
M  V30 12 C 8.0119 8.3357 0.0 0
M  V30 13 C 8.8361 5.7989 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 N 6.6781 9.1057 0.0 0
M  V30 17 C 4.6200 1.3336 0.0 0
M  V30 18 C 9.4764 8.8116 0.0 0
M  V30 19 C 10.3008 6.2747 0.0 0
M  V30 20 N 3.0800 1.3336 0.0 0
M  V30 21 C 0.7700 2.6673 0.0 0
M  V30 22 C 0.7700 5.3347 0.0 0
M  V30 23 C 10.6209 7.7812 0.0 0
M  V30 24 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 15
M  V30 3 1 3 17
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 19
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 16
M  V30 18 2 12 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 14 21
M  V30 22 1 15 22
M  V30 23 2 17 20
M  V30 24 1 18 23
M  V30 25 2 19 23
M  V30 26 1 21 24
M  V30 27 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 504-02-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 506-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 611-09-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2415289-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24930749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1309-38-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM KIT-6 mesoporous silica-coated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, catalyst prepared and used,
recyclable catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aqueous-Mediated green synthesis of novel spiro[indole-quinazoline]
derivatives using kit-6 mesoporous silica coated Fe3O4 nanoparticles as
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abdolmohammadi, Shahrzad; Shariati, Shahab; Fard, Narges Elmi; Samani,
Amir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2020), 57(7), 2729-2737

$RFMT $RIREG SCHEME166 STEP1
$RXN



  3  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-1,6-dihydro-4-(4-methylphenyl)-6-oxo-5-pyrimidinecarbonitrile
C12H10N4O
86700-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 C 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 2 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86700-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31372517
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 111-40-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with fullerene
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 99685-96-8
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM reaction product wth diethylenetriamine
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, diethylenetriamine functionalized fullerene catalyst
prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fullerene-C60/NH2 : A recyclable heterogeneous catalyst for the green
synthesis of chromene and pyrimidine derivatives and antibacterial
evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mirza-Aghayan, Maryam; Mohammadi, Marzieh; Boukherroub, Rabah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2022), 59(6), 1102-1115

$RFMT $RIREG SCHEME167 STEP1
$RXN



  3  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-methylphenyl)-5-pyrimidinecarbonitrile
C12H11N5
107199-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 C 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107199-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25307326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of
4-Amino-5-pyrimidinecarbonitriles A mixture of aldehyde 1 (1 mmol),
malononitrile 2 (1 mmol), amidine hydrochloride or guanidinum carbonate
(1 mmol), and ZnO nanoparticles (0.1 mmol) in H2O (5 mL) was stirred for
15 min [the progress of the reaction was monitored by thin-layer
chromatography (TLC) using n-hexane/ethyl acetate as an eluent (2:3)].
Upon completion of the reaction, the reaction mixture was filtered to
isolate the solid product. Then the solid product was diluted with
chloroform, and the catalyst was removed by simple centrifugation (the
catalyst is not soluble in chloroform). After evaporation of solvent,
more purification was obtained by recrystallization from ethanol. Table
3. Entry d, yield 96% Mp (°C) Observed (lit.)[13]: 130 (130)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnO nanoparticles, a mild and efficient reusable catalyst for the one-pot
synthesis of 4-amino-5-pyrimidinecarbonitriles under aqueous conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hekmatshoar, Rahim; Kenary, Ghodsieh Nanva; Sadjadi, Sodeh; Beheshtiha,
Yahya S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(13), 2007-2013

$RFMT $RIREG SCHEME168 STEP1
$RXN



  3  1
$MOL
Acetophenone
C8H8O
98-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenyl)-6-phenyl-2-pyrimidinamine
C16H12ClN3
59807-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 Cl 12.0033 6.9302 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 N 6.6685 2.3101 0.0 0
M  V30 6 C 4.0012 3.8501 0.0 0
M  V30 7 C 5.3348 1.5400 0.0 0
M  V30 8 N 4.0012 2.3101 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 8.0022 6.1601 0.0 0
M  V30 11 C 9.3360 3.8501 0.0 0
M  V30 12 C 9.3360 6.9302 0.0 0
M  V30 13 C 10.6697 4.6201 0.0 0
M  V30 14 C 10.6697 6.1601 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 19 C 1.3337 6.9302 0.0 0
M  V30 20 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 15
M  V30 10 2 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-86-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59807-18-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5445942
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
2-Amine-4,6-diarylpyrimidine The mixture of aromatic aldehydes 1 (2
mmol), aromatic ketones 2 (2mmol), guanidine carbonate 3 (3 mmol), and
NaOH (2 mmol) was put in a reaction flask at 70 °C for about 25min. After
completing the reaction, the reaction mixture was poured into water, and
then washed with water thoroughly. The product was filtered, dried, and
recrystallized from 95% ethanol.
2-Amine-4-(4-chlorophenyl)-6-phenylpyrimidine (4c) This compound was
obtained as yellow crystals, yield 96%. mp 147-149 °C; IR (KBr, ν, cm-1):
3493, 3312, 3192, 1634, 1596, 1583, 1542, 1493, 1458, 1397, 1360, 1235,
1220, 1175, 1127, 1094, 1018, 849, 824, 812, 770, 697, 644; 1H NMR
(400MHz, DMSO-d6) (δ, ppm): 8.27 (2H, d, J = 8.8 Hz, ArH), 8.22 (2H, t, J
= 3.2Hz, ArH), 7.75 (1H, s, C5-H), 7.59 (2H, d, J = 8.8 Hz, ArH), 7.53
(3H, t, J = 3.2Hz, ArH), 6.81 (2H, s, NH2). Anal, calcd. for C16H12ClN3:
C, 68.21; H, 4.29; N, 14.91. Found: C, 68.07; H, 4.33; N, 15.03.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-waste reduction, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and facile three-component reaction for the synthesis of
2-amine-4,6-diarylpyrimidine under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhuang, Qiya; Han, HongXia; Wang, Suhui; Tu, Shuajiang; Rong, Liangce
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(3), 516-522

$RFMT $RIREG SCHEME169 STEP1
$RXN



  3  1
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-bromophenyl)-1,6-dihydro-6-oxo-5-pyrimidinecarbonitrile
C11H7BrN4O
1229519-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 O 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Br 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 C 6.6684 3.8500 0.0 0
M  V30 15 C 6.6684 6.9300 0.0 0
M  V30 16 C 8.0021 4.6200 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 2 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1229519-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31372510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 111-40-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with fullerene
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 99685-96-8
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM reaction product wth diethylenetriamine
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, diethylenetriamine functionalized fullerene catalyst
prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fullerene-C60/NH2 : A recyclable heterogeneous catalyst for the green
synthesis of chromene and pyrimidine derivatives and antibacterial
evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mirza-Aghayan, Maryam; Mohammadi, Marzieh; Boukherroub, Rabah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2022), 59(6), 1102-1115

$RFMT $RIREG SCHEME170 STEP1
$RXN



  3  1
$MOL
3,4,5-Trimethoxybenzaldehyde
C10H12O4
86-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3100 0.0 0
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9301 0.0 0
M  V30 7 C 6.6686 5.3901 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Acetylpyridine
C7H7NO
1122-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 N 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Pyridinyl)-6-(3,4,5-trimethoxyphenyl)-2-pyrimidinamine
C18H18N4O3
1091617-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0009 8.4700 0.0 0
M  V30 2 C 5.3347 9.2400 0.0 0
M  V30 3 O 1.3336 3.8500 0.0 0
M  V30 4 C 1.3336 2.3100 0.0 0
M  V30 5 N 8.0020 0.0000 0.0 0
M  V30 6 O 1.3336 6.9300 0.0 0
M  V30 7 C 0.0000 6.1600 0.0 0
M  V30 8 C 5.3347 4.6200 0.0 0
M  V30 9 C 5.3347 6.1600 0.0 0
M  V30 10 C 4.0009 3.8500 0.0 0
M  V30 11 C 4.0009 6.9300 0.0 0
M  V30 12 C 2.6673 4.6200 0.0 0
M  V30 13 C 2.6673 6.1600 0.0 0
M  V30 14 C 6.6684 3.8500 0.0 0
M  V30 15 C 8.0020 4.6200 0.0 0
M  V30 16 N 6.6684 2.3100 0.0 0
M  V30 17 C 9.3358 3.8500 0.0 0
M  V30 18 C 8.0020 1.5400 0.0 0
M  V30 19 N 9.3358 2.3100 0.0 0
M  V30 20 C 10.6694 4.6200 0.0 0
M  V30 21 C 12.0031 3.8500 0.0 0
M  V30 22 N 10.6694 6.1600 0.0 0
M  V30 23 C 13.3367 4.6200 0.0 0
M  V30 24 C 12.0031 6.9300 0.0 0
M  V30 25 C 13.3367 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 86-81-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-62-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1091617-18-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1452540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of
4-aryl-6-(pyridin-2-yl)pyrimidin-2-amine derivatives. The mixture of
aromatic aldehydes 1 (1 mmol), 2-acetylpyridine 2 (1 mmol), guanidine
carbonate 3 (1.5 mmol), and NaOH (0.2 mmol) was put in a reaction flask
at under 70 °C for about 45 min. After completing the reaction, the
reaction mixture was poured into water (0.5 % HCl), and then thoroughly
washed with water. The product was filtered, dried, and recrystallized
from 95% ethanol.
4-(pyridin-2-yl)-6-(3,4,5-trimethoxyphenyl)pyrimidin-2-amine (4n), Yield:
96% Melting point 163–164 °C (lit [32], 208 °C); IR (KBr) ν: 3,336,
3,198, 2,361, 2,341, 1,717, 1,698, 1,648, 1,560, 1,541, 1,507, 1,457,
1,363, 1,309, 1,221, 1,010, 846, 789, 669 cm-1; 1H NMR (300 MHz, CDCl3)
δ: 3.88 (3H, s, OCH3), 3.92 (6H, s, 2XOCH3), 5.57 (2H, s, NH2), 7.32–7.37
(3H, m, ArH), 7.78 (1H, t, J = 7.8 Hz, ArH), 8.05 (1H, s, ArH), 8.35 (1H,
d, J = 7.8 Hz, ArH), 8.70 (1H, d, J = 5.2 Hz, ArH); 13C NMR (300 MHz,
CDCl3) δ: 56.15, 60.83, 103.75, 104.27, 121.54, 124.94, 132.84, 136.90,
140.07, 149.16, 153.23, 154.54, 163.39, 164.54, 165.98. HRMS m/z
calculated for C18H18N4O3 [M + Na]+: 361.1277, found: 361.1284.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile synthesis of polydentate ligand:
pyridylpyrimidine-2-amine under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tao, Shimin; Xia, Sheng; Rong, Liangce; Cao, Changsheng; Tu, Shujiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2012), 38(8), 2065-2073

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Guanidine carbonate
CH5N3.xCH2O3
100224-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-[2-(Difluoromethyl)-1-ethyl-1H-imidazol-5-yl]-3-(dimethylamino)-2-prop...
C11H15F2N3O
893420-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1471 0.4759 0.0 0
M  V30 2 C 1.6824 0.0000 0.0 0
M  V30 3 C 6.2079 1.8386 0.0 0
M  V30 4 C 7.5415 2.6086 0.0 0
M  V30 5 O 6.2079 0.2986 0.0 0
M  V30 6 C 8.8752 1.8386 0.0 0
M  V30 7 N 10.2088 2.6086 0.0 0
M  V30 8 C 11.5426 1.8386 0.0 0
M  V30 9 C 10.2088 4.1486 0.0 0
M  V30 10 C 0.9052 2.9657 0.0 0
M  V30 11 F 0.2789 1.5589 0.0 0
M  V30 12 F 0.0000 4.2116 0.0 0
M  V30 13 N 3.4673 1.9823 0.0 0
M  V30 14 C 4.8741 2.6086 0.0 0
M  V30 15 C 2.4369 3.1267 0.0 0
M  V30 16 C 4.7132 4.1403 0.0 0
M  V30 17 N 3.2069 4.4605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 2 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-(Difluoromethyl)-1-ethyl-1H-imidazol-5-yl]-2-pyrimidinamine
C10H11F2N5
893420-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1471 0.9473 0.0 0
M  V30 2 C 1.6823 0.4714 0.0 0
M  V30 3 C 0.9051 3.4372 0.0 0
M  V30 4 F 0.2787 2.0302 0.0 0
M  V30 5 F 0.0000 4.6831 0.0 0
M  V30 6 N 10.2089 3.0801 0.0 0
M  V30 7 C 4.8741 3.0801 0.0 0
M  V30 8 N 3.4672 2.4536 0.0 0
M  V30 9 C 4.7131 4.6116 0.0 0
M  V30 10 C 2.4368 3.5981 0.0 0
M  V30 11 N 3.2068 4.9318 0.0 0
M  V30 12 C 6.2079 2.3101 0.0 0
M  V30 13 N 7.5415 3.0801 0.0 0
M  V30 14 C 6.2079 0.7700 0.0 0
M  V30 15 C 8.8752 2.3101 0.0 0
M  V30 16 C 7.5415 0.0000 0.0 0
M  V30 17 N 8.8752 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 10
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100224-74-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 893420-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893420-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2869984
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 629-14-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(2-Difluoromethyl-3-ethyl-3H-imidazol-4-yl)-pyrimidin-2-ylamine
(E)-1-(2-Difluoromethyl-3-ethyl-3H-imidazo-1-4-yl)-3-dimethylamino-propenone
(Method 41; 2.7 g, 0.011 mol) and guanidine carbonate (4.0 g, 0.-022 mol)
were added to ethylene glycol diethyl ether (30 ml) and heated at 137°C
for 2 days. The solvent was removed in vacuo to yield a yellow solid. DCM
(5.0 ml) was added followed by ether (50 ml), the obtained solid was
filtered and dried. A white solid was obtained (2.5 g, 96%).
4-(2-Difluoromethyl-3-ethyl-3H-imidazol-4-yl)-pyrimidin-2-ylamine, Yield
(2.5 g, 96%). NMR (400.132 MHz) 8.27 (d, 1H), 7.72 (s, 1H), 7.23 (t, 1H),
6.97 (d, 1H), 6.71 (s, 2H), 4.70 (q, 2H), 1.30 (t, 3H); m/z 240.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazolyl-pyrimidine compounds as CDK2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, David; Finlay, Maurice Raymond; Green, Clive; Jones, Clifford
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007015064 A1 2007-02-08

$RFMT $RIREG SCHEME172 STEP1
$RXN



  3  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-methylphenyl)-5-pyrimidinecarbonitrile
C12H11N5
107199-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 C 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107199-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27150458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the preparation of
4-amino-5-Pyrimidinecarbonitriles A mixture of aldehyde 1 (1 mmol),
malononitrile (1 mmol), amidine hydrochloride or guanidinum carbonate 3
(1 mmol) and CuO microspheres (0.1 mmol) in 5 cm3 H2O was stirred for 15
min, the progress of the reaction being monitored by TLC using
n-hexane/ethyl acetate (2:3) as eluent. Upon completion of the reaction,
the reaction mixture was filtered to isolate the solid product. The solid
product was dissolved in chloroform and the catalyst was then removed by
simple filtration. After evaporation of the solvent, the products were
purified by recrystallization from ethanol.Table 4 Synthesis of
4-amino-5-pyrimidinecarbonitriles 4 Compound 4a Table 4 Synthesis of
4-amino-5-pyrimidinecarbonitriles 4 Compound4d Yield 96%. M.p./°C
129-130, Lit. m.p./°C [14] 130
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Granulated copper oxide nanocatalyst, a mild and efficient reusable
catalyst for the one-pot synthesis of 4-amino-5-pyrimidinecarbonitriles
under aqueous conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmadi, Seyed Javad; Sadjadi, Sodeh; Hosseinpour, Morteza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2011), 142(11), 1163-1168

$RFMT $RIREG SCHEME173 STEP1
$RXN



  3  1
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl cyanoacetate
C4H5NO2
105-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 O 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 N 6.6686 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-4-piperidone
C12H15NO
3612-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 9.3358 0.0000 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 0.7700 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 C 6.6684 0.0000 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 2 2 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-oxo-9-(phenylmethyl)-1,3,9-triazaspiro[5.5]undec-1-ene-5-carbonitrile
C16H19N5O
945302-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1601 0.0 0
M  V30 2 N 2.6673 7.7001 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 C 8.0021 6.1601 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6673 4.6201 0.0 0
M  V30 8 C 4.0011 5.3901 0.0 0
M  V30 9 C 5.3348 3.0800 0.0 0
M  V30 10 N 4.0011 2.3100 0.0 0
M  V30 11 C 1.3337 3.8500 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 N 1.3337 2.3100 0.0 0
M  V30 16 N 6.6684 5.3901 0.0 0
M  V30 17 C 9.3359 5.3901 0.0 0
M  V30 18 C 10.6695 6.1601 0.0 0
M  V30 19 C 9.3359 3.8500 0.0 0
M  V30 20 C 12.0032 5.3901 0.0 0
M  V30 21 C 10.6695 3.0800 0.0 0
M  V30 22 C 12.0032 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 2 3 11
M  V30 4 1 4 14
M  V30 5 1 5 16
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 2 14 15
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 3612-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945302-66-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12942554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel and efficient domino reaction for the one-pot synthesis of
spiro-2-aminopyrimidinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramezanpour, Sorour; Hashtroudi, Mehri Seyed; Bijanzadeh, Hamid Reza;
Balalaie, Saeed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2008), 49(25), 3980-3982

$RFMT $RIREG SCHEME174 STEP1
$RXN



  3  1
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl cyanoacetate
C5H7NO2
105-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenethyl-4-piperidone
C13H17NO
39742-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 O 11.5503 2.6673 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 7.7002 1.3337 0.0 0
M  V30 6 C 7.7002 4.0010 0.0 0
M  V30 7 C 9.2402 1.3337 0.0 0
M  V30 8 C 9.2402 4.0010 0.0 0
M  V30 9 C 10.0102 2.6673 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 2.3101 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 10
M  V30 4 2 3 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-oxo-9-(2-phenylethyl)-1,3,9-triazaspiro[5.5]undec-1-ene-5-carbonitrile
C17H21N5O
17503-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.1601 0.0 0
M  V30 2 N 2.6673 7.7002 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 C 8.0022 6.1601 0.0 0
M  V30 6 C 9.3360 5.3901 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 N 4.0010 2.3101 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 N 1.3337 2.3101 0.0 0
M  V30 17 N 6.6685 5.3901 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 10.6697 7.7002 0.0 0
M  V30 20 C 12.0033 5.3901 0.0 0
M  V30 21 C 12.0033 8.4702 0.0 0
M  V30 22 C 13.3370 6.1601 0.0 0
M  V30 23 C 13.3370 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 2 3 12
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-56-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 39742-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17503-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3813493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel and efficient domino reaction for the one-pot synthesis of
spiro-2-aminopyrimidinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramezanpour, Sorour; Hashtroudi, Mehri Seyed; Bijanzadeh, Hamid Reza;
Balalaie, Saeed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2008), 49(25), 3980-3982

$RFMT $RIREG SCHEME175 STEP1
$RXN



  3  1
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Tetralone
C10H10O
529-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dimethoxyphenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine
C20H19N3O2
97145-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3337 0.0 0
M  V30 2 O 10.0101 1.3337 0.0 0
M  V30 3 C 9.2401 0.0000 0.0 0
M  V30 4 O 11.5501 4.0011 0.0 0
M  V30 5 C 12.3201 5.3348 0.0 0
M  V30 6 C 3.0800 5.3348 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 2.3100 6.6684 0.0 0
M  V30 9 N 2.3100 4.0011 0.0 0
M  V30 10 C 5.3901 4.0011 0.0 0
M  V30 11 C 5.3901 6.6684 0.0 0
M  V30 12 C 3.0800 8.0022 0.0 0
M  V30 13 C 0.7700 6.6684 0.0 0
M  V30 14 C 3.0800 2.6675 0.0 0
M  V30 15 N 4.6201 2.6675 0.0 0
M  V30 16 C 4.6201 8.0022 0.0 0
M  V30 17 C 2.3100 9.3359 0.0 0
M  V30 18 C 0.0000 8.0022 0.0 0
M  V30 19 C 0.7700 9.3359 0.0 0
M  V30 20 C 6.9301 4.0011 0.0 0
M  V30 21 C 7.7001 2.6675 0.0 0
M  V30 22 C 7.7001 5.3348 0.0 0
M  V30 23 C 9.2401 2.6675 0.0 0
M  V30 24 C 9.2401 5.3348 0.0 0
M  V30 25 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 4 5
M  V30 5 1 4 25
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 10 20
M  V30 16 1 11 16
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 2 14 15
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 529-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 97145-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7404205
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile synthesis of pyrimidine and quinazoline
derivatives via one-pot three-component reaction under solvent-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rong, Liangce; Han, Hongxia; Wang, Haiying; Jiang, Hong; Tu, Shuajiang;
Shi, Daqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2009), 46(2), 152-157

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Guanidine bicarbonate
CH5N3.CH2O3
124-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-[2-(Difluoromethyl)-1-ethyl-1H-imidazol-5-yl]-3-(dimethylamino)-2-prop...
C11H15F2N3O
893420-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1471 0.4759 0.0 0
M  V30 2 C 1.6824 0.0000 0.0 0
M  V30 3 C 6.2079 1.8386 0.0 0
M  V30 4 C 7.5415 2.6086 0.0 0
M  V30 5 O 6.2079 0.2986 0.0 0
M  V30 6 C 8.8752 1.8386 0.0 0
M  V30 7 N 10.2088 2.6086 0.0 0
M  V30 8 C 11.5426 1.8386 0.0 0
M  V30 9 C 10.2088 4.1486 0.0 0
M  V30 10 C 0.9052 2.9657 0.0 0
M  V30 11 F 0.2789 1.5589 0.0 0
M  V30 12 F 0.0000 4.2116 0.0 0
M  V30 13 N 3.4673 1.9823 0.0 0
M  V30 14 C 4.8741 2.6086 0.0 0
M  V30 15 C 2.4369 3.1267 0.0 0
M  V30 16 C 4.7132 4.1403 0.0 0
M  V30 17 N 3.2069 4.4605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 2 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-(Difluoromethyl)-1-ethyl-1H-imidazol-5-yl]-2-pyrimidinamine
C10H11F2N5
893420-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1471 0.9473 0.0 0
M  V30 2 C 1.6823 0.4714 0.0 0
M  V30 3 C 0.9051 3.4372 0.0 0
M  V30 4 F 0.2787 2.0302 0.0 0
M  V30 5 F 0.0000 4.6831 0.0 0
M  V30 6 N 10.2089 3.0801 0.0 0
M  V30 7 C 4.8741 3.0801 0.0 0
M  V30 8 N 3.4672 2.4536 0.0 0
M  V30 9 C 4.7131 4.6116 0.0 0
M  V30 10 C 2.4368 3.5981 0.0 0
M  V30 11 N 3.2068 4.9318 0.0 0
M  V30 12 C 6.2079 2.3101 0.0 0
M  V30 13 N 7.5415 3.0801 0.0 0
M  V30 14 C 6.2079 0.7700 0.0 0
M  V30 15 C 8.8752 2.3101 0.0 0
M  V30 16 C 7.5415 0.0000 0.0 0
M  V30 17 N 8.8752 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 10
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 124-46-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 893420-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893420-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2404001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-80-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(2-Difluoromethyl-3-ethyl-3H-imidazol-4-yl)-pyrimidin-2-ylamine (E)- 1
-(2-Difluoromethyl-3
-ethyl-3H-imidazol-4-yl)-3-dimethylamino-propenone(Method 49; 2.7 g, 0.01
1 mol) and guanidine carbonate (4.0 g, 0.022 mol) were added to ethylene
glycol diethyl ether (30 ml) and heated at 137°C for 2 days. The solvent
was removed in vacuo to yield a yellow solid. DCM (5.0 ml) was added
followed by ether (50 ml), the obtained solid was filtered and dried. A
white solid was obtained, yield 2.5 g, 96%. NMR(400.132 MHz) 8.27 (d,
1H), 7.72 (s, 1H), 7.23 (t, 1H), 6.97 (d, 1H), 6.71 (s, 2H), 4.70 (q,2H),
1.30 (t, 3H); m/z 240.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-(4-(imidazol-4-yl)-pyrimidin-2-ylamino)benzamides as CDK
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, David; Finlay, Maurice Raymond; Green, Clive; Jones, Clifford
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006064251 A1 2006-06-22

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Methoxyphenyl)-3,3-bis(methylthio)-2-propen-1-one
C12H14O2S2
33868-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 3.8500 2.6674 0.0 0
M  V30 3 O 3.8500 5.3349 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 S 1.5400 4.0011 0.0 0
M  V30 6 S 1.5400 1.3338 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 O 10.7800 4.0011 0.0 0
M  V30 10 C 11.5500 5.3349 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 6.9300 5.3349 0.0 0
M  V30 14 C 8.4700 2.6674 0.0 0
M  V30 15 C 8.4700 5.3349 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenyl)-6-(methylthio)-2-pyrimidinamine
C12H13N3OS
54807-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 N 4.0011 0.0000 0.0 0
M  V30 4 O 10.6695 6.9301 0.0 0
M  V30 5 C 12.0032 6.1601 0.0 0
M  V30 6 C 5.3348 3.8500 0.0 0
M  V30 7 C 4.0011 4.6201 0.0 0
M  V30 8 N 5.3348 2.3100 0.0 0
M  V30 9 C 2.6673 3.8500 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 N 2.6673 2.3100 0.0 0
M  V30 12 C 6.6684 4.6201 0.0 0
M  V30 13 C 8.0021 3.8500 0.0 0
M  V30 14 C 6.6684 6.1601 0.0 0
M  V30 15 C 9.3359 4.6201 0.0 0
M  V30 16 C 8.0021 6.9301 0.0 0
M  V30 17 C 9.3359 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33868-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54807-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12202018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave-Assisted Solvent-Free Synthesis of Highly Functionalized
Pyrimidine Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yan, Shengjiao; Niu, Yanfei; Chen, Xuebing; Liu, Yongjiang; Lin, Jun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2012), 49(4), 877-882

$RFMT $RIREG SCHEME178 STEP1
$RXN



  3  1
$MOL
4-Fluorobenzaldehyde
C7H5FO
459-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 F 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Tetralone
C10H10O
529-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diguanidinium carbonate
CH5N3.1/2CH2O3
593-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 O 1.3337 3.8501 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 N 0.0000 2.3101 0.0 0
M  V30 7 N 2.6673 2.3101 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 5 6
M  V30 5 1 5 7
M  V30 6 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Fluorophenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine
C18H14FN3
244613-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.0000 0.0 0
M  V30 2 F 12.0033 6.9302 0.0 0
M  V30 3 C 4.0012 3.8501 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 N 4.0012 2.3101 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 5.3348 6.1601 0.0 0
M  V30 9 C 2.6673 6.1601 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 N 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 6.9302 0.0 0
M  V30 14 C 1.3337 6.9302 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 9.3360 3.8501 0.0 0
M  V30 20 C 9.3360 6.9302 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 22
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 17
M  V30 13 1 8 13
M  V30 14 1 9 13
M  V30 15 2 9 14
M  V30 16 1 10 15
M  V30 17 2 11 12
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 459-57-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 529-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 593-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 244613-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1474072
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile synthesis of pyrimidine and quinazoline
derivatives via one-pot three-component reaction under solvent-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rong, Liangce; Han, Hongxia; Wang, Haiying; Jiang, Hong; Tu, Shuajiang;
Shi, Daqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2009), 46(2), 152-157

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-(3-Bromobenzo[b]thien-2-yl)-3-(dimethylamino)-2-propen-1-one
C13H12BrNOS
1003909-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.0203 5.3182 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 C 7.4148 3.1854 0.0 0
M  V30 4 O 6.0811 5.4955 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 N 10.0823 3.1854 0.0 0
M  V30 7 C 11.4160 3.9554 0.0 0
M  V30 8 C 10.0823 1.6454 0.0 0
M  V30 9 C 2.3101 2.6673 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 3.3405 3.8119 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 S 4.5864 1.6538 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 15 C 4.7475 3.1854 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 2 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3-Bromobenzo[b]thien-2-yl)-2-pyrimidinamine
C12H8BrN3S
1003898-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.0203 5.3182 0.0 0
M  V30 2 N 10.0823 3.1854 0.0 0
M  V30 3 C 4.7475 3.1854 0.0 0
M  V30 4 C 3.3405 3.8119 0.0 0
M  V30 5 S 4.5865 1.6538 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 6.0811 3.9554 0.0 0
M  V30 13 N 7.4148 3.1854 0.0 0
M  V30 14 C 6.0811 5.4955 0.0 0
M  V30 15 C 8.7486 3.9554 0.0 0
M  V30 16 C 7.4148 6.2655 0.0 0
M  V30 17 N 8.7486 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 15
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1003909-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003898-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-277924
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(3-Bromobenzo[b]thiophen-2-yl)pyrimidin-2-amine: A 500 mL round bottom
flask was charged with 1-(3-bromobenzo[b]thiophen-
2-yl)-3-(dimethylamino)prop-2-en-1-one (20 g, 64.72 mmol), ethanol (300
mL), and guanidine (9.5 g, 161.02 mmol). The resulting solution was
stirred for 1 hour at reflux. Reaction progress was monitored by TLC
(EtOAc/petroleum ether = 1:1). Work up: half of solvent was removed by
evaporation giving slurry. Solid was isolated by filtration, then washed
three times with 80 mL of cold ethanol, giving 20.5 g (94.6%)
4-(3-Bromobenzo[b]thiophen-2-yl)pyrimidin-2-amine, yield (20.5 g,94.6%)
1HNMR (300 MHz, DMSO-d6) δ: 8.45 (d, 1H), 8.09 (d, 1H), 7.88 (m, 1H),
7.64 (m, 1H), 7.60-7.54 (m, 2H), 6.90 (s, 2H). LCMS (M+1)+: 306.10.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothiophene derivatives, processes for preparing them, pharmaceutical
compositions containing them, and their use as inhibitors of Rho kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kahraman, Mehmet; Borchardt, Allen J.; Cook, Travis G.; Davis, Robert L.;
Gardiner, Elisabeth M. M.; Malecha, James W.; Noble, Stewart A.; Prins,
Thomas J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008011560 A2 2008-01-24

$RFMT $RIREG SCHEME180 STEP1
$RXN



  4  1
$MOL
p-Acetotoluidide
C9H11NO
103-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 C 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl oxalate
C4H6O4
553-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 O 1.3338 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 O 4.0011 0.0000 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-methoxyphenyl)-6-(4-methylphenyl)-5H-pyrrolo[3,4-d]pyrimidine-5,...
C20H16N4O3
2641047-08-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.8702 6.6519 0.0 0
M  V30 2 O 9.5808 1.9570 0.0 0
M  V30 3 N 3.8500 0.0000 0.0 0
M  V30 4 O 1.5400 9.3358 0.0 0
M  V30 5 C 0.0000 9.3358 0.0 0
M  V30 6 C 13.9321 7.5991 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 6.9300 2.6674 0.0 0
M  V30 10 C 7.1904 5.1454 0.0 0
M  V30 11 N 3.8500 2.6674 0.0 0
M  V30 12 C 8.4364 2.9876 0.0 0
M  V30 13 N 6.1600 1.3336 0.0 0
M  V30 14 N 8.5974 4.5191 0.0 0
M  V30 15 C 4.6200 1.3336 0.0 0
M  V30 16 C 3.8500 5.3347 0.0 0
M  V30 17 C 4.6200 6.6684 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 3.8500 8.0021 0.0 0
M  V30 20 C 1.5400 6.6684 0.0 0
M  V30 21 C 2.3100 8.0021 0.0 0
M  V30 22 C 9.9310 5.2891 0.0 0
M  V30 23 C 11.2646 4.5191 0.0 0
M  V30 24 C 9.9310 6.8291 0.0 0
M  V30 25 C 12.5984 5.2891 0.0 0
M  V30 26 C 11.2646 7.5991 0.0 0
M  V30 27 C 12.5984 6.8291 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 12
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 6 27
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 16
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 22
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103-89-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 553-90-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2641047-08-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33784395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, catalyst prepared and used,
supported on clinoptilolite, reusable catalyst used, orange peel aqueous
extract used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu@KF/Clinoptilolite Nanoparticles Promoted Green Synthesis of Pyrimidine
Derivatives: Study of Antioxidant Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmadi, Naser; Sayyed-Alangi, S. Zahra; Varasteh-Moradi, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2022), 42(7), 4019-4033

$RFMT $RIREG SCHEME181 STEP1
$RXN



  6  1
$MOL
5-Methylisatin
C9H7NO2
608-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 O 7.9110 2.7104 0.0 0
M  V30 3 C 0.0000 1.1704 0.0 0
M  V30 4 C 4.0011 1.9404 0.0 0
M  V30 5 C 4.0011 3.4804 0.0 0
M  V30 6 C 5.4658 1.4645 0.0 0
M  V30 7 C 2.6674 1.1704 0.0 0
M  V30 8 N 5.4658 3.9564 0.0 0
M  V30 9 C 2.6674 4.2504 0.0 0
M  V30 10 C 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 1.9404 0.0 0
M  V30 12 C 1.3338 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenacyl bromide
C9H9BrO2
2632-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Br 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C45H37ClN6O6
2719837-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 65 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 11.4598 15.2318 0.0 0
M  V30 2 C 4.5267 7.6345 0.0 0
M  V30 3 O 3.0452 7.2137 0.0 0
M  V30 4 O 5.6318 6.5619 0.0 0
M  V30 5 C 2.6690 5.7203 0.0 0
M  V30 6 O 8.5056 1.3336 0.0 0
M  V30 7 C 9.2756 0.0000 0.0 0
M  V30 8 C 2.4973 10.1349 0.0 0
M  V30 9 O 1.5192 11.3244 0.0 0
M  V30 10 O 1.9561 8.6930 0.0 0
M  V30 11 C 0.0000 11.0721 0.0 0
M  V30 12 C 9.8394 14.8190 0.0 0
M  V30 13 O 5.1151 1.6803 0.0 0
M  V30 14 C 3.6145 1.3338 0.0 0
M  V30 15 N 10.9593 8.0751 0.0 0
M  V30 16 C 12.1036 9.1057 0.0 0
M  V30 17 C 11.5856 6.6684 0.0 0
M  V30 18 N 13.4374 8.3357 0.0 0
M  V30 19 N 13.1171 6.8293 0.0 0
M  V30 20 C 9.4528 8.3953 0.0 0
M  V30 21 N 8.9770 9.8600 0.0 0
M  V30 22 N 8.4224 7.2509 0.0 0
M  V30 23 C 7.4707 10.1802 0.0 0
M  V30 24 C 6.9161 7.5711 0.0 0
M  V30 25 C 6.4401 9.0358 0.0 0
M  V30 26 C 7.2183 11.6994 0.0 0
M  V30 27 C 4.9029 9.1279 0.0 0
M  V30 28 C 5.8733 12.4494 0.0 0
M  V30 29 C 8.5404 12.4892 0.0 0
M  V30 30 C 4.0165 10.3871 0.0 0
M  V30 31 N 4.4483 11.8654 0.0 0
M  V30 32 C 5.8503 13.9892 0.0 0
M  V30 33 C 8.5173 14.0291 0.0 0
M  V30 34 C 7.1722 14.7791 0.0 0
M  V30 35 C 11.9427 10.6372 0.0 0
M  V30 36 C 10.5359 11.2636 0.0 0
M  V30 37 C 13.1886 11.5425 0.0 0
M  V30 38 C 10.3748 12.7951 0.0 0
M  V30 39 C 13.0276 13.0740 0.0 0
M  V30 40 C 11.6207 13.7003 0.0 0
M  V30 41 C 10.8156 5.3347 0.0 0
M  V30 42 C 11.5856 4.0009 0.0 0
M  V30 43 C 9.2756 5.3347 0.0 0
M  V30 44 C 10.8156 2.6673 0.0 0
M  V30 45 C 8.5056 4.0009 0.0 0
M  V30 46 C 9.2756 2.6673 0.0 0
M  V30 47 C 14.8442 8.9620 0.0 0
M  V30 48 C 15.0051 10.4936 0.0 0
M  V30 49 C 16.0901 8.0568 0.0 0
M  V30 50 C 16.4121 11.1200 0.0 0
M  V30 51 C 17.4970 8.6831 0.0 0
M  V30 52 C 17.6579 10.2148 0.0 0
M  V30 53 C 6.4658 6.0984 0.0 0
M  V30 54 C 4.9653 5.7519 0.0 0
M  V30 55 C 7.5161 4.9720 0.0 0
M  V30 56 C 4.5150 4.2792 0.0 0
M  V30 57 C 7.0658 3.4993 0.0 0
M  V30 58 C 5.5653 3.1530 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 40
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 27
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 46
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 30
M  V30 11 1 9 11
M  V30 12 1 12 33
M  V30 13 1 13 14
M  V30 14 1 13 58
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 1 16 18
M  V30 19 1 16 35
M  V30 20 2 17 19
M  V30 21 1 17 41
M  V30 22 1 18 19
M  V30 23 1 18 47
M  V30 24 1 20 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 23 26
M  V30 30 2 24 25
M  V30 31 1 24 53
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 2 26 29
M  V30 35 2 27 30
M  V30 36 1 28 31
M  V30 37 2 28 32
M  V30 38 1 29 33
M  V30 39 1 30 31
M  V30 40 1 32 34
M  V30 41 2 33 34
M  V30 42 2 35 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 2 37 39
M  V30 46 2 38 40
M  V30 47 1 39 40
M  V30 48 2 41 42
M  V30 49 1 41 43
M  V30 50 1 42 44
M  V30 51 2 43 45
M  V30 52 2 44 46
M  V30 53 1 45 46
M  V30 54 2 47 48
M  V30 55 1 47 49
M  V30 56 1 48 50
M  V30 57 2 49 51
M  V30 58 2 50 52
M  V30 59 1 51 52
M  V30 60 2 53 54
M  V30 61 1 53 55
M  V30 62 1 54 56
M  V30 63 2 55 57
M  V30 64 2 56 58
M  V30 65 1 57 58
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 608-05-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2632-13-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2719837-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24291228
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, (iron/copper/zinc)oxide
supported on carbon nanotubes catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fe3O4/CuO/ZnO@MWCNT MNCs as an efficient organometallic nanocatalyst
promoted synthesis of new 1,2,4-triazolpyrimidoazepine derivatives:
Investigation of antioxidant and antimicrobial activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirangi, Hannaneh Sadat; Varasteh Moradi, Ali; Ahmadi Golsefidi, Maziar;
Hossaini, Zinatossadat; Jalilian, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Organometallic Chemistry (2022), 36(1), e6460

$RFMT $RIREG SCHEME182 STEP1
$RXN



  5  1
$MOL
5-Methyl-1H-indene-1,2,3-trione
C10H6O3
188179-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4211 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 O 0.0000 2.7106 0.0 0
M  V30 4 C 7.9110 4.2506 0.0 0
M  V30 5 C 3.9099 3.4806 0.0 0
M  V30 6 C 3.9099 1.9406 0.0 0
M  V30 7 C 2.4452 3.9564 0.0 0
M  V30 8 C 5.2435 4.2506 0.0 0
M  V30 9 C 2.4452 1.4647 0.0 0
M  V30 10 C 5.2435 1.1706 0.0 0
M  V30 11 C 1.5400 2.7106 0.0 0
M  V30 12 C 6.5772 3.4806 0.0 0
M  V30 13 C 6.5772 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl bromoacetate
C4H7BrO2
105-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Br 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzaldehyde
C8H5NO
105-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Indeno[2,1-d]pyrimidine-4-carboxylic acid, 2-[5-(4-cyanophenyl)-1,5-dihydr...
C37H28N6O4
2858811-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.8462 5.1870 0.0 0
M  V30 2 O 10.6853 3.6552 0.0 0
M  V30 3 O 12.2532 5.8133 0.0 0
M  V30 4 C 11.9312 2.7502 0.0 0
M  V30 5 C 11.7703 1.2185 0.0 0
M  V30 6 O 4.2371 5.9416 0.0 0
M  V30 7 C 1.5065 9.8103 0.0 0
M  V30 8 N 0.0000 9.4899 0.0 0
M  V30 9 O 15.6376 8.3249 0.0 0
M  V30 10 C 16.8836 9.2301 0.0 0
M  V30 11 C 5.4075 0.0000 0.0 0
M  V30 12 N 8.6763 10.0605 0.0 0
M  V30 13 C 7.5319 11.0909 0.0 0
M  V30 14 C 10.0102 10.8305 0.0 0
M  V30 15 N 8.1583 12.4978 0.0 0
M  V30 16 N 9.6898 12.3368 0.0 0
M  V30 17 C 8.5154 8.5290 0.0 0
M  V30 18 N 7.1086 7.9025 0.0 0
M  V30 19 N 9.7613 7.6237 0.0 0
M  V30 20 C 6.9475 6.3709 0.0 0
M  V30 21 C 9.6004 6.0920 0.0 0
M  V30 22 C 8.1934 5.4657 0.0 0
M  V30 23 C 5.7016 5.4657 0.0 0
M  V30 24 C 7.7175 4.0011 0.0 0
M  V30 25 C 6.1775 4.0011 0.0 0
M  V30 26 C 8.4875 2.6673 0.0 0
M  V30 27 C 5.4075 2.6673 0.0 0
M  V30 28 C 7.7175 1.3337 0.0 0
M  V30 29 C 6.1775 1.3337 0.0 0
M  V30 30 C 6.0255 10.7708 0.0 0
M  V30 31 C 4.9951 11.9152 0.0 0
M  V30 32 C 5.5496 9.3061 0.0 0
M  V30 33 C 3.4888 11.5950 0.0 0
M  V30 34 C 4.0433 8.9859 0.0 0
M  V30 35 C 3.0127 10.1304 0.0 0
M  V30 36 C 11.4170 10.2040 0.0 0
M  V30 37 C 12.6628 11.1093 0.0 0
M  V30 38 C 11.5779 8.6725 0.0 0
M  V30 39 C 14.0698 10.4829 0.0 0
M  V30 40 C 12.9849 8.0462 0.0 0
M  V30 41 C 14.2307 8.9514 0.0 0
M  V30 42 C 7.3883 13.8316 0.0 0
M  V30 43 C 5.8482 13.8316 0.0 0
M  V30 44 C 8.1583 15.1652 0.0 0
M  V30 45 C 5.0782 15.1652 0.0 0
M  V30 46 C 7.3883 16.4989 0.0 0
M  V30 47 C 5.8482 16.4989 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 23
M  V30 7 3 7 8
M  V30 8 1 7 35
M  V30 9 1 9 10
M  V30 10 1 9 41
M  V30 11 1 11 29
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 13 30
M  V30 17 2 14 16
M  V30 18 1 14 36
M  V30 19 1 15 16
M  V30 20 1 15 42
M  V30 21 1 17 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 20 23
M  V30 27 2 21 22
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 25
M  V30 31 2 24 26
M  V30 32 2 25 27
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 2 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 42 2 36 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 2 38 40
M  V30 46 2 39 41
M  V30 47 1 40 41
M  V30 48 2 42 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 2 44 46
M  V30 52 2 45 47
M  V30 53 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 188179-81-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-36-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 105-07-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2858811-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34651279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with CuO and ZnO, supported on MWCNT MNCs
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, alternative reaction
conditions gave lower yield, recyclable and reusable catalyst used (stage
1), carbon nanotube support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fe3O4/CuO/ZnO@MWCNT MNCs Promoted the Green Synthesis of
Indenopyrimidin-1,2,4-Triazoles as Hybrid Molecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aghaei-Meybodi, Zahra; Mirabi, Ali; Khandan, Samira; Azizi, Bayan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(8), 7319-7342

$RFMT $RIREG SCHEME183 STEP1
$RXN



  5  1
$MOL
1H-Indene-1,2,3-trione
C9H4O3
938-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methylphenacyl bromide
C9H9BrO
619-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzaldehyde
C8H5NO
105-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4,5-Dihydro-3-(4-methoxyphenyl)-4-[4-(4-methylbenzoyl)-9-oxo-9H-indeno[2,1...
C41H28N6O3
2858811-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 57 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 7.1599 0.0 0
M  V30 2 O 5.3348 5.6199 0.0 0
M  V30 3 O 8.7124 12.8909 0.0 0
M  V30 4 C 13.3573 13.8118 0.0 0
M  V30 5 N 13.6775 15.3181 0.0 0
M  V30 6 O 6.2527 1.5063 0.0 0
M  V30 7 C 6.5729 0.0000 0.0 0
M  V30 8 C 0.0000 10.2400 0.0 0
M  V30 9 N 10.6697 7.1599 0.0 0
M  V30 10 C 12.0765 7.7863 0.0 0
M  V30 11 C 10.8306 5.6282 0.0 0
M  V30 12 N 13.1071 6.6419 0.0 0
M  V30 13 N 12.3371 5.3080 0.0 0
M  V30 14 C 9.3360 7.9299 0.0 0
M  V30 15 N 9.3360 9.4700 0.0 0
M  V30 16 N 8.0022 7.1599 0.0 0
M  V30 17 C 8.0022 10.2400 0.0 0
M  V30 18 C 6.6685 7.9299 0.0 0
M  V30 19 C 6.6685 9.4700 0.0 0
M  V30 20 C 7.6820 11.7463 0.0 0
M  V30 21 C 5.5241 10.5004 0.0 0
M  V30 22 C 6.1504 11.9072 0.0 0
M  V30 23 C 3.9924 10.3395 0.0 0
M  V30 24 C 5.2452 13.1533 0.0 0
M  V30 25 C 3.0873 11.5854 0.0 0
M  V30 26 C 3.7136 12.9922 0.0 0
M  V30 27 C 12.3967 9.2926 0.0 0
M  V30 28 C 11.2523 10.3232 0.0 0
M  V30 29 C 13.8614 9.7686 0.0 0
M  V30 30 C 11.5724 11.8295 0.0 0
M  V30 31 C 14.1816 11.2749 0.0 0
M  V30 32 C 13.0372 12.3053 0.0 0
M  V30 33 C 9.6862 4.5978 0.0 0
M  V30 34 C 10.0064 3.0915 0.0 0
M  V30 35 C 8.2215 5.0736 0.0 0
M  V30 36 C 8.8618 2.0609 0.0 0
M  V30 37 C 7.0771 4.0432 0.0 0
M  V30 38 C 7.3972 2.5367 0.0 0
M  V30 39 C 14.6386 6.8028 0.0 0
M  V30 40 C 15.5439 5.5569 0.0 0
M  V30 41 C 15.2650 8.2096 0.0 0
M  V30 42 C 17.0754 5.7178 0.0 0
M  V30 43 C 16.7965 8.3707 0.0 0
M  V30 44 C 17.7018 7.1247 0.0 0
M  V30 45 C 4.0012 7.9299 0.0 0
M  V30 46 C 2.6673 7.1599 0.0 0
M  V30 47 C 4.0012 9.4700 0.0 0
M  V30 48 C 1.3337 7.9299 0.0 0
M  V30 49 C 2.6673 10.2400 0.0 0
M  V30 50 C 1.3337 9.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 18
M  V30 3 1 1 45
M  V30 4 2 3 20
M  V30 5 3 4 5
M  V30 6 1 4 32
M  V30 7 1 6 7
M  V30 8 1 6 38
M  V30 9 1 8 50
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 1 10 27
M  V30 15 2 11 13
M  V30 16 1 11 33
M  V30 17 1 12 13
M  V30 18 1 12 39
M  V30 19 1 14 15
M  V30 20 2 14 16
M  V30 21 2 15 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 1 17 20
M  V30 25 2 18 19
M  V30 26 1 19 21
M  V30 27 1 20 22
M  V30 28 1 21 22
M  V30 29 2 21 23
M  V30 30 2 22 24
M  V30 31 1 23 25
M  V30 32 1 24 26
M  V30 33 2 25 26
M  V30 34 2 27 28
M  V30 35 1 27 29
M  V30 36 1 28 30
M  V30 37 2 29 31
M  V30 38 2 30 32
M  V30 39 1 31 32
M  V30 40 2 33 34
M  V30 41 1 33 35
M  V30 42 1 34 36
M  V30 43 2 35 37
M  V30 44 2 36 38
M  V30 45 1 37 38
M  V30 46 2 39 40
M  V30 47 1 39 41
M  V30 48 1 40 42
M  V30 49 2 41 43
M  V30 50 2 42 44
M  V30 51 1 43 44
M  V30 52 2 45 46
M  V30 53 1 45 47
M  V30 54 1 46 48
M  V30 55 2 47 49
M  V30 56 2 48 50
M  V30 57 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 938-24-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-41-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 105-07-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2858811-03-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34651282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with CuO and ZnO, supported on MWCNT MNCs
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, optimization study,
optimized on catalysts solvents, temperatures and time, catalyst prepared
and used, recyclable and reusable catalyst used, carbon nanotube support
used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fe3O4/CuO/ZnO@MWCNT MNCs Promoted the Green Synthesis of
Indenopyrimidin-1,2,4-Triazoles as Hybrid Molecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aghaei-Meybodi, Zahra; Mirabi, Ali; Khandan, Samira; Azizi, Bayan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(8), 7319-7342

$RFMT $RIREG SCHEME184 STEP1
$RXN



  5  1
$MOL
1H-Indene-1,2,3-trione
C9H4O3
938-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl bromoacetate
C4H7BrO2
105-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Br 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[1,5-dihydro-3-(4-methoxyphenyl)-5-(4-nitrophenyl)-1-phenyl-4H-1,2,4-...
C35H26N6O6
2858811-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3701 11.3120 0.0 0
M  V30 2 O 10.2092 12.8435 0.0 0
M  V30 3 O 11.7769 10.6855 0.0 0
M  V30 4 C 11.4550 13.7487 0.0 0
M  V30 5 C 11.2941 15.2803 0.0 0
M  V30 6 O 3.7609 10.5572 0.0 0
M  V30 7 N 1.0304 6.6887 0.0 0 VAL=5
M  V30 8 O 0.0000 5.5442 0.0 0
M  V30 9 O 0.5546 8.1533 0.0 0
M  V30 10 O 15.1614 8.1739 0.0 0
M  V30 11 C 16.4072 7.2687 0.0 0
M  V30 12 N 8.2002 6.4385 0.0 0
M  V30 13 C 7.0559 5.4079 0.0 0
M  V30 14 C 9.5339 5.6685 0.0 0
M  V30 15 N 7.6822 4.0011 0.0 0
M  V30 16 N 9.2137 4.1620 0.0 0
M  V30 17 C 8.0393 7.9700 0.0 0
M  V30 18 N 6.6324 8.5963 0.0 0
M  V30 19 N 9.2852 8.8752 0.0 0
M  V30 20 C 6.4714 10.1279 0.0 0
M  V30 21 C 9.1242 10.4068 0.0 0
M  V30 22 C 7.7173 11.0331 0.0 0
M  V30 23 C 5.2256 11.0331 0.0 0
M  V30 24 C 7.2414 12.4978 0.0 0
M  V30 25 C 5.7014 12.4978 0.0 0
M  V30 26 C 8.0114 13.8314 0.0 0
M  V30 27 C 4.9314 13.8314 0.0 0
M  V30 28 C 7.2414 15.1651 0.0 0
M  V30 29 C 5.7014 15.1651 0.0 0
M  V30 30 C 5.5494 5.7281 0.0 0
M  V30 31 C 4.5190 4.5837 0.0 0
M  V30 32 C 5.0736 7.1928 0.0 0
M  V30 33 C 3.0127 4.9038 0.0 0
M  V30 34 C 3.5673 7.5129 0.0 0
M  V30 35 C 2.5367 6.3685 0.0 0
M  V30 36 C 10.9408 6.2948 0.0 0
M  V30 37 C 12.1867 5.3896 0.0 0
M  V30 38 C 11.1018 7.8263 0.0 0
M  V30 39 C 13.5936 6.0159 0.0 0
M  V30 40 C 12.5087 8.4528 0.0 0
M  V30 41 C 13.7546 7.5476 0.0 0
M  V30 42 C 6.9122 2.6674 0.0 0
M  V30 43 C 5.3722 2.6674 0.0 0
M  V30 44 C 7.6822 1.3336 0.0 0
M  V30 45 C 4.6022 1.3336 0.0 0
M  V30 46 C 6.9122 0.0000 0.0 0
M  V30 47 C 5.3722 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 23
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 35
M  V30 10 1 10 11
M  V30 11 1 10 41
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 13 30
M  V30 17 2 14 16
M  V30 18 1 14 36
M  V30 19 1 15 16
M  V30 20 1 15 42
M  V30 21 1 17 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 20 23
M  V30 27 2 21 22
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 25
M  V30 31 2 24 26
M  V30 32 2 25 27
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 2 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 42 2 36 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 2 38 40
M  V30 46 2 39 41
M  V30 47 1 40 41
M  V30 48 2 42 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 2 44 46
M  V30 52 2 45 47
M  V30 53 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 938-24-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-36-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2858811-07-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34651284
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction product with CuO and ZnO, supported on MWCNT MNCs
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, recyclable and reusable catalyst used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fe3O4/CuO/ZnO@MWCNT MNCs Promoted the Green Synthesis of
Indenopyrimidin-1,2,4-Triazoles as Hybrid Molecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aghaei-Meybodi, Zahra; Mirabi, Ali; Khandan, Samira; Azizi, Bayan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(8), 7319-7342

$RFMT $RIREG SCHEME185 STEP1
$RXN



  6  1
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl propiolate
C4H4O2
922-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 3.8500 1.3336 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenacyl bromide
C9H9BrO2
2632-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Br 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Isocyanobenzaldehyde
C8H5NO
1087346-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 N 6.9301 1.3337 0.0 0 CHG=1 VAL=4
M  V30 4 C 8.4701 1.3337 0.0 0 CHG=-1
M  V30 5 C 2.3100 1.3337 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 3 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[1,5-dihydro-5-(4-isocyanophenyl)-3-(4-methoxyphenyl)-1-phenyl-4H-1,...
C43H33N7O4
2719837-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.0655 11.0390 0.0 0 CHG=1 VAL=4
M  V30 2 C 1.2954 12.3728 0.0 0 CHG=-1
M  V30 3 C 12.4979 9.9587 0.0 0
M  V30 4 O 13.2645 11.2942 0.0 0
M  V30 5 O 13.2713 8.6269 0.0 0
M  V30 6 C 14.8045 11.2981 0.0 0
M  V30 7 O 12.6246 1.5315 0.0 0
M  V30 8 C 12.7856 0.0000 0.0 0
M  V30 9 O 15.7328 4.7155 0.0 0
M  V30 10 C 17.0244 5.5543 0.0 0
M  V30 11 N 6.6770 5.5434 0.0 0
M  V30 12 C 5.1455 5.7043 0.0 0
M  V30 13 C 6.9972 4.0371 0.0 0
M  V30 14 N 4.5190 4.2975 0.0 0
M  V30 15 N 5.6635 3.2671 0.0 0
M  V30 16 C 7.7074 6.6879 0.0 0
M  V30 17 N 7.2315 8.1525 0.0 0
M  V30 18 N 9.2138 6.3676 0.0 0
M  V30 19 C 8.2620 9.2970 0.0 0
M  V30 20 C 10.2442 7.5121 0.0 0
M  V30 21 C 9.7684 8.9767 0.0 0
M  V30 22 C 7.5731 10.6742 0.0 0
M  V30 23 C 10.9579 9.9549 0.0 0
M  V30 24 C 8.2205 12.0716 0.0 0
M  V30 25 C 6.0394 10.5362 0.0 0
M  V30 26 C 10.9348 11.4946 0.0 0
M  V30 27 N 9.7166 12.4367 0.0 0
M  V30 28 C 7.3341 13.3309 0.0 0
M  V30 29 C 5.1528 11.7955 0.0 0
M  V30 30 C 5.8003 13.1929 0.0 0
M  V30 31 C 4.3755 7.0381 0.0 0
M  V30 32 C 2.8355 7.0381 0.0 0
M  V30 33 C 5.1455 8.3718 0.0 0
M  V30 34 C 2.0655 8.3718 0.0 0
M  V30 35 C 4.3755 9.7054 0.0 0
M  V30 36 C 2.8355 9.7054 0.0 0
M  V30 37 C 8.4041 3.4106 0.0 0
M  V30 38 C 9.6500 4.3159 0.0 0
M  V30 39 C 8.5650 1.8791 0.0 0
M  V30 40 C 11.0568 3.6895 0.0 0
M  V30 41 C 9.9718 1.2528 0.0 0
M  V30 42 C 11.2177 2.1579 0.0 0
M  V30 43 C 3.0127 3.9774 0.0 0
M  V30 44 C 1.9823 5.1217 0.0 0
M  V30 45 C 2.5368 2.5127 0.0 0
M  V30 46 C 0.4759 4.8016 0.0 0
M  V30 47 C 1.0304 2.1925 0.0 0
M  V30 48 C 0.0000 3.3370 0.0 0
M  V30 49 C 11.6164 6.8130 0.0 0
M  V30 50 C 12.9080 7.6517 0.0 0
M  V30 51 C 11.6969 5.2751 0.0 0
M  V30 52 C 14.2801 6.9525 0.0 0
M  V30 53 C 13.0692 4.5760 0.0 0
M  V30 54 C 14.3607 5.4146 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 36
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 23
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 42
M  V30 9 1 9 10
M  V30 10 1 9 54
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 16
M  V30 14 1 12 14
M  V30 15 1 12 31
M  V30 16 2 13 15
M  V30 17 1 13 37
M  V30 18 1 14 15
M  V30 19 1 14 43
M  V30 20 1 16 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 19 22
M  V30 26 2 20 21
M  V30 27 1 20 49
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 22 25
M  V30 31 2 23 26
M  V30 32 1 24 27
M  V30 33 2 24 28
M  V30 34 1 25 29
M  V30 35 1 26 27
M  V30 36 1 28 30
M  V30 37 2 29 30
M  V30 38 2 31 32
M  V30 39 1 31 33
M  V30 40 1 32 34
M  V30 41 2 33 35
M  V30 42 2 34 36
M  V30 43 1 35 36
M  V30 44 2 37 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 2 39 41
M  V30 48 2 40 42
M  V30 49 1 41 42
M  V30 50 2 43 44
M  V30 51 1 43 45
M  V30 52 1 44 46
M  V30 53 2 45 47
M  V30 54 2 46 48
M  V30 55 1 47 48
M  V30 56 2 49 50
M  V30 57 1 49 51
M  V30 58 1 50 52
M  V30 59 2 51 53
M  V30 60 2 52 54
M  V30 61 1 53 54
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 922-67-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2632-13-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 1087346-01-7
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2719837-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24291215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, (iron/copper/zinc)oxide
supported on carbon nanotubes catalyst prepared and used, alternative
preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fe3O4/CuO/ZnO@MWCNT MNCs as an efficient organometallic nanocatalyst
promoted synthesis of new 1,2,4-triazolpyrimidoazepine derivatives:
Investigation of antioxidant and antimicrobial activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirangi, Hannaneh Sadat; Varasteh Moradi, Ali; Ahmadi Golsefidi, Maziar;
Hossaini, Zinatossadat; Jalilian, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Organometallic Chemistry (2022), 36(1), e6460

$RFMT $RIREG SCHEME186 STEP1
$RXN



  3  1
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diamino-6-(4-bromophenyl)-5-pyrimidinecarbonitrile
C11H8BrN5
1072135-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 N 2.6674 7.7000 0.0 0
M  V30 3 N 0.0000 4.6200 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 Br 9.3358 6.9300 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 5.3347 6.1600 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6684 6.9300 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072135-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25965611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, reusable catalyst,
alumina-supported potassium fluoride catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM KF/Al2O3: as a solid phase and recyclable basic catalyst for synthesis
mono and bis pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abaszadeh, Mehdi; Seifi, Mohammad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Iranian Journal of Chemistry & Chemical Engineering (2017), 36(1), 35-43

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis[2-bromoethanone]
C12H10Br2O2S2
1191035-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1605 0.0000 0.0 0
M  V30 2 C 4.2793 0.0000 0.0 0
M  V30 3 C 10.1297 2.7105 0.0 0
M  V30 4 C 10.8997 4.0441 0.0 0
M  V30 5 O 10.8997 1.3768 0.0 0
M  V30 6 Br 12.4398 4.0441 0.0 0
M  V30 7 C 2.3101 2.7105 0.0 0
M  V30 8 C 1.5400 4.0441 0.0 0
M  V30 9 O 1.5400 1.3768 0.0 0
M  V30 10 Br 0.0000 4.0441 0.0 0
M  V30 11 C 6.2199 1.9404 0.0 0
M  V30 12 C 6.2199 3.4805 0.0 0
M  V30 13 C 7.6846 1.4646 0.0 0
M  V30 14 C 4.7552 1.4646 0.0 0
M  V30 15 S 4.7552 3.9563 0.0 0
M  V30 16 S 7.6846 3.9563 0.0 0
M  V30 17 C 8.5897 2.7105 0.0 0
M  V30 18 C 3.8501 2.7105 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,5′-(3,4-Dimethylthieno[2,3-b]thiophene-2,5-diyl)bis[1H-imidazol-2-amine]
C14H14N6S2
1311467-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5513 5.4511 0.0 0
M  V30 2 C 8.3474 6.2581 0.0 0
M  V30 3 N 0.0000 0.0000 0.0 0
M  V30 4 N 14.7224 3.1293 0.0 0
M  V30 5 C 6.8528 3.9565 0.0 0
M  V30 6 C 7.1730 2.4500 0.0 0
M  V30 7 C 5.3213 4.1174 0.0 0
M  V30 8 C 8.1865 4.7265 0.0 0
M  V30 9 S 8.7046 2.2891 0.0 0
M  V30 10 S 5.8393 1.6800 0.0 0
M  V30 11 C 4.6948 2.7106 0.0 0
M  V30 12 C 9.3311 3.6961 0.0 0
M  V30 13 C 3.1885 2.3904 0.0 0
M  V30 14 N 2.5620 0.9835 0.0 0
M  V30 15 C 2.0439 3.4209 0.0 0
M  V30 16 C 1.0304 1.1444 0.0 0
M  V30 17 N 0.7103 2.6509 0.0 0
M  V30 18 C 10.8374 4.0163 0.0 0
M  V30 19 N 11.9818 2.9857 0.0 0
M  V30 20 C 11.4637 5.4231 0.0 0
M  V30 21 C 13.3156 3.7557 0.0 0
M  V30 22 N 12.9954 5.2621 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 1 3 16
M  V30 4 1 4 21
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 14 1 11 13
M  V30 15 1 12 18
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1191035-71-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311467-67-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7567129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactions of some new thienothiophene derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mabkhot, Yahia Nasser; Al-Majid, Abdullah Mohammad; Alamary, Abdullah
Saleh; Warad, Ismail; Sedigi, Yamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2011), 165142-5148

$RFMT $RIREG SCHEME188 STEP1
$RXN



  6  1
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenacyl bromide
C9H9BrO2
2632-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Br 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dimethyl 2-[1,5-dihydro-3,5-bis(4-methoxyphenyl)-1-phenyl-4H-1,2,4-triazo...
C45H38N6O7
2719837-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 65 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.8319 14.9202 0.0 0
M  V30 2 C 13.1655 15.6902 0.0 0
M  V30 3 C 4.1426 8.0892 0.0 0
M  V30 4 O 2.6253 7.8255 0.0 0
M  V30 5 O 5.1295 6.9069 0.0 0
M  V30 6 C 2.0950 6.3796 0.0 0
M  V30 7 O 7.4412 1.4068 0.0 0
M  V30 8 C 8.0675 0.0000 0.0 0
M  V30 9 C 2.3856 10.7879 0.0 0
M  V30 10 O 1.5372 12.0732 0.0 0
M  V30 11 O 1.6968 9.4105 0.0 0
M  V30 12 C 0.0000 11.9811 0.0 0
M  V30 13 O 4.1054 2.1060 0.0 0
M  V30 14 C 2.5769 1.9184 0.0 0
M  V30 15 N 10.5860 7.8550 0.0 0
M  V30 16 C 11.8319 8.7602 0.0 0
M  V30 17 C 11.0619 6.3904 0.0 0
M  V30 18 N 13.0777 7.8550 0.0 0
M  V30 19 N 12.6019 6.3904 0.0 0
M  V30 20 C 9.1213 8.3310 0.0 0
M  V30 21 N 8.8011 9.8373 0.0 0
M  V30 22 N 7.9769 7.3004 0.0 0
M  V30 23 C 7.3366 10.3131 0.0 0
M  V30 24 C 6.5122 7.7763 0.0 0
M  V30 25 C 6.1921 9.2827 0.0 0
M  V30 26 C 7.2445 11.8504 0.0 0
M  V30 27 C 4.6728 9.5350 0.0 0
M  V30 28 C 5.9851 12.7369 0.0 0
M  V30 29 C 8.6418 12.4978 0.0 0
M  V30 30 C 3.9229 10.8800 0.0 0
M  V30 31 N 4.5070 12.3050 0.0 0
M  V30 32 C 6.1232 14.2706 0.0 0
M  V30 33 C 8.7797 14.0316 0.0 0
M  V30 34 C 7.5205 14.9181 0.0 0
M  V30 35 C 11.8319 10.3002 0.0 0
M  V30 36 C 13.1655 11.0702 0.0 0
M  V30 37 C 10.4982 11.0702 0.0 0
M  V30 38 C 13.1655 12.6102 0.0 0
M  V30 39 C 10.4982 12.6102 0.0 0
M  V30 40 C 11.8319 13.3802 0.0 0
M  V30 41 C 10.1567 5.1446 0.0 0
M  V30 42 C 8.6251 5.3055 0.0 0
M  V30 43 C 10.7831 3.7376 0.0 0
M  V30 44 C 7.7199 4.0596 0.0 0
M  V30 45 C 9.8779 2.4917 0.0 0
M  V30 46 C 8.3462 2.6527 0.0 0
M  V30 47 C 14.5424 8.3310 0.0 0
M  V30 48 C 14.8626 9.8373 0.0 0
M  V30 49 C 15.6868 7.3004 0.0 0
M  V30 50 C 16.3272 10.3131 0.0 0
M  V30 51 C 17.1515 7.7763 0.0 0
M  V30 52 C 17.4717 9.2827 0.0 0
M  V30 53 C 5.9105 6.3587 0.0 0
M  V30 54 C 6.8373 5.1288 0.0 0
M  V30 55 C 4.3819 6.1711 0.0 0
M  V30 56 C 6.2356 3.7113 0.0 0
M  V30 57 C 3.7803 4.7535 0.0 0
M  V30 58 C 4.7070 3.5235 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 40
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 27
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 46
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 30
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 58
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 1 16 18
M  V30 19 1 16 35
M  V30 20 2 17 19
M  V30 21 1 17 41
M  V30 22 1 18 19
M  V30 23 1 18 47
M  V30 24 1 20 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 23 26
M  V30 30 2 24 25
M  V30 31 1 24 53
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 2 26 29
M  V30 35 2 27 30
M  V30 36 1 28 31
M  V30 37 2 28 32
M  V30 38 1 29 33
M  V30 39 1 30 31
M  V30 40 1 32 34
M  V30 41 2 33 34
M  V30 42 2 35 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 2 37 39
M  V30 46 2 38 40
M  V30 47 1 39 40
M  V30 48 2 41 42
M  V30 49 1 41 43
M  V30 50 1 42 44
M  V30 51 2 43 45
M  V30 52 2 44 46
M  V30 53 1 45 46
M  V30 54 2 47 48
M  V30 55 1 47 49
M  V30 56 1 48 50
M  V30 57 2 49 51
M  V30 58 2 50 52
M  V30 59 1 51 52
M  V30 60 2 53 54
M  V30 61 1 53 55
M  V30 62 1 54 56
M  V30 63 2 55 57
M  V30 64 2 56 58
M  V30 65 1 57 58
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2632-13-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2719837-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24291214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM carbon nanotubes-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, (iron/copper/zinc)oxide
supported on carbon nanotubes catalyst prepared and used, alternative
preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fe3O4/CuO/ZnO@MWCNT MNCs as an efficient organometallic nanocatalyst
promoted synthesis of new 1,2,4-triazolpyrimidoazepine derivatives:
Investigation of antioxidant and antimicrobial activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirangi, Hannaneh Sadat; Varasteh Moradi, Ali; Ahmadi Golsefidi, Maziar;
Hossaini, Zinatossadat; Jalilian, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Organometallic Chemistry (2022), 36(1), e6460

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-[1,1′-Biphenyl]-4-yl-4-methyl-5-thiazolyl)-2-(methylsulfonyl)pyrimidine
C21H17N3O2S2
2097306-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4665 5.7870 0.0 0
M  V30 2 S 1.4069 2.7843 0.0 0 VAL=6
M  V30 3 C 0.0000 3.4106 0.0 0
M  V30 4 O 2.0333 4.1911 0.0 0
M  V30 5 O 0.7806 1.3774 0.0 0
M  V30 6 C 6.7124 3.3420 0.0 0
M  V30 7 S 8.1771 2.8659 0.0 0
M  V30 8 C 6.7124 4.8820 0.0 0
M  V30 9 C 9.0823 4.1120 0.0 0
M  V30 10 N 8.1771 5.3578 0.0 0
M  V30 11 C 5.4665 2.4367 0.0 0
M  V30 12 N 4.0597 3.0631 0.0 0
M  V30 13 C 5.6275 0.9051 0.0 0
M  V30 14 C 2.8137 2.1578 0.0 0
M  V30 15 C 4.3816 0.0000 0.0 0
M  V30 16 N 2.9748 0.6263 0.0 0
M  V30 17 C 10.6223 4.1120 0.0 0
M  V30 18 C 11.3923 5.4456 0.0 0
M  V30 19 C 11.3923 2.7782 0.0 0
M  V30 20 C 12.9323 5.4456 0.0 0
M  V30 21 C 12.9323 2.7782 0.0 0
M  V30 22 C 13.7023 4.1120 0.0 0
M  V30 23 C 15.2423 4.1120 0.0 0
M  V30 24 C 16.0123 5.4456 0.0 0
M  V30 25 C 16.0123 2.7782 0.0 0
M  V30 26 C 17.5523 5.4456 0.0 0
M  V30 27 C 17.5523 2.7782 0.0 0
M  V30 28 C 18.3223 4.1120 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 2 5
M  V30 5 1 2 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 9 17
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(2-[1,1′-Biphenyl]-4-yl-4-methyl-5-thiazolyl)-2-pyrimidinyl]guanidine
C21H18N6S
2097141-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.8558 5.7870 0.0 0
M  V30 2 N 16.9154 2.7843 0.0 0
M  V30 3 C 18.1612 1.8791 0.0 0
M  V30 4 N 18.0003 0.3474 0.0 0
M  V30 5 N 19.5682 2.5054 0.0 0
M  V30 6 C 11.6099 3.3420 0.0 0
M  V30 7 S 10.1452 2.8659 0.0 0
M  V30 8 C 11.6099 4.8820 0.0 0
M  V30 9 C 9.2400 4.1120 0.0 0
M  V30 10 N 10.1452 5.3578 0.0 0
M  V30 11 C 12.8558 2.4367 0.0 0
M  V30 12 N 14.2626 3.0631 0.0 0
M  V30 13 C 12.6948 0.9051 0.0 0
M  V30 14 C 15.5086 2.1578 0.0 0
M  V30 15 C 13.9407 0.0000 0.0 0
M  V30 16 N 15.3475 0.6263 0.0 0
M  V30 17 C 7.7000 4.1120 0.0 0
M  V30 18 C 6.9300 5.4456 0.0 0
M  V30 19 C 6.9300 2.7782 0.0 0
M  V30 20 C 5.3900 5.4456 0.0 0
M  V30 21 C 5.3900 2.7782 0.0 0
M  V30 22 C 4.6200 4.1120 0.0 0
M  V30 23 C 3.0800 4.1120 0.0 0
M  V30 24 C 2.3100 5.4456 0.0 0
M  V30 25 C 2.3100 2.7782 0.0 0
M  V30 26 C 0.7700 5.4456 0.0 0
M  V30 27 C 0.7700 2.7782 0.0 0
M  V30 28 C 0.0000 4.1120 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 9 17
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2097306-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097141-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21050547
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigating the Antibacterial Activity of Biphenylthiazoles against
Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and
VRSA)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hagras, Mohamed; Mohammad, Haroon; Mandour, Mohamed S.; Hegazy, Youssef
A.; Ghiaty, Adel; Seleem, Mohamed N.; Mayhoub, Abdelrahman S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(9), 4074-4085

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Diethoxy-3-butyn-2-one
C8H12O3
25234-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 3.0800 5.3347 0.0 0
M  V30 3 O 3.0800 2.6674 0.0 0
M  V30 4 O 5.3900 4.0011 0.0 0
M  V30 5 C 1.5400 5.3347 0.0 0
M  V30 6 O 3.8500 6.6685 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 5.3347 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 3 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Diethoxymethyl)-2-pyrimidinamine
C9H15N3O2
1014-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8500 0.0 0
M  V30 2 O 6.6684 4.6201 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 C 8.0022 3.8500 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 C 6.6684 0.0000 0.0 0
M  V30 8 N 0.0000 3.8500 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 N 2.6675 3.8500 0.0 0
M  V30 11 C 4.0011 6.1601 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 2.6675 6.9301 0.0 0
M  V30 14 N 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25234-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1014-03-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9919876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Amino-4-(diethoxymethyl)pyrimidine (11) A 60% NaH dispersion in oil
(0.040 g, 1.0 mmol) was washed with hexane and added to a round-bottom
flask where guanidine hydrochloride (0.096 g, 1.0 mmol) dissolved in EtOH
(5 mL) was kept under N2. The mixture was stirred at r.t. for 15 min and
1 (0.156 g, 1.00 mmol) in EtOH (1 mL) was then added. The mixture was
stirred during the addition and subsequently at r.t. for 45 min. EtOH was
then evaporated on a rotary evaporator and the resulting solid product
was recrystallized from EtOH. 2-Amino-4-(diethoxymethyl)pyrimidine (11),
Yield: 0.187 g (95%); white solid mp 125–126 °C. IR (KBr): 3600–3100 (s),
3322 (s), 3192 (s), 2979 (s), 2966 (s),2926 (s), 2908 (s), 2898 (s), 2878
(s), 2779 (m), 2102 (w), 1998 (w), 1914 (w), 1644 (s), 1575 (s), 1488
(s), 1475 (s), 1450 (s), 1397 (s), 1367 (m), 1354 (s), 1346 (s), 1321
(s), 1209 (s), 1160 (m), 1138 (s), 1124 (s), 1116 (s), 1107 (s), 1063
(s), 1039 (s), 1015 (s), 917 (m), 881 (w), 843 (s), 796 (s), 768 (w), 732
(m), 646 (s), 634 (m), 536(m), 464 (m) cm–1. 1H NMR (400 MHz, CDCl3): δ =
8.32 (d, J = 5.0 Hz, 1 H), 6.88 (d, J = 5.0 Hz, 1 H), 5.28 (br s, 2 H),
5.22 (s, 1 H), 3.69–3.58 (m, 4 H), 1.25 (t, J = 7.0 Hz, 6 H). 13C NMR
(100 MHz, CDCl3): δ = 167.9, 163.6, 159.7, 109.2, 101.8,62.7, 15.8. HRMS
(DART): m/z [M + H]+ calcd for C9H16N3O2: 198.1242; found: 198.1226.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Michael addition of various nitrogen and oxygen nucleophiles to
1,1-diethoxybut-3-yn-2-one
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sengee, Myagmarsuren; Sydnes, Leiv K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2011), (23), 3899-3907

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Ethyl 2-cyano-3-(3,4,5-trimethoxyphenyl)-2-propenoate
C15H17NO5
2601-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 O 4.0010 0.7700 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9302 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 C 8.0022 4.6201 0.0 0
M  V30 9 C 9.3360 5.3901 0.0 0
M  V30 10 C 8.0022 3.0801 0.0 0
M  V30 11 O 10.6697 4.6201 0.0 0
M  V30 12 O 9.3360 6.9302 0.0 0
M  V30 13 N 8.0022 1.5400 0.0 0
M  V30 14 C 12.0033 5.3901 0.0 0
M  V30 15 C 13.3370 4.6201 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 4.0010 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 5.3348 3.0801 0.0 0
M  V30 20 C 4.0010 5.3901 0.0 0
M  V30 21 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 3 10 13
M  V30 14 1 11 14
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethoprim
C14H18N4O3
738-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.3901 0.0 0
M  V30 2 O 1.3337 5.3901 0.0 0
M  V30 3 C 1.3337 6.9301 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 C 5.3348 0.0000 0.0 0
M  V30 6 N 9.3359 6.9301 0.0 0
M  V30 7 O 1.3337 2.3100 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 N 12.0032 2.3100 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0011 5.3901 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 2.6673 3.0800 0.0 0
M  V30 16 C 8.0021 4.6201 0.0 0
M  V30 17 C 9.3359 5.3901 0.0 0
M  V30 18 C 8.0021 3.0800 0.0 0
M  V30 19 N 10.6695 4.6201 0.0 0
M  V30 20 N 9.3359 2.3100 0.0 0
M  V30 21 C 10.6695 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 15
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2601-03-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 738-70-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34382047
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7783-90-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical (visible light used), catalyst prepared and used,
recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nano Ag/AgCl wires-photocatalyzed hydrogen production and transfer
hydrogenation of Knoevenagel-type products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Attia, Yasser A.; Mohamed, Yasser M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2022), 46(4), 1677-1686

$RFMT $RIREG SCHEME192 STEP1
$RXN



  6  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methylisatin
C9H7NO2
608-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 O 7.9110 2.7104 0.0 0
M  V30 3 C 0.0000 1.1704 0.0 0
M  V30 4 C 4.0011 1.9404 0.0 0
M  V30 5 C 4.0011 3.4804 0.0 0
M  V30 6 C 5.4658 1.4645 0.0 0
M  V30 7 C 2.6674 1.1704 0.0 0
M  V30 8 N 5.4658 3.9564 0.0 0
M  V30 9 C 2.6674 4.2504 0.0 0
M  V30 10 C 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 1.9404 0.0 0
M  V30 12 C 1.3338 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl bromopyruvate
C5H7BrO3
70-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 Br 0.0000 2.3100 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetaldehyde
C2H4O
75-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-phenylbenzenecarbohydrazonoyl chloride
C14H13ClN2O
40277-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 N 4.0010 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-(4-methoxyphenyl)benzenecarbohydrazonoyl chloride
C15H15ClN2O2
2808427-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 Cl 6.6687 0.0000 0.0 0
M  V30 4 N 9.3360 1.5400 0.0 0
M  V30 5 O 1.3338 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 O 14.6708 4.6201 0.0 0
M  V30 8 C 16.0046 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 10.6698 2.3101 0.0 0
M  V30 16 C 10.6698 3.8501 0.0 0
M  V30 17 C 12.0035 1.5400 0.0 0
M  V30 18 C 12.0035 4.6201 0.0 0
M  V30 19 C 13.3372 2.3101 0.0 0
M  V30 20 C 13.3372 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[2-[1,5-dihydro-1,3-bis(4-methoxyphenyl)-5-methyl-4H-1,2,4-triazol-4-...
C46H42N8O6
2808427-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 68 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.9986 11.8187 0.0 0
M  V30 2 O 12.1432 10.7881 0.0 0
M  V30 3 O 11.3190 13.3250 0.0 0
M  V30 4 C 13.6077 11.2640 0.0 0
M  V30 5 C 13.9280 12.7704 0.0 0
M  V30 6 C 14.5602 10.8579 0.0 0
M  V30 7 C 7.4035 2.4026 0.0 0
M  V30 8 O 1.0304 10.3224 0.0 0
M  V30 9 C 0.0000 11.4670 0.0 0
M  V30 10 O 12.1145 1.2459 0.0 0
M  V30 11 C 13.0196 0.0000 0.0 0
M  V30 12 O 21.6221 11.8051 0.0 0
M  V30 13 C 22.9558 11.0351 0.0 0
M  V30 14 C 9.5341 11.3427 0.0 0
M  V30 15 N 9.2139 12.8491 0.0 0
M  V30 16 O 8.2004 10.5727 0.0 0
M  V30 17 N 7.6824 13.0100 0.0 0
M  V30 18 C 7.0559 11.6032 0.0 0
M  V30 19 C 10.1604 9.9359 0.0 0
M  V30 20 C 9.2552 8.6900 0.0 0
M  V30 21 N 11.6919 9.7749 0.0 0
M  V30 22 C 9.8817 7.2830 0.0 0
M  V30 23 N 7.7236 8.5289 0.0 0
M  V30 24 C 12.3184 8.3680 0.0 0
M  V30 25 C 8.7371 6.2526 0.0 0
M  V30 26 N 11.4132 7.1221 0.0 0
M  V30 27 C 7.4035 7.0226 0.0 0
M  V30 28 C 8.7371 4.7126 0.0 0
M  V30 29 C 6.0698 6.2526 0.0 0
M  V30 30 C 7.4035 3.9426 0.0 0
M  V30 31 C 6.0698 4.7126 0.0 0
M  V30 32 C 10.2443 13.9935 0.0 0
M  V30 33 C 11.7508 13.6733 0.0 0
M  V30 34 C 9.7685 15.4582 0.0 0
M  V30 35 C 12.7812 14.8179 0.0 0
M  V30 36 C 10.7989 16.6026 0.0 0
M  V30 37 C 12.3053 16.2824 0.0 0
M  V30 38 C 5.5496 11.2831 0.0 0
M  V30 39 C 5.0737 9.8184 0.0 0
M  V30 40 C 4.5190 12.4275 0.0 0
M  V30 41 C 3.5673 9.4982 0.0 0
M  V30 42 C 3.0127 12.1073 0.0 0
M  V30 43 C 2.5369 10.6426 0.0 0
M  V30 44 N 13.8500 8.2070 0.0 0
M  V30 45 C 14.6200 6.8734 0.0 0
M  V30 46 C 14.8804 9.3514 0.0 0
M  V30 47 N 16.1264 7.1936 0.0 0
M  V30 48 N 16.2874 8.7251 0.0 0
M  V30 49 C 13.9937 5.4664 0.0 0
M  V30 50 C 14.8989 4.2206 0.0 0
M  V30 51 C 12.4620 5.3055 0.0 0
M  V30 52 C 14.2724 2.8138 0.0 0
M  V30 53 C 11.8356 3.8985 0.0 0
M  V30 54 C 12.7409 2.6527 0.0 0
M  V30 55 C 17.6210 9.4951 0.0 0
M  V30 56 C 17.6210 11.0351 0.0 0
M  V30 57 C 18.9547 8.7251 0.0 0
M  V30 58 C 18.9547 11.8051 0.0 0
M  V30 59 C 20.2885 9.4951 0.0 0
M  V30 60 C 20.2885 11.0351 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 46
M  V30 7 1 7 30
M  V30 8 1 8 9
M  V30 9 1 8 43
M  V30 10 1 10 11
M  V30 11 1 10 54
M  V30 12 1 12 13
M  V30 13 1 12 60
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19
M  V30 17 1 15 17
M  V30 18 1 15 32
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 18 38
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 2 22 26
M  V30 29 1 23 27
M  V30 30 1 24 26
M  V30 31 1 24 44
M  V30 32 1 25 27
M  V30 33 2 25 28
M  V30 34 2 27 29
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 2 30 31
M  V30 38 2 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 37
M  V30 44 2 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 42
M  V30 48 2 41 43
M  V30 49 1 42 43
M  V30 50 1 44 45
M  V30 51 1 44 46
M  V30 52 2 45 47
M  V30 53 1 45 49
M  V30 54 1 46 48
M  V30 55 1 47 48
M  V30 56 1 48 55
M  V30 57 2 49 50
M  V30 58 1 49 51
M  V30 59 1 50 52
M  V30 60 2 51 53
M  V30 61 2 52 54
M  V30 62 1 53 54
M  V30 63 2 55 56
M  V30 64 1 55 57
M  V30 65 1 56 58
M  V30 66 2 57 59
M  V30 67 2 58 60
M  V30 68 1 59 60
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 608-05-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-23-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 75-07-0
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 40277-63-2
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 2808427-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2808427-58-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33458184
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, baker's yeast catalyst used (stage 1),
alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Baker's Yeast Promoted One-Pot Synthesis of New
1,2,4-Triazolpyrimido-1,3,4-Oxadiazoles: Investigation of Antioxidant and
Antimicrobial Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mashal, Neda; Azizian, Javad; Larijani, Kambiz; Nematollahi, Fereshteh;
Azizian, Homa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(5), 4478-4495

$RFMT $RIREG SCHEME193 STEP1
$RXN



  6  1
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methylisatin
C9H7NO2
608-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 O 7.9110 2.7104 0.0 0
M  V30 3 C 0.0000 1.1704 0.0 0
M  V30 4 C 4.0011 1.9404 0.0 0
M  V30 5 C 4.0011 3.4804 0.0 0
M  V30 6 C 5.4658 1.4645 0.0 0
M  V30 7 C 2.6674 1.1704 0.0 0
M  V30 8 N 5.4658 3.9564 0.0 0
M  V30 9 C 2.6674 4.2504 0.0 0
M  V30 10 C 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 1.9404 0.0 0
M  V30 12 C 1.3338 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenacyl bromide
C8H7BrO
70-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetaldehyde
C2H4O
75-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)benzenecarbohydrazonoyl chloride
C14H13ClN2O
60981-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 Cl 4.0010 0.0000 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 1.5400 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-(4-methoxyphenyl)benzenecarbohydrazonoyl chloride
C15H15ClN2O2
2808427-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 Cl 6.6687 0.0000 0.0 0
M  V30 4 N 9.3360 1.5400 0.0 0
M  V30 5 O 1.3338 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 O 14.6708 4.6201 0.0 0
M  V30 8 C 16.0046 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 10.6698 2.3101 0.0 0
M  V30 16 C 10.6698 3.8501 0.0 0
M  V30 17 C 12.0035 1.5400 0.0 0
M  V30 18 C 12.0035 4.6201 0.0 0
M  V30 19 C 13.3372 2.3101 0.0 0
M  V30 20 C 13.3372 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1,5-Dihydro-1,3-bis(4-methoxyphenyl)-5-methyl-4H-1,2,4-triazol-4-yl]-4-[2,...
C49H42N8O4
2808427-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  61 70 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.8615 10.8578 0.0 0
M  V30 2 O 0.7700 12.5885 0.0 0
M  V30 3 C 0.0000 13.9223 0.0 0
M  V30 4 C 5.7048 2.4026 0.0 0
M  V30 5 O 10.4157 1.2459 0.0 0
M  V30 6 C 11.3209 0.0000 0.0 0
M  V30 7 O 19.9232 11.8051 0.0 0
M  V30 8 C 21.2570 11.0351 0.0 0
M  V30 9 C 7.8353 11.3426 0.0 0
M  V30 10 N 6.9300 12.5885 0.0 0
M  V30 11 O 9.3000 11.8185 0.0 0
M  V30 12 N 7.8353 13.8345 0.0 0
M  V30 13 C 9.3000 13.3585 0.0 0
M  V30 14 C 8.4617 9.9358 0.0 0
M  V30 15 C 7.5565 8.6900 0.0 0
M  V30 16 N 9.9933 9.7749 0.0 0
M  V30 17 C 8.1828 7.2830 0.0 0
M  V30 18 N 6.0250 8.5289 0.0 0
M  V30 19 C 10.6196 8.3679 0.0 0
M  V30 20 C 7.0385 6.2526 0.0 0
M  V30 21 N 9.7144 7.1221 0.0 0
M  V30 22 C 5.7048 7.0226 0.0 0
M  V30 23 C 7.0385 4.7126 0.0 0
M  V30 24 C 4.3710 6.2526 0.0 0
M  V30 25 C 5.7048 3.9426 0.0 0
M  V30 26 C 4.3710 4.7126 0.0 0
M  V30 27 C 3.8343 9.0326 0.0 0
M  V30 28 C 3.8343 7.4926 0.0 0
M  V30 29 C 2.5005 9.8026 0.0 0
M  V30 30 C 2.5005 6.7226 0.0 0
M  V30 31 C 1.1669 9.0326 0.0 0
M  V30 32 C 1.1669 7.4926 0.0 0
M  V30 33 C 5.3900 12.5885 0.0 0
M  V30 34 C 4.6200 13.9223 0.0 0
M  V30 35 C 4.6200 11.2548 0.0 0
M  V30 36 C 3.0800 13.9223 0.0 0
M  V30 37 C 3.0800 11.2548 0.0 0
M  V30 38 C 2.3100 12.5885 0.0 0
M  V30 39 C 10.5458 14.2637 0.0 0
M  V30 40 C 11.9528 13.6374 0.0 0
M  V30 41 C 10.3849 15.7954 0.0 0
M  V30 42 C 13.1986 14.5426 0.0 0
M  V30 43 C 11.6308 16.7005 0.0 0
M  V30 44 C 13.0376 16.0741 0.0 0
M  V30 45 N 12.1513 8.2070 0.0 0
M  V30 46 C 12.9213 6.8734 0.0 0
M  V30 47 C 13.1817 9.3514 0.0 0
M  V30 48 N 14.4276 7.1935 0.0 0
M  V30 49 N 14.5885 8.7251 0.0 0
M  V30 50 C 12.2948 5.4664 0.0 0
M  V30 51 C 13.2000 4.2205 0.0 0
M  V30 52 C 10.7633 5.3055 0.0 0
M  V30 53 C 12.5737 2.8137 0.0 0
M  V30 54 C 10.1369 3.8985 0.0 0
M  V30 55 C 11.0420 2.6527 0.0 0
M  V30 56 C 15.9223 9.4951 0.0 0
M  V30 57 C 17.2559 8.7251 0.0 0
M  V30 58 C 15.9223 11.0351 0.0 0
M  V30 59 C 18.5896 9.4951 0.0 0
M  V30 60 C 17.2559 11.8051 0.0 0
M  V30 61 C 18.5896 11.0351 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 47
M  V30 2 1 2 3
M  V30 3 1 2 38
M  V30 4 1 4 25
M  V30 5 1 5 6
M  V30 6 1 5 55
M  V30 7 1 7 8
M  V30 8 1 7 61
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 1 10 33
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 13 39
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 15 18
M  V30 22 2 16 19
M  V30 23 1 17 20
M  V30 24 2 17 21
M  V30 25 1 18 22
M  V30 26 1 19 21
M  V30 27 1 19 45
M  V30 28 1 20 22
M  V30 29 2 20 23
M  V30 30 2 22 24
M  V30 31 1 23 25
M  V30 32 1 24 26
M  V30 33 2 25 26
M  V30 34 2 27 28
M  V30 35 1 27 29
M  V30 36 1 28 30
M  V30 37 2 29 31
M  V30 38 2 30 32
M  V30 39 1 31 32
M  V30 40 2 33 34
M  V30 41 1 33 35
M  V30 42 1 34 36
M  V30 43 2 35 37
M  V30 44 2 36 38
M  V30 45 1 37 38
M  V30 46 2 39 40
M  V30 47 1 39 41
M  V30 48 1 40 42
M  V30 49 2 41 43
M  V30 50 2 42 44
M  V30 51 1 43 44
M  V30 52 1 45 46
M  V30 53 1 45 47
M  V30 54 2 46 48
M  V30 55 1 46 50
M  V30 56 1 47 49
M  V30 57 1 48 49
M  V30 58 1 49 56
M  V30 59 2 50 51
M  V30 60 1 50 52
M  V30 61 1 51 53
M  V30 62 2 52 54
M  V30 63 2 53 55
M  V30 64 1 54 55
M  V30 65 2 56 57
M  V30 66 1 56 58
M  V30 67 1 57 59
M  V30 68 2 58 60
M  V30 69 2 59 61
M  V30 70 1 60 61
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 608-05-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-11-1
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 75-07-0
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 60981-60-4
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 2808427-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2808427-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33458182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, baker's yeast catalyst used (stage 1),
alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Baker's Yeast Promoted One-Pot Synthesis of New
1,2,4-Triazolpyrimido-1,3,4-Oxadiazoles: Investigation of Antioxidant and
Antimicrobial Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mashal, Neda; Azizian, Javad; Larijani, Kambiz; Nematollahi, Fereshteh;
Azizian, Homa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(5), 4478-4495

$RFMT $RIREG SCHEME194 STEP1
$RXN



  4  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C40H63N9O8
2914868-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 21.5600 14.6705 0.0 0
M  V30 2 N 20.7900 13.3369 0.0 0
M  V30 3 O 20.7900 16.0041 0.0 0
M  V30 4 C 19.2500 13.3369 0.0 0 CFG=1
M  V30 5 C 18.4800 12.0031 0.0 0
M  V30 6 C 18.4800 14.6705 0.0 0
M  V30 7 N 16.9400 12.0031 0.0 0
M  V30 8 O 19.2500 10.6694 0.0 0
M  V30 9 C 16.9400 14.6705 0.0 0
M  V30 10 C 16.1700 10.6694 0.0 0 CFG=1
M  V30 11 C 16.1700 16.0041 0.0 0
M  V30 12 C 14.6300 10.6694 0.0 0
M  V30 13 C 16.9400 9.3358 0.0 0
M  V30 14 C 16.9400 17.3379 0.0 0
M  V30 15 N 13.8600 9.3358 0.0 0
M  V30 16 O 13.8600 12.0032 0.0 0
M  V30 17 C 16.1700 8.0021 0.0 0
M  V30 18 N 16.1700 18.6716 0.0 0
M  V30 19 C 12.3200 9.3358 0.0 0 CFG=1
M  V30 20 C 16.9400 6.6684 0.0 0
M  V30 21 C 14.6300 8.0021 0.0 0
M  V30 22 C 11.5500 8.0021 0.0 0
M  V30 23 C 11.5500 10.6694 0.0 0
M  V30 24 N 10.0100 8.0021 0.0 0
M  V30 25 O 12.3200 6.6684 0.0 0
M  V30 26 C 10.0100 10.6694 0.0 0
M  V30 27 C 9.2400 6.6685 0.0 0 CFG=1
M  V30 28 C 9.2400 12.0032 0.0 0
M  V30 29 C 7.7000 6.6685 0.0 0
M  V30 30 C 10.0100 5.3347 0.0 0
M  V30 31 O 7.7000 12.0032 0.0 0
M  V30 32 O 10.0100 13.3369 0.0 0
M  V30 33 N 6.9300 5.3347 0.0 0
M  V30 34 O 6.9300 8.0021 0.0 0
M  V30 35 C 9.2400 4.0011 0.0 0
M  V30 36 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 37 C 10.0100 2.6674 0.0 0
M  V30 38 C 4.6200 6.6685 0.0 0
M  V30 39 C 4.6200 4.0011 0.0 0
M  V30 40 C 9.2400 1.3336 0.0 0
M  V30 41 C 3.0800 6.6684 0.0 0
M  V30 42 N 5.3900 2.6674 0.0 0
M  V30 43 O 3.0800 4.0011 0.0 0
M  V30 44 N 10.0100 0.0000 0.0 0
M  V30 45 C 2.3100 8.0021 0.0 0
M  V30 46 C 0.7700 8.0021 0.0 0
M  V30 47 N 0.0000 9.3358 0.0 0
M  V30 48 C 25.4100 16.0041 0.0 0
M  V30 49 C 26.1800 14.6705 0.0 0
M  V30 50 C 23.8700 16.0041 0.0 0
M  V30 51 C 26.1800 17.3379 0.0 0
M  V30 52 C 25.4100 13.3369 0.0 0
M  V30 53 C 27.7200 14.6705 0.0 0
M  V30 54 C 23.1000 14.6705 0.0 0
M  V30 55 C 27.7200 17.3379 0.0 0
M  V30 56 C 23.8700 13.3369 0.0 0
M  V30 57 C 28.4900 16.0041 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 54
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13 CFG=1
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 19 22
M  V30 23 1 19 23 CFG=3
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 1 24 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 27 30 CFG=1
M  V30 31 1 28 31
M  V30 32 2 28 32
M  V30 33 1 29 33
M  V30 34 2 29 34
M  V30 35 1 30 35
M  V30 36 1 33 36
M  V30 37 1 35 37
M  V30 38 1 36 38 CFG=3
M  V30 39 1 36 39
M  V30 40 1 37 40
M  V30 41 1 38 41
M  V30 42 1 39 42
M  V30 43 2 39 43
M  V30 44 1 40 44
M  V30 45 1 41 45
M  V30 46 1 45 46
M  V30 47 1 46 47
M  V30 48 2 48 49
M  V30 49 1 48 50
M  V30 50 1 48 51
M  V30 51 1 49 52
M  V30 52 1 49 53
M  V30 53 2 50 54
M  V30 54 2 51 55
M  V30 55 2 52 56
M  V30 56 2 53 57
M  V30 57 1 54 56
M  V30 58 1 55 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 4 10 19 27 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C47H69N12O8.CHO2
2896161-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  71 76 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.4884 13.0314 0.0 0
M  V30 2 C 13.8220 13.8013 0.0 0
M  V30 3 O 13.8220 15.3413 0.0 0
M  V30 4 C 0.8537 11.0546 0.0 0
M  V30 5 N 0.0000 9.7729 0.0 0
M  V30 6 O 0.1708 12.4346 0.0 0
M  V30 7 O 8.4869 13.8368 0.0 0
M  V30 8 O 1.5390 6.9554 0.0 0
M  V30 9 O 5.6103 4.7129 0.0 0
M  V30 10 C 9.6999 9.9597 0.0 0
M  V30 11 C 11.0638 10.6743 0.0 0
M  V30 12 C 11.1270 12.2130 0.0 0
M  V30 13 C 12.3649 9.8505 0.0 0
M  V30 14 C 8.2051 6.1940 0.0 0
M  V30 15 C 8.1640 4.6547 0.0 0
M  V30 16 C 9.4765 3.8493 0.0 0
M  V30 17 O 10.8302 4.5834 0.0 0
M  V30 18 O 9.4354 2.3100 0.0 0
M  V30 19 O 9.6306 8.4159 0.0 0
M  V30 20 C 7.4604 15.0519 0.0 0
M  V30 21 N 8.9449 14.6266 0.0 0 CHG=1 VAL=4
M  V30 22 N 6.3518 13.9784 0.0 0
M  V30 23 N 7.0856 16.5490 0.0 0
M  V30 24 C 10.0533 15.6985 0.0 0
M  V30 25 C 9.3183 13.1244 0.0 0
M  V30 26 C 6.7252 12.4808 0.0 0
M  V30 27 C 4.8705 14.3990 0.0 0
M  V30 28 C 8.1955 17.6218 0.0 0
M  V30 29 C 5.6008 16.9725 0.0 0
M  V30 30 N 9.6796 17.1995 0.0 0 CFG=3
M  V30 31 N 8.2116 12.0574 0.0 0 CFG=3
M  V30 32 N 4.4898 15.9015 0.0 0 CFG=3
M  V30 33 C 10.8205 18.2582 0.0 0
M  V30 34 C 8.5599 10.5445 0.0 0
M  V30 35 C 2.9593 16.2449 0.0 0
M  V30 36 C 12.2926 17.7257 0.0 0
M  V30 37 C 7.3372 9.5470 0.0 0
M  V30 38 C 1.9810 15.0207 0.0 0
M  V30 39 C 12.4467 16.1604 0.0 0
M  V30 40 C 5.9383 10.1428 0.0 0
M  V30 41 C 2.6039 13.6085 0.0 0
M  V30 42 C 11.1374 15.3405 0.0 0
M  V30 43 C 4.6214 9.5891 0.0 0
M  V30 44 C 1.7183 12.3458 0.0 0
M  V30 45 C 11.1547 13.8013 0.0 0 CFG=2
M  V30 46 C 3.8637 8.3521 0.0 0 CFG=1
M  V30 47 C 2.3906 10.9558 0.0 0 CFG=1
M  V30 48 C 9.8065 13.0429 0.0 0
M  V30 49 N 4.2074 6.9089 0.0 0
M  V30 50 C 2.2990 8.2947 0.0 0
M  V30 51 N 1.5470 9.6648 0.0 0
M  V30 52 N 9.7686 11.5042 0.0 0
M  V30 53 C 5.5632 6.2523 0.0 0
M  V30 54 C 8.3988 10.7835 0.0 0 CFG=1
M  V30 55 C 6.8926 6.9994 0.0 0 CFG=2
M  V30 56 C 8.3334 9.2456 0.0 0
M  V30 57 N 6.9571 8.5374 0.0 0
M  V30 58 C 15.1556 13.0314 0.0 0
M  V30 59 C 16.4892 13.8013 0.0 0
M  V30 60 C 15.1556 11.4914 0.0 0
M  V30 61 C 17.8229 13.0314 0.0 0
M  V30 62 C 16.4892 10.7215 0.0 0
M  V30 63 C 17.8229 11.4914 0.0 0
M  V30 64 C 19.1565 13.8013 0.0 0
M  V30 65 C 19.1565 10.7215 0.0 0
M  V30 66 C 20.4901 13.0314 0.0 0
M  V30 67 C 20.4901 11.4914 0.0 0
M  V30 68 H 5.3844 8.1100 0.0 0
M  V30 69 C 10.2450 0.0000 0.0 0
M  V30 70 O 8.9114 0.7700 0.0 0 CHG=-1
M  V30 71 O 11.5787 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 45 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 58
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 47
M  V30 8 2 7 48
M  V30 9 2 8 50
M  V30 10 2 9 53
M  V30 11 1 10 11
M  V30 12 1 10 54
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 55 14 CFG=1
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 19 56
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 22 27
M  V30 28 1 23 28
M  V30 29 1 23 29
M  V30 30 1 24 30
M  V30 31 1 25 31
M  V30 32 1 26 31
M  V30 33 1 27 32
M  V30 34 1 28 30
M  V30 35 1 29 32
M  V30 36 1 30 33
M  V30 37 1 31 34
M  V30 38 1 32 35
M  V30 39 1 33 36
M  V30 40 1 34 37
M  V30 41 1 35 38
M  V30 42 1 36 39
M  V30 43 1 37 40
M  V30 44 1 38 41
M  V30 45 1 39 42
M  V30 46 1 40 43
M  V30 47 1 41 44
M  V30 48 1 42 45
M  V30 49 1 43 46
M  V30 50 1 44 47
M  V30 51 1 45 48
M  V30 52 1 46 49
M  V30 53 1 46 50
M  V30 54 1 46 68 CFG=1
M  V30 55 1 47 51 CFG=3
M  V30 56 1 48 52
M  V30 57 1 49 53
M  V30 58 1 50 51
M  V30 59 1 54 52 CFG=1
M  V30 60 1 53 55
M  V30 61 1 54 56
M  V30 62 1 55 57
M  V30 63 1 56 57
M  V30 64 2 58 59
M  V30 65 1 58 60
M  V30 66 1 59 61
M  V30 67 2 60 62
M  V30 68 2 61 63
M  V30 69 1 61 64
M  V30 70 1 62 63
M  V30 71 1 63 65
M  V30 72 2 64 66
M  V30 73 2 65 67
M  V30 74 1 66 67
M  V30 75 1 69 70
M  V30 76 2 69 71
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 45 46 47 54 55)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2914868-16-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2896161-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35759486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-89-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM isolated yield = 88%,alternate reaction conditions gave 84%
yield,reaction carried out under air in stage 1,last stage is carried out
by HPLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Construction of complex macromulticyclic peptides via stitching with
formaldehyde and guanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Bo; Wan, Zhao; Zheng, Hanliang; Cai, Shaokun; Tian, Han-Wen; Tang,
Hong; Chu, Xin; He, Gang; Guo, Dong-Sheng; Xue, Xiao-Song; Chen, Gong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2022), 144(22), 10080-10090

$RFMT $RIREG SCHEME195 STEP1
$RXN



  4  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Guanidine
CH5N3
113-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 N 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C40H65N9O6
2914873-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 17.3383 5.3901 0.0 0
M  V30 2 C 17.3383 6.9302 0.0 0 CFG=2
M  V30 3 C 16.0045 7.7002 0.0 0
M  V30 4 N 18.6720 7.7002 0.0 0
M  V30 5 N 16.0045 9.2402 0.0 0
M  V30 6 O 14.6708 6.9302 0.0 0
M  V30 7 C 20.0057 6.9302 0.0 0
M  V30 8 C 14.6708 10.0102 0.0 0 CFG=1
M  V30 9 C 21.3393 7.7002 0.0 0
M  V30 10 O 20.0057 5.3901 0.0 0
M  V30 11 C 14.6708 11.5503 0.0 0
M  V30 12 C 13.3372 9.2402 0.0 0
M  V30 13 C 22.6731 6.9302 0.0 0
M  V30 14 N 13.3372 12.3203 0.0 0
M  V30 15 O 16.0045 12.3203 0.0 0
M  V30 16 C 24.0068 7.7002 0.0 0
M  V30 17 C 13.3372 13.8603 0.0 0 CFG=1
M  V30 18 C 25.3405 6.9302 0.0 0
M  V30 19 C 12.0035 14.6303 0.0 0
M  V30 20 C 14.6708 14.6303 0.0 0
M  V30 21 C 26.6742 7.7002 0.0 0
M  V30 22 N 10.6697 13.8603 0.0 0
M  V30 23 O 12.0035 16.1704 0.0 0
M  V30 24 C 14.6708 16.1704 0.0 0
M  V30 25 N 28.0080 6.9302 0.0 0
M  V30 26 C 9.3360 14.6303 0.0 0 CFG=1
M  V30 27 C 16.0045 16.9404 0.0 0
M  V30 28 C 8.0023 13.8603 0.0 0
M  V30 29 C 9.3360 16.1704 0.0 0
M  V30 30 C 16.0045 18.4804 0.0 0
M  V30 31 N 8.0023 12.3203 0.0 0
M  V30 32 O 6.6687 14.6303 0.0 0
M  V30 33 C 8.0023 16.9404 0.0 0
M  V30 34 N 17.3383 19.2504 0.0 0
M  V30 35 C 6.6687 11.5503 0.0 0 CFG=2
M  V30 36 C 8.0023 18.4804 0.0 0
M  V30 37 C 6.6687 16.1704 0.0 0
M  V30 38 C 5.3348 12.3203 0.0 0
M  V30 39 C 6.6687 10.0102 0.0 0
M  V30 40 C 4.0012 11.5503 0.0 0
M  V30 41 N 5.3348 9.2402 0.0 0
M  V30 42 O 8.0023 9.2402 0.0 0
M  V30 43 C 2.6675 12.3203 0.0 0
M  V30 44 C 1.3338 11.5503 0.0 0
M  V30 45 N 0.0000 12.3203 0.0 0
M  V30 46 C 16.0045 4.6201 0.0 0
M  V30 47 C 16.0045 3.0801 0.0 0
M  V30 48 C 14.6708 5.3901 0.0 0
M  V30 49 C 14.6708 2.3101 0.0 0
M  V30 50 C 17.3383 2.3101 0.0 0
M  V30 51 C 13.3372 4.6201 0.0 0
M  V30 52 C 13.3372 3.0801 0.0 0
M  V30 53 C 14.6708 0.7700 0.0 0
M  V30 54 C 17.3383 0.7700 0.0 0
M  V30 55 C 16.0045 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 46
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20 CFG=3
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 24 27
M  V30 28 1 26 28
M  V30 29 1 26 29 CFG=3
M  V30 30 1 27 30
M  V30 31 1 28 31
M  V30 32 2 28 32
M  V30 33 1 29 33
M  V30 34 1 30 34
M  V30 35 1 31 35
M  V30 36 1 33 36
M  V30 37 1 33 37
M  V30 38 1 35 38 CFG=3
M  V30 39 1 35 39
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 2 39 42
M  V30 43 1 40 43
M  V30 44 1 43 44
M  V30 45 1 44 45
M  V30 46 1 46 47
M  V30 47 2 46 48
M  V30 48 2 47 49
M  V30 49 1 47 50
M  V30 50 1 48 51
M  V30 51 1 49 52
M  V30 52 1 49 53
M  V30 53 2 50 54
M  V30 54 2 51 52
M  V30 55 2 53 55
M  V30 56 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 8 17 26 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C47H71N12O6.CHO2
2896162-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  69 74 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4247 11.8303 0.0 0
M  V30 2 N 1.6307 13.3564 0.0 0
M  V30 3 O 0.0000 11.2457 0.0 0
M  V30 4 O 6.9211 16.8279 0.0 0
M  V30 5 O 15.1921 7.6133 0.0 0
M  V30 6 O 10.7081 12.6667 0.0 0
M  V30 7 O 2.4260 13.8408 0.0 0
M  V30 8 C 4.4327 15.7131 0.0 0
M  V30 9 C 2.9220 16.0115 0.0 0
M  V30 10 C 2.4249 17.4692 0.0 0
M  V30 11 C 1.9081 14.8522 0.0 0
M  V30 12 C 13.7032 15.3663 0.0 0
M  V30 13 C 15.1922 10.0048 0.0 0
M  V30 14 O 11.3689 11.3777 0.0 0
M  V30 15 C 6.9531 5.8864 0.0 0
M  V30 16 N 5.9932 7.0953 0.0 0
M  V30 17 N 8.4839 6.1281 0.0 0 CHG=1 VAL=4
M  V30 18 N 6.3932 4.4489 0.0 0
M  V30 19 C 6.5430 8.5316 0.0 0
M  V30 20 C 4.4805 6.8777 0.0 0
M  V30 21 C 9.0435 7.5831 0.0 0
M  V30 22 C 9.4487 4.9353 0.0 0
M  V30 23 C 4.8570 4.2239 0.0 0
M  V30 24 C 7.3711 3.2456 0.0 0
M  V30 25 N 8.0873 8.7561 0.0 0 CFG=3
M  V30 26 N 3.8883 5.4338 0.0 0 CFG=3
M  V30 27 N 8.9003 3.4872 0.0 0 CFG=3
M  V30 28 C 8.5205 10.2576 0.0 0
M  V30 29 C 2.2834 5.4772 0.0 0
M  V30 30 C 9.8928 2.3100 0.0 0
M  V30 31 C 7.2412 11.2118 0.0 0
M  V30 32 C 1.6971 6.9311 0.0 0
M  V30 33 C 11.3778 2.4418 0.0 0
M  V30 34 C 7.4630 12.7175 0.0 0
M  V30 35 C 2.6856 8.1414 0.0 0
M  V30 36 C 12.3275 3.5366 0.0 0
M  V30 37 C 8.9263 13.2620 0.0 0
M  V30 38 C 2.1930 9.5560 0.0 0
M  V30 39 C 12.1654 5.0600 0.0 0
M  V30 40 C 8.9509 14.9015 0.0 0 CFG=2
M  V30 41 C 2.6433 10.8887 0.0 0 CFG=1
M  V30 42 C 13.3944 5.9552 0.0 0
M  V30 43 C 7.3917 15.3615 0.0 0
M  V30 44 N 10.5311 15.3112 0.0 0
M  V30 45 N 3.9053 11.7176 0.0 0
M  V30 46 C 13.6747 7.3506 0.0 0
M  V30 47 N 6.4216 14.1190 0.0 0
M  V30 48 C 11.4209 14.0317 0.0 0
M  V30 49 C 3.8488 13.2514 0.0 0
M  V30 50 N 12.8960 8.6470 0.0 0
M  V30 51 C 4.9297 14.2555 0.0 0 CFG=1
M  V30 52 C 12.9332 14.0325 0.0 0 CFG=2
M  V30 53 C 13.6522 10.0063 0.0 0 CFG=1
M  V30 54 N 13.7132 12.6799 0.0 0
M  V30 55 C 12.9086 11.3486 0.0 0
M  V30 56 C 15.9633 11.3378 0.0 0
M  V30 57 C 17.5033 11.3364 0.0 0
M  V30 58 C 15.1946 12.6722 0.0 0
M  V30 59 C 18.2746 12.6694 0.0 0
M  V30 60 C 18.2722 10.0020 0.0 0
M  V30 61 C 15.9658 14.0052 0.0 0
M  V30 62 C 17.5058 14.0037 0.0 0
M  V30 63 C 19.8146 12.6679 0.0 0
M  V30 64 C 19.8122 10.0006 0.0 0
M  V30 65 C 20.5833 11.3336 0.0 0
M  V30 66 H 8.9765 16.4414 0.0 0
M  V30 67 C 10.2917 0.0000 0.0 0
M  V30 68 O 8.9580 0.7700 0.0 0 CHG=-1
M  V30 69 O 11.6253 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 41 1 CFG=1
M  V30 4 2 4 43
M  V30 5 2 5 46
M  V30 6 2 6 48
M  V30 7 2 7 49
M  V30 8 1 8 9
M  V30 9 1 51 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 52 12 CFG=3
M  V30 13 1 53 13 CFG=3
M  V30 14 1 13 56
M  V30 15 2 14 55
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 18 23
M  V30 24 1 18 24
M  V30 25 1 19 25
M  V30 26 1 20 26
M  V30 27 1 21 25
M  V30 28 1 22 27
M  V30 29 1 23 26
M  V30 30 1 24 27
M  V30 31 1 25 28
M  V30 32 1 26 29
M  V30 33 1 27 30
M  V30 34 1 28 31
M  V30 35 1 29 32
M  V30 36 1 30 33
M  V30 37 1 31 34
M  V30 38 1 32 35
M  V30 39 1 33 36
M  V30 40 1 34 37
M  V30 41 1 35 38
M  V30 42 1 36 39
M  V30 43 1 37 40
M  V30 44 1 38 41
M  V30 45 1 39 42
M  V30 46 1 40 43
M  V30 47 1 40 44
M  V30 48 1 40 66 CFG=3
M  V30 49 1 41 45
M  V30 50 1 42 46
M  V30 51 1 43 47
M  V30 52 1 44 48
M  V30 53 1 45 49
M  V30 54 1 46 50
M  V30 55 1 47 51
M  V30 56 1 48 52
M  V30 57 1 49 51
M  V30 58 1 50 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 1 54 55
M  V30 62 1 56 57
M  V30 63 2 56 58
M  V30 64 2 57 59
M  V30 65 1 57 60
M  V30 66 1 58 61
M  V30 67 1 59 62
M  V30 68 1 59 63
M  V30 69 2 60 64
M  V30 70 2 61 62
M  V30 71 2 63 65
M  V30 72 1 64 65
M  V30 73 1 67 68
M  V30 74 2 67 69
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 40 41 51 52 53)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113-00-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2914873-44-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2896162-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35759571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-89-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM isolated yield = 82%,reaction carried out under air in stage 1,last stage
is carried out by HPLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Construction of complex macromulticyclic peptides via stitching with
formaldehyde and guanidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Bo; Wan, Zhao; Zheng, Hanliang; Cai, Shaokun; Tian, Han-Wen; Tang,
Hong; Chu, Xin; He, Gang; Guo, Dong-Sheng; Xue, Xiao-Song; Chen, Gong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2022), 144(22), 10080-10090

$RFMT $RIREG SCHEME196 STEP1
$RXN



